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Studying the principles of cell identity transitions 
using naïve pluripotency induction as a model 
 





In multicellular biology, an astounding array of cellular identities are specified from the same 
genome, by drawing on a finite pool of transcription factors and signalling pathways in different 
permutations. How are signal and transcription network interplay computed by the cell to 
instruct identity? Must a given identity always be established by the same mechanism? 
 
To address these questions, I created defined and tractable systems based on reprogramming 
from epiblast stem cells to naïve pluripotency. By independent modulation of genetic and 
signalling parameters followed by isolation of successfully transitioning cells, I showed that 
naïve pluripotency can be established via distinct routes. These differ in their transcriptional 
trajectories and in their mechanisms, each with different genetic and signal requirements. 
Relative to development, one route initially moves forward, with productive cells acquiring 
mesodermal signature prior to naïve pluripotency induction. In contrast, another route 
overshoots backwards, transiently resembling the earlier embryo and recapitulating key 
aspects of naïve epiblast establishment in vivo. 
 
These remarkably distinct routes ultimately converge on the same naïve pluripotent endpoint, 
revealing surprising flexibility for the establishment of a single identity from a single origin. This 
provides evidence for cellular identity as a multidimensional attractor state (Kauffman, 1993), 
and extends the paradigm by which transcription factors and signals are used in different 
combinations to generate different cell types: they can also be used in different ways to 
generate the same cell type. 
 
How can the naïve pluripotent identity be reached via such different routes? I reconciled route 
differences, finding precise Oct4 expression as a unifying, essential and sufficient feature. 
Different routes achieve this required Oct4 expression by diverse logics, highlighting that 
successful identity change does not simply require activation of the destination network but 
instead pivots on the mechanism that permits a transition to occur. 
 
Fixing Oct4 at this level is sufficient to reprogram EpiSCs and more advanced cell types under 
signal instruction alone, yet is also compatible with bonafide development when returned to 
the in vivo context. At this expression level, I therefore deem Oct4 to be a ‘transition’ factor, a 
novel concept that I define as permitting identity change in various directions depending on 
environmental instruction. 
 
In sum, this thesis furthers our knowledge of naïve pluripotency induction in vitro and in vivo, 
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CHAPTER 1: GENERAL INTRODUCTION 
 
 
1.1 Cellular identity 
 
1.1.1 What is cellular identity? 
 
Multicellular animals are built from an astounding array of cell types. Each cell has properties 
appropriate to its particular role as a building block and functional element of the whole animal. 
For example, sensory neurons must contain appropriate receptors and apparatus to transduce 
stimuli into action potentials along axons, cardiomyocytes require contractility and fatigue-
resistance, while hepatocytes contain abundant endoplasmic reticuli to support protein 
synthesis and export. Not only does each of the >200 cell types have to be specified during 
development and tissue homeostasis, but they must also work together to produce and 
support the coherent organism. 
 
Gradual loss of unneeded genes during development would provide a simple explanation for 
fidelity in fate restriction and inheritance of identity memory from mother to daughter cell. 
Whilst programmed genome rearrangement occurs to a limited extent in a handful of species 
(Smith, 2017b), such a paradigm is incompatible with the remarkable regulative responses 
following injuries, developmental perturbations, or during metamorphosis. A paradigm shift in 
our comprehension of cell fate determination was provided by the landmark work of John 
Gurdon, in which he demonstrated that terminally differentiated adult cells in fact possess all 
the genetic information necessary to make an entire animal (Gurdon, 1962). Thus, since 
different cells contain the same information, the key is how they decide and remember which 
subset of the genome to use.  
 
 
1.1.2 What determines cellular identity? 
 
We thus move up a level, to consider genomic regulation as the governor of cellular identity. 
Since the genome is the same in almost every cell, there must be other forms of informational 
input that instruct cellular diversification. In single-celled organisms, we know that expression 
of a given gene depends on the presence and activity of transcriptional machinery, and that 
this can be modulated in response to environmental cues (Lee et al., 2002; Reznikoff, 1989). 
Extrapolating to multicellular animals, a brute-force solution could be that, for each cell type, 
there exists a particular signal responsible for turning on a unique master transcriptional 
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regulator, which in turn activates an identity-specific gene-set. Genomic sequencing in the 
1990s exposed a fundamental flaw in this simplistic hypothesis: there simply were not enough 
genes in the genome to permit such linear identity computation in addition to supportive 
biochemical functions (Lander et al., 2001). Correspondingly, forced expression of single 
transcription factors (TFs) affects identity in a context-dependent manner, usually altering 
phenotypes only to those of closely related cell types (Farah et al., 2000; Graf and Enver, 
2009; Schäfer et al., 1990). 
 
An immense scientific effort has led us to today’s appreciation of the elegant efficiency with 
which differential use of the same genome generates the spectacular diversity of cellular form 
and function. The finite number of TFs and signalling pathways are used and re-used in 
different combinations, concentrations, spatiotemporal and epigenetic contexts (Section 
1.1.3). These parameters provide the additional layers of informational complexity required to 
generate distinct identities: context and history modulate how cells compute inputs and 
execute decisions within the framework of the single genome. Whilst we now grasp this in a 
general sense, our understanding of the specifics is incipient and constitutes one of the most 
exciting areas of research in this post-genomic era. 
 
 
1.1.3 Identity stability 
 
Once a cellular identity is established, how is it stably maintained over time and, if appropriate, 
divisions? How does a cell remember its identity without being continually exposed to active 
specification events? Identity fidelity is critical to healthy organismal function, with 
misregulation leading to developmental defects and diseases such as cancer. 
 
Gene regulatory networks (GRN) specify the set of interacting genes and proteins responsible 
for identity governance, many of which are TFs. GRN architecture dictates the logic by which 
these variables interact, and can explain many aspects of gene expression regulation across 
space and time. Networks of cross-regulating TFs can self-reinforce a stable identity state 
while repressing others (Davidson et al., 2002; Huang et al., 2007; Levine and Davidson, 2005; 
Swiers et al., 2006). Network properties such as hysteresis can also protect identity by 
rendering established states insensitive to noise, and facilitate the paradigm of signal reuse 
during developmental patterning. A network state dependent on historical as well as ongoing 
inputs contains a ‘memory’, allowing the same perturbatory signal to fulfil a different function 
at a later timepoint without disrupting past decisions (Briscoe and Small, 2015; Herrera-
Delgado et al., 2018). 
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A cellular identity with a stable GRN can be thought of as an attractor, occupying a local 
minimum in an ‘energetic’ landscape of gene expression space (Kauffman, 1993; Enver et al., 
2009). Modelling of cellular identity in dynamical systems terms formalises qualitative 
metaphors of stable cell states as ‘valleys’ separated by ‘hills’ in Waddington’s landscape 
(Huang, 2012; Jaeger and Monk, 2014; Moris et al., 2016; Waddington, 1957). 
Conceptualisation of cell identity as a solution (attractor) to a dynamical model explains the 
robust and discrete nature of cellular identity: when subjected to noise or minor fluctuations, 
the system will tend to gravitate back to that equilibrium state. 
 
Epigenetic regulation is a complementary approach by which cells restrict genome usage to 
the required identity subset and protect the identity from noise (Nashun et al., 2015; Pujadas 
and Feinberg, 2012). By modifications to the DNA and the chromatin packaging it, the 
accessibility of gene loci and their subnuclear localisation can be flexibly regulated (Goldberg 
et al., 2007; Ho et al., 2014; Nashun et al., 2015; Xie et al., 2013). This reinforces cell identity 
decisions: most TFs cannot engage effectively with heterochromatin, and thus the programs 
for unwanted identities can be robustly silenced (Voss and Hager, 2014). Since epigenetic 
modifications are stably inherited during subsequent cell divisions, this provides a memory 
long after the specifying event has occurred, and can also restrict the range of available fates 
in any subsequent decisions (Jost, 2014; Shipony et al., 2014; Zhu et al., 2013). The 
epigenetic landscape is thus a crucial parameter for the installation and stable maintenance 
of different identities from a single genome, modulating the context in which TFs operate. 
 
 
1.1.4 Cell identity transitions 
 
Cell identity stability must be balanced with the means to reliably change identity when 
appropriate. During animal development, a series of identity transitions occurs with exquisite 
precision, producing a functional organism from a single fertilised egg. Not only must the 
required cell types be generated, but also choreographed in the appropriate space, time and 
quantities. Identity transitions must also be instigated on demand, in response to events and 
the environment during tissue homeostasis and repair. 
 
TFs are understood to be key regulators of cellular identity (Section 1.1.2). Impressively, 
ectopic imposition of one or a few TFs can suffice to coordinate a fate change. For example: 
MyoD drives the conversion of murine fibroblasts to myocytes (Davis et al., 1987); 
Antennapedia misexpression in Drosophila elicits the formation of legs instead of antennae 
(Schneuwly et al., 1987); delivery of Oct4, Sox2, Klf4 and cMyc reprograms somatic cells to 
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pluripotent stem cells in a variety of vertebrate species (Friedrich Ben-Nun et al., 2011; 
Ogorevc et al., 2016; Takahashi and Yamanaka, 2006). This remarkable ability of a handful 
of TFs to orchestrate the global changes required to change cell type is a testament to their 
causative role in identity transition, and demonstrates that in certain cases activation of one 
or a few nodes can trigger installation of a complete identity TF network. 
 
What, then, regulates the identity-specifying TFs themselves? In addition to cross-regulation 
within networks, the expression and activity of the TFs themselves can be induced or 
repressed by external signals. As introduced in Section 1.1.2, permutations and 
concentrations of signals/TFs regulate cell identity specification and maintenance. However, 
for a signal to play an instructive role in an identity transition, the cell must be competent to 
transduce it, i.e. the relevant machinery must be expressed, which is itself a function of the 
transcriptional state of the cell. Assuming transducability, signal interpretation is in turn 
dependent on the underlying TF network architecture (Briscoe and Small, 2015). Signalling 
and transcriptional parameters thus engage in a complex interplay in order to drive and direct 
identity transitions. 
 
Forced fate changes in vitro are usually inefficient and heterogeneous, indicative of barriers 
between identities even when appropriate TFs and signals are supplied. Other cell-intrinsic 
properties can determine whether and how a signal or TF is interpreted, such as the epigenetic 
accessibility of target genes for perturbation. Interaction between TFs and the epigenetic 
landscape is bidirectional, with the chromatin structure modulating TF engagement yet in turn 
being altered by TF-recruited modifiers (Nashun et al., 2015). Thus, not only must the driving 
factors for an identity change coordinate remodelling of the epigenetic landscape from the 
source to destination signature, but this in itself actively interacts with the ongoing transition. 
Epigenetic barriers are regularly encountered during attempts to force fate transition (Chen et 
al., 2013; Gaspar-Maia et al., 2013; Mikkelsen et al., 2008; Pasque et al., 2012; Sridharan et 
al., 2013). A privileged class of TFs termed ‘pioneers’ are able to bind closed heterochromatin 
and thereby initiate locus activation, including POU, FOXA and GATA TF family members 
(King and Klose, 2017; Zaret and Carroll, 2011). Pioneer factors provide a necessary balance 
to the nucleosome-rich eukaryotic chromatin structure, and are critical for the initiation of 
developmental lineages with different expression programs (Kornberg and Lorch, 1999; Spitz 
and Furlong, 2012; Voss and Hager, 2014). 
 
Cell identity transitions can be formalised according to the attractor model introduced in 
Section 1.1.3. In these dynamical systems terms, a change in identity entails the transition 
from one attractor state to another, overcoming an energetic barrier between states. Whether 
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or not a cell succeeds in such a transition can be described by probability functions, whereby 
reduction of the barrier renders the transition more likely. Whilst attractor states can withstand 
some degree of noise, strong perturbations can destabilise the source attractor and modulate 
the relative accessibilities of alternative solutions in gene expression space, thus triggering a 
cell identity transition (Ferrell, 2012; Huang et al., 2007; Kauffman, 1993). In this way, cues 
can provide cells with both the driving force and the directional impetus in order to execute 
appropriate identity transitions. 
 
 
1.1.5 Identity potency 
 
The potency of a cell refers to the compilation of cell types that it can generate in response to 
appropriate cues, either directly or indirectly via progenitor stages. High potency states exist 
transiently during early development, whilst multi/bi/unipotent stem cells play critical roles in 
tissue growth, homeostasis and repair (Simons and Clevers, 2011). Cell types with a degree 
of potency are particularly intriguing: not only do such cells have an identity in themselves with 
the properties they need to fulfil their functions, but a major aspect of their function itself is to 
retain access to other fates. 
 
At the beginning of mammalian development, the fertilised zygote is considered totipotent 
because it ultimately gives rise to all cell types of the embryo and the supporting 
extraembryonic tissues such as placenta and yolk sac. However, we would not formally 
consider the zygote to be a stem cell, because it does not self-renew: its very nature 
necessitates a transient existence. Following a period of proliferation and specification of the 
extraembryonic trophectoderm and primitive endoderm lineages, pluripotent cells constitute 
the epiblast of the blastocyst (Gardner et al. 1971, 1979, 1985) (Figure 1.1.1A). Pluripotency 
is defined as the potential to form all cell types of the embryo-proper and by extension the 





Figure 1.1.1: Early murine development 
(A) Early mammalian development has been best characterised in the mouse model. 
Knowledge accumulated from murine systems over the last 50 years has led to our current 
appreciation that pluripotency exists in vivo as a continuum of states from embryonic day 
(E)3.5–8.0 (Morgani et al., 2017; Smith, 2017a), during which time the epiblast forms and 
progresses. Following specification of the trophectoderm externally (Sutherland et al., 1990), 
the inner cell mass (ICM) at E3.25 co-expresses both Nanog and Gata6 TFs. By E3.75 Nanog 
or Gata6 are expressed in a mutually exclusive ‘salt and pepper’ pattern (Chazaud et al., 2006; 
Plusa et al., 2008). The emergent Nanog+ epiblast and Gata6+ primitive endoderm (PrE) 
lineages undergo sorting and consolidation, such that by the E4.0 pre-implantation blastocyst 
they are segregated both physically and in terms of fate. In peri- and post-implantation stages, 
epiblast progression through formative then primed pluripotency capacitates it for subsequent 
differentiation, triggered by signals such as fibroblast growth factor (FGF), bone 
morphogenetic protein (BMP), Wnt and Nodal.  
(B) When injected into the pre-implantation blastocyst, naïve pluripotent stem cells contribute 





1.2.1 Naïve pluripotency capture and culture 
 
The naïve pluripotent identity captures the imagination due to both its conceptual elegance 
and the promise it holds as a tool for biological research and therapeutic applications. Since 
naïve pluripotent cells possess an unbiased potential to make all lineages of the developed 
organism, propagation of this identity in vitro offers a putative source material for any required 
tissue via differentiation, as well as a window into understanding the molecular basis of this 
remarkable cellular state itself.  
 
Pluripotency was first captured in vitro in the 1970s as murine embryonal carcinoma cells 
(ECCs) from testicular and embryo-derived carcinomas. Whilst a subset of ECCs were 
capable of forming multiple healthy tissues, their heterogeneous and tumorous origin was 
problematic (Kahan and Ephrussi, 1970; Martin and Evans, 1975). By applying optimised ECC 
culture conditions (batch-tested foetal calf serum (FCS) and co-culture with mitotically 
inactivated fibroblastic feeders), pluripotent cell lines were successfully derived directly from 
murine blastocysts (Evans and Kaufman, 1981; Martin, 1981). These embryonic stem cells 
(ESCs) simultaneously retain the capacity for indefinite self-renewal in vitro and the potential 
to resume normal development. Following blastocyst injection, ESCs contribute to all tissues 
of chimeric adults, including the germ lineage (Bradley et al., 1984) (Figure 1.1.1B). 
Remarkably, this permits transmission of the ESC genome to the next generation, 
revolutionizing the engineering of mouse genetic models (Robertson et al., 1986; Thomas et 
al., 1986; Thompson et al., 1989). 
 
Deconvolution of the signal milieu provided by FCS and feeders led to recognition of two key 
ligands for ESC culture: the cytokine leukaemia inhibitory factor (LIF) from feeders (Smith et 
al., 1988; Williams et al., 1988), and bone morphogenetic protein 4 (BMP4) from FCS (Ying et 
al., 2003). Despite promotion of mesendodermal differentiation by BMP4 in other contexts, 
when applied together LIF and BMP promote ESC maintenance by blocking differentiation 
(Wiles and Johansson, 1999; Ying et al., 2003). In the presence of LIF, feeders are no longer 
required and from hereon all cultures are assumed to be feeder-free unless explicitly stated 
otherwise. 
 
LIF signals through a bipartite receptor comprised of LIF receptor (Lifr) and glycoprotein 130 
(Gp130), triggering activation of Janus kinase-2 (Jak2) associated with the intracellular 
domain of Gp130. Three signalling pathways lie downstream of Jak2 in ESCs: phosphatidyl 
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inositol-3 kinase (PI3K), extracellular signal-related kinase (Erk), and signal transducer and 
activator of transcription 3 (Stat3). Curiously, Erk signalling is actually antagonistic to self-
renewal (Burdon et al., 1999) whereas Stat3 is responsible for the beneficial effect of LIF on 
ESC maintenance (Boeuf et al., 1997; Matsuda et al., 1999; Niwa et al., 1998). In order to 
activate Stat3, Jak2 phosphorylates the intracellular domain of GP130, causing recruitment of 
latent cytoplasmic Stat3 to Gp130 via the Stat3 Src homology-2 (SH2) phosphotyrosine-
binding domain. Jak2 then phosphorylates tyrosine-705 of Stat3 (PStat3), allowing SH2-
mediated homodimerization of PStat3 and consequent nuclear translocation and activity 
(Johnston and Grandis, 2011; Kisseleva et al., 2002). Suppressor of cytokine signalling 3 
(Socs3) binds to Gp130-Jak2 complexes, prevents Stat3 binding to Jak2, and thus inhibits 
Stat3 phosphorylation and activation (Kershaw et al., 2013). Socs3 transcription is rapidly and 
strongly induced by PStat3, to form a classic negative feedback loop in which PStat3 and 
Socs3 levels oscillate in antiphase (Yoshiura et al., 2007) (Figure 1.2.4). 
 
ESCs cultured in FCS+LIF or BMP4+LIF exhibit heterogeneity both morphologically and in 
terms of marker expression, and spontaneous differentiation is not uncommon (Chambers et 
al., 2007; Festuccia et al., 2012; Hayashi et al., 2008; Reynolds et al., 2012; Smith, 2001; 
Toyooka et al., 2008). Since ESC differentiation involves Fgf-stimulation of Erk mitogen-
activated protein kinases (Kunath et al., 2007), inhibitors were tested to block autocrine Fgf 
signalling. Small molecule inhibition of Fgf receptors or of Erk-activating Mek1/2 permits ESC 
self-renewal in the presence of LIF only (Ying et al., 2008). Culture robustness is further 
improved by concomitant inhibition of glycogen synthase kinase 3 (Gsk3). Strikingly, Mek/Erk 
inhibition by PD0325901 (PD), Gsk3 inhibition by CHIR99021 (CH) and exogenous LIF ligand 
applied in any pairwise combination is sufficient to support ESC self-renewal (Dunn et al., 
2014; Ying et al., 2008). Since culture with the two inhibitors (2i) alleviates the requirement for 
Stat3-agonist LIF, this finally permitted the generation of Stat3-/- ESCs and derivation of ESCs 
from non-permissive mouse strains in which the Erk:Stat3 activation ratio downstream of LIF 
is too high (Ohtsuka and Niwa, 2015; Ying et al., 2008). However, addition of LIF to wild-type 
ESCs increases clonogenicity, confers robust and rapid expansion, and enhances ESC-






Figure 1.2.1: Signals governing naïve pluripotency 
LIF promotes naïve pluripotency self-renewal via activation of Stat3 and PI3K/Akt signalling 
(Boeuf et al., 1997; Matsuda et al., 1999; Niwa et al., 1998). PI3K/Akt is also activated by 
insulin-like growth factors (IGFs). Mek/Erk signalling lies downstream of both LIF and FGF 
ligands, and drives differentiation (Burdon et al., 1999). In serum-containing medium, BMP 
signalling inhibits differentiation via Smad activity (Ying et al., 2003). PKC inhibitors promote 
ESC self-renewal (Dutta et al. 2011) but are not routinely applied. β-catenin activity inhibits 
Tcf3, thus alleviating pluripotency gene repression (Lyashenko et al., 2011; Wray et al., 2011). 
The ‘ground-state’ of naïve pluripotency is captured in 2iLIF medium, the components of which 
are starred: LIF ligand; Chiron to inhibit Gsk3; PD03 to inhibit Mek/Erk signalling. 
 
 
2i together with LIF (2iLIF) yields an optimal culture of naïve ESCs (starred in Figure 1.2.1). 
Not only does this regime have benefits in terms of molecular definition, but importantly the 
homogeneity and undifferentiated status of resultant ESCs at clonal density is markedly 
improved over conventional FCS+LIF conditions (Wray et al., 2010, 2011). Unlike in pairwise 
combinations, provision of all three 2iLIF components fully suppresses lineage marker 
expression and differentiation biases (Hackett et al., 2017). Together this demonstrates that 
thorough insulation from pro-differentiation signals is sufficient for robust ESC maintenance. 
On this basis, a prevailing hypothesis is that ESC self-renewal is a cell-autonomous program 
and that 2iLIF-cultured ESCs embody the ‘ground-state’ of unbiased naïve pluripotency (Silva 
and Smith, 2008; Wray et al., 2010; Ying et al., 2008).  
 
Since naïve pluripotency arises only transiently during development, the indefinite self-
renewal capacity of ESCs raises questions regarding their in vivo correspondence. The ability 
of blastocyst-injected ESCs to seamlessly re-enter full development indicates functional 
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equivalence to the pre-implantation epiblast, the founder population of the embryo (Gardner 
et al. 1971, 1979, 1985) (Figure 1.1.1B). Whilst ESCs can be derived in 2iLIF from the ICM of 
mid- to mature-blastocyst stages, the resultant cell lines have functional, transcriptional, 
signalling and epigenetic signatures which match that of the naïve epiblast just prior to 
implantation (Boroviak et al., 2014; Nichols et al., 2009). Although it cannot formally be 
excluded that other changes occur during ESC derivation and adaptation, they do recapitulate 
the defining features of the naïve epiblast and are thus considered its in vitro counterpart. A 
parallel can be drawn to the natural long-term maintenance of naïve pluripotency during 
LIF/Stat3-dependent facultative diapause of murine embryos; perhaps this innate ability 
underpins the relative ease of murine naïve ESC derivation compared to other species 
(Nichols and Smith, 2009; Nichols et al., 2001).  
 
 
1.2.2 The transcription factor network governing naïve pluripotency 
 
The TF network governing murine naïve pluripotency is arguably one of the best defined of all 
mammalian cell types. This is largely thanks to the ability of ESCs to undergo indefinite 
clonogenic self-renewal, facilitating genetic manipulation and providing unlimited material for 
analysis, coupled with stringent functional assays such as clonal assays and chimeric 
contribution (Martello and Smith, 2014; Tam and Rossant, 2003). Over the last 30 years, many 
pluripotency regulators have been identified and interactions between them characterised. 
 
Oct4, Sox2 and Nanog are thought to comprise the core of the pluripotency TF network due 
to their expression in both naïve and primed pluripotent states, and each is essential for 
pluripotency establishment during embryonic development. Oct4 was the first pluripotency 
factor to be identified, based on its expression pattern in the early embryo and germ cells 
(Okamoto et al., 1990; Schöler et al., 1990; Yeom et al., 1996). Oct4 is required for 
establishment of naïve pluripotency in vivo; without it, the ICM is allocated normally but then 
generates trophectoderm instead (Nichols et al., 1998). As a member of the POU family, Oct4 
contains two DNA-binding domains (POU and homeodomain) connected by a unique linker 
proposed to recruit epigenetic modulators to Oct4 target genes (Esch et al., 2013), and is a 
rare example of a ‘pioneer’ TF able to bind its targets even when their chromatin is closed 
(King and Klose, 2017; You et al., 2011). 
 
Curiously, either deletion or overexpression of Oct4 in vitro leads to ESC differentiation (Niwa 
et al., 2000; Shimozaki et al., 2003; Thomson et al., 2011; Zeineddine et al., 2006). Oct4 
expression at wild-type-level permits either ESC self-renewal or multilineage differentiation 
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depending on the signalling environment, whereas a low level of Oct4 locks ESCs in self-
renewal and prevents differentiation in vitro or in vivo (Karwacki-Neisius et al., 2013; 
Radzisheuskaya et al., 2013). Thus, while Oct4 is essential for naïve pluripotency 
establishment and maintenance, its action is highly dose-sensitive and context-dependent. 
Consistent with its requirement for appropriate differentiation, Oct4 is expressed in multiple 
lineages of the early embryo up to the late somite stage (DeVeale et al., 2013; Downs, 2008; 
Osorno et al., 2012). Considering this remarkable set of phenotypes, we understand 
surprisingly little about the molecular mechanisms of Oct4 action, perhaps due to the inherent 
difficulty of perturbing it independently of the identity context. 
 
Sox2 is a SRY-box TF that, like Oct4, is essential for pluripotency establishment in vivo (Avilion 
et al., 2003) or ESC maintenance in vitro (Masui et al., 2007). Sox2 and Oct4 proteins 
physically interact (van den Berg et al., 2010; Gagliardi et al., 2013; Pardo et al., 2010) and 
cooperatively regulate shared target genes (Ambrosetti et al., 1997; Chen et al., 2008; Kuroda 
et al., 2005; Nakatake et al., 2006; Nishimoto et al., 1999; Tokuzawa et al., 2003; Tomioka et 
al., 2002; Yuan et al., 1995). However, constitutive Oct4 expression can rescue Sox2 null 
ESCs, indicating that Oct4 can maintain pluripotency Sox2-independently and suggesting that 
a key role of Sox2 is to support Oct4 expression (Masui 2007). Like Oct4, Sox2 action is dose-
dependent, with overexpression driving differentiation (Kopp et al., 2008; Zhao et al., 2004). 
However the Sox2 expression profile differs from that of Oct4: in addition to expression in the 
early embryo (Avilion et al., 2003; Keramari et al., 2010), it is also expressed in a variety of 
later embryonic and adult lineages including neurectoderm, gut endoderm and epithelial 
tissues (Sarkar and Hochedlinger, 2013). 
	 
Recently, a ‘seesaw’ model of pluripotency regulation was proposed, in which opposing pro-
mesendoderm and pro-neurectoderm activities of Oct4 and Sox2 respectively balance to a 
metastable pluripotency state (Loh and Lim, 2011; Shu et al., 2013; Teo et al., 2011; Thomson 
et al., 2011; Wang et al., 2012). However, this model is difficult to reconcile with the lack of 
lineage gene expression in 2iLIF (Hackett et al., 2017), the rescue of Sox2-/- ESCs by 
constitutive Oct4 (Masui et al., 2007), the robust self-renewal of Sox2+/+ low-Oct4 ESCs 
(Radzisheuskaya et al., 2013), the multilineage differentiation triggered by Oct4 or Sox2 
overexpression in various conditions (Kopp et al., 2008; Niwa et al., 2000; Shimozaki et al., 
2003; Thomson et al., 2011), or the expression and roles of Oct4 and Sox2 in multiple lineages 
during development (Clavel et al., 2012; DeVeale et al., 2013; Downs, 2008; Gontan et al., 
2008; Pevny and Nicolis, 2010; Que et al., 2007; Wegner and Stolt, 2005). Again, perhaps, it 
is a question of context: throughout development, different interaction partners of and 
differential pairing between Oct/Sox family members profoundly modulate their roles (Adachi 
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et al., 2013; Aksoy et al., 2013; Buecker et al., 2014; Kondoh and Kamachi, 2010; Yang et al., 
2014). 
 
Nanog is a homeodomain-containing TF unique to vertebrates (Chambers et al., 2003). Like 
Oct4 and Sox2, Nanog is required for naïve pluripotency establishment in vivo (Mitsui et al., 
2003; Silva et al., 2009) and its expression correlates more closely with in vivo pluripotency 
than that of Oct4 or Sox2 (Osorno et al., 2012; Silva et al., 2009). Curiously, once naïve 
pluripotency is established Nanog becomes dispensable for its maintenance, allowing the 
generation of Nanog-/- ESCs that can contribute to all somatic tissues upon blastocyst 
injection, but only in a limited manner to the germline (Chambers et al., 2007; Zhang et al., 
2018). However, Nanog-/- and Nanog-low ESCs are more prone to differentiation than wild-
type ESCs (Chambers et al., 2003, 2007; MacArthur et al., 2012; Mitsui et al., 2003). Unlike 
Oct4/Sox2, Nanog overexpression is beneficial for pluripotency maintenance, supporting ESC 
self-renewal in minimal culture conditions such as serum without LIF (Chambers et al., 2003; 
Mitsui et al., 2003) or even in basal medium (N2B27) only (Ying et al., 2003). Whilst Oct4, 
Sox2 and Nanog cross-regulate each other and are considered the core of the pluripotency 
network (Young, 2011), the complex and at times contrasting phenotypes outlined above 
indicate complementary as well as shared roles. Indeed, a portion of Nanog-bound genes are 
co-occupied by Oct4/Sox2 in ESCs, but many are not (Loh et al., 2006; Marson et al., 2008; 
Nishiyama et al., 2013). Given also their common expression, other parameters must 
modulate the actions of Oct4/Sox2/Nanog between naïve vs primed pluripotency contexts 
(see Section 1.2.6). 
 
Naïve-specific TFs integrate with the Oct4/Sox2/Nanog core to form the regulatory network 
governing naïve pluripotency (Figure 1.2.2). Such factors are expressed in naïve but not 
primed pluripotent cells both in vivo and in vitro, and include Esrrb, Gbx2, Klf2, Klf4, Klf5, 
PStat3, Tbx3, Tfcp2l1 and Tcl1. Whilst single depletion of these factors can generally be 
tolerated (Festuccia et al., 2012; Ivanova et al., 2006; Jiang et al., 2008; Martello et al., 2012; 
Ye et al., 2013; Ying et al., 2008), ESC self-renewal is most robust when all are present, and 
combinatorial depletion often triggers collapse of the pluripotent identity (Dunn et al., 2014; 
Jiang et al., 2008). Like Nanog, individual forced expression of Esrrb, Klf2, Klf4, Tbx3 or 
Tfcp2l1 can support ESC self-renewal in the absence of LIF or in minimal conditions 
(Festuccia et al., 2012; Hall et al., 2009; Ivanova et al., 2006; Martello et al., 2012, 2013; Niwa 
et al., 2009; Ye et al., 2013). Other factors such as Rex1 are expressed specifically in naïve 
but not primed pluripotent cells, but do not play an active role in naïve identity regulation and 




There is a great deal of positive regulation between the factors comprising the naïve regulatory 
network (Chen et al., 2008; Dunn et al., 2014; Marson et al., 2008). In addition to interactions 
amongst the Oct4/Sox2/Nanog core (Young, 2011), Esrrb has been identified as a direct target 
of Nanog (Festuccia et al., 2012). Stat3 targets include Klf4, Klf5, Tfcp2l1 and Gbx2 (Bourillot 
et al., 2009; Hall et al., 2009; Martello et al., 2013; Niwa et al., 2009; Tai and Ying, 2013; Ye 
et al., 2013). Klf2 is positively regulated by Oct4 (Hall et al., 2009). This intricate set of 
regulatory interactions was recently formalised in a data-constrained computational model, 
compatible with known ESC decisions between self-renewal or differentiation (Dunn et al., 
2014). Whilst the predictive power of this model was impressive at 70% accuracy, clearly a 
significant portion of identity computation logic remains to be defined.  
  
Besides instructing the necessary cellular attributes, there are further requirements for naïve 
pluripotency governance in terms of the properties of the regulatory network itself. Whilst 
robust ESC self-renewal and tolerance of single factor depletion indicates a stable, flexible 
and noise-resistant network, this must be balanced with the capacity for timely network 
dissolution when appropriate for differentiation. The latter requirement has often been 
overlooked in simplistic models of the pluripotency network as a positive feedback loop 
(Martello and Smith, 2014; Young, 2011), and surprisingly few repressive interactions have 
been defined within the pluripotency network. Therefore, whilst it is not a core aim of my thesis, 
I will endeavour to highlight any putative negative regulatory relationships if appropriate. 
 
 
1.2.3 Interplay between signal inputs and transcriptional control of naïve pluripotency 
 
Exogenous 2iLIF signals actively interact with this internal TF network in order to sustain the 
ground state of naïve pluripotency in vitro. As outlined in Section 1.2.2, Mek/Erk inhibition by 
PD assists in naïve pluripotency capture by blocking autonomous Fgf-triggered differentiation. 
However, PD also positively regulates the naïve network itself: alleviation of Fgf/Erk-mediated 
suppression leads to upregulation of Klf2, Nanog, Tfcp2l1 and perhaps others (Lanner et al., 
2010; Silva et al., 2009; Ye et al., 2013; Yeo et al., 2014), although we do not fully understand 
the mechanisms. 
 
Gsk3 inhibition by CH leads to increased signalling of several intracellular pathways, including 
canonical Wnt/βCatenin (Doble and Woodgett, 2003). Since βCatenin-/- ESCs cannot be 
sustained by 2i or CH+LIF, this appears to be the primary pathway by which CH promotes 
ESC self-renewal (Lyashenko et al., 2011; Wray et al., 2011). Upon Gsk3 inhibition, βCatenin 
accumulates and binds to nuclear Tcf/Lef TFs (Clevers, 2006). In ESCs, the predominate 
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factor Tcf3 acts, unusually, as a transcriptional repressor rather than activator (Cavallo et al., 
1998; Merrill et al., 2004; Pereira et al., 2006; Wray et al., 2011). Complex formation with 
βCatenin leads to Tcf3 displacement from DNA (Shy et al., 2013) and consequently to 
derepression of Tcf3-target genes, which include Esrrb, Nanog, Tfcp2l1 and Klf2 in ESCs 
(Martello et al., 2012; Ye et al., 2013). Esrrb appears to be the principal functional effector of 
Gsk3 inhibition in ESCs (Martello et al., 2012), although other factors and/or pathways may 
well be involved. 
  
As introduced in Section 1.2.2, Stat3 activation mediates the beneficial effect of LIF for ESC 
maintenance (Boeuf et al., 1997; Matsuda et al., 1999; Niwa et al., 1998). Indeed Stat3-/- 
ESCs exhibit no functional response to LIF (Martello et al., 2013). PStat3 thus forms a bridge 
between the signalling environment and the TF regulatory network, of which it is a member. 
Direct positive targets of PStat3 include Klf4, Klf5, Tfcp2l1 and Gbx2 (Section 1.2.2), of which 
forced Tfcp2l1 expression most effectively phenocopies LIF provision in ESCs (Martello et al., 
2013). Interestingly, Tfcp2l1 is a convergent target of all 2iLIF signalling components (Martello 
et al., 2012, 2013; Ye et al., 2013). In contrast, core pluripotency factors Oct4 and Sox2 are 
not directly regulated by 2iLIF signals; we thus infer that their expression in naïve or primed 
pluripotent cells relies on network connectivity with the naïve- or primed-specific factors 
(Martello and Smith, 2014). 
 
 
Figure 1.2.2: Naïve pluripotency TF network and 2iLIF signal inputs 
Schematic depicting the interconnected TF network governing the naïve pluripotent identity, 
together with known points of input from 2iLIF signal components. Core and naïve-specific 
pluripotency factors are indicated in blue and green respectively. PD=PD03; CH=Chiron.  
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1.2.4 Epigenetic landscape of naïve pluripotency 
 
The naïve epiblast and ESCs cultured in 2iLIF share an unusual epigenetic landscape. With 
the exception of imprinted and repetitive regions, genome-wide DNA hypomethylation is 
observed (Ficz et al., 2013; Habibi et al., 2013; Leitch et al., 2013; Smith et al., 2012). These 
low levels of methylated cytosine in the DNA (30% mC) are attributed to suppression of de 
novo DNA methyltransferases Dnmt3a and Dnmt3b, and to activity of Tet oxidisers of mC. 
Since mC is generally considered a repressive epigenetic mark, lack thereof is postulated to 
underpin the unrestricted potential of naïve cells. Likewise, heterochromatin (Ahmed et al., 
2010; Efroni et al., 2008; Park et al., 2004) and repressive histone modifications (Hawkins et 
al., 2010; Loh et al., 2007; Meshorer et al., 2006; Wen et al., 2009) are relatively scarce in the 
naïve epigenome but accumulate during differentiation. 
 
As with any cell type, naïve pluripotent cells contain an identity-specific set of active enhancers 
(Buecker et al., 2014; Heintzman et al., 2009; Whyte et al., 2013). However, in addition to this, 
naïve pluripotent cells exhibit unusually loose genomic packaging overall, rich in open 
euchromatin (Gaspar-Maia et al., 2009, 2011; Meshorer et al., 2006), activating histone 
modifications (Krejčí et al., 2009), and with a highly flexible scaffold (Bhattacharya et al., 
2009). Together, these epigenetic characteristics may correlate with the extensive and 
unbiased developmental capacity of naïve pluripotent cells, rendering them free from lineage 
specification yet allowing access to downstream identity programs on demand.  
 
Another defining epigenetic feature of naïve pluripotency is the presence of two active X 
chromosomes in female cells (Mak et al., 2004; Okamoto et al., 2004; Rastan and Robertson, 
1985), setting the stage for random X chromosome inactivation during subsequent female 
development. Both the unrestricted epigenetic landscape and X chromosome status are 
actively instated during naïve pluripotency establishment, and are intimately linked with its TF 
network strength (Sousa et al., 2018). This provides a strong argument for naïve pluripotency 
as a gain-of-function during development, rather than passive loss of totipotency from the 
zygote. Intriguingly, many of these active epigenetic reprogramming events are recapitulated 
during development of primordial germ cells (PGCs) (Hajkova et al., 2002, 2008; Monk et al., 
1987; Seki et al., 2007), coinciding with transient reexpression of pluripotency factors 
(Seisenberger et al., 2012) and suggesting an intimate link between the pluripotency control 
network and epigenetic wiping. 
 
ESCs cultured in FCS+LIF exhibit colocalisation of histone H3 trimethylated on lysine 4 
(H3K4me3, activating) and histone H3 trimethylated on lysine 27 (H3K27me3, repressive) at 
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~3000 bivalent promoters (Azuara et al., 2006; Bernstein et al., 2006). Together with 
heterogeneous TF expression (Section 1.2.2) and promiscuous transcriptional hyperactivity in 
FCS+LIF (Efroni et al., 2008), this led to the conceptualisation of pluripotency as a metastable 
state, poised on the verge of lineage specification. However, in 2iLIF this is not the case. When 
insulated from pro-differentiation signals, transcriptional hyperactivity is not apparent, only 
~1000 bivalent genes are observed, and lineage-specific gene expression is repressed 
(Hackett et al., 2017; Marks et al., 2012). Thus, 2iLIF-cultured ESCs offer an epigenetic ‘blank 
slate’, counterparts of the naïve epiblast. Bizarrely, the DNA of ESCs cultured in FCS+LIF is 
aberrantly (but reversibly) hypermethylated to the level of somatic cells (>70% mC), providing 
further evidence that their epigenetic status is a culture-induced artefact and urging use of the 
2iLIF environment instead (Ficz et al., 2013; Hackett et al., 2017). 
 
 
1.2.5 Generation of naïve pluripotency by nuclear reprogramming 
 
As introduced in Section 1.1, differentiated cells contain the same genome as ESCs. 
Therefore, it should theoretically be possible to persuade differentiated cells to alter their 
usage of the genome to that of the ESC state. This would circumvent the requirement for 
embryos, and allow the generation of pluripotent cells genetically matched to existing adult 
organisms. 
 
Indeed, the epigenome of differentiated cells can be reprogrammed to naïve pluripotency in 
vitro, by fusion with an ESC (Tada et al., 2001) or by forced overexpression of key members 
of the pluripotency TF network. The latter was initially achieved by retroviral transduction of 
murine fibroblasts with Oct4, Klf4, Sox2 and cMyc transgenes (Takahashi and Yamanaka, 
2006) in FCS+LIF conditions. Induced pluripotent stem cells (iPSCs) have since been 
generated by a range of methods, from a variety of differentiated tissues and species 
(reviewed in Ezashi et al., 2016; Raab et al., 2014; Theunissen and Jaenisch, 2014). iPSCs 
share defining functional characteristics with ESCs (Okita et al., 2007; Wernig et al., 2007), 
although some concerns have been expressed regarding epigenetic memory of the source 
tissue in early passages (Ohi et al., 2011; Polo et al., 2010). 
 
Reprogramming of somatic cells to iPSCs is a testament to the power of TFs as specifiers of 
cellular identity. Perhaps unsurprisingly, many beneficial factors for reprogramming are those 
also implicated in ESC maintenance (Section 1.2.3). Intriguingly, expression onset of such 
factors in vivo precedes naïve epiblast emergence (Boroviak et al., 2014; Guo et al., 2010), 
consistent with the notion of naïve pluripotency specification in vivo as an active 
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reprogramming event rather than a passive loss of totipotency. It will be of interest to ascertain 
to what extent there are parallels between naïve pluripotent identity specification in vivo vs 
during in vitro reprogramming.  
 
Oct4 is the only member of the original Yamanaka cocktail which cannot be substituted by 
other family members, and all reprogramming methods either include exogenous Oct4 or 
factors/chemicals which activate endogenous Oct4 (Radzisheuskaya and Silva, 2014). The 
importance of Oct4 in somatic reprogramming was underscored by the recent discovery that 
CRISPR-targeted epigenetic activation of the endogenous Oct4 locus is sufficient to trigger 
fibroblast reprogramming to iPSCs, albeit at only 0.01% efficiency (Liu et al., 2018).  
 
As in ESC maintenance, the signalling environment also plays a key role during the induction 
of naïve pluripotency. LIF is required in the culture medium for almost all reprogramming 
methods, while PD and CH enhance reprogramming efficiency (Silva et al., 2008; Sridharan 
et al., 2009; Tang et al., 2012; Theunissen et al., 2011; Yang et al., 2010). This indicates that 
2iLIF components not only maintain the naïve pluripotent identity, but can play an active role 




1.2.6 Primed pluripotency 
 
In the post-implantation epiblast, the pluripotent compartment has progressed to its primed 
form (Nichols and Smith, 2009) (Figure 1.1.1A). This is a distinct identity, with markedly 
different transcriptional, epigenetic and metabolic profiles to naïve pluripotency (Figure 1.2.3). 
These cells can be captured in culture as epiblast stem cells (EpiSCs) and require stimulation 
rather than inhibition of Fgf signalling, together with the addition of ActivinA (FA) (Brons et al., 
2007; Tesar et al., 2007). Whilst 2iLIF-cultured ESCs are the in vitro counterpart of the E4.0–
4.5 naïve epiblast, EpiSCs correspond to E7.25–8.0. At this time, gastrulation and germ layer 
specification are well underway, i.e. the epiblast is already acquiring both positional and 
identity specification within a rich and polarised signalling environment (Beddington and 
Robertson, 1999). Transcriptionally, EpiSCs resemble the anterior primitive streak of the late 
gastrula stage (Kojima et al., 2014; Tsakiridis et al., 2014). Since they express some lineage 
markers, activate enhancers of developmental regulators and exhibit differentiation biases 
(Bernemann et al., 2011; Factor et al., 2014; Kojima et al., 2014; Tsakiridis et al., 2014), 




Primed EpiSCs and naïve ESCs share hallmarks of pluripotency: environment-dependent self-
renewal or multilineage differentiation in vitro, the capacity to form teratomas when injected 
into adult mice, and expression of core pluripotency TFs Oct4, Sox2 and Nanog. However, 
EpiSCs do not contribute to adult chimeras following blastocyst-injection (Guo et al., 2009; 
Tesar et al., 2007). When clumps of EpiSCs are grafted onto post-implantation epiblast stages, 
integration and initial contribution to all three germ layers is seen after 48 hours of embryo 
culture (Huang et al., 2012). This indicates functional pluripotency in their corresponding 
embryonic environment, but it cannot be excluded that EpiSC pluripotency is at the population 
rather than single-cell level. Furthermore, EpiSCs have passed the window of competence for 
PGC specification, signifying a significant loss of developmental potential (Hayashi et al., 
2011; Ohinata et al., 2009). 
 
Important molecular differences between ESCs and EpiSCs further delineate these as distinct 
cellular identities (Figure 1.2.3). While there are two active X chromosomes in female naïve 
cells, one of these has been randomly inactivated in primed epiblast cells and correspondingly 
in EpiSCs (Guo et al., 2009; Okamoto et al., 2004). Compared to the open ESC epigenetic 
landscape (Section 1.2.5), EpiSCs exhibit a more closed chromatin conformation (Hassan-
Zadeh et al., 2017), many-fold higher levels of DNA methylation (Auclair et al., 2014; Hackett 
et al., 2013; Veillard et al., 2014; Zylicz et al., 2015), and utilise different enhancer elements 
even for mutually expressed genes (Buecker et al., 2014; Factor et al., 2014).  
 
In vivo, the epiblast converts to a columnar epithelium upon implantation (Kaufman, 1992). 
Correspondingly, EpiSCs grow in vitro in flat, compact colonies and, unlike clonogenic ESCs, 
do not survive single-cell dissociation (Brons et al., 2007; Tesar et al., 2007). A metabolic 
switch also occurs between naïve and primed pluripotent states, with bivalent usage of both 
glycolysis and mitochondrial respiration in the former while the latter are predominately 
glycolytic (Zhou et al., 2012).  
 
Whilst ESCs and EpiSCs both express Oct4, Sox2 and Nanog, there are regulatory 
differences corresponding to those observed in vivo. Oct4 expression level is similar, but is 
driven from its distal vs proximal enhancer in naïve vs primed cells respectively (Buecker et 
al., 2014; Yeom et al., 1996). The transition from one to the other is gradual and Oct4 
expression is maintained throughout implantation (Han et al., 2010). In contrast, Nanog is 
downregulated during implantation then reexpressed in the prospective primitive streak of 
gastrulating embryos (Hart et al., 2004). Sox2 expression persists in the epiblast throughout 
implantation, then becomes anteriorly restricted by mid–late-streak stages (Avilion et al., 2003; 
Wong, 2015). EpiSCs express both Nanog and Sox2, but at <20% of ESC-level and there is 
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some evidence their expression levels are reciprocal within single EpiSCs (Guo et al., 2009; 
Han et al., 2010; Wong, 2015), recapitulating their opposing gradients in the post-implantation 
epiblast. The action of the Oct4/Sox2/Nanog network core also differs between naïve and 
primed pluripotent cells, with distinct genomic targets and binding partners such as Oct6, Otx2 
and Sox3 in the primed state (Buecker et al., 2014; Galonska et al., 2015; Tesar et al., 2007). 
 
The transcriptional network governing EpiSC identity is far less well characterised than that of 
naïve pluripotency. In addition to Oct4/Sox2/Nanog, Utf1, Otx2, Oct6, Sox3 and Zic2/3 (Brons 
et al., 2007; Corsinotti et al., 2017; Galonska et al., 2015; Iwafuchi-Doi et al., 2012; Tesar et 
al., 2007), the regulatory network governing primed pluripotency presumably includes 
additional factors, connected in an unknown network topology. Other markers of EpiSCs 
include Fgf5, T/Brachyury, Eomes, FoxA2, Lefty, Sox17, Gata4. With the exception of Fgf5, 
these are considered indicators of differentiation priming/bias rather than intrinsic components 
of the EpiSC regulatory network, and vary greatly between EpiSC lines (Kojima et al., 2014; 
Morgani et al., 2017).  
 
The mechanisms by which FA signals sustain EpiSC identity in vitro are also partially 
understood. Nanog has been identified as a direct but non-essential target of Activin/Smad2/3 
signalling in EpiSCs (Greber et al., 2010; Osorno et al., 2012; Vallier et al., 2009). Meanwhile, 
Fgf/Erk signalling blocks neuroectodermal specification, and supresses naïve factors such as 
Klf2 (Greber et al., 2010; Yeo et al., 2014). An improved understanding of the EpiSC TF 
network will be required before we can define how the signalling environment interacts with 
this to govern the primed pluripotent identity. 
 
Provision of FA causes ESC differentiation into an EpiSC-like state (Guo et al., 2009), 
recapitulating epiblast progression from Erk-independence to -dependence. Conversely, 
naïve culture conditions are insufficient to convert EpiSCs back to naïve pluripotency1 (Figure 
1.2.3). This indicates a barrier between the primed and naïve pluripotent identities, in the form 
of epigenetic restriction, network hysteresis, and/or signal insensitivity. EpiSC reprogramming 
can be achieved by forced expression of certain TFs, in cooperation with switch to the 2iLIF 
signalling environment. The first such factor identified was Klf4 (Guo et al., 2009). Since then 
it has become apparent that almost any single member of the naïve TF network can drive 
EpiSC reprogramming, including Esrrb, Gbx2, Klf2, Klf4, PStat3, Tbx3 and Tfcp2l1 (Festuccia 
et al., 2012; Guo et al., 2009; Hall et al., 2009; Martello et al., 2013; Silva et al., 2009; Yang 
                                               
1 Except in rare cases at very low efficiency, for a few privileged feeder-derived EpiSC lines or subpopulations 
thereof (Han et al., 2010). However, such cells likely occupy an earlier identity to start with (Morgani et al., 2017). 
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et al., 2010; Ye et al., 2013). This hints at a fascinating flexibility in naïve network installation. 
Whilst single-factor EpiSC reprogramming has so far been inefficient (<1–3%), efficiencies of 
up to 10% have been reported due to synergy between drivers (Gillich et al., 2012; Yang et 
al., 2010). It is not yet known whether the TF network interactions are the same during naïve 
pluripotency induction as opposed to maintenance. 
 
Epigenetic perturbation can also prompt EpiSC reprogramming (Zhang et al., 2016). This 
suggests that the epigenetic landscape plays an instructive role in reprogramming, albeit via 
expression modulation of lineage- vs pluripotency-specifying TFs and in the presence of 2iLIF 
signals. Indeed, 2i has been shown to trigger reconfiguration of Oct4/Sox2/Nanog genomic 
binding prior to epigenomic remodelling (Galonska et al., 2015), and to upregulate naïve TF 
network members and known reprogramming drivers such as Klf2 and Tfcp2l1 (Martello et al., 
2013; Ye et al., 2013; Yeo et al., 2014). The instructive role of the environment in EpiSC 
reprogramming is further demonstrated by the limiting nature of Stat3 activation for EpiSC 
reprogramming (Yang et al., 2010), and the dominance of forced Stat3 activation over 
antagonistic cues (van Oosten et al., 2012). 
 
 
Figure 1.2.3: Primed and naïve pluripotency 
Summary of the differences between naïve and primed pluripotent identities. Representative 
phase images are shown of ESCs cultured in 2iLIF and EpiSCs in FA. Scale bars: 100 µm.  
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1.2.7 Human pluripotency 
 
Following the advances in the murine system, human pluripotent cells were first captured in 
vitro 20 years ago, from supernumerary embryos (Thomson et al., 1998). However, despite 
being derived from pre-implantation blastocysts, conventional human (h)ESCs share defining 
features with primed murine EpiSCs, such as signalling requisites, flattened morphology, 
intolerance to culture at clonal density, glycolytic metabolism, proximal Oct4 enhancer usage, 
epigenetic landscape, and an inactive X chromosome if female (Greber et al., 2010; Nichols 
and Smith, 2009; Tesar et al., 2007). Heterogeneity and lineage bias are also prevalent in 
conventional (primed) hESCs (Blauwkamp et al., 2012; Enver et al., 2009; Hough et al., 2014; 
Osafune et al., 2008; Stewart et al., 2006). 
 
For some time, it remained unclear whether this represented the properties of the human pre-
implantation blastocyst, or whether it was a culture-induced state due to suboptimal conditions. 
Assuming it existed, extensive efforts to capture the putative human naïve pluripotent identity 
recently bore fruit, in an exciting advancement during the course of my PhD studies. By 
expression of Klf2+Nanog transgenes and/or modulation of the signalling environment, hESCs 
were reset to a naïve state that shares molecular attributes and transcriptional governance 
with murine naïve ESCs (Takashima et al., 2014; Theunissen et al., 2014). Subsequently, 
naïve ESCs were successfully derived directly from embryos (Guo et al., 2016), with which 
they share hallmark naïve-specific Mek/Erk independence (Roode et al., 2012) and 
transcriptional signature (Stirparo et al., 2018). This forms a strong argument for the 
conservation of naïve–primed pluripotency progression in mammals, although with species-
specific features within this overarching framework. 
 
However, we have yet to reach a consensus regarding the optimal culture condition for capture 
and propagation of human naïve pluripotency (Davidson et al., 2015; Morgani et al., 2017). In 
part, this is impeded by limited scope for in vivo comparison or validation. An improved 
mechanistic understanding of murine primed-to-naïve identity conversion could instruct 
ongoing attempts to improve cognate naïve hESCs. Furthermore, functionality of naïve hESCs 
for in vitro multilineage differentiation is currently challenged by protracted timelines and 
difficulty accessing mature cell types. Since the in vivo human naïve epiblast is clearly capable 
of achieving this in a timely manner, likely our culture methods and differentiation protocols 




1.3 Experimental study of cell identity transitions 
 
1.3.1 Outstanding questions regarding mechanisms of cell identity transition 
 
Returning to a general consideration of cell identity transitions, execution of a transition 
necessitates a multitude of molecular changes to occur. The source transcriptional network 
needs to be dismantled and the destination program installed. Likewise, the epigenome, signal 
production and sensitivity, metabolism, morphology, substructures and specialised 
functionalities must be appropriately reconfigured. As outlined in Section 1.1, many of these 
cellular properties are ultimately dictated by the transcriptional network in charge of a given 
identity. Therefore, for this thesis I focus on reconfiguration of the transcriptional control 
network as a defining feature of cell identity transition. Outstanding questions regarding how 
this is achieved include: 
1. How does imposition of one/a few TFs lead to coordination of the destination network? 
2. How do external signals interact with the TFs to instruct the destination identity? 
3. Are there multiple routes by which a given identity change can occur, or must it always 
follow the same progression of mechanistic steps? 
4. Are there limiting steps for network rewiring? 
5. Do cells need a ‘licence’ to execute a transition? 
 
The specifics of these parameters will undoubtedly differ on a case-by-case basis. 
Nevertheless, at their core these are fundamental questions of wide interest. In particular, 
question 3 pertains to key principles for our understanding of multicellular biology as a function 
of genome-subset usage choreographed over space and time. Returning to the model of 
cellular identity as an attractor (Sections 1.1.3–4), question 3 can be posed as: 
3. Is an identity attractor multidimensional, with multiple ways by which it can be 
approached, or do transitions follow a set path through an energetic ‘valley’? 
 
Empirical evidence supporting theories of cellular identity as a multidimensional attractor was 
provided in a landmark work by Huang et al., 2005. They showed two transcriptionally distinct 
routes of promyelocytic HL60 cell differentiation into neutrophils, although they noted some 
disparity in the resulting neutrophil identities. A limitation for the further understanding of the 
principles governing cell identity change has been a lack of suitable in vitro cell types and of 
defined, tractable systems to study the transitions occurring between these. Here, I aim to 
address this by generation and implementation of appropriate in vitro models.  
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1.3.2 Requirements of an appropriate identity transition model 
 
In order to experimentally address the above questions (Section 1.3.1), identity transition 
models are required with the following attributes: 
a. Source and destination identities must be well defined. 
b. Source and intermediate cells must be amenable to perturbation. 
c. Genetic and signal variables can be controlled and independently manipulated. 
d. Responses should be sufficiently rapid to ascribe direct regulatory relationships. 
e. For the sake of technical feasibility, an efficient identity change would be preferable. 
f. Either we are confident that averages are representative of the intended identity change, 
or there is a means to isolate productively transitioning cells. 
 
 
1.3.3 Choice of naïve pluripotency as the destination cell identity 
 
I chose murine naïve pluripotency as the destination identity for the study of cell identity 
transitions. This provides several advantages: the destination identity is extremely well defined 
in terms of its molecular signature (Section 1.2), while functional assays such as clonogenic 
expansion and chimeric contribution leave no doubt as to whether the identity in question has 
indeed been generated (Figure 1.1.1B).  
 
Its high degree of molecular and functional definition render naïve pluripotency an appropriate 
destination for consideration of whether identity attractors are multidimensional, conceivably 
overcoming previous limitations with destination discrepancies (Huang et al., 2005). 
Furthermore, the defined serum-free culture of naïve pluripotent cells in 2iLIF leaves little room 
for other identities to propagate, particularly since Erk-signalling is required for most cell types, 
and this can be further strengthened by implementation of naïve selection reporters 
(Chambers et al., 2007; Toyooka et al., 2008; Wray et al., 2011). The well characterised 
homogeneity of 2iLIF cultures lends further confidence to the uniformity of identities 
propagated therein (Hackett et al., 2017), although of course validation will be essential. 
 
It is intrinsically intriguing to generate the identity that itself has the unbiased potential to form 
all others of the adult organism. Furthermore, a deeper understanding of murine naïve 
pluripotent identity specification may improve stem-cell based developmental models, and 
inform capture and manipulation of cognate pluripotent cells from other species. 
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1.3.4 Choice of EpiSC reprogramming to naïve pluripotency as the model system 
 
Having set naïve pluripotency as the destination identity, I then had to decide on the source 
cell type for a tractable model of identity transitions. Reprogramming of somatic cells to iPSCs 
requires multiple genetic and signal variables to be introduced simultaneously in order to 
achieve reprogramming, prohibiting causal ascription of changes to individual inputs (Smith, 
Sindhu & Meissner, 2016). Somatic cell reprogramming is a multi-step process, of which naïve 
pluripotency establishment is the final transition and occurs at low efficiency. 
 
In stark contrast, reprogramming of EpiSCs requires only one driving naïve factor, combined 
with defined modulation of the culture signalling environment (Section 1.2.8). Indeed, both 
EpiSC and naïve iPSC culture regimes are defined, serum- and feeder-free, with a shared 
N2B27 basal medium and fibronectin coating. The only environmental variables are thus 
exchange of FA ligands for 2iLIF components, and in certain cases even this is unnecessary 
(van Oosten et al., 2012). Together with independent manipulation of driving transgene(s), 
this proffers an exceptional degree of parameter control. Nevertheless, EpiSC reprogramming 
constitutes a transition between truly distinct identities (Section 1.2.8), and thus provides an 
appropriate model system in which to study regulatory principles of naïve identity acquisition. 
 
 
1.3.5 Challenges to overcome 
 
Despite the above advantages, a number of challenges persist in order to generate a tractable 
system for the mechanistic study of identity change during EpiSC reprogramming to naïve 
iPSCs. At the start of my doctoral studies, the transcriptional kinetics of naïve network 
induction during EpiSC reprogramming were unknown. Therefore, I needed to ascertain 
whether these are/can be sufficiently rapid to support mechanistic study of identity installation 
(see Chapter 3). 
 
Bulk averages are confounded by the heterogeneous and asynchronous nature of 
reprogramming. Enrichment or tracing of productive intermediates has been addressed in 
somatic cell reprogramming (Buganim et al., 2012; O’Malley et al., 2013; Polo et al., 2012). 
Here, starting instead from EpiSCs, I will need to overcome this limitation by developing 
methodology to isolate the productive reprogramming population and/or by improving 




Whilst the action of PD and CH small molecule inhibitors is not dependent on intrinsic 
properties of the cell, meaningful provision of exogenous LIF necessitates competence of the 
receiving cell to transduce the signal. EpiSCs have an inadequate ability to activate Stat3 in 
response to LIF, with LIF receptor (LIFR) identified as the limiting component (Yang et al., 
2010). However, due to the importance of PStat3 in the naïve pluripotent network (Section 
1.2) it should be included as a reprogramming driver. Fortunately, specific and sustained Stat3 
activation can be achieved by supplying granulocyte colony stimulating factor (GCSF) to cells 
expressing GY118F, a chimeric transmembrane receptor (Burdon et al., 1999; Niwa et al., 
1998) (Figure 1.2.4). The GY118F extracellular domain is that of the human GCSF receptor, 
whereas the transmembrane and intracellular domains are based on murine GP130, with a 
point mutation of tyrosine-118 to phenylalanine. The Y118F mutation prevents Jak-mediated 
activation of Mek/Erk and PI3K pathways, and blocks Socs3-mediated negative feedback by 
eliminating the Socs3 binding site on GP130 (Auernhammer et al., 1999; Schmitz et al., 2000). 
GCSF-stimulation of GY118F is capable of activating Stat3 in EpiSCs and driving their 
reprogramming to naïve iPSCs (van Oosten et al., 2012; Yang et al., 2010), and thus I will 





Figure 1.2.4: Stat3 activation by endogenous LIFR vs by transgenic GY118F 
Schematic comparing LIF/LIFR and GCSF/GY118F signal transduction pathways.  
(A) LIF ligand binds the extracellular domains of LIFR and GP130, triggering a tyrosine kinase 
signalling cascade that activates Stat3, Mek/Erk and PI3K pathways. Socs3 expression is 
rapidly induced by PStat3, then binds to GP130-Jak2 complexes. This prevents Stat3 binding 
to Jak2 and thus inhibits Stat3 phosphorylation and activation, forming a classic negative 
feedback loop in which PStat3 and Socs3 levels oscillate in antiphase (Kershaw et al., 2013; 
Schmitz et al., 2000; Yoshiura et al., 2007).  
(B) Specific and sustained Stat3 activation can be achieved by supplying GCSF to cells 
expressing GY118F transgene. The Y118F point mutation prevents stimulation of Mek/Erk 




Finally, I considered how best to introduce other single reprogramming factors to EpiSCs. 
When I started my doctoral studies, reported cases of EpiSC reprogramming had been driven 
by constitutive overexpression of factors in EpiSCs that would coordinate reprogramming 
upon switch to 2iLIF. However, given my interest in studying whether there could be multiple 
routes for transition between two given identities, I was concerned that prolonged expression 
of naïve factors in EpiSCs prior to the reprogramming assay could compromise the 
equivalency of the starting identity. Whilst transient transfections overcome this problem, they 
introduce others such as transfection stress at the critical moment of reprogramming initiation, 
and challenges in reproducibility. Therefore, I decided to try stably-integrated dox-inducible 
driver transgenes (see Chapters 3–4). 
 
 
1.3.6 Summary of aims 
 
I aim to study the principles underpinning cell identity transitions, using reprogramming of 
EpiSCs to naïve iPSCs as a model. This necessitates development of defined and tractable 
identity transition models. Using these systems, I seek to address the following biological 
questions: 
 
How is the naïve pluripotent identity instructed by interplay between transcriptional 
networks and environmental signals? 
Chapter 3, with returns to this theme in Chapters 4–5. 
 
Are there multiple routes by which to transit from EpiSC to naïve iPSC identity? 






CHAPTER 2: MATERIALS AND METHODS 
 
 
2.1 Tissue culture 
 
2.1.1 Murine tissue culture 
 
ESCs and iPSCs were cultured in N2B27+2i+LIF (2iLIF) unless otherwise indicated. EpiSCs 
were cultured in N2B27+FGF2+ActivinA (FA). XAV was also added to FA for Chapters 4–7, 
following evidence that it homogenises primed cultures (Kim et al., 2013; Sumi et al., 2013). 
Cell lines are of predominately 129 genetic background unless stated otherwise. N2B27 
medium comprised 1:1 DMEM/F-12 and Neurobasal (Gibco), 2 mM L-glutamine (Gibco), 1x 
penicillin-streptomycin (Sigma), 0.1 mM 2-mercaptoethanol (Gibco), 1% B27 (Gibco) and 
0.5% N2 (homemade). As required, N2B27 was supplemented with 20 ng/ml murine LIF 
(homemade), 3 μM CHIR99021 (Chiron; CH) and 1 μM PD0325901 (PD03; PD) (Stewart lab, 
Dresden), 12.5 ng/ml FGF2 and 20 ng/ml ActivinA (homemade), 6.25 µg/ml XAV 939 (Tocris), 
3 µM DMH2 (Tocris), or 0.6 µM LDN193189 (Sigma). 
 
Cells were occasionally cultured in FCS+LIF or KSR+LIF instead, if necessary for the objective 
of the experiment. FCS+LIF medium contained GMEM (Sigma), 10% fetal calf serum (Gibco), 
1x non-essential amino acids (Gibco), 1 mM sodium pyruvate (Sigma), 2 mM L-glutamine 
(Gibco), 1x penicillin-streptomycin (Sigma), 0.1 mM 2-mercaptoethanol (Gibco), 20 ng/ml 
murine LIF (homemade), and 10ng/ml BMP4 (Miltenyi Biotec) was supplemented as indicated. 
KSR medium contained GMEM (Sigma), 10% KnockOut Serum Replacement (Invitrogen), 1% 
fetal calf serum (Gibco), 1x non-essential amino acids (Gibco), 1 mM sodium pyruvate 
(Sigma), 2 mM L-glutamine (Gibco), 1x penicillin-streptomycin (Sigma) and 0.1 mM 
2-mercaptoethanol (Gibco). 
 
For ESCs and iPSCs, tissue-culture flasks (Falcon) were coated with 0.15% gelatin (Sigma) 
in PBS (Sigma) and incubated in 7% CO2. For EpiSC culture and reprogramming experiments, 
tissue-culture flasks were coated with 10 µg/ml fibronectin (Millipore) in PBS (Sigma) and 
incubated in 7% CO2 (Chapter 3) or 7% CO2 and 5% O2 (Chapters 4–7). ESCs, iPSCs and 
EpiSCs were dissociated with accutase (Millipore) during passaging. For optimal performance 
of EpiSCs, lines were maintained by plating 25000 cells/cm2 every other day (usually 1:6 split 




2.1.2 Murine cell transfection 
 
For transgene integration transfections, 1 μg piggyBac (PB) vectors of interest, 0.5 μg PBase 
expression vector (CAG.PBase) and 10 μl Lipofectamine-2000 (Invitrogen) were incubated for 
20 min in 500 ml DMEM (Gibco), then applied to 500,000 cells/6well in 3 ml medium for 18 
hours. Selection was applied to transfectants for at least 5 passages prior to use: 50–150 
μg/ml hygromycin-B (Life Technologies), 0.33–1.00 µg/ml puromycin (ThermoFisher), 20 
μg/ml blasticidin (Gibco), 200 μg/ml G418 (Invitrogen) or 100 μg/ml zeocin (Invitrogen) as 
appropriate. PB-vectors stably integrate into host genome TTAA-sites in the presence of 
PBase transposase; CAG.PBase does not integrate and is lost with passaging (Cambridge 
Bioscience). 
 
siRNA transfections were performed using RNAiMAX transfection reagent (Invitrogen) and 




2.1.3 EpiSC reprogramming 
 
EpiSCs were plated in FA without selection at a density of 1000/cm2. For siRNA experiments, 
5000/cm2 was used instead to compensate for transfection toxicity. The following day, 
reprogramming was induced by medium change to 2iLIF or subset components thereof as 
indicated. GY118F transgenic receptor was stimulated with 30 ng/ml human GCSF 
(Peprotech), whereas expression of other transgenes was induced with 1 µg/ml doxycycline 
(MP Biomedicals).  
 
After 4–7 days, transgene induction was withdrawn and selection applied to select for naïve 
iPSC colonies. As appropriate: 20 μg/ml blasticidin (Gibco) was used to select for 
Rex1::dGFP.IRES.bsd reporter activity; 1 µg/ml puromycin (ThermoFisher) or 200 μg/ml G418 
(Invitrogen) to select for Oct4::GFP.IRES.puro or Oct4::βgeo; 50–100 μg/ml G418 (Invitrogen) 
to select for Nanog::βgeo. 
 
On day 8–12, 4x images were acquired using CellSens software and an X-51 Olympus 
microscope system with motorized stage and camera. iPSC colonies with active Rex1, Nanog 
or Oct4 reporter were counted manually. Unless stated otherwise, reprogramming data 




2.1.4 FixedOct4 EpiSCs 
 
FixedOct4 EpiSCs were generated from Oct4-/βgeo CAG.Oct4wt.2A.mCherry iPSCs 
(Radzisheuskaya et al., 2013) by differentiation in N2B27+Fgf2+ActivinA for 10 passages. 
Oct4 F/βgeo CAG.EmptyVector EpiSCs were generated as a control from the same parental 
line. Reprogramming was conducted in N2B27+2iLIF as above. 200 μg/ml G418 (Invitrogen) 
was applied to select for endogenous Oct4 promoter activity after 4 days of reprogramming. 
 
 
2.1.5 Somatic cell reprogramming from E9.5 chimeras 
 
High contribution E9.5 chimeras were generated following blastocyst injection of Oct4-/βgeo 
CAG.Oct4wt.2A.mCherry iPSCs (Radzisheuskaya et al., 2013). The anterior portion of E9.5 
chimeras were manually dissociated then cultured in N2B27- or KSR-based LIFaza or 2iLIF. 
KSR-medium comprised GMEM (Sigma), 10% KSR (Invitrogen), 1% FCS (Sigma), 1x non-
essential amino acids (Gibco), 1 mM sodium pyruvate (Sigma), 2 mM L-glutamine (Gibco), 1x 
penicillin-streptomycin (Sigma), 0.1 mM 2-mercaptoethanol (Gibco). 5-Azacytidine (aza) was 
added as indicated (1 μM, Sigma). After 6 days, aza was removed and 2iLIF was applied to 
all, followed by addition of G418 (400 μg/ml) at day 10. iPSCs could be derived after a period 
in LIFaza in both N2B27- and KSR-based media.  
 
 
2.1.6 Human tissue culture 
 
H9 hESCs (WiCell, agreement #17-W0189) and derivate lines thereof were maintained in E8 
media (homemade) on tissue-culture plates coated with Geltrex (ThermoFisher) and 
incubated at 7% CO2 and 5% O2. For expansion, hESCs were passaged in small clumps 
following dissociation with 0.5 mM EDTA (ThermoFisher). For transfection or resetting assays, 
hESCs were dissociated to single cells using accutase. H9 iK2N.Venus hESC line was a kind 
gift from Austin Smith (Takashima et al., 2014). 
 
 
2.1.7 Human cell transfection 
 
For transgene integration transfections, 1.2 μg piggyBac (PB) vectors of interest and 1.2 μg 
PBase expression vector (CAG.PBase) were electroporated into 1 million hESCs using the 
Neon transfection system (ThermoFisher) according to manufacturer’s instructions. Two 
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pulses of electroporation were provided, each for 2 ms at 1200 V, then hESCs were plated at 
clonal density with 10µM ROCKi/Y-27632 (Calbiochem). After two days, ROCKi was 
withdrawn and selection applied until stable cell lines were established: 50 μg/ml hygromycin-
B (Life Technologies) for PB.TetO.GOI.PGK.hph or PB.CAG.GY118F.PGK.hph, and 0.33 
µg/ml puromycin (ThermoFisher) for PB.CAG.rtTA3.PGK.pac. 
 
 
2.1.8 Human cell resetting 
 
Resetting of primed H9 iK2N.Venus hESCs towards the naïve state was conducted in 
N2B27+2iLIF on mitotically inactivated MEFs, as previously described (Takashima et al., 
2014). 1 µg/ml doxycycline (MP Biomedicals) or 3 µM DMH2 (Tocris) were applied as 
indicated. 4x images were acquired using CellSens software and an X-51 Olympus 
microscope system with motorized stage and camera. Venus+ colony size was analysed in 
ImageJ using the automated ‘Analyse Particles’ function. 
 
 
2.2 Embryo work 
 
2.2.1 Derivation of EpiSCs 
 
To derive Nanog F/βgeo EpiSCs, Nanog F/F (Chambers et al., 2003) and Nanog +/βgeo 
(Mitsui et al., 2003) mice were crossed and EpiSCs were derived from resultant E6.5 embryos. 
Epiblasts were manually dissected from extra-embryonic tissues and plated on fibronectin-
coated plates in FGF2+ActivinA medium. Nanog genotyping was performed on extra-
embryonic tissues and confirmed on downstream EpiSC cultures. 
 
To derive Rex1-reporter EpiSCs, Rex1::dGFP.IRES.bsd homozygous 129 studs (Kalkan et 
al., 2017) were crossed with wild-type 129 females and EpiSCs were derived from resultant 
E6.5 embryos. Epiblasts were manually dissected from extra-embryonic tissues and plated on 
fibronectin-coated plates in FGF2+ActivinA+XAV medium.  
 
After 5–7 days of culture, regions of the explant exhibiting EpiSC morphology were manually 





2.2.2 Embryo culture and analysis 
 
Wild-type 129 mice were crossed and embryos flushed from oviducts at 2.75 dpc using M2 
medium (Millipore). Embryos were subsequently incubated in Blast medium (Origio) and 
periodically inspected. At cavitation onset, embryos were randomly divided into Blast medium 
supplemented either with 3 µM DMH2 (Tocris) or 1:1000 DMSO, cultured for a further 36 h 
then fixed in 4% paraformaldehyde (Sigma) in PBS for 15 min at room temperature. 
 
Embryos were permeabilised in 0.25% Triton X-100 (Sigma) in PBS for 30 min, then blocked 
in 3% donkey serum (Sigma), 0.1% BSA (Sigma) and 0.01% Tween-20 (Sigma) for 30 min at 
room temperature. Embryos were incubated overnight at 4°C in blocking buffer with the 
following primary antibodies: Klf4 (1:300, goat pAb, R&D); Nanog (1:300, rat mAb, 
eBioscience); Oct4 (1:300, rabbit mAb, Cell Signaling). The following day, washes were 
performed in blocking buffer. AlexaFluor secondary antibodies (Life Technologies) were used 
against the appropriate species at 1:1000 in blocking buffer. Embryos were gradually 
acclimatised then mounted in Vectashield with DAPI (Vector Laboratories). 
 
Images were taken with an Eclipse Ti Spinning Disk confocal microscope (Nikon) equipped 
with an Andor Revolution XD System at 40x magnification. Presented images are maximum 
intensity projections of Z-stack slices processed with ImageJ.  
 
Staining quantification was carried out with Imaris: nuclei were identified in the DAPI channel 
and the fluorescence of each other channel recorded; cells were assigned to the 
trophectoderm lineage based on position (outer cells), while remaining cells were classified 
as inner cell mass. There was no significant loss of fluorescence in the Z-dimension and no 
batch effect was detected in the stainings, so no further normalisation was deemed necessary. 
 
 
2.2.3 Blastocyst injection 
 
Chimeras were generated by William Mansfield, using standard microinjection methodology 
and host blastocysts of strain C57BL/6 (black). All animal work was performed in accordance 





2.3 Flow cytometry 
 
Cell sorting was performed using a MoFlo Legacy Cell Sorter (Beckman) or an S3 Cell Sorter 
(BioRad). dGFP was excited using a 488 nm laser and detected using a 530/30 filter. 
Rex1+/dGFP EpiSCs and ESCs were used to determine negative and positive dGFP gates 
respectively.  
 
After sorting of reprogramming intermediates, number of iPSC colonies are quantified relative 
to the number of ESC colonies, because replating of sorted ESCs provides a control for cell 
death due to the stress of sorting. ESCs already stably occupy the destination naïve 





Cells were fixed for 10 min with 4% paraformaldehyde (Sigma) in PBS, permeabilised in 0.4% 
Triton X-100 (Sigma) in TBS, then blocked in 5% donkey serum (Sigma) and 0.1% Triton X-
100 in TBS. Samples were incubated overnight at 4°C in blocking buffer with the following 
primary antibodies: Klf4 (1:300, goat pAb, R&D); Nanog (1:300, rat mAb, eBioscience); Oct4 
(1:300, rabbit mAb, Cell Signaling); Oct4 (1:100, mouse mAb, Santa Cruz); PSmad1/5 (1:100, 
rabbit mAb, Cell Signaling). The following day, washes were performed with 0.1% Triton X-
100 in TBS, and samples incubated with Dapi and AlexaFluor secondary antibodies against 
the appropriate species at 1:1000 (Life Technologies).  
 
Samples were imaged using an Eclipse Ti Spinning Disk confocal microscope (Nikon) 
equipped with an Andor Revolution XD System at 40x or 60x magnification, or using a Leica 
DMI6000 microscope at 20x. Images were processed with ImageJ. Presented images are 





E9.5 embryos were fixed for 4 h at 4°C with 4% paraformaldehyde (Sigma) in PBS, gradually 
adjusted to 20% sucrose over 2 days, then mounted in OCT and snap frozen on liquid nitrogen. 
8 µm cryosections were taken then stored at -80°C. Following rehydration in PBS, sections 
were permeabilised in 0.25% Triton X-100 (Sigma) in PBS, then blocked in 5% donkey serum 
(Sigma) and 0.1% Triton X-100 in PBS. Sections were incubated overnight at 4°C in blocking 
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buffer with the following primary antibodies: Nanog (1:300, rat mAb, eBioscience); Oct4 
(1:300, rabbit mAb, Cell Signaling); Oct4 (1:300, goat pAb, Santa Cruz); Sox1 (1:300, rabbit 
pAb, Cell Signaling); Sox2 (1:300, rat mAb, eBioscience). The following day, washes were 
performed with 0.1% Triton X-100 in TBS, and samples incubated with Dapi and AlexaFluor 
secondary antibodies against the appropriate species at 1:1000 (Life Technologies).  
 
Sections were imaged using a Zeiss ApoTome microscope at 20x then tiled. After imaging, 
H&E histological staining was performed on the same sections according to standard 
methodologies. These sections were then re-imaged in the same pipeline. 
 
 
2.6 Western blotting 
 
Cells were lysed in RIPA buffer (Sigma) containing Complete-ULTRA protease-inhibitor and 
PhoStop phosphatase-inhibitor cocktails (Roche), and sonicated with Bioruptor200 
(Diagenode) at high frequency, alternating 30 s on/off for 3 min. SDS-PAGE electrophoresis 
was performed using Bolt 10% Bis-Tris Plus gels (ThermoFisher) in a Novex MiniCell 
(ThermoFisher). Protein transfer was performed using the semi-dry iBlot2 system 
(ThermoFisher) and iBlot Transfer Stacks (ThermoFisher).  
 
The following primary antibodies were used: Esrrb (1:1000, mouse mAb, R&D); Klf4 (1:1000, 
goat pAb, R&D Systems); Nanog (1:5000, rabbit pAb, Bethyl Laboratories); Oct4 (1:1000, 
rabbit mAb, Cell Signaling); P-Y705-Stat3 (1:1000, rabbit mAb, Cell Signaling #9145); total 
Stat3 (1:1000, rabbit pAb, Cell Signaling); αTubulin (1:10000, mouse mAb, Abcam). 
 
Detection was achieved using HRP-linked secondary antibodies at 1:10000 against the 
appropriate species (GE Healthcare) and ECL Plus Western Blotting Detection System (GE 
Healthcare).  
 
Membranes were stripped between PStat3 and total Stat3 blots (stripping buffer and protocol 







Genomic DNA was extracted by incubation at 95°C for 20 min in 25 mM NaOH + 0.2 mM 
EDTA, followed by addition of an equal volume of 40 mM Tris HCl and vortexing.  
 
 
2.7.1 Nanog genotyping 
 
Genotyping to distinguish between Nanog F/+, Nanog F/βgeo and derivative Nanog GFP/βgeo 
EpiSCs was conducted using Taq DNA polymerase (Qiagen) and the following thermocycler 
program:  
94°C for 5 min; 35 cycles of 94°C for 10 s, 60°C for 20 s, 72°C for 60 s; then 72°C for 3 min.  
 
An equal mix of 3 primers was used:  
βgeo  AATGGGCTGACCGCTTCCTC  
S5  ACCTCAGCCTCCAGCAGATG  
A53  CAGAATGCAGACAGGTCTACAGCCCG. 
 
An 800 bp product is amplified from Flox (F) and wild-type Nanog alleles, whereas the βgeo 
allele yields a 600 bp product. 
 
 
2.7.2 Oct4 genotyping 
 
Genotyping to distinguish between Oct4-/βgeo, Oct4 F/βgeo and Oct4+/+ cells was conducted 
using Taq DNA Polymerase (Qiagen) and the following thermocycler program:  
95°C for 3 min; 30 cycles of 94°C for 15 s, 60°C for 30 s, 72°C for 60 s; then 72°C for 10 min.  
 
Primer GAGCTTATGATCTGATGTCCATCTCTGTGC binds in the Oct4 final intron, which is 
present in both wild-type and Flox (F) alleles.  
Primer GGGCTGACCGCTTCCTCGTGCTTTACG binds in the βgeo allele.  
Primer GCCTTCCTCTATAGGTTGGGCTCCAACC binds 3' downstream of Oct4 and is 





2.8 Plasmids and cloning 
 
Existing piggyBac (PB) vectors were used to drive constitutive expression of: Nanog 
(PB.CAG.Nanog.PGK.hph); GY118F (PB.CAG.dsRed.IRES.hph.CAG.GY118F), coding 
sequence as described in Niwa et al., 1998; Klf4 (PB.CAG.Klf4.IRES.zeo); Esrrb 
(CAG.Esrrb.IRES.zeo); Control (CAG.empty.PGK.hph). Gateway cloning (Invitrogen) was 
used to re-insert GY118F to PB.CAG.GY118F.PGK.hph when dsRed would confound 
multichannel IF. 
 
TetO.FLBioNanog.UbiP.rtTA3 was amplified from a previously described dox-inducible Nanog 
construct [S26] using Phusion Taq polymerase (New England Biolabs). TetO denotes the 
operator/promoter and rtTA3 encodes the dox-controlled transactivator of the ‘Tet-On’ system 
[S27], FLBioNanog codes for FLAG- and biotin-tagged murine Nanog, and the ubiquitous 
promoter UbiP drives constitutive expression of rtTA3. TetO.FLBioNanog.UbiP.rtTA3 was 
then inserted into PB bsd destination vector by Gateway cloning (Invitrogen). To ensure that 
FLBioNanog was expressed only in the presence of dox, the constitutive CAG promoter was 
removed from the destination vector by restriction digestion and re-ligation. The resulting 
iFLBioNanog construct confers constitutive blasticidin resistance, allowing selection of 
successfully transfected cells irrespective of dox presence. 
 
For other dox-inducible transgenes, PB hph destination vector was modified to contain TetO 
rather than CAG promoter (kind gift from Aliaksandra Radzisheuskaya). Genes of interest 
(Esrrb, Klf2, Klf4, Klf5, Nanog, Tfcp2l1) were cloned into the resultant vector using Gateway 
technology (Invitrogen) according to manufacturer’s instructions, producing inducible 
expression vectors in the form PB.TetO.GOI.PGK.hph. Constitutive rtTA3 expression vector 
was generated in the same manner, but retaining CAG instead of TetO promoter and thus 





Total RNA was extracted using RNeasy kits, according to manufacturer’s spin protocol, 
including on-column DNaseI digest (Qiagen). cDNA was produced using the SuperscriptIII 
VILO cDNA synthesis kit, following the recommended protocol. From bulk cultures, 0.2–1.0 μg 
of input RNA was used. Less RNA was used from sorted samples, corresponding to that 
extracted from 150–10000 cells. cDNA dilution ratios were adjusted accordingly. RT-qPCR 
reactions were performed using StepOnePlus Real Time PCR System with recommended 
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thermocycler settings (Applied Biosystems) and TaqMan Fast Universal PCR Master Mix 
(Applied Biosystems). Gene expression relative to Gapdh in each well was determined using 
FAM-labelled TaqMan assay probe together with VIC-labelled Gapdh probe (Applied 
Biosystems). Unless stated otherwise, RT-qPCR data presented in this thesis are the mean 
of 3 technical replicates.  
 
 
Table 1: Applied Biosystems TaqMan RT-qPCR assays 























Table 2: Applied Biosystems TaqMan RT-qPCR custom assays 
Gene Forward primer (5'–3') 
Reverse primer  
(5'–3') 
Probe  





























2.10.1 ChIP procedure 
 
Nanog ChIP was performed as follows: cells (10×106 for each sample) were fixed for 10 min 
in 1% formaldehyde, washed with ice-cold PBS and incubated for 10 min in lysis buffer 1 
(50 mM HEPES at pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP40 and 0.25% 
Triton X-100) and then for 10 min in lysis buffer 2 (10 mM Tris at pH 8.0, 200 mM NaCl, 
1 mM EDTA and 0.5 mM EGTA). Nuclei were pelleted, resuspended in shearing buffer 
(1% SDS, 10 mM EDTA and 50 mM Tris at pH 8.0) and sonicated to obtain an average DNA 
fragment size of 500 base pairs. Lysates were diluted 1:10 in dilution buffer (50 mM Tris-HCl at 
pH 8.0, 167 mM NaCl, 1.1% Triton X-100 and 0.11% Na deoxycholate) and pre-cleared for 2 h 
at 4°C with Dynabeads Protein G magnetic beads (Life Technologies) that were pre-incubated 
with isotype IgG antibody. The chromatin was then incubated overnight at 4°C with 2 μg of 
rabbit polyclonal antibody against Nanog (Bethyl Laboratories) or an isotype IgG control 
(Santa Cruz Biotechnology). Lysates were then incubated for 1 h at 4°C with blocked 
Dynabeads magnetic beads, and the beads were washed twice in wash buffer 1 (50 mM Tris-
HCl at pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS, 0.1% Na 
deoxycholate and 0.5 mM EGTA), once in wash buffer 2 (50 mM Tris-HCl at pH 8.0, 
500 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS, 0.1% Na deoxycholate and 
0.5 mM EGTA), once in wash buffer 3 (50 mM Tris at pH 8.0, 250 mM LiCl, 0.5% Na 
deoxycholate, 0.5% NP40, 1 mM EDTA and 0.5 mM EGTA) and twice in wash buffer 4 
(50 mM Tris at pH 8.0, 10 mM EDTA and 5 mM EGTA). Chromatin was eluted for 30 min at 
65°C in elution buffer (1% SDS and 0.1 M NaHCO3). Samples were incubated overnight at 
65°C to reverse the crosslinking and purified using the QIAquick PCR Purification kit (Qiagen). 
Chromatin was analysed by Fast SYBR Green RT-qPCR (Applied Biosystems). Enrichment 
was calculated relative to the Input sample. 
 
 
Table 3: ChIP primers 
Region Forward primer (5'–3') Reverse primer (5'–3') 
Socs3 proximal GAAAAGGCTTGAGGGTCGGA CGGGCCTGGAATGTCAAACT 
Socs3 distal TCAGGAGTCCCTGTGCTCTAA GGCAGACGGGTCTACTTTGAA 





2.10.2 Analysis of published ChIP-seq datasets 
 
The following published ChIP-seq datasets were used to examine TF binding and histone 
modifications at genomic regions of interest in ESCs: Nanog (accession number GSE11724); 
PStat3 (GSE11431); Med12 (GSE22562); RNA PolII (GSE23943); H3K27ac (GSE24164); 
H3K36me3 (GSE23943); H3K4me3 (GSE23943) and H3K27me3 (GSE23943). Raw ChIP-
seq datasets were downloaded from the Gene Expression Omnibus 
(http://www.ncbi.nlm.nih.gov/geo/), realigned to the mouse mm9 genome with Bowtie software 
(http://bowtie-bio.sourceforge.net), and peaks were called with MACS software 
(http://liulab.dfci.harvard.edu/MACS) using default parameters. ‘K4-K36’ domains were 





Amplification and labelling of RNA were performed using the TotalPrep-96 RNA Amplification 
Kit for the Illumina platform (Ambion). Subsequent hybridization, staining and scanning were 
performed according to the Whole Genome Gene Expression Direct Hybridization Guide on 
the MouseWG-6 v2.0 Expression BeadChip (Illumina). Data were loaded into the R package 
lumi (Du et al., 2008) and then divided into subsets to be analysed. The data were transformed 
using Variance Stabilization (Lin et al., 2008) and normalised using quantile normalization. 
Comparisons were performed in the R package limma (Smyth, 2004) and the results were 





2.12.1 Bulk RNAseq library preparation 
 
Sequencing libraries were prepared according to the SmartSeq2 protocol (Picelli et al., 2014) 
with the following amendments: purified RNA was used diluted to 5 ng/µl; ERCC spike-ins 
(Invitrogen) were added at 1 µl of 1:10000 dilution per 5 ng; 13 cycles of amplification were 
used to obtain cDNA (rather than 21 cycles used for single cells). Nextera XT reactions were 
scaled-down by half, using 0.4 ng cDNA input per reaction. Pooled libraries were sequenced 
on the Illumina HiSeq 4000 (paired-end 150 bp reads). Each datapoint in a bulk RNAseq 
timecourse is a single replicate, to allow all samples to be sequenced together in the same 
lane to avoid technical biases. Trends were independently confirmed by RT-qPCR. 
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2.12.2 scRNAseq library preparation 
 
Single cells were index-sorted individually by FACS (BD Influx 5) into wells of a 96-well PCR 
plate containing lysis buffer on days 2, 3 and 4 following reprogramming induction. dGFP+ 
DAPI- cells were sorted for all reprogramming, ESC and iPSC samples. dGFP- DAPI- cells 
were sorted for EpiSCs. scRNAseq was performed as previously described (Nestorowa et al., 
2016; Picelli et al., 2014; Wilson et al., 2015). The Illumina Nextera XT DNA kit was used to 
prepare libraries. Pooled libraries were sequenced on the Illumina HiSeq 4000 (single-end 
125 bp reads). Samples from all cell lines were included in each sequencing lane, to control 
for technical lane effects (Figure 5.2.3A). 
 
 
2.12.3 RNAseq alignment 
 
GENCODE M12 mouse gene annotation from Ensembl release 87 was used for read 
alignment (Yates et al., 2016) and splice-junction donor/acceptor overlap settings were 
tailored to the read length of each dataset. Alignments to gene loci were quantified with 
HTSeq-count (Anders et al., 2015) based on annotation from Ensembl release 87. Sequencing 
libraries with fewer than 500,000 mapped reads were excluded from subsequent analyses. 
Read distribution bias across gene bodies was computed as the ratio between the total reads 
spanning the 50th to the 100th percentile of gene length, and those between the first and 49th. 
Samples with ratio >2 were not considered further. 
 
 
2.12.4 Published embryo scRNAseq datasets 
 
Sequencing data of single-cell mouse embryo profiling studies SRP110669 (Mohammed et 
al., 2017; E3.5, E4.5, E6.5) and SRP020490 (Deng et al., 2014; compacted morula) were 
downloaded from the European Nucleotide Archive (Toribio et al., 2017) and aligned as above. 
 
 
2.12.5 Transcriptome analysis 
 
Principal component and cluster analyses were performed based on log2 FPKM values and 
were computed with the Bioconductor packages DESeq2 (Love et al., 2014), Sincell (Juliá et 
al., 2015) or FactoMineR (Lê et al., 2008) in addition to custom scripts. Default parameters 
were used unless otherwise indicated. For global analyses, genes that registered zero counts 
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in all single-cell samples were omitted. Euclidean distance and average agglomeration 
methods were used for cluster analyses unless otherwise indicated. t-SNE analysis was 
computed using Rtsne R package (Krijthe, 2015) with default parameters. k-means hard 
clustering was performed using the Mfuzz R package (Futschik and Carlisle, 2005) and the 
optimal number of k clusters were selected using the elbow method. 
 
 
2.12.6 Selection of high-variability genes 
 
Genes exhibiting the greatest expression variability (and thus contributing substantial 
discriminatory power) were identified by fitting a non-linear regression curve between average 
log2 FPKM and the square of coefficient of variation. Indicated specific thresholds were applied 
along the x-axis (average log2 FPKM) and y-axis (CV2) to identify the most variable genes.  
 
 
2.12.7 Quadratic programming 
 
Fractional identity of single cells was computed using the R package DeconRNASeq (Gong 
and Szustakowski, 2013). This package utilises quadratic programming to estimate the 
proportion of distinctive cell types. The average expression of bulk RNAseq samples (EpiSCs 
or iPSCs, Fig. S3C) or the average expression of scRNAseq samples (EpiSCs, iPSCs or 
embryo stages, Fig. 3D) were used as signature datasets. The fraction of identity between 
single cells and the signature datasets was computed using the whole transcriptome. 
Reprogramming pseudotimes for single cells were assigned by ordering cells based on their 
fraction of similarity to EpiSCs (origin) and iPSCs (destination) (Fig. S3C), as previously 
described (Treutlein et al., 2016). 
 
 
2.12.8 LOESS regression 
 
Smooth curve local regression (LOESS) lines were fitted to scatter plots of log2 FPKM vs 
pseudotime using the R stats package (R Core Team, 2016). Smoothness parameter of 1/3 
and 2 degrees of local polynomial were used for curve fitting.  
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CHAPTER 3: NANOG AMPLIFIES STAT3 ACTIVATION AND THEY 





As introduced in Section 1.2.3, the core pluripotency network comprises the TFs Nanog, Oct4 
and Sox2. In the naïve pluripotent state, active PStat3 integrates with this network downstream 
of a LIF-stimulated tyrosine kinase signalling cascade (Chen et al., 2008). LIF is included in 
all optimal culture conditions for induction or maintenance of naïve cells, including during 
somatic cell reprogramming. For EpiSC reprogramming, Stat3 activation is limiting (Yang et 
al., 2010) and, notably, Stat3 signalling alone is sufficient to drive reprogramming in the 
complete absence of additional culture requisites (van Oosten et al., 2012). 
 
In the absence of maternal Stat3, Stat3-/- embryos fail to form a naïve pluripotent epiblast (Do 
et al., 2013). This classifies Stat3 as a member of the small group of genes essential for the 
establishment of embryonic naïve pluripotency, along with Nanog, Oct4 and Sox2 (Avilion et 
al., 2003; Nichols et al., 1998; Silva et al., 2009). Oct4 and Sox2 have distinct biological 
properties from Nanog and Stat3: despite being essential for the maintenance of pluripotent 
cells, their overexpression does not enhance ESC self-renewal and instead causes loss of 
ESC identity (Figure 3.1.1) (Kopp et al., 2008; Niwa et al., 2000; Radzisheuskaya et al., 2013). 
In contrast, forced expression of Nanog and increased Stat3 activation are each reported to 
enhance pluripotent cell self-renewal (Chambers et al., 2003; Matsuda et al., 1999). There are 
several other pluripotency-associated genes that promote ESC maintenance (Section 1.2.3). 
However, unlike Nanog and Stat3, these genes are not required in vivo for the establishment 
of the naïve pluripotent epiblast (Figure 3.1.1). 
 
Nanog and PStat3 thus hold a special position in the naïve TF network, as rare factors that 
are both required for naïve pluripotency establishment and beneficial for its maintenance if 
elevated (Figure 3.1.1). Nanog is a nuclear TF by default, whereas Stat3 activation is 
dependent on the presence and transduction of exogenous LIF signal. Therefore, the 
relationship between Nanog and LIF/Stat3 signalling is an important and appropriate model in 








Figure 3.1.1: Nanog and PStat3 hold a special status amongst naïve pluripotency TFs 
Venn diagram depicting which naïve TFs are essential for naïve pluripotency establishment in 
the embryo, and/or which enhance pluripotency maintenance when elevated in ESCs. 
 
 
It is not known whether Nanog and LIF/Stat3 input to the naïve TF network in an independent 
or concerted manner. However, in the literature there are several hints at a functional 
relationship between Nanog and PStat3. Nanog was initially identified due to its ability to 
support ESC self-renewal in the absence of LIF (Chambers et al., 2003; Mitsui et al., 2003). 
Furthermore, Nanog overexpression can induce naïve pluripotency in minimal culture 
conditions if exogenous LIF is supplied (Theunissen et al., 2011). Nanog overexpression and 
forced Stat3 activation demonstrate hitherto unexplained functional synergy during EpiSC 
reprogramming (Yang et al., 2010). 
 
Therefore, in Chapter 3 I investigate whether Nanog and LIF/Stat3 signalling are 
mechanistically linked by assessing their relationship in pluripotent cells and during induction 
of a naïve pluripotent program. Although Nanog and Stat3 are essential for embryonic 
pluripotency establishment and ESC derivation, they promote but are not required for in vitro 
ESC maintenance (Chambers et al., 2007; Ying et al., 2008). This permits the study of 
Nanog-/- and Stat3-/- ESCs and suggests differences between network requirements for naïve 






Please note: certain datasets are not included in this thesis, due to their prior usage in my 
Bachelors dissertation (University of Cambridge, Biochemistry Part II, 2012). Where 
conceptually necessary, references are instead provided to the corresponding figures in the 
resultant publication (Stuart et al 2014, Current Biology), in the format ‘CB Figure X’. This 
paper can be found in the Appendix after page 215, and its text is my own original writing. 
 
 
3.2.1 Nanog amplifies Stat3 phosphorylation and suppresses Socs3 transcription 
 
I first investigated the effect of Nanog on Stat3 activation in ESCs, since the naïve pluripotency 
network is established and functional in this cellular context. Wild-type (WT) and constitutively 
Nanog-overexpressing (NanogOE) ESCs were harvested following LIF-induction 
timecourses. Western blotting revealed that higher Nanog increased PStat3 level and 
enhanced ESC sensitivity to LIF stimulation (Figure 3.2.1A, see also CB Figure 1A–B). 
 
To explain how Nanog drives PStat3 elevation without directly binding the Stat3 protein or 
gene (Marson et al., 2008; Torres and Watt, 2008), I examined the effect of Nanog on 
components of the LIF/Stat3 signalling pathway in ESCs. By RT-qPCR, no correlation was 
reliably found between Nanog and transcript levels of positive signal transducers Lif, Lifr, 
Gp130, Jak2 and Stat3 (my Bachelors dissertation), despite Nanog binding to Lif, Lifr and 
Gp130 gene regulatory sequences in ESCs according to published ChIP-seq data (Marson et 
al., 2008). However, Nanog also binds the Socs3 gene, which is a negative regulator of Stat3 
activation (Kershaw et al., 2013; Schmitz et al., 2000). This prompted my hypothesis that 
Nanog represses Socs3 transcription.  
 
Since Socs3 transcription is upregulated by PStat3 to form a classic negative feedback loop 
(Schmitz et al., 2000; Yoshiura et al., 2007), determining whether Nanog overexpression 
causes Socs3 repression is obfuscated by the effect of PStat3 on Socs3. To disentangle the 
opposing yet interconnected influences of Nanog and PStat3 on Socs3 expression, I designed 
experiments in which the PStat3 level is not significantly influenced by Nanog. ESCs can be 
maintained without exogenous LIF by 2i medium as introduced in Section 1.2.2 (Ying et al., 
2008). In the absence of LIF-stimulated Socs3 activation, the effect of Nanog on Socs3 
transcription can be assessed. From RT-qPCR analysis of wild-type, Nanog-/- and NanogOE 
ESCs cultured in 2i, strong negative correlation was evident between Nanog and Socs3 
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expression levels (Figure 3.2.1B). Furthermore, in the absolute absence of PStat3 in 





Figure 3.2.1: Nanog amplifies Stat3 phosphorylation and negatively correlates with Socs3 
(A) Western blot analysis of PStat3 and total Stat3 protein expression in wild-type (WT) and 
constitutively Nanog-overexpressing (NanogOE) ESCs in response to LIF stimulation for 0, 2 
and 12 hours. LIF was withdrawn from FCS culture for 36 hours prior to re-addition, and 
selection for pluripotent cells was maintained throughout. Positive feedback of PStat3 
induction on Stat3 and Nanog expression was observed, in accordance with previous work 
(Bourillot et al., 2009; Martello et al., 2013; van Oosten et al., 2012).  
(B) RT-qPCR analysis of Nanog and Socs3 expression in ESCs cultured in 2i without LIF for 
at least 7 days, relative to Gapdh and normalised to the highest values. Mean ± SD (n=3) is 
shown. NanogOE: constitutive Nanog-overexpression. EV: empty vector. 
 
 
To permit Nanog perturbation within a single cell line, I generated a doxycycline (dox)-
inducible Nanog transgene (iNanog). I amplified TetO.FLBioNanog.UbiP.rtTA3 from a 
previously described dox-inducible Nanog construct (Fidalgo et al., 2012). FLBioNanog codes 
for FLAG- and biotin-tagged murine Nanog. TetO denotes the operator/promoter and rtTA3 
encodes the dox-controlled transactivator of the ‘Tet-On’ system (Gossen et al., 1995). The 
ubiquitous promoter UbiP drives constitutive expression of rtTA3. 
TetO.FLBioNanog.UbiP.rtTA3 was then inserted into piggyBac (PB) blasticidin-resistant 
destination vector by Gateway cloning. To ensure that FLBioNanog was expressed only in the 
presence of dox, I removed the constitutive CAG promoter from the destination vector by 
restriction digestion and re-ligation. The resulting iFLBioNanog (iNanog) construct confers 
constitutive blasticidin resistance, allowing selection of successfully transfected cells 






Figure 3.2.2: Validation of dox-inducible Nanog transgene 
Western blot of Nanog protein expression in Nanog-/- iNanog ESCs following dox induction in 
FCS+LIF, compared to wild-type (WT) ESCs (N.B. endogenous Nanog expression level is 
much lower in FCS+LIF than in 2iLIF). FLAG- and biotin-tagged (FB) Nanog expressed from 
iNanog was detected at a higher molecular weight than endogenous (E) Nanog, as expected. 
 
 
To independently manipulate Nanog and PStat3 levels within a single cell line, iNanog can be 
used to induce Nanog on-demand. However, simple LIF-induction of PStat3 could be 
influenced by whether or not Nanog was co-induced, due to the induction of Socs3 by 
LIF/Stat3 vs the negative correlation between Socs3 and Nanog (Figure 3.2.1). To solve this 
problem, I engineered Nanog-/- ESCs containing both iNanog and GY118F (iPStat3) 
transgenes. As introduced in Section 1.3.5, Stat3 can be specifically activated by GCSF-
stimulation of the GY118F receptor transgene, which, crucially, is insensitive to repression by 
Socs3 (see Figure 1.2.4 for schematic). Thus, when GCSF/GY118F are used in the absence 
of LIF, Socs3 downregulation by Nanog should have little or no effect on PStat3 levels: nearly 
all Stat3 activation will be attributable to Socs3-insensitivie GY118F rather than Socs3-
sensitive LIFR-GP130 (Burdon et al., 1999; Niwa et al., 1998). Therefore, in 
Nanog-/- iNanog+iPStat3 cells in 2i, Nanog and/or PStat3 induction are independent variables. 
 
In 2i without LIF, I induced Nanog expression and Stat3 activation separately and in 
combination by dox/GCSF respectively. Induction of Nanog alone caused Socs3 repression, 
while Socs3 induction in response to Stat3 activation was reduced by 60% when Nanog was 
also induced (Figure 3.2.3A). This suggests that Socs3 repression is a mechanism by which 
Nanog augments LIF signal transduction in ESCs, resulting in higher levels of active PStat3. 
The same trends were observed in Nanog-/- iNanog+iPStat3 EpiSCs in standard FA 
conditions (Figure 3.2.3A), demonstrating that Nanog-mediated Socs3 repression is not 
restricted to ESCs, and may be of functional relevance during Nanog-driven reprogramming. 
 
In order to test whether Nanog could directly repress Socs3 transcription, Nanog-ChIP was 
performed 3 hours after dox-induction of Nanog in a null ESC background. Induction of Nanog 
expression rapidly led to enriched Nanog binding at the Socs3 gene in ESCs, consistent with 





Figure 3.2.3: Nanog binds the Socs3 promoter and represses its transcription 
(A) RT-qPCR analysis of Socs3 expression in Nanog-/- iNanog+iPStat3 ESCs or EpiSCs 
following induction with dox and/or GCSF. ESCs were cultured in 2i without LIF, and EpiSCs 
in FA. Mean expression is shown relative to Gapdh and normalised to wild-type FCS+LIF ESC 
level=1, ± SD (n=3). Lower panels: zoomed in on the respective dox inductions. 
(B) Published ESC ChIP-seq data (Marson et al., 2008) reveal that Nanog binds the upstream 
regulatory region of the Socs3 gene. Arrow indicates the direction of Socs3 transcription. 
(C) ChIP analysis of Nanog binding at the regulatory region of Socs3. Proximal and distal 
Nanog binding sites are as indicated. Nanog expression was dox-induced in Nanog-/- iNanog 
ESCs in 2i culture and samples were harvested at 0 and 3 hours. Data shown are the mean 
of 3 technical replicates from each of 2 experiments (i and ii). Error bars indicate ± SD. This 





3.2.2 Nanog and PStat3 synergistically upregulate Klf4 and novel Klf4 enhancer RNA 
 
To further explore the newfound mechanistic link between Nanog and LIF/Stat3 signalling, I 
investigated the effect of Nanog on expression of LIF/Stat3 targets in ESCs. In the steady-
state presence of LIF, I found strong positive correlation between levels of Nanog and Klf4, a 
canonical PStat3 target (Bourillot et al., 2009; Niwa et al., 2009; van Oosten et al., 2012) (CB 
Figures 1A, S1B). Interestingly, in response to LIF stimulation, Klf4 upregulation required both 
Nanog and Stat3 to be present, while Nanog overexpression cooperated with LIF to 
substantially increase the rate and levels of Klf4 induction (Figure 3.2.4A). Oct4 expression 





Figure 3.2.4: Nanog modulates the response of Klf4 to LIF 
(A–B) RT-qPCR analysis of gene expression, relative to Gapdh and normalised to the highest 
value. Mean expressions are shown, ± SD (n=3). 
(A) Klf4 expression in constitutively Nanog-overexpressing (NanogOE), wild-type (WT), 
Nanog-/- and Stat3-/- ESCs in response to LIF stimulation for 0, 2 and 12 hours. Left: LIF was 
withdrawn from FCS culture for 36 hours prior to re-addition. Selection for pluripotent cells was 
maintained throughout. Right: LIF was added after at least 7 days in 2i without LIF, because 
Stat3-/- ESCs cannot be cultured in FCS. 
(B) Oct4 expression confirms undifferentiated status. Nanog is present as appropriate. 
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Since Nanog and PStat3 both bind the Klf4 enhancer (Figure 3.2.5A), it is possible that they 
regulate Klf4 transcription directly. However, the Klf4 enhancer lies around 60 kb downstream 
of the Klf4 transcription start site and Nanog/PStat3 do not bind the Klf4 promoter. This 
prompted two hypotheses, which are not mutually exclusive: (1) formation of a classic 
enhancer-promoter loop, and/or (2) cis-action of non-coding enhancer RNA. Interestingly, the 
Klf4 enhancer was recently identified as an archetypal ‘super-enhancer’ (Whyte et al., 2013), 
bound by high levels of the transcriptional coactivator Mediator (Figure 5.2.5A) that may assist 
in higher-order chromatin organisation. Consistent with hypothesis (1), published Hi-C data 
indicated a high frequency of physical interaction between Klf4 enhancer and promoter regions 
(Figure 3.2.5B) (Dixon et al., 2012). 
 
To test hypothesis (2), I explored the molecular characteristics of the Klf4 enhancer utilising 
publicly available ChIPseq and RNAseq data (Figure 3.2.5). RNA PolII binding and H3K27ac 
co-enrichment suggested active transcription from this enhancer in ESCs, over a 20 kb region 
(chromosome 4: 55475000–55495000 on assembly mm9). Furthermore, a ‘K4-K36 domain’ 
was predicted here, which, in the absence of a known protein-coding gene, is thought to 
demarcate PolII-transcribed non-coding RNA (Guttman et al., 2009). Indeed, published 
RNAseq (Martello et al., 2013) indicated bidirectional transcription from the Klf4 enhancer in 
ESCs (Figure 3.2.5). 
 
I experimentally confirmed the existence of novel RNA expressed from the Klf4 enhancer, 
which I now term K4eRNA, by conducting RT-PCR on ESC cDNA template (Figure 3.2.5C). 
The cDNA was synthesised using random hexamer primers, to avoid polyA+ transcript bias. 
Genomic DNA was used as a positive control for PCR primers, and cDNA preparations without 
reverse transcriptase provided a negative control to ensure that RT-PCR signal was solely 
attributable to RNA, not gDNA contamination. Transcript was detected from mm9 
4:55470000–55495000, with a gap from mm9 4:55480000–55484000. This was consistent 





Figure 3.2.5: Identification of novel enhancer RNA at the Klf4 locus 
(A) The Klf4 locus is shown on assembly mm9, together with publicly available ESC ChIPseq 
and RNAseq data. Novel enhancer RNA (K4eRNA) is indicated by the golden box. 
(B) Adapted from Whyte et al, 2013, based on data from Dixon et al, 2012. Hi-C interaction 
frequency is displayed above the Klf4 locus, and shows that the Klf4 enhancer and promoter 
regions interact at high frequency (boxed-square) in ESCs. OSN: Oct4/Sox2/Nanog. 
(C) Transcription from the Klf4 enhancer was confirmed by RT-PCR. ESC cDNA (c), genomic 
DNA (g), and cDNA preparations without reverse transcriptase (–) were used as templates for 
RT-PCR. Primers were designed to amplify 60–150 bp regions every 1–2 kb from mm9 4: 
55470000–55500000. Expression was detected from mm9 4:55470000–55495000, with a gap 
from mm9 4:55480000–55484000. Representative expressed regions are shown, centred on 
mm9 4:55470000, 55472000 and 55474000. L: molecular weight ladder. 
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If K4eRNA is responsible for signal transduction between the Klf4 enhancer and promoter, 
then its expression should show positive or negative correlation with Klf4, depending on 
whether it is an activating or repressive regulator. RT-qPCR analysis of K4eRNA expression 
revealed that it positively correlated with Klf4, responding to Nanog and LIF/Stat3 in the same 
manner (Figure 3.2.6A). Therefore, I hypothesize that K4eRNA is a cis-activator of Klf4 
transcription, since Nanog and PStat3 bind only to the Klf4 enhancer but not promoter. 
 
The correlation between Nanog and K4eRNA/Klf4 was abrogated in the absence of PStat3 in 
Stat3+/+ ESCs without LIF and in Stat3-/- ESCs (Figure 3.2.6B), demonstrating that Nanog-
driven K4eRNA/Klf4 upregulation was PStat3-dependent. However, the effect of Nanog on 
K4eRNA/Klf4 transcription cannot be solely attributable to Nanog-mediated PStat3 elevation, 
since Stat3 hyperactivation in the absence of Nanog could not rescue K4eRNA/Klf4 
expression (Figure 3.2.6B). Together, this indicates co-dependent action of Nanog and PStat3 





Figure 3.2.6: K4eRNA responds to Nanog and PStat3 in the same manner as Klf4 
(A–B) RT-qPCR analysis of gene expression, relative to Gapdh and normalised to the highest 
value. Mean expressions are shown, ± SD (n=3). 
(A) K4eRNA expression in Nanog-/-, wild-type (WT) and constitutively Nanog-overexpressing 
(NanogOE) ESCs in response to LIF stimulation. LIF was withdrawn from FCS culture for 36 
hours prior to re-addition. Selection for pluripotent cells was maintained throughout. 
(B) Left: Klf4 and K4eRNA expression in Nanog-/-, wild-type (WT) and constitutively Nanog-
overexpressing (NanogOE) ESCs cultured in steady-state FCS+LIF. Right: Klf4 and K4eRNA 
expression in NanogOE Stat3-/-, NanogOE Stat3+/+, and Stat3-activated (GY118F+GCSF) 





The relationship between Nanog, PStat3 and K4eRNA/Klf4 expression was further dissected 
using Nanog-/- iNanog+iPStat3 ESCs in 2i without LIF. Together, dox-induction of Nanog 
expression and GCSF-stimulation of Stat3 activation elicited K4eRNA/Klf4 upregulation in a 
synergistic manner compared to induction of either factor alone (Figure 3.2.7). This synergistic 
action of Nanog and PStat3 is specific to K4eRNA/Klf4: other pluripotency factors did not 
respond in this manner, including Nanog-target Esrrb (Festuccia et al., 2012) and PStat3-





Figure 3.2.7: Nanog and PStat3 synergistically upregulate K4eRNA and Klf4 
RT-qPCR analysis of mean gene expression, relative to Gapdh and normalised to the highest 
value, ± SD (n=3). Expression of Klf4 and K4eRNA (A) or Esrrb, Klf5, and Oct4 (B) are shown 
in Nanog-/- iNanog+iPStat3 ESCs following induction with dox and/or GCSF in 2i without LIF.  
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3.2.3 Nanog and PStat3 induce rapid and efficient reactivation of naïve genes 
 
Having mechanistically linked Nanog and PStat3 in ESCs where the pluripotency network is 
fully operational, I turned to EpiSCs to study the role of these connected mechanisms during 
naïve pluripotency establishment. This necessitated generation of Nanog-/- background 
EpiSCs (Figure 3.2.8) to eliminate confounding endogenous Nanog expression. 
 
NanogF/F (Chambers et al., 2003) and Nanog+/- (Mitsui et al., 2003) mice were crossed, and 
EpiSCs were derived from resultant Nanog-/F and Nanog+/F post-implantation embryos in 
collaboration with Jenny Nichols. I then treated Nanog-/F EpiSCs with TAT-CRE, to excise 
LoxP-flanked Nanog exons and bring GFP under control of the Nanog promoter. This resulted 
in Nanog-/- EpiSCs with βgeo and GFP expressions driven by endogenous Nanog promoters 
(Figure 3.2.8A–B). Retention of EpiSC identity was confirmed by RT-qPCR and morphology 





Figure 3.2.8: Generation of Nanog-/- embryo-derived EpiSCs 
(A) Schematic of the strategy used to generate Nanog-/- EpiSCs, not to scale. All alleles are 
under control of the endogenous Nanog promoter, and the Nanog 5' UTR is unchanged. Key: 
floxed-Nanog (F); wild-type Nanog (+); deleted Nanog (-); endogenous Nanog exons (1,2,3,4); 
splice-acceptor (SA); internal ribosome entry site (IRES); geneticin resistance (βgeo); stop 
codon (S); LoxP site (L); puromycin resistance (Pac). GFP coding sequence is brought under 
control of the endogenous Nanog promoter after floxing.  
(B) Genotyping PCR was conducted with 3 primers, 1 of which is common to F, + and βgeo 
alleles. 1 primer recognizes both F and + alleles, to give an 800 bp product. 1 primer anneals 
to the βgeo allele, yielding a 600 bp product. L: molecular weight ladder.  
Left: Genotyping of embryo-derived EpiSCs revealed that #2 was Nanog-/F. Right: Nanog-/- 
clonal EpiSC lines (#2cre02, 11, and 15) were obtained after treating #2 Nanog-/F EpiSCs 
with TAT-CRE. Nanog-/- ESC samples containing different knock-out alleles were included as 
negative controls (–), while #2 Nanog-/F and #4 Nanog+/F EpiSCs provided positive controls. 
Nanog-/- #2cre15 EpiSCs were used in all subsequent experiments. 
(C) RT-qPCR analysis of Nanog-/- and Nanog+/F EpiSCs derived from Nanog-/F and 
Nanog+/F littermate embryos, cultured in FA. Mean gene expression was measured relative 
to Gapdh and normalised to the highest value, ± SD (n=3). Lack of Nanog expression in 
Nanog-/- EpiSCs confirmed null genotype, while expression of Oct4 and Fgf5 but not Rex1 or 
Klf4 confirmed EpiSC identity. 
(D) Representative phase and Nanog::GFP images of the Nanog-/- EpiSCs derived from 




The aforementioned iNanog+iPStat3 system provides a powerful platform for the quantitative 
dissection of Nanog and PStat3 mechanisms, since they can be induced separately and in 
combination within a single cell line. Therefore, I introduced these transgenes to Nanog-/- 
EpiSCs and performed timecourse inductions. In the first instance, I maintained EpiSC FA 
culture conditions throughout so that responses could be ascribed exclusively to transgene 
induction.  
 
Strikingly, Nanog and PStat3 co-dependently reactivated Klf4 and K4eRNA in this distinct 
cellular and environmental context (Figure 3.2.9). This demonstrated that their effect on Klf4 
was not an ESC-specific phenomenon, and may be of functional relevance for Nanog/PStat3-
driven reprogramming. 
 
Known Nanog-target Esrrb (Festuccia et al., 2012) responded to dox-induction of Nanog 
expression in EpiSCs. Similarly, known PStat3 targets Klf5 (Bourillot et al., 2009; Niwa et al., 
2009) and Tfcp2l1 (Martello et al., 2013; Ye et al., 2013) were upregulated following GCSF-
induction of Stat3 activation (Figure 3.2.9). However, the synergistic response of Klf4 to Nanog 
and PStat3 remained unique.  
 
Although Klf2 is not considered a PStat3 target in ESCs (Hall et al., 2009), I found that it was 
upregulated within 1 hour in response to Stat3 activation in EpiSCs whilst maintaining FA 
conditions (Figure 3.2.9). This suggests that Klf2 is a target of PStat3 in EpiSCs, raising the 
possibility of different network topologies during establishment vs maintenance of naïve 
pluripotency. Unlike Klf4, Klf2 induction in response to PStat3 was dampened rather than 
augmented by co-induction of Nanog. Another curious case of opposing action between 
PStat3 and Nanog was proffered by Sox2, a core pluripotency factor expressed in both primed 
and naïve pluripotent states. Sox2 expression was transiently boosted by PStat3 but 
repressed by Nanog (Figure 3.2.9). These contradictory effects appeared to balance each 
other in the scenario of co-induction – please see Section 8.2.2 for related discussion. 
 
In total, Nanog and PStat3 rapidly reactivated many key components of the naïve pluripotency 
network to near ESC-level, shedding light on their ability to drive fast and efficient 
reprogramming. This is even more remarkable when taking into account that the assay used 








Figure 3.2.9: Nanog and PStat3 induce rapid reactivation of naïve genes in EpiSCs 
RT-qPCR analysis of Nanog-/- iNanog+iPStat3 EpiSCs following induction with dox/GCSF in 
FA. Mean expression was measured relative to Gapdh and normalised to FCS+LIF ESC-
level=1, ± SD (n=3). 
 
 
3.2.4 Combined PStat3 and Klf4 bypass Nanog in reprogramming 
 
Although Nanog is dispensable for pluripotency maintenance (Chambers et al., 2007), it is 
required for establishment of the pluripotent epiblast during preimplantation embryonic 
development (Silva et al., 2009). Correspondingly, Nanog is essential for naïve pluripotency 
establishment during conventional in vitro reprogramming experiments (Silva et al., 2009). 
Rescue of Nanog-/- reprogramming thus provides a means of functionally testing proposed 
downstream mechanisms of Nanog. 
 
So far, I have described two new Nanog mechanisms: PStat3 elevation by Socs3 repression, 
and Klf4 upregulation in cooperation with PStat3. Therefore, I investigated the ability of PStat3 
and Klf4 to rescue reprogramming of Nanog-/- EpiSCs. I also tested Esrrb, since it has 
previously been reported as a Nanog downstream target able to bypass Nanog in 
reprogramming of ESC-derived EpiSCs (Festuccia et al., 2012). Expression of GFP and βgeo 
under the control of endogenous Nanog promoters provided visual and selective reporters in 
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our system, since EpiSCs cannot survive long-term in the reprogramming culture conditions 
(Figure 3.2.10A). 
 
Forced expression of Nanog, Esrrb, Klf4 or PStat3 individually can drive reprogramming of 
Nanog+/+ EpiSCs in 2iLIF conditions (Festuccia et al., 2012; Guo et al., 2009; Silva et al., 
2009; Yang et al., 2010). I verified the ability of Nanog-/- EpiSCs to generate iPSCs in 2iLIF 
when rescued by Nanog expression, and confirmed that Stat3 activation in conjunction with 
Nanog expression drove rapid reprogramming at high efficiency (Figure 3.2.10B). However, 
in the absence of Nanog, individual and combined expression of Esrrb, Klf4 and PStat3 could 
not rescue reprogramming in 2iLIF (Figure 3.2.10B).  
 
Since Nanog is a reported target of PD03 (Lanner et al., 2010; Silva et al., 2009), I 
hypothesised that PD03 may be detrimental in the absence of Nanog and thus tested PD03-
free reprogramming conditions. I tried to rescue Nanog-/- reprogramming with individual and 
combined expression of Esrrb, Klf4 and PStat3 in Chiron (CH)+LIF (Figure 3.2.10C) and in 
FCS+LIF. To my surprise, I found that Esrrb overexpression was unable to drive 
Nanog-/- EpiSC reprogramming in any condition. I speculate that this is due to differences in 
reprogramming propensity between these EpiSCs derived from Nanog-/F embryos, and ESC-
derived secondary EpiSC systems (Festuccia et al., 2012). Individually, Klf4 and PStat3 also 
failed to yield iPSCs. Although they initially generated GFP+ colonies in CH+LIF (Figure 
3.2.10C), these lacked the capacity to self-renew after passaging into 2iLIF, suggesting that 
reprogramming was incomplete. 
 
In combination, PStat3+Esrrb and PStat3+Klf4 yielded Nanog-/- GFP+ iPSCs in CH+LIF 
conditions (Figure 3.2.10C). Although Nanog-/- iPSCs could not be established in 2iLIF or 
PD03+LIF, once naïve pluripotency was established in CH+LIF, Nanog-/- iPSCs could be 
passaged indefinitely in 2iLIF, consistent with known discrepancies between Nanog 
requirement in pluripotency establishment vs maintenance. After passaging in 2iLIF, gene 
expression profile and observed chimeric competence of Nanog-/- iPSCs formally 
demonstrated their reacquisition of a naïve pluripotent program (Figure 3.2.10D–E). 
 
Together, this highlights PStat3 activation as a key functional mechanism acting downstream 
of Nanog, which, in conjunction with overexpression of either Nanog-target Klf4 or Esrrb, can 
efficiently rescue Nanog-/- reprogramming. It is of interest to note that Klf4 but not Nanog 
overexpression can drive EpiSC reprogramming in the presence of JAK inhibitor (Yang et al., 
2010), further supporting the placement of Nanog upstream and Klf4 downstream of Stat3 





Figure 3.2.10: Combined PStat3 and Klf4 bypass Nanog in reprogramming 
(A) Schematic depicting the protocol for reprogramming of Nanog-/- EpiSCs containing βgeo 
and GFP reporters under the endogenous Nanog promoters. 
(B) Representative images taken on day 12 of reprogramming in 2iLIF. The mean number of 
GFP+ iPSC colonies is indicated as % of cells initially plated, ± SD (n=3). Scale bars: 100 µm. 
(C) Representative images taken on day 12 of reprogramming in CH+LIF. Quantification of 
reprogramming efficiency by GFP+ colony counting was inappropriate in this case, since 
CH+LIF is a permissive medium compared to 2iLIF and yielded some GFP+ colonies that 
were not true iPSCs. After passaging in 2iLIF, clean iPSC lines were obtained as indicated. 
Scale bars: 100 µm. 
(D) RT-qPCR analysis of gene expression in CH+LIF-derived Nanog-/- iPSCs after passaging 
in 2iLIF, compared to parental EpiSCs in FA and wild-type and Nanog-/- ESCs in 2iLIF. 
Expression patterns of Nanog, Esrrb and Klf4 verified the genotypes. Full reprogramming to 
naïve iPSCs was confirmed by reactivation of naïve genes, maintenance of Oct4, and 
repression of Fgf5 expression. Mean gene expression ± SD (n=3) is shown relative to Gapdh 
and normalised to wild-type ESC level, except Fgf5 which is normalised to control EpiSCs.  
(E) Chimeric mouse obtained after injecting PStat3+Klf4 EpiSC-derived Nanog-/- iPSCs into 
C57/BL6 blastocysts. Agouti coat colour indicates chimeric contribution (MF1/129 




Nanog is dispensable for the initial formation of reprogramming intermediates (pre-iPSCs) 
from somatic cells, but is essential for pre-iPSCs to transit to naïve pluripotency in 2i+LIF (Silva 
et al., 2009). In an exciting parallel to my findings in EpiSCs, collaborators demonstrated that 
Nanog-/- pre-iPSCs could also reprogram in alternative conditions (CH+LIF or KSR+LIF), 
albeit with low speed and efficiency (CB Figure S4C–D). Microarray analysis of our combined 
samples revealed that pre-iPSC-derived and EpiSC-derived Nanog-/- iPSCs clustered closely 
with both wild-type and Nanog-/- ESCs, demonstrating reprogramming to a naïve pluripotent 
identity (Figure 3.2.11). It should be noted that retroviral Klf4 and exogenous LIF provided the 
reprogramming impetus for these pre-iPSCs, again implicating PStat3 and Klf4 in the rescue 





Figure 3.2.11: Acquisition of naïve gene expression signature in Nanog-/- iPSCs 
Correlation heatmap of gene expression between: wild-type (WT) ESCs, Nanog-/- ESCs, pre-
iPSC-derived Nanog-/- iPSCs, PStat3+Klf4 EpiSC-derived Nanog-/- iPSCs all in 2iLIF; 
parental Nanog-/- pre-iPSCs in FCS+LIF; parental Nanog-/- EpiSCs in FA. 2 technical 
replicates were included for each cell line. Pre-iPSC and derived iPSC samples were 






3.3.1 Modulation of LIF signal transduction by Nanog 
 
Two mechanisms of signal/TF interplay are exemplified by the work of Chapter 3: (1) 
modulation of extrinsic signal sensitivity by a nuclear TF, and (2) cooperation between the 
nuclear TF and the activated TF downstream of the extrinsic signal transduction cascade. This 
highlights the importance of considering the intrinsic properties of a cell when computing the 
efficacy and output of signal exposure. A signal does not simply give the cell an instruction, 
but rather is interpreted as a function of the internal network state, even when the basic 
transduction machinery is already present. 
 
In this particular case, I demonstrated that Nanog enhanced transduction of extracellular LIF 
signal by transcriptionally downregulating the Socs3 repressor, and additionally cooperated 
with resultant active PStat3 to elicit synergistic and co-dependent upregulation of Klf4. This 
mechanistically connects Nanog and PStat3, two important factors for the establishment and 
maintenance of naïve pluripotency (Figure 3.1.1). Their convergence on Klf4 lends greater 
biological significance to the inclusion of Klf4 in the canonical ‘Yamanaka’ cocktail for somatic 
cell reprogramming. 
 
These findings may provide some insight into how Stat3 signalling has different consequences 
in different contexts. Here, Nanog potentiates the positive input of PStat3 to the naïve 
pluripotent network. In contexts without Nanog, PStat3 positively regulates specification of 
other cell types such as primitive endoderm, astrocytes and inflammatory Th17 T cells (Bonni 
et al., 1997; Egwuagu, 2009; Morgani and Brickman, 2015). In contrast, LIF/Stat3 and Nanog 
are again both important for PGC specification, a process with many recapitulated features of 
naïve pluripotency induction (Chambers et al., 2007; Hayashi et al., 2011; Murakami et al., 
2016; Ohinata et al., 2009). It would be of interest to test whether Nanog is involved in 
restricting PStat3 to its pluripotency-related target genes, and whether Nanog also amplifies 





Figure 3.3.1: Newfound role of Nanog in the modulation of LIF/Stat3 signal transduction 
Schematics depicting LIF/Stat3 signal transduction to target genes Socs3 and Klf4 in the 
absence (A) and presence (B) of Nanog. The work of Chapter 3 demonstrated that Nanog 
represses Socs3 and amplifies LIF signal transduction, resulting in higher levels of active 
PStat3. Furthermore, I found that Nanog and PStat3 upregulate Klf4 in a co-dependent and 
synergistic manner. Functionally, PStat3 elevation and Klf4 expression allowed bypass of the 
requirement for Nanog in reprogramming. 
 
 
3.3.2 Multifaceted relationship between Nanog and the environment 
 
Nanog thus contributes to the naïve TF network by concurrently inducing the expression of 
Esrrb (Festuccia et al., 2012), enhancing LIF/Stat3 signal transduction, and inducing Klf4 
expression in cooperation with PStat3 (Figure 3.3.1). Ultimately, combinations of these factors 
allowed in vitro bypassing of Nanog for the establishment of a naïve pluripotent cell state 
(Figure 3.2.10, CB Figure S4C–D). However, the slower kinetics and reduced efficiency of 
Nanog-/- somatic reprogramming implied the existence of further mechanisms by which 
Nanog operates. These may include additional downstream effectors of reprogramming, and 
the activities of Nanog partners such as Tet1/2 (Costa et al., 2013).  
 
Intriguingly, 2i conditions abolished Nanog-/- reprogramming rescue, whereas usually 2i 
promotes naïve pluripotency induction (Silva et al., 2008). This condition-specific rescue adds 
another layer of complexity to TF/signal interplay. PD03 appeared to be the problematic 
component in the absence of Nanog (Figure 3.2.10). How does loss of a TF flip the impact of 
a signal from beneficial to detrimental? Nanog is reportedly upregulated in response to PD03 




Recently, PD03 has been implicated in both appropriate and inappropriate hypomethylation 
of naïve ESCs (Choi et al., 2017; Ficz et al., 2013). I wonder whether there is a concerted 
action of Nanog and PD03 on the epigenome that becomes deleteriously dysregulated in the 
Nanog-/- context. Upon further exploration of the microarray data (Figure 3.2.11), I noticed 
that several genes pertaining to epigenetic regulation were differentially expressed between 
wild-type and Nanog-/- ESCs in 2iLIF. Nanog-/- ESCs exhibited higher expression of DNA 
methyltransferases, lower expression of methylation-sensitive genes, lower expression of 
PGC-related genes, and aberrant overexpression of the imprinted H19/Igf2 locus. Preliminary 
RT-qPCR analysis corroborated the inverse relationship between de novo methyl transferase 
3b (Dnmt3b) and methylation-sensitive Dazl expression in response to Nanog modulation. 





Figure 3.3.2: Condition-dependent relationship between Nanog and epigenetic regulation? 
Microarray and RT-qPCR gene expression analysis of Dnmt3b and Dazl in Nanog-/-, WT, 
NanogOE and Nanog-/- iNanog ESCs in 2iLIF or FCS+LIF ± dox for 7 days. For microarray 
data, expression is shown relative to WT ESCs. For RT-qPCR, mean expression was 
measured relative to Gapdh and normalised to the highest value, ± SD (n=3). 
 
 
In this epigenetic light, it is interesting to note that bypass of Nanog in somatic reprogramming 
was enhanced by KSR medium (CB Figure S4C). KSR contains ascorbic acid, a co-factor of 
dioxygenases including the jumonji histone demethylases and Tets (Blaschke et al., 2013; 
Esteban and Pei, 2012; Yin et al., 2013). Together, this raises the possibility that Nanog does 
not simply modulate canonical signal transduction to downstream transcriptional targets, but 




3.3.3 Klf4-directed synergy between Nanog and PStat3 
 
Induction of Nanog and PStat3 in EpiSCs led to rapid upregulation of many naïve TF network 
components (Figure 3.2.9). Some of these were attributable to either Nanog or Stat3, as 
expected for their direct target genes, whereas Klf4 induction resulted from a co-dependent 
synergy. The relative reprogramming contributions of Klf4 vs other targets of Nanog/PStat3 
should be further defined, for example by generation of Klf4-/- EpiSCs. Like Nanog and PStat3 
themselves, the Klf4-directed synergy may be of greater functional relevance during 
establishment rather than maintenance of naïve pluripotency (Figure 3.2.6B). 
 
Synergistic upregulation was not observed at other shared targets of Nanog/PStat3, such as 
Socs3 (Figure 3.2.3), and thus must be specified by genomic sequences or other bound 
factors at the Klf4 locus. Since Nanog and PStat3 proteins do not directly bind each other it 
seems unlikely that they regulate each other’s recruitment to the Klf4 enhancer (Torres and 
Watt, 2008). Indeed, preliminary ChIP experiments indicated that PStat3 enrichment at the 
Klf4 enhancer was not significantly modulated by Nanog expression in ESCs (Graziano 
Martello, unpublished). Perhaps Klf4 transcription is regulated by a multicomponent complex, 
which either cannot form or function positively in the absence of Nanog or PStat3. Meanwhile, 
comparative study of the gene regulatory sequences at other shared Nanog/PStat3 targets 
could pinpoint the special features of the Klf4 locus that cause it to respond in this manner. 
Such questions are at the core of understanding how differential gene regulation is achieved 
by a limited set of expressed factors (Section 1.1). 
 
Preliminary evidence suggested that the Nanog/PStat3/Klf4 regulatory relationship may also 
operate in other contexts of naïve pluripotency establishment, including during in vivo epiblast 
emergence and resetting of conventional primed human ESCs. In agreement with my findings 
in vitro, Nanog-/- murine blastocysts failed to activate PStat3 in their ICM (Kurowski et al., in 
preparation). Meanwhile, single-cell RNAseq revealed a reduced strength of positive 
correlation between Nanog and Klf4 expression in Stat3-/- ICMs (Boroviak et al., in 
preparation). In primed human ESCs, co-induction of Nanog+PStat3 led to synergistic 
upregulation of both Klf4 and Klf2, respectively indicating conservation and divergence of 
naïve network induction logic between species (Figure 3.2.9 vs 3.3.3). Further work will be 
required to unravel the functional relevance of these observations and how they fit within their 






Figure 3.3.3: Synergistic response of Klfs to Nanog and PStat3 in human ESCs 
H9 conventional primed human ESCs were transfected with iNanog and GY118F (iPStat3), 
stably selected, then treated with dox and/or GCSF for 24 hours whilst maintaining primed 
culture conditions. Mean Klf4 and Klf2 expression were measured by RT-qPCR relative to 
Gapdh and normalised to the highest value, ± SD (n=3). This was conducted in collaboration 
with Tim Lohoff. 
 
 
3.3.4 Role and conservation of the novel Klf4 enhancer RNA 
 
This work identified novel RNA expressed from the Klf4 enhancer (K4eRNA), with preliminary 
evidence suggestive of its role as a cis-activator of Klf4 transcription (Section 3.2.2). 
Unfortunately, attempts to knock-down K4eRNA were unsuccessful for technical reasons, thus 
precluding confirmation of this hypothesis. Studies conducted on bidirectionally transcribed 
eRNAs in other cell types have found that only one of the two strands is functional, but this 
does not necessarily correlate with orientation relative to the cis target (Lam et al., 2013; Li et 
al., 2013). Further K4eRNA transcript mapping and sequence analysis may assist in the 
identification of key regions to target on each strand. 
 
As outlined earlier, the Klf4 enhancer could regulate Klf4 transcription by expression of cis- 
activating K4eRNA, or by formation of a classic enhancer-promoter loop via Mediator. In fact, 
these two hypotheses can be amalgamated: it was recently demonstrated that enhancer-
expressed non-coding RNA can activate its target gene in cis by directly binding to and 
recruiting Mediator, modulating the kinase activity of Mediator towards histone H3 serine 10, 
and promoting Mediator-regulated DNA looping between the enhancer and promoter (Lai et 
al., 2013). Additionally, it was recently proposed that functional eRNA can induce enhancer-
promoter looping in a TF- and cohesin-stabilized manner (Li et al., 2013). It will be of interest 
to examine whether K4eRNA is targeted to the Klf4 promoter in this manner via Mediator or 
cohesin, by another protein intermediate, or by direct nucleic acid binding. First, RNA and DNA 
fluorescence in situ hybridisation should be performed to assess K4eRNA localisation relative 
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to the Klf4 enhancer and promoter. According to Hi-C analysis of three-dimensional higher 
order genomic organisation, a DNA loop does form between the Klf4 enhancer and promoter 
in ESCs (Figure 3.2.5B) (Dixon et al., 2012; Whyte et al., 2013). 
 
More is known about the mechanistic action of repressive than activating non-coding RNAs, 
such as those involved in X chromosome inactivation and imprinting. It is plausible that, like 
repressive non-coding RNAs, activating eRNAs recruit epigenetic modifiers or remodellers to 
their target locus. Around the Klf4 transcription start site in FCS+LIF ESCs, there is a 
conspicuous ‘poised’ bivalent chromatin domain of overlapping repressive H3K27me3 and 
activating H3K4me3 (publicly available ESC ChIP-seq data). Therefore, additional hypotheses 
are that K4eRNA recruits H3K27me3-demethylases, or H3K4-methylases, to tip the ‘poised’ 
domain towards a more active chromatin state. Recruitment of chromatin modifiers could be 
accomplished by a different region of the K4eRNA to that responsible for targeting to the Klf4 
gene, and may be better conserved on the structural than sequence level. Thus far, very few 
functional eRNAs have been identified, and what little is known about their mechanisms of 
action indicates that they do not all act in the same fashion (Mousavi et al., 2013). Therefore, 
if K4eRNA is functional, dissection of the molecular mechanism by which it cis-activates Klf4 
transcription could reveal novel gene regulatory mechanisms of broad relevance. 
 
For a preliminary assessment of whether K4eRNA is conserved in other species, I aligned the 
murine Klf4 enhancer sequence against animal genomes available in 2013, using Ensembl 
Comparative Genomics tools. Expressed regions of the enhancer sequence are well 
conserved in the Klf4 enhancers of all mammals, including the monotreme platypus (Figure 
3.3.4). Small conserved regions are found downstream of Klf4 in bird, reptile and amphibian 
genomes, but I could not find conserved sequence in fish. In mammals, birds, reptiles and 
amphibians, Klf4 is found in a gene desert, with the putative K4eRNA sequence far 
downstream of Klf4. Since it is unusually well conserved, gene organisation around the Klf4 
locus is likely to be of functional importance. In contrast, organisational constraints do not 
apply in fish, where Klf4 is found in typical gene-rich regions, and other protein-coding genes 
can be found immediately downstream of Klf4 (Figure 3.3.4). In the future, it will be of interest 
to determine the molecular mechanism of K4eRNA action, whether it is indeed expressed from 
these conserved enhancer sequences in other species, and whether eRNA expression is a 








Figure 3.3.4: Conservation of the K4eRNA locus 
The DNA sequence encoding murine K4eRNA was aligned against available animal genomes 
using Ensembl Comparative Genomics tools on default settings on 01.06.13. Conserved 
regions are delineated by red boxes. Regions of the murine K4eRNA sequence are well 
conserved in the Klf4 enhancers of all mammals, including the monotreme platypus. Small 
conserved regions are found downstream of Klf4 in available bird, reptile and amphibian 
genomes, but not in fish: representative examples are shown here (chicken, Chinese soft-
shelled turtle, Xenopus and stickleback respectively). Gene organisation around the Klf4 locus 
is unusually well conserved in mammals, birds, reptiles and amphibians, but not in fish. 
Genomes are displayed on the most up-to-date assemblies as of 01.06.13 (mm10 rather than 
mm9 for mouse). Unfortunately I did not take a note of the default settings of the Ensembl 
Comparative Genomics tools on 01.06.13 and therefore this Figure should be considered as 










CHAPTER 4:  





As outlined in Chapter 1, a core aim of this thesis is to understand how TFs and signals interact 
to specify a cellular identity. The results in Chapter 3 provided an example of exogenous signal 
transduction modulation (LIF/Stat3) by a nuclear TF (Nanog). Importantly, this work also laid 
the groundwork for the utility of EpiSC reprogramming as an identity transition model for 
mechanistic study (Section 1.3). In Figure 3.2.9, I showed for the first time that the kinetics of 
naïve network reactivation in EpiSCs are rapid enough to study direct effects of factor 
induction on destination program installation, even whilst maintaining EpiSC FA conditions. 
Therefore, by independently varying factor inductions with signal perturbations, it should be 
feasible to disentangle the contributions of TFs and the environment to transcriptional rewiring. 
I test this in Section 4.2.1. 
 
A number of technical barriers remained to the causal connection of molecular events to 
individual inputs (Section 1.3). Therefore, for the remainder of Chapter 4 I focus on solving 
these problems and developing appropriate tools to answer my biological questions.  
 
Compared to somatic cell reprogramming, EpiSC reprogramming is relatively efficient and 
thus better suited to mechanistic dissection of identity transitions. However, even in the best 
case scenarios, EpiSC reprogramming had so far not been achieved with efficiencies over 
~10% (Section 1.2.8). Due to the resultant heterogeneity, averages are confounded and thus 
cells undergoing the change of interest must be resolved from the bulk in order to study 
transition mechanism(s) (Figure 4.1.1). With this motivation, I establish and validate 
methodology to isolate productive EpiSC reprogramming intermediates in Section 4.2.2. 
 
When considering how interplay between TFs and signals elicit a cell identity transition, a 
fundamental outstanding question is whether there are multiple mechanisms by which to 
undergo a given identity transition. More detailed introductions to this concept can be found in 
Chapter 1 and in Section 5.1. Here, in Sections 4.2.3–5, I develop and optimise the tools that 
will be required to answer this question, i.e. different inducible single-factor reprogramming 





Figure 4.1.1: Productive intermediates must be isolated from the bulk 
Schematic illustrating the heterogeneous and asynchronous nature of reprogramming, 
necessitating a method by which to isolate productively transitioning intermediates (greens) 





4.2.1 Interaction between TFs and signalling environment during reprogramming 
 
In Figure 3.2.9, I assessed the initial transcriptional response of Nanog-/- iNanog+iPStat3 
EpiSCs following inductions whilst maintaining EpiSC FA culture conditions. Having 
established this baseline for the responses attributable solely to transgenes, I then extended 
the analysis to intersect with the contribution of signal variables to naïve network reactivation 
during reprogramming. First I confirmed the ability of Nanog and PStat3 to dominantly drive 
reprogramming despite FA conditions (Figure 4.2.1A–C). As expected (van Oosten et al., 
2012) reprogramming occurred, but at substantially lower efficiency than in 2iLIF. 
Nonetheless, resultant iPSCs exhibited naïve expression profile and chimera competence 
(Figure 4.2.1D–E) thus validating FA+dox+GCSF as a reprogramming condition. 
 
Following Nanog+PStat3 induction with dox+GCSF in either FA or 2iLIF, bulk timecourse 
expression analysis over 6 days revealed upregulation of naïve genes in both conditions. 
Some genes initially responded in a similar manner irrespective of environment (Klf4, 
K4eRNA, Klf2, Rex1), suggestive of early regulation by TF drivers rather than the environment. 
The divergence in these upregulation kinetics after day 3 may reflect the ultimately higher 
reprogramming efficiency in 2iLIF than FA and/or a later signal sensitivity. In contrast, Tfcp2l1 
and Nr5a2 were positively regulated by 2iLIF throughout, whereas Klf5 and Esrrb were 
damped initially.  
 
The responses of Sox2 and Oct4 were extremely surprising, both undergoing substantial 
downregulation in 2iLIF compared to FA. Given the higher reprogramming efficiency in 2iLIF 
(Figure 4.2.1B) these profiles in the bulk averages were counterintuitive. Notably, as core 
pluripotency factors, Oct4 and Sox2 are expressed in primed EpiSCs as well as naïve iPSCs. 
Considering this, two hypotheses came to mind: (1) transient suppression of Oct4/Sox2 may 
be necessary to dismantle the self-renewing primed network and rebuild the naïve network, 
which supports Oct4/Sox2 in a different configuration and from different enhancer elements, 





Figure 4.2.1: Reprogramming gene expression profiles in FA or 2iLIF 
(A) Schematic depicting the reprogramming of Nanog-/- iNanog+iPStat3 (iN+iPS3) EpiSCs 
driven by dox+GCSF in FA or 2iLIF. Nanog-/- EpiSCs contain βgeo and GFP reporters under 
the Nanog promoters, and so G418 was added at day 7 to select for endogenous Nanog 
promoter activity. Since Nanog promoter can also be active in EpiSC FA conditions, additional 
selection for naïve cells was added at day 7 by applying inhibitors of Fgf and Tgfβ signalling 
(PD173074 and A83-01 respectively). On day 12, GFP+ colonies were scored, then passaged 
into 2iLIF+G418 naïve-specific conditions. 
(B) Mean number of GFP+ colonies at day 12 per 20,000 cells plated ± SD (n=3). 
(C) Representative images taken on passage 7 in 2iLIF+G418. Scale bars: 100 µm. 
(D) RT-qPCR analysis of gene expression on passage 7 in 2iLIF+G418, compared to parental 
EpiSCs in FA. Mean gene expression ± SD (n=3) is shown relative to Gapdh and normalised 
to wild-type ESC level, except Fgf5 which is normalised to control EpiSCs. 
(E) Chimeric mouse obtained after injecting Nanog-/- iNanog+iPStat3 iPSCs into C57/BL6 
blastocysts, following reprogramming from EpiSCs in FA+dox+GCSF. Agouti coat colour 
indicates chimeric contribution (MF1/129 background).  
(F) RT-qPCR analysis of Nanog-/- iNanog+iPStat3 EpiSCs following induction with dox+GCSF 
in FA or 2iLIF over 6 days. Mean expression was measured relative to Gapdh and normalised 
to FCS+LIF ESC-level =1, ± SD (n=3). Mariana Alves provided technical assistance.  
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I tested whether delaying the signal switch caused a reduction or increase in reprogramming, 
by delaying the drop in Oct4/Sox2 expression (Figure 4.2.2A–B). Interestingly, the longer the 
cells spent in FA+dox+GCSF prior to 2iLIF switch, the higher the reprogramming efficiency. 
This suggests that delaying the Oct4/Sox2 drop is beneficial, consistent with hypothesis (2), 
although greater proliferation in FA than 2iLIF may exaggerate the effect. By timecourse gene 
expression analysis, I found that the Oct4/Sox2 drops were prompted by addition of 2iLIF 
rather than withdrawal of FA (Figure 4.2.2C), and that switching from FA to 2iLIF on day 1, 2 
or 3 elicited a similar degree of Oct4/Sox2 suppression by the following day (Figure 4.2.2D). 
Inverse trends were exhibited by Tfcp2l1 and Nr5a2, which are naïve-specific and positive 
responders to 2iLIF (Figure 4.2.1F). It would be of future interest to ascertain whether this 
reflects concerted yet opposite responses of Oct4/Sox2 vs Tfcp2l1/Nr5a2 to the 2iLIF signals, 






Figure 4.2.2: Network modulation by timing of signal switch in reprogramming 
(A) Schematic depicting the reprogramming of Nanog-/- iNanog+iPStat3 (iN+iPS3) EpiSCs 
driven by dox+GCSF. Conditions were swapped from FA to 2iLIF on each day from 0–5, with 
all in 2iLIF from day 6. G418 was added at day 6 to select for endogenous Nanog promoter 
activity, together with additional selection for naïve cells using inhibitors of Fgf and Tgfβ 
signalling (PD173074 and A83-01 respectively). On day 12, GFP+ colonies were scored. 
(B) Mean number of GFP+ colonies at day 12 per 8000 cells plated ± SD (n=3). 
(C–D) RT-qPCR analysis of Nanog-/- iNanog+iPStat3 EpiSCs following induction with 
dox+GCSF in FA, basal N2B27 medium (-) or 2iLIF over 6 days (C), or with medium switched 
from FA to 2iLIF on day 1, 2 or 3 (D). Mean expression was measured relative to Gapdh and 
normalised to FCS+LIF ESC-level =1, ± SD (n=3). 
 
 
Whilst the observations in Figures 4.2.1–2 exposed a fascinating puzzle, unfortunately the 
analysis of bulk averages cannot resolve the mechanistic meaning of these curious expression 
responses. This is further confounded by the disparate reprogramming efficiencies in FA vs 
2iLIF (Figure 4.2.1B). Therefore, I devote the remainder of this Chapter to development of 
defined and tractable reprogramming systems of high efficiency, in which isolation of 
productively transitioning reprogramming intermediates is possible. Further analyses would 
also be better conducted in a wild-type rather than Nanog-/- background, so that Nanog 
transgene need only be used when desired rather than required for reprogramming in 2iLIF. 
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4.2.2 Isolation of productive reprogramming intermediates 
 
Reprogramming is a heterogeneous and asynchronous process, in which cells undergoing the 
identity transition of interest are a minority subpopulation (Figure 4.1.1). As highlighted above, 
this presents a major challenge to mechanistic study, since bulk averages are confounded by 
unproductive events. To study the molecular events specifically in reprogramming cells, there 
are two possibilities: either develop a 100% efficient and synchronous system, or find a way 
to isolate the productive subpopulation. If possible at all, achieving the former would likely 
require a large number of inputs and manipulations, thus precluding the ability to conduct 
controlled single-variable experiments. Therefore, in order to understand how each factor and 
signal contributes to elicit identity change, the latter strategy is preferable.  
 
I first considered which genes might provide an appropriate reporter of reprogramming 
progression. Reporters that have been previously used to select for iPSCs following EpiSC 
reprogramming include Oct4 (Guo et al., 2009) and Nanog (Festuccia et al., 2012; van Oosten 
et al., 2012). However, Nanog and Oct4 are expressed in both EpiSCs and iPSCs and thus 
are not specific to the naïve state (Section 1.2.8). Whilst Nanog or Oct4 activation in addition 
to the ability to clonally expand in 2iLIF are indicative of the naïve identity when considered 
together, such reporters do not permit accurate analysis of naïve pluripotency establishment 
in more permissive environmental conditions such as subsets of 2iLIF (Figure 3.2.10C). This 
renders Nanog and total-Oct4 reporters unsuitable for the study of signal and TF interactions 
during reprogramming. I attempted reprogramming using Oct4-ΔPE naïve-reporter EpiSCs 
(kind gift from the Surani lab) but unfortunately their reprogramming efficiencies were 
untenably low in my hands for unknown reasons. Furthermore, isolation of cells based on 
Oct4-ΔPE reporter would preclude unbiased analysis of Oct4 expression behaviour during the 
transition. 
 
Considering the gene expression kinetics in Figures 3.2.9 and 4.2.1F, Rex1 appeared a 
suitable reporter candidate. Rex1 is expressed in naïve ESCs/iPSCs but not in EpiSCs, thus 
offering specificity for the destination identity. Its upregulation during initiation of EpiSC 
reprogramming positively correlated with future reprogramming efficiency, and occurred early 
enough for intermediate isolation to be feasible (unlike, for example, late-responding Nr0b1). 
Importantly, during ESC maintenance and differentiation, Rex1 has been extensively 
characterised as a sensitive yet passive proxy of naïve network strength (Kalkan et al., 2017). 
 
To obtain Rex1 reporter EpiSCs, Rex1::dGFP.IRES.bsd homozygous stud mice were crossed 
with wild-type females and EpiSCs derived from the resultant E6.5 embryos (Figure 4.2.3A). 
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These Rex1::dGFP reporter EpiSCs thus contain monoallelic destabilised GFP under the 
control of endogenous Rex1 promoter. In order to assess whether Rex1::dGFP reporter 
activation demarcates productive reprogramming intermediates, I employed dox-inducible 
Klf2.2A.Nanog (K2N) as the reprogramming driver. The choice of K2N here was in part due to 
ongoing toxicity issues with GCSF/GY118F-forced Stat3-activation as the driver, which I 
resolve in the next section. Furthermore, K2N is a known efficient driver (dos Santos et al., 
2014) suitable for proof-of-principle system validation, and had recently been reported as able 
to revert conventional primed human ESCs to a novel naïve state (Takashima et al., 2014) in 
a fascinating parallel to murine primed EpiSC reprogramming to naïve iPSCs. 
 
Following Rex1::dGFP iK2N EpiSC reprogramming induction with 2iLIF+dox, sorting for 
emergent Rex1::dGFP reporter activation enriched for the productive subpopulation (Figure 
4.2.3B–D). Importantly, this subpopulation represented intermediates that were destined to 
form iPSCs, but that had not already done so: sorted intermediates expressed lower levels of 
naïve markers than established iPSCs, and were still dox-dependent for clonogenicity in 2iLIF 
(Figure 4.2.3C–F). Naïve gene reactivation was higher in the dGFP+ intermediates, and 
progressed over time in conjunction with gradual Rex1 upregulation (Figure 4.2.3F). Together, 
this indicates that Rex1::dGFP reporter can be used to resolve productive intermediates from 
the average, rendering transitioning events available for mechanistic study.  
 
Again, both Oct4 and Sox2 dropped in the bulk average following reprogramming induction in 
2iLIF (Figure 4.2.3F). Strikingly, Oct4 and Sox2 behaviour resolved in opposite manners in 
the Rex1::dGFP+ subpopulation: Oct4 was maintained at or slightly above EpiSC/ESC 
expression level throughout the productive transition, whereas Sox2 was suppressed more in 
the dGFP+ fraction. This highlights the importance of studying productive rather than bulk 
populations in order to understand the logic of cell identity transitions, and it will be of great 
interest to ascertain whether these opposing Oct4/Sox2 responses are K2N-specific or a 






Figure 4.2.3: Validation of Rex1::dGFP reporter for isolation of productive intermediates 
(A) Schematic of the strategy used to generate Rex1+/dGFP.IRES.bsd (Rex1::dGFP) EpiSCs. 
Wild-type females were crossed with homozygous males, and heterozygous EpiSCs derived 
from resultant E6.5 embryos. All alleles are under control of the endogenous Rex1 promoter. 
dGFP has a half-life of 2 hours. Bsd confers resistance to blasticidin. Scale bar: 100 µm. 
(B) Reprogramming of Rex1::dGFP iKlf2.2A.Nanog (iK2N) EpiSCs was induced by 2iLIF+dox. 
Emergent dGFP+ cells were isolated by FACS on day 3 and analysed by RT-qPCR and clonal 
assay in 2iLIF+dox. 
(C) RT-qPCR analysis of Rex1 expression in emergent dGFP+, dGFP- and bulk sorted 
populations at day 3. This Rex1 expression is from the wild-type allele of the heterozygous 
cells, and positively correlates with dGFP driven by the other Rex1 promoter. Mean expression 
is shown relative to Gapdh then normalised to wild-type ESC level=1, ± SD (n=3). 
(D) Representative phase and dGFP images were taken on day 10, after clonal assay on cells 
sorted at day 3. Scale bars: 100 µm. 
(E) RT-qPCR analysis of gene expression of Rex1::dGFP iK2N iPSCs at passage 5, together 
with parental EpiSCs and wild-type ESCs. Mean expression is shown relative to Gapdh then 
normalised to wild-type 2iLIF ESC level=1, ± SD (n=3). 
(F) RT-qPCR analysis of gene expression in emergent dGFP+, dGFP- and bulk sorted 
populations on days 3–6. Mean expression is shown relative to Gapdh then normalised to 
wild-type 2iLIF ESC level=1, ± SD (n=3).  
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4.2.3 Optimisation of Stat3 activation by GCSF/GY118F 
 
PStat3 is one of the most important drivers to include in the study of EpiSC reprogramming. 
PStat3 is one of very few naïve factors that is essential for pluripotency establishment in vivo 
(Do et al., 2013) (Figure 3.1.1). Furthermore, it is to date the only known single factor to 
dominantly instruct naïve pluripotency whilst maintaining primed-specifying FA culture 
conditions (van Oosten et al., 2012). Unlike Oct4, PStat3 is rapidly lost in the peri-implantation 
epiblast, indicative of a naïve-specific role in the pluripotency continuum. Elegantly, provision 
of PStat3 as the driving TF overlaps with one of the three exogenous signals instructing naïve 
pluripotency: Stat3 is activated by the LIF component of 2iLIF. Therefore, whilst other TF 
drivers provide an additional input on top of 2iLIF, forced Stat3 activation together with PD03 
and Chiron yields only three variables to dissect in terms of input to cellular identity 
computation. However, as alluded to above, I repeatedly noticed some toxicity issues 
associated with GCSF treatment of GY118F-containing EpiSCs of various genetic 
backgrounds. This was problematic both in terms of efficiency reduction, and contamination 
of early timepoint samples with dying material. Therefore, methodology for forcing Stat3 
activation merited optimisation. 
 
In order to activate Stat3 in EpiSCs, provision of LIF is insufficient since EpiSCs have a limited 
ability to transduce LIF signal via LIFR/GP130 (Yang et al., 2010). Treatment with IL6 and 
soluble IL6 receptor could be an alternative, but would nevertheless rely on endogenous 
GP130 and would stimulate Mek/Erk signalling in addition to Jak/Stat3. Since GCSF-
stimulation of the GY118F receptor transgene elicits specific and sustained Stat3 activation 
(Burdon et al., 1999) (Figure 1.2.4), it remained the most promising approach. Anecdotally, in 
preliminary reprogramming experiments driven by iNanog+GY118F.dsRed from a 
heterogeneous starting EpiSC population, I noticed that iPSCs generated with or without 
GCSF exhibited lower or higher levels of dsRed respectively (Figure 4.2.4A). This suggested 
to me that the level of GY118F.dsRed might be important, with too much being incompatible 
with reprogramming and/or survival following GCSF-stimulation. In contrast, perhaps a degree 
of leak could explain the preference for high GY118F.dsRed when reprogramming was driven 
by dox alone. There is precedent in the literature for the level of PStat3 playing an important 
role in cell fate decisions. For example, Stat3 activation above a certain threshold can induce 
ESCs to differentiate towards the trophectoderm lineage, rather than promoting self-renewal 
(Tai et al., 2014). Therefore, I asked whether a particular level of PStat3 was optimal for naïve 
pluripotency specification during reprogramming, and if so whether I could achieve this by 
defined modulation of the GCSF/GY118F system. 
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I first took advantage of established Stat3+/+ and Stat3-/- ESCs to investigate how levels of 
GY118F, Stat3 and PStat3 pertain to naïve pluripotency maintenance. In the ESC context, 
cellular identity is stably established and thus controlled manipulation of factors can provide 
information regarding compatibility with the naïve identity. Rather than generating an array of 
clonal lines, I instead let the ESCs inform me as to their preferred PStat3 level, then applied 
this lesson to reprogramming system design. I transfected Stat3+/+ and Stat3-/- ESCs with 
transgenes driving constitutive Stat3 and/or GY118F expression in a variety of combinations 
and ratios, then selected stable transgenic lines both in the presence and absence of 
LIF/GCSF stimulation (Figure 4.2.4B). Subsequently, I performed acute induction of previously 
unstimulated populations, and compared resultant PStat3 levels with those exhibited following 
3 weeks of self-selection (Figure 4.2.4C–E). Whilst acute inductions elicited high PStat3 levels, 
long-term self-selection generally yielded PStat3 levels that were the same as those exhibited 
in wild-type 2iLIF ESC cultures (Figure 4.2.4 red stars). Therefore, the preferred PStat3 
dosage for naïve pluripotency maintenance is the endogenous level. This is in sharp contrast 
to other naïve factors known to drive reprogramming of EpiSCs into iPSCs, such as Nanog, 
Esrrb, Tfcp2l1 and Klfs, whose overexpression is beneficial for ESC self-renewal (Martello and 
Smith, 2014). Even when total Stat3 protein is grossly overexpressed (Figure 4.2.4 purple 
circles), ESCs have the capacity to precisely restrict the phosphorylated subset. 
 
Further insights were obtained by careful observation of ESC cultures during this self-selection 
process (Figure 4.2.4F–G). GCSF stimulation of GY118F.dsRed was highly detrimental in a 
Stat3-/- background, causing a great deal of death from which a surviving population 
eventually emerged with no visible dsRed. Meanwhile, GCSF-stimulated Stat3+/+ 
GY118F.dsRed ESCs self-selected a low level of GY118F following a period of cell death 
(Figure 4.2.4F), in the same manner as iPSCs reprogrammed by GCSF/GY118F (Figure 
4.2.4A). Interestingly, Stat3-/- ESCs constitutively expressing Stat3 but not GY118F did not 
die in response to LIF stimulation, but initially exhibited a high frequency of spontaneous 
differentiation (Figure 4.2.4G). Together, this suggests that the naïve pluripotent identity is 
compatible with levels of PStat3 below a particular threshold, consistent with the work of Tai 
et al., 2014. Above this, cells appear to die if PStat3 activation is driven by Socs3-insensitive 





Figure 4.2.4: Lessons from the naïve state regarding appropriate Stat3 activation level 
(A) Representative images of passage 5 iPSCs in 2iLIF, generated by reprogramming of 
Rex1::dGFP iNanog+GY118F.dsRed EpiSCs in 2iLIF±dox±GCSF. Scale bars: 100 µm. 
(B) Experimental strategy to ascertain the preferred PStat3 level in ESCs. Numbers refer to 
the µg of plasmid transfected per 250,000 cells in a 6well. 
(C–E) Western blot analysis2 of PStat3, total Stat3, Oct4 and αTubulin following stimulation 
with LIF or GCSF for 30 minutes, 18 hours or 3 weeks (3w). Key: see panel B. The same 
membrane was stripped between PStat3 and total Stat3 blots. Apologies for the error in 
loading order in panel C (dashed line).  
(F–G) Representative phase and dsRed images during the selection process in ESCs. Scale 
bars: 100 µm. 
                                               
2 Matched RNA samples are in the Silva lab -80 for anyone who would like to continue this work. 
  Additionally, EpiSCs differentiated from the 3w self-selected ESCs are in the Silva lab cell bank. 
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Since stimulation of PStat3 above endogenous level appears incompatible with naïve 
pluripotency maintenance, it could plausibly also be suboptimal for naïve identity 
establishment during reprogramming. Perhaps this accounts for the toxicity I was observing 
during GCSF/GY118F-mediated reprogramming, and the prior reporting of GY118F-driven 
reprogramming efficiencies at 1–2% (Yang et al., 2010). Assessment of the relationships 
between GY118F, Stat3 and reprogramming first necessitated the generation of Stat3-/- and 
matched control EpiSCs. Therefore, I differentiated Stat3-/- and littermate Stat3+/+ ESCs into 
EpiSCs for 8 passages in FA, then transfected them with various combinations and ratios of 
Stat3 and GY118F transgenes (Figure 4.2.5A). After 5 passages of selection for stable 
transgene integration without induction, I tested their reprogramming propensity in 2i with 
LIF/GCSF. Since Stat3-/- and littermate Stat3+/+ cells do not contain any pluripotency 
reporter, it is not possible to select for or quantify reprogramming in the usual manner. Instead, 
after 4 days of reprogramming I passaged all cells 4 times in 2iLIF with thorough dissociation 
to single cells, applying additional inhibitors of Fgf (PD173074) and Tgfβ (A83-01) signalling 
to eliminate unreprogrammed material that should not survive such conditions. The number of 
colonies at passage 4 thus gives a semi-quantitative reflection of reprogramming efficiency, 
representative images of which are shown in Figure 4.2.5B–C. 
 
Despite their origin as differentiated ESCs rather than embryo-derived EpiSCs, Stat3+/+ and 
Stat3-/- Stat3-rescued EpiSCs were not permissive for reprogramming in only 2iLIF (Figure 
4.2.5B), indicating that a full conversion to ‘late-stage’ EpiSCs had been achieved by the 
differentiation (Han et al., 2010). GCSF/GY118F rescued reprogramming of Stat3+/+ but not 
Stat3-/- EpiSCs, formally demonstrating that GY118F drives reprogramming in a Stat3-
dependent manner. Reprogramming did occur for Stat3-/- Stat3+GY118F EpiSCs. 
Intriguingly, GCSF stimulation generated iPSCs at higher efficiency when a lower dose of 
GY118F had been transfected (Figure 4.2.5C 2i+GCSF). Conversely, leaky reprogramming 
without GCSF occurred at a higher efficiency with a higher dose of GY118F (Figure 4.2.5C 
2iLIF). Together, these observations are consistent with the hypothesis that too much PStat3 
is detrimental to reprogramming, yet also demonstrated that some PStat3 was required. The 
latter was confirmed by RT-qPCR analysis of naïve gene expression after 4 days of 
reprogramming: prevention of Oct4 loss together with upregulation of naïve genes Klf4 and 






Figure 4.2.5: Balance between Stat3 and GY118F in EpiSC reprogramming 
(A) Stat3-/- and littermate Stat3+/+ ESCs were differentiated to EpiSCs by 8 passages in FA. 
Representative phase images of ESCs and resultant EpiSCs are shown. The EpiSCs were 
then transfected as indicated, and stably selected for 5 passages. Numbers refer to the µg of 




(B–C) Representative phase images of iPSCs after 4 passages of all material in 2iLIF with 
additional inhibitors of Fgf (PD173074) and Tgfβ (A83-01) signalling to eliminate 
unreprogrammed material. The number of colonies thus reflects reprogramming efficiency. 
Scale bars: 100 µm. 
(D) RT-qPCR analysis of gene expression in parental ESCs, EpiSCs after differentiation then 
transfection, day 4 of reprogramming from EpiSCs, and resultant iPSCs. Mean expression is 
shown relative to Gapdh then normalised to Stat3+/+ 2iLIF ESC level=1. Key: see panel A. 
 
 
To conclusively demonstrate a causal relationship between PStat3 induction level and 
reprogramming propensity, clonal lines with different transgene amounts should be generated 
and compared side-by-side. Despite many attempts, I was never able to generate clonal 
transgenic lines from EpiSCs by either picking or sorting. On the rare occasion that a clone 
expanded, its reprogramming ability was permanently compromised. This is not surprising, 
since EpiSCs are epithelial and known not to tolerate clonal passaging, yet it unfortunately 
limited further advancement of this line of inquiry. Nevertheless, the circumstantial evidence 
described in this Section 4.2.3 gave sufficient grounds to test transfection of Rex1::dGFP 
EpiSCs with a low dose of GY118F as an improved tool for PStat3-driven reprogramming. 
 
I transfected embryo-derived Rex1::dGFP EpiSCs (Section 4.2.2) with high and low amounts 
of GY118F transgene: 1.0 or 0.1 µg per 250,000 cells, subsequently selected with 150 or 
50 µg/ml hygromycin respectively. Both hygromycin concentrations killed untransfected 
controls. The reprogramming efficiency and kinetics of the low GY118F line were much greater 
than the high GY118F (Figure 4.2.6A). This reprogramming was, as expected, entirely GCSF-
dependent (Figure 4.2.6A–B). Importantly, the level of PStat3 induced by each line positively 
correlated with the amount of GY118F transfected, and negatively correlated with its 
reprogramming propensity (Figure 4.2.6C–D). I had considered further manipulation of 
Rex1::dGFP EpiSCs to include Stat3 transgene as well as GY118F, in case the EpiSC level 
of Stat3 was too low to respond optimally to GCSF/GY118F and in light of promising results 
in the Stat3-/- Stat3+GY118F 1:0.1 EpiSCs of Figure 4.2.5. However, endogenous Stat3 was 
quickly upregulated in response to GCSF/GY118F (Figure 4.2.6D), indicating that EpiSCs 
were competent to implement the positive feedback loop of PStat3 on Stat3 expression 
previously observed in ESCs (Figure 3.2.1) (Bourillot et al., 2009; Martello et al., 2013; van 
Oosten et al., 2012). Since low GY118F was sufficient for excellent reprogramming 
performance, and to avoid unnecessary perturbations, I continued without additional Stat3 







Figure 4.2.6: High-efficiency low-GY118F reprogramming 
(A) Representative phase dGFP images of Rex1::dGFP high GY118F EpiSCs on day 10 of 
reprogramming, low GY118F on day 5 and resultant iPSCs. High refers to transfection with 
1.0 µg of GY118F plasmid per 250,000 cells, while low refers to 0.1 µg. Scale bars: 100 µm. 
(B) RT-qPCR analysis of gene expression 48 hours after reprogramming induction of low 
GY118F EpiSCs with 2iLIF±GCSF, or maintenance in FA. Mean expression is shown relative 
to Gapdh then normalised to wild-type 2iLIF ESC level=1, ± SD (n=3). 
(C–D) Western blot analysis of PStat3, total Stat3 and αTubulin in high and low GY118F 
Rex1::dGFP EpiSCs, following stimulation with GCSF in the indicated conditions. The same 
membrane was stripped between PStat3 and total Stat3 blots. These western blots were 
performed by Petros Fessas.  
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4.2.4 Further technical improvements to EpiSC culture and reprogramming 
 
Prior to returning to the study of reprogramming mechanisms, I made a few further 
improvements to technical aspects of EpiSC culture and reprogramming. Since the 
metabolism of EpiSCs is largely glycolytic rather than oxidative (Zhou et al., 2012), I tested 
whether EpiSC maintenance and reprogramming could be improved under hypoxic conditions. 
Indeed, culture at 5% rather than atmospheric oxygen levels improved EpiSC morphology 
(Figure 4.2.7A), reprogramming efficiency and kinetics (Figure 4.2.7B). From hereon, all 
EpiSC cultures and reprogramming experiments are performed in low oxygen conditions.  
 
At the time of this work, new publications indicated that addition of XAV939 (XAV) improved 
EpiSC cultures by reducing heterogeneity, spontaneous differentiation and lineage marker 
expression (Kim et al., 2013; Sugimoto et al., 2015; Sumi et al., 2013). XAV is a small molecule 
that attenuates Wnt signalling, although its mechanisms of action in EpiSCs remain 
incompletely understood. Like Fgf signalling in naïve ESCs, endogenous Wnt signalling in 
EpiSCs promotes spontaneous differentiation, lineage priming, and heterogeneity (Kurek et 
al., 2015; Tsakiridis et al., 2014). This corresponds to the driving force of Wnt in vivo to push 
the epiblast towards primitive streak/mesodermal fates (Huelsken et al., 2000; Liu et al., 1999). 
Therefore, by inhibiting Wnt signalling, EpiSCs are held in a more homogenous state proposed 
to represent the ‘ground state’ of primed pluripotency (Morgani et al., 2017; Sumi et al., 2013). 
It is a further testament to the identity distinction between naïve and primed pluripotent states, 
that Wnt signalling promotes self-renewal while Fgf signalling triggers differentiation of the 
former, while the converse applies to the latter. 
 
Work in the Nichols group confirmed that addition of XAV to FA EpiSC culture conditions 
improved derivation and maintenance of more homogenous EpiSC lines. Therefore, in 
collaboration we derived fresh Rex1::dGFP EpiSCs under hypoxia in FA+XAV, which I use for 
the remainder of this thesis. 
 
Together, these improvements to EpiSC culture and reprogramming should facilitate the 
mechanistic study of cell identity transitions in this model system. Not only is it now possible 
to isolate productively transitioning intermediates on the basis of Rex1::dGFP reporter 
activation (Section 4.2.2), but higher efficiencies lend more meaning to analysis of earlier 







Figure 4.2.7: Improved EpiSC reprogramming in hypoxia 
(A) Representative 10x phase images of EpiSCs cultured in FA in hypoxic vs normoxic 
conditions. This was still without XAV. Scale bars: 100 µm. 
(B) Representative 10x and 4x phase and dGFP images of Rex1::dGFP iPStat3 EpiSC 
reprogramming at 48 and 72 h in hypoxic vs normoxic conditions. Reprogramming is driven 
by GCSF stimulation in 2iLIF. Scale bars: 100 µm.  
85 
 
4.2.5 Model set of single reprogramming drivers 
 
In order to causally ascribe independent genetic and signal variables to reprogramming 
events, use of single drivers is necessary. Therefore, I tested reprogramming efficacy of 
individual naïve factors in the new FA+XAV embryo-derived Rex1::dGFP EpiSCs under 
hypoxia (Figure 4.2.8A–C). Dox-inducible (i) transgenes were used for Esrrb, Klf2, Klf4, 
Nanog, Tfcp2l1 and Klf5. Stat3 activation by phosphorylation (iPStat3) was elicited by GCSF-
stimulation of the GY118F receptor transgene, with the optimised low GY118F dosage as 
established in Section 4.2.3. Use of stably-integrated inducible transgenes has several 
benefits, including experiment reproducibility, and induction upon demand permits analysis of 
direct downstream effects in a controlled manner from an uncompromised starting cell identity. 
This is in contrast to the majority of published EpiSC reprogramming experiments conducted 
with constitutively expressed transgenes or transient transfections. 
 
Control EmptyVector+CAG.rtTA3 (EVrtTA3) did not yield any iPSCs (Figure 4.2.8B–C). This 
confirms that the starting cells represented ‘late-stage’ EpiSCs (Han et al., 2010) and that 
there is no background to TF-driven reprogramming. Impressively, following only 4 days of 
single-driver induction, reprogramming efficiencies of up to 80% were observed. This is a 
testament to the system optimisation of Chapter 4. Previously reported EpiSC reprogramming 
efficiencies with single drivers have ranged from <1–3%, while efficiencies <10% have been 
achieved with multiple drivers (Gillich et al., 2012; Yang et al., 2010). Here, substantially higher 
efficiencies and faster kinetics were achieved, without compromising on the number or control 
of variables. 
 
iEsrrb, iPStat3 and iKlf2 were the three most efficient single drivers in 2iLIF (Figure 4.2.8C). 
iPSCs established from these lines had identity-appropriate gene expression signatures 
(Figure 4.2.8D). When analysed by unsupervised hierarchical clustering for all expressed 
genes, they did not cluster according to line, indicating transcriptional equivalency to each 
other and to ESCs (Figure 4.2.8E). Interestingly, Esrrb, PStat3 and Klf2 each inputs to the 
naïve network along a different regulatory axis (Figure 4.2.8F), that of Chiron, LIF and PD03 
respectively (Martello et al., 2012; Niwa et al., 1998; Yeo et al., 2014). Therefore, I take iEsrrb, 
iPStat3 and iKlf2 as a complementary model set of single reprogramming drivers for 





Figure 4.2.8: Model set of single reprogramming drivers 
(A) Reprogramming protocol for Rex1::dGFP EpiSCs. iGOI: inducible driver gene-of-interest. 
(B) Representative phase images of iEsrrb and EVrtTA3 wells on day 8. Scale bars: 500 µm. 
(C) Mean number of iPSC colonies on day 8 ±SD (n=3) per 2000 cells plated. Note that only 
4 days of transgene induction is a stringent test of driver efficacy. 
(D) Mean expression of iPSCs at passage 5, together with control EpiSCs and ESCs (n=16). 
Greys: primed markers. Blues: core pluripotency markers. Oranges: naïve markers. 
(E) Unsupervised hierarchical cluster of sequenced single cells, computed with the Ward.D2 
agglomeration method and Euclidean distances, for all expressed genes (FPKM>0). 
(F) Schematic depicting the inputs of Esrrb, PStat3 and Klf2 to the naïve network. 
The RNAseq analyses were conducted in collaboration with Giuliano Stirparo, and colony 
forming assay with Tim Lohoff.  
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To confirm that Rex1::dGFP reporter activation demarcated productive intermediates for 
iEsrrb, iPStat3 and iKlf2 as it did for iK2N (Section 4.2.2), I isolated emergent dGFP+ 
reprogramming subpopulations from each driver on days 2 and 3. When replated in 
2iLIF+dox/GCSF, emergent dGFP+ cells were indeed destined to form naïve colonies with 
efficiency comparable to ESCs (Figure 4.2.9 A–B). iPSCs thus obtained were chimera and 






Figure 4.2.9: Functional validation of single-driver Rex1::dGFP EpiSC reprogramming 
(A) FACS-plot showing emergence of Rex1::dGFP expression during reprogramming. The 
example here is iEsrrb 2iLIF+dox day 3. Rex1::dGFP ESCs and EpiSCs were used to 
determine positive (pos) and negative (neg) gates respectively. 
(B) Rex1::dGFP+ cells were isolated by FACS on days 2 and 3 and plated for clonal assay: 
reprogramming intermediates were plated in 2iLIF+dox, established Rex1::dGFP ESCs in 
2iLIF. Dox was withdrawn and blasticidin applied on day 6. Colonies were scored manually on 
day 9. Mean number of iPSC colonies ±SD (n=3) is indicated as a percentage of ESC colonies 
for each experiment. 
(C–E) Blastocyst injection of Rex1::dGFP iPSCs (agouti) yielded high-contribution, germline 
competent chimeras. 
(C) Constitutive GFP transgene was added to visualise mid-gestation chimerism. 
(D) Litter of juvenile chimeras. 






The combined work of Chapter 4 led to the generation of a tractable identity transition model 
set. This comprises Rex1::dGFP embryo-derived EpiSCs cultured in FA+XAV under hypoxia, 
stably containing inducible transgenes for single reprogramming drivers. iEsrrb and iKlf2 are 
dox-inducible, whereas iPStat3 is achieved by applying GCSF to cells transfected with a low 
amount of GY118F (see Figure 1.2.4).  
 
This meets the requirements for an identity transition model, as specified in Section 1.3.2: 
 
a. Source and destination identities are distinct and well defined: ‘ground-state’ primed 
EpiSCs and naïve iPSCs respectively (Sections 1.2, 1.3.3, 1.3.4, 4.2.4). 
b. Source and intermediate cells are amenable to perturbation. 
c. Genetic and signal variables can be controlled and independently manipulated: 
i. Single driver TFs can be induced on demand using dox or GCSF (Section 4.2.5). 
Further genetic manipulation can be achieved using siRNA to knock-down 
specific genes, thanks to the amenability of EpiSCs to transfection. 
ii. Signal variables are defined and minimal, comprising only exchange of FA+XAV 
to 2iLIF thanks to the shared N2B27 basal medium and fibronectin coating. 
iii. Signal variables can be manipulated independently of genetic drivers whilst still 
achieving the identity transition of interest (Section 4.2.1) (van Oosten et al., 
2012). 
d. Transcriptional responses are sufficiently rapid to infer regulatory relationships and 
study network installation kinetics (Sections 3.2.3, 4.2.1). 
e. In 2iLIF, the chosen drivers elicit reprogramming at high efficiencies (35–80%), whereas 
control EVrtTA3 EpiSCs do not yield any iPSCs (Section 4.2.5). Therefore, this is a clean 
system in which mechanistic study is technically feasible on a reasonable scale. 
f. Thanks to the Rex1::dGFP reporter, productive reprogramming intermediates can be 
isolated from the bulk populations (Sections 4.2.2, 4.2.5). 
 
Using this model set, I now return to the key biological questions of the thesis (Section 1.3). 
In Chapters 5–7, I will interrogate how the naïve pluripotent identity is instructed from EpiSCs 
by TF/signal interplay, and whether there are multiple routes for this identity transition to occur.  
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CHAPTER 5:  





As described in Chapter 1, a stable cellular identity can be considered as an attractor, 
occupying a local minimum in an ‘energetic’ landscape of cell states (Kauffman, 1993; 
reviewed in Enver et al., 2009). A key outstanding question is whether attractors are 
multidimensional, with multiple routes of approach to a single identity, or whether a given 
identity transition follows a single path with a set sequence of mechanistic steps. To answer 
this fundamental biological question requires a tractable system with well defined start and 
end identities. Lack thereof has limited progress to date: for example, the landmark work by 
Huang et al., 2005 demonstrated two distinct routes of promyelocytic HL60 cell differentiation 
into neutrophils, but they noted disparity in the resulting neutrophil identities and thus had not 
in fact reached a single attractor state at the end. 
 
Here I seek to understand whether the defined identity transition from EpiSCs to iPSCs can 
occur via multiple routes. Work of the preceding Chapters has led to establishment, 
optimisation and validation of an appropriate model set: embryo-derived, hypoxic, FA+XAV-
cultured Rex1::dGFP EpiSCs with iEsrrb, iPStat3 or iKlf2 single reprogramming drivers. 
Crucially, these reach the same destination identity (Figure 4.2.8D–E). Now, I interrogate the 
transcriptional trajectories elicited by each driver to determine whether they follow the same 
route merely with different speeds/efficiencies, or whether the routes themselves are distinct. 
By isolation of productive cells based on Rex1::dGFP emergence, I will be able to ask whether 
the mechanistic sequence of events is the same or different within the productive 
subpopulation of different drivers. For example, in Figure 5.1.1 I illustrate three hypothetical 
scenarios for reprogramming from EpiSC to iPSC identity. The starred cells represent 
productive intermediates at an early stage along the reprogramming path(s). Is each starred 
cell equivalent, i.e. productive cells in scenarios A–C asynchronously follow the same 
transition route? Or are there differences between the expression signatures of the starred 








Figure 5.1.1: Are routes distinct or equivalent within the productive subpopulations? 
Schematic illustrating the three scenarios of reprogramming. Scenario A is 100% efficient and 
synchronous. Scenarios B and C more realistically depict asynchronous reprogramming with 
varying degrees of efficiency and heterogeneity. Blue: EpiSCs. Dark green: iPSCs. 
Intensifying shades of green: productive progression towards iPSC identity. Starred cells 






Rex1::dGFP reporter activity emerges from day 2 of reprogramming (Section 4.2.5). 
Therefore, analysis inexorably divides into two temporal phases (Figure 5.1.2). Prior to day 2, 
there is unfortunately no means of prospectively knowing whether a given cell will reprogram 
(and it is possible that the cells themselves may not have decided yet). Thanks to the high 
efficiencies of iEsrrb-, iPStat3- and iKlf2-driven identity transitions (Figure 4.2.8C), it will 
nevertheless be worth performing analysis of bulk averages at early timepoints in order to 
ascertain the immediate responses to driver induction (Sections 5.2.1–5.2.2). From day 2 
onwards, analysis of single emergent Rex1::dGFP+ cells will enable direct comparison of 






Figure 5.1.2: Overview of reprogramming phases for Rex1::dGFP EpiSCs 
Schematic of Rex1::dGFP EpiSC reprogramming driven by iEsrrb or iKlf2 in 2iLIF+dox, or by 
iPStat3 in 2iLIF+GCSF. By 48 h, dGFP+ cells are detectable for all lines. Analysis thus divides 
into two temporal phases. Early initiation events in direct response to transgene induction are 
assessed in bulk. Following reporter activation, productively progressing cells can be isolated 





5.2.1 Initiation of naïve network wiring is driver-specific 
 
I analysed the initial transcriptional response to each driver from 1–48 hours in bulk (Figures 
5.1.2, 5.2.1A). Transgene induction was independently varied with environmental changes, to 
assess the contribution of and interplay between genetic and signal variables. iPStat3 drove 
moderate activation of naïve genes in EpiSC conditions, while responses were slightly 
stronger in 2iLIF, consistent with known boosting of naïve expression by 2i (reviewed in 
Hackett and Surani, 2014). iEsrrb led to substantially faster and stronger network upregulation 
in 2iLIF than iPStat3 (Figure 5.2.1A). However, for iEsrrb the response was highly condition-
dependent, suggesting that Esrrb and 2iLIF work in synergy to rapidly induce naïve genes. 
 
Surprisingly, Klf2 induction did not lead to upregulation of naïve network genes in any 
condition, and curiously even silenced Sox2 (Figure 5.2.1A). Considering that Klf2 is a potent 
reprogramming driver (Figure 4.2.8C), its initial lack of naïve gene induction presented a 
conundrum. Principle component analysis (PCA) showed a remarkable transcriptional 
divergence following Klf2 induction (Figure 5.2.1B), and morphological changes during 
reprogramming initiation were also driver-specific (Figure 5.2.1C). Nonetheless, these 
divergent routes ultimately re-converged on the same naïve pluripotent destination identity 
(Figures 4.2.8D–E, 5.2.1B). 
 
I asked which genes could cause such a transcriptional divergence, and found robust 
upregulation of mesodermal markers in a Klf2-specific manner (Figure 5.2.1D). This indicated 
initial instigation of a different program downstream of Klf2, rather than simply a delayed naïve 
induction kinetic. To ascertain whether mesodermal marker expression occurred in cells 
destined for successful reprogramming or in an unproductive subpopulation, I later turn to 





Figure 5.2.1: Initiation of naïve network wiring is driver-specific 
(A) Heatmap of mean gene expression from 0–48 h, measured by RT-qPCR relative to Gapdh 
then normalised to ESC-level=1. 
(B) PCA based on the most variable genes (log2 FPKM>1, CV2 > 0.5 calculated for each driver 
then merged to a single list). 
(C) Representative phase images 24 h after reprogramming induction. Scale bars: 100 µm. 
(D) Gene expression of mesodermal markers following reprogramming induction in 2iLIF. 
The RT-qPCR was carried out with technical assistance from Tim Lohoff. The RNAseq 




5.2.2 Signal contribution to reprogramming initiation is modulated by the driver 
 
I explored the interaction between drivers and signals in the timecourse bulk RNAseq of 
reprogramming initiation. k-means clustering revealed that iKlf2-driven initiation clustered 
separately from iEsrrb or iPStat3, irrespective of timepoint or environment (Figure 5.2.2A), 
corroborating the remarkable divergence of iKlf2-initiation observed in Figure 5.2.1. The 
signalling environment did not play a strong role in the early transcriptional behaviour of iKlf2-
driven reprogramming, with more similarity between timepoints than conditions for iKlf2 
(Figure 5.2.2A–B).  
 
In contrast, iEsrrb and 2i components interacted to elicit a transcriptional trajectory distinct 
from that of iEsrrb in EpiSC FA conditions (Figure 5.2.2A–B). The environmental influence 
was moderate during iPStat3-driven initiation: 2i signals did not dramatically alter the 
transcriptional trajectory, but did appear to accelerate it (Figure 5.2.2B). 
 
Together, expression analyses revealed that the pattern and kinetics of naïve network 
reactivation were driver-dependent, and that signal contribution was markedly modulated by 
the driver (Figures 5.2.1–2). Nonetheless, these divergent processes ultimately re-converged 




Figure 5.2.2: Signal contribution to reprogramming initiation is modulated by the driver 
(A) k-means clustering of bulk RNAseq samples, based on expressed genes (FPKM>0). 
(B) PCA based on expressed genes (FPKM>0) for each driver. 
The RNAseq analyses were conducted in collaboration with Giuliano Stirparo.  
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5.2.3 Single-cell RNAseq defines distinct productive trajectories 
 
Since reprogramming to naïve pluripotency is heterogeneous and asynchronous, cells 
undergoing the change of interest must be resolved from the average in order to study 
transition mechanism(s) (Figures 4.1.1, 5.1.1). 
 
To resolve the logic of the three routes, I performed single-cell (sc)RNAseq on productive 
intermediates for each driver at 48, 72 and 96 h (Figure 5.2.3A). Intermediate identity was 
confirmed by naïve vs EpiSC gene expression profiles (Figure 5.2.3B). Sample relationships 
determined by t-Distributed Stochastic Neighbour Embedding (t-SNE) dimensionality 
reduction and by hierarchical clustering revealed that Rex1::dGFP+ sorted intermediates 
arranged by driver rather than timepoint (Figure 5.2.3C–D). This demonstrates that 
reprogramming routes are transcriptionally distinct throughout the productive transitions, not 
only during bulk initiation. Again, the iKlf2 route was transcriptionally more different from those 
of iPStat3 and iEsrrb (Figures 5.2.1B, 5.2.3D).  
 
I then examined the kinetics of naïve network activation in single cells. In order to deconvolute 
the asynchronous nature of reprogramming, cells were ordered by fraction of similarity to origin 
EpiSCs and destination iPSCs (Figure 5.2.4A). Pseudotime coordinates thus generated 
largely agreed with real-time. iEsrrb exhibited the fastest kinetics of naïve network 
orchestration for the majority of naïve genes, while iKlf2 was slowest (Figure 5.2.4B–C). Thus, 
single-cell analyses confirmed the different kinetics of naïve network activation observed in 





Figure 5.2.3: Single-cell RNAseq of productive reprogramming intermediates 
(A) Schematics depicting the isolation of productive single cells from each driver line, and the 
96-well plate layout into which single cells were index-sorted for scRNAseq. One, two and one 
such plates were prepared for days 2, 3 and 4 respectively. Cells from all lines were included 
on each plate on each day, to minimise downstream batch effects. Sorted reprogramming 
intermediates (2iLIF+dox/GCSF) and ESCs/iPSCs (2iLIF) were Rex1::dGFP+, whereas 
EpiSCs (FA) were Rex1::dGFP-. iGOI: inducible gene-of-interest. 
(B–D) Shared legend. 
(B) Expression scatter plots of genes expressed in EpiSCs (Otx2, Utf1) or in naïve 
ESCs/iPSCs (Dazl, Nr0b1). 
(C) t-SNE plot showing relationships between sequenced single cells. 
(D) Unsupervised hierarchical cluster of sequenced single cells, computed with the Ward.D2 
agglomeration method and Euclidean distances. 





Figure 5.2.4: Kinetics of naïve network induction in productive single cells 
(A) Computation of fraction of identity between each single cell vs EpiSCs in FA and iPSCs in 
2iLIF. Signature EpiSC and iPSC datasets were generated by averaging of bulk RNAseq 
samples. Single cells were ordered from lowest to highest iPSC/EpiSC identity fractions to 
generate pseudotime coordinates from reprogramming start to end. 
(B) Scatter plots of expression vs pseudotime, fitted with LOESS regression lines. 
(C) Overlay of LOESS regression fit lines from the above plots, to facilitate comparison. 




Strikingly, the induction of mesodermal markers revealed during bulk initiation persisted in 
productive single cells for iKfl2 (Figures 5.2.1D, 5.2.5A–B). This indicated that transient 
activation of mesodermal markers was not just due to differentiation of a population of 
unproductive cells, but was a transcriptional response occurring during productive3 





Figure 5.2.5: Expression of mesodermal markers in single iKlf2 intermediates 
(A) Scatter plots of mesodermal markers (Mesp1, Lefty1, Fgf8, T) against Nanog expression 
in single iKlf2 reprogramming intermediates. 
(B) Scatter plots of mesodermal markers against Nanog expression in single iEsrrb and 
iPStat3 intermediates, EpiSC (start) and ESC/iPSC (end) identity controls. The y-axes are to 
the same scales as above to facilitate comparison.  
                                               
3 Since first submission of this thesis, I generated T/Rex1 double-reporter EpiSCs and performed 
reporter live-imaging of iKlf2-driven reprogramming. This confirmed that T+ intermediates convert into 
Rex1+ iPSCs, i.e. that productive iKlf2 reprogramming proceeds via a T+ state on the protein level. 
Sequential activation of T then Rex1 reporter is consistent with the low % of T+ cells captured by 
scRNAseq of Rex1+ intermediates in Figure 5.2.5A above. For details, please see Appendix page 178. 
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To place the reprogramming trajectories in the context of development, we compared 
scRNAseq of productive intermediates with E2.5–E6.5 embryos (Deng et al., 2014; 
Mohammed et al., 2017). Single-cell transcriptome analyses revealed that iPStat3 
reprogramming intermediates transiently acquired more similarity to the early inner cell mass 
(ICM) (Figure 5.2.6A–B) and exhibited a Nanog+Gata6+ double-positive signature (Figure 
5.2.7A–B). Nanog+Gata6+ co-expression arises in the early ICM of pre-implantation embryos 
(Figure 1.1.1A) (Plusa et al., 2008), prompting the hypothesis that iPStat3-driven 
reprogramming goes further back to an early ICM-like state, then forwards into the 
consolidated naïve identity. There is a temporal sequence of naïve gene activation in the 
embryo (Boroviak et al., 2015). Earlier markers (Klf2, Tfcp2l1) are expressed in 
Nanog+Gata6+ early ICM. In contrast, later markers (Gbx2, Nr0b1) are not activated until after 
Nanog+Gata6- naïve epiblast has segregated from Nanog-Gata6+ primitive endoderm (PrE). 
iPStat3 reprogramming intermediates emulated this in vivo progression: Klf2 and Tfcp2l1 were 
turned on earlier and are co-expressed with Gata6, whereas Gbx2 and Nr0b1 were activated 
later in Gata6- cells (Figure 5.2.7C). In sum, iPStat3-driven reprogramming recapitulated 
defining molecular features of naïve pluripotency establishment in vivo. In contrast, iKlf2 
intermediates retained similarity to later developmental stages and transiently expressed 





Figure 5.2.6: Developmental context of productive reprogramming intermediates 
(A) PCA based on the most variable genes (log2 FPKM>1, CV2>0.5) for reprogramming 
intermediates and embryo single cells. Mor: compacted morula. ICM: inner cell mass. Epi: 
epiblast. PrE: primitive endoderm. PC1 separates in vivo vs in vitro datasets; PC2 portrays 
developmental progression4. 
(B) Fraction of similarity to signature datasets5 was computed by quadratic programming for 
each reprogramming single cell (days 2, 3, 4), and is presented as box-and-whisker plots. 
The RNAseq analyses were conducted in collaboration with Giuliano Stirparo. 
 
  
                                               
4 Please note that since the sorted reprogramming cells were already Rex1+, early stages of greater 
diversion are not represented here, particularly that of Klf2 towards mesoderm. Subsequent sequencing 
that captures this can be found in the Appendix page 176. 
 





Figure 5.2.7: Nanog+Gata6+ iPStat3 intermediates emulate developmental progression 
(A–B) Scatter plots of Gata6 vs Nanog expression in iPStat3, iEsrrb and iKlf2 reprogramming 
intermediates, E3.5 and E4.5 embryos. EpiSC (start) and ESC/iPSC (end) identity controls. 
ICM: inner cell mass. Epi: epiblast. PrE: primitive endoderm. 
(C) Scatter plots of Gata6 vs earlier or later ICM markers in iPStat3 reprogramming 






The work of Chapter 5 demonstrates that iEsrrb, iPStat3 and iKlf2 each drive identity transition 
from EpiSC to naïve iPSC identity along a distinct transcriptional trajectory (Figure 5.3.1). This 
provides empirical evidence supporting theories of cellular identity as a multidimensional 
attractor (Huang et al., 2005; Kauffman, 1993), whereby there are multiple routes of approach 
towards a single identity. In the future, I hope that relevant experts will formally model the 
RNAseq data of Chapter 5 using dynamical systems mathematics. 
 
 
Figure 5.3.1: Summary of transcriptional trajectories for reprogramming routes 
Schematic of reprogramming transcriptional trajectories relative to early development. 
 
 
Returning to the hypothetical scenarios outlined in Figure 5.1.1, this work shows that the 
starred cells are not equivalent. In addition to differences in reprogramming kinetics and 
efficiencies, the single productive intermediates for each driver have distinct transcriptional 
signatures (Section 5.2.3). Furthermore, the influence of signals on the transcriptional 
trajectory was driver-dependent (Figures 5.2.1–2), indicative of distinct underlying transition 
mechanisms. This theme is explored further in Chapter 6. 
 
The rapid upregulation of naïve genes by iEsrrb is intuitive for an efficient reprogramming 
driver. In contrast, iKlf2 presents a fascinating conundrum. Not only does it fail to upregulate 
naïve genes within the first 48 h (Figure 5.2.1A), it follows a highly divergent initiation trajectory 
(Figure 5.2.1B), exhibits mesodermal marker expression even in productive intermediates 
(Figure 5.2.5A) and clusters separately from other drivers at all times and in all conditions 
(Figures 5.2.2A, 5.2.3C–D). How, then, does this ultimately provide the logic for an efficient 
transition into the naïve pluripotent identity? I return to this paradox in Chapter 7. 
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iPStat3-driven reprogramming transcriptionally recapitulates key aspects of naïve epiblast 
specification in vivo (Figures 5.2.6–7). This suggests that, in some cases, reprogramming can 
overshoot backwards in development then proceed forwards again into the consolidated naïve 
identity. I wonder whether this action of PStat3 in reprogramming reflects its role(s) during in 
vivo pre-implantation development. PStat3 expression is observed in vivo from the 8-cell stage 
onwards, and it has recently been reported to play a context-dependent role in PrE as well as 
epiblast fate specification (Anderson et al., 2017; Morgani and Brickman, 2015). If transferred 
to an appropriate environment, could the PStat3-driven Nanog+Gata6+ reprogramming 
intermediates be open to PrE as well as epiblast fates6? 
  
                                               
6 Since first submission of this thesis, I performed this experiment and found that iPStat3 Gata6+ 
intermediates do indeed contribute to PrE as well as epiblast. Please see Appendix page 179.  
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CHAPTER 6:  





Demonstration of transcriptionally distinct routes for identity transition between EpiSCs and 
iPSCs provided evidence in support of cellular identity as a multidimensional attractor (Chapter 
5). Some degree of transcriptional divergence might be expected simply due to different direct 
gene targets of each TF driver, although this is unlikely to offer a sufficient explanation given 
the extent of differences when placed in a developmental context (Figures 5.2.5–5.2.7). To 
conclusively determine whether transition routes are distinct, mechanistic attributes must also 
be considered.  
 
Therefore, in Chapter 6 I independently manipulate genetic and environmental parameters, 
interrogating whether the requirements for and interplays between TFs and signals are driver-
dependent during reprogramming of EpiSCs to naïve pluripotency. I then test my findings in 
other contexts of naïve pluripotency establishment: development of the naïve epiblast in 





6.2.1 Downstream genetic mediators of reprogramming drivers 
 
To test whether the aforementioned transcriptional trajectories were indicative of differences 
in their transition mechanisms, I assessed the routes’ genetic and signal requirements. 
Putative downstream genetic mediators were identified by examining expression of known 
reprogramming drivers 24 hours after induction of iEsrrb, iKlf2 or iPStat3 (Figure 6.2.1A). 
Endogenous Esrrb was not strongly upregulated by either iKlf2 or iPStat3 by 24 hours, and is 
thus unlikely to be implicated in their reprogramming initiation mechanisms. In contrast, 
endogenous Klf2 reached 50% and 20% of ESC-level in iPStat3 and iEsrrb respectively.  
 
Given this early response, I tested whether Klf2 was a functional mediator of iPStat3- or iEsrrb-
driven reprogramming by knock-down (KD) of Klf2 at reprogramming onset. I found that 
transient Klf2 KD abolished reprogramming driven by iPStat3 but not iEsrrb (Figure 6.2.1B–
D). This implicated Klf2 as a critical functional mediator of reprogramming initiation by iPStat3. 
Curiously, iPStat3 reprogramming sensitivity to Klf2 KD was somewhat context-dependent, 





Figure 6.2.1: Route-specific dependence on Klf2 as a reprogramming mediator 
(A) Gene expression of selected reprogramming drivers 24 h after induction of iEsrrb, iKlf2, 
iPStat3 or EVrtTA3 in 2iLIF+dox/GCSF, relative to iPSC-level=1. EpiSC control is in FA.  
y-axis iEsrrb: Esrrb=3.32. iKlf2: Klf2=8.30. 
(B–D) Klf2 KD was performed at reprogramming onset with a single pulse of siRNA. iGOI: 
inducible gene-of-interest. iPSC colonies were scored on day 8, presented as mean ±SD 
(n=3). Representative phase images are shown on day 8. Scale bars: 100 µm. 
(E) Klf2 KD was performed at iPStat3-driven reprogramming onset with a single pulse of 
siRNA, in the indicated conditions +GCSF from day 0–4, then iPSC colonies were selected 
from day 4–8 in 2iLIF+blasticidin. iPSC colonies were scored on day 8, presented as mean 
±SD (n=3). PD=PD03; CH=Chiron; 2i=PD+CH.  
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6.2.2 Exogenous signal requirements for each reprogramming route 
 
To assess mechanistic differences between routes in terms of exogenous signal 
requirements, I challenged the first 4 days of reprogramming with different 2iLIF signal 
permutations (Figure 6.2.2A–B). iPStat3 yielded iPSCs in the absence of both PD03 and 
Chiron, but together PD03 and Chiron synergistically boosted the efficiency. However, the 
impact of PD03 and Chiron was driver-dependent: Chiron was essential for iKlf2-driven 
reprogramming, with no benefit from additional supplementation with PD03. Functional 
redundancy between Klf2 and PD03 has been previously noted (Yeo et al., 2014), and the 
inability of iKlf2 to drive reprogramming without direction from an exogenous signal is in 
agreement with the observation that iKlf2 does not directly induce naïve gene expression 
(Figure 5.2.1A). Unlike iKlf2, reprogramming driven by iEsrrb was highly LIF-dependent 






Figure 6.2.2: Route-specific requirements for exogenous signals 
(A) Schematic depicting the experimental strategy. Reprogramming was induced in different 
conditions from day 0–4, then iPSC colonies were selected from day 4–8 in 2iLIF+blasticidin 
(bsd). iPSC colonies were scored on day 8. 
(B) Mean number of iPSC colonies on day 8, ±SD (n=3). PD=PD03; CH=Chiron; 2i=PD+CH.  
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6.2.3 Differential modulation of exogenous signal transduction to target genes 
 
iEsrrb induction in LIF led to greater upregulation of canonical PStat3 targets than induction 
of iPStat3 itself (Figure 6.2.3B).This was not due to elevation of PStat3 protein by Esrrb (Figure 
6.2.3C) and thus demonstrated downstream synergy between Esrrb and PStat3 that amplified 
LIF/Stat3 transduction to the naïve TF network. 
 
A turning point occurred 6 h after induction: from 0–6 h, Klf2 was upregulated similarly in 2i±LIF 
for both iEsrrb and negative control EpiSCs; after 6 h, Klf2 expression continued to increase 
in iEsrrb+2iLIF, but collapsed in iEsrrb+2i and all control conditions (Figure 6.2.3D–E). Klf4 
upregulation also launched in earnest after 6 h with iEsrrb+2iLIF. Thus, cooperation between 
Esrrb and LIF became effectual after 6 h, consolidating and extending the 2i-mediated 





Figure 6.2.3: Synergy with Esrrb amplifies LIF/Stat3 target gene upregulation 
(A) Representative phase images of iEsrrb on day 8 in 2iLIF+blasticidin, after reprogramming 
from day 0–4 in 2iLIF+dox or 2i+dox as indicated. White arrow indicates an iPSC colony. Scale 
bars: 100 µm. 
(B) Gene expression of selected LIF/Stat3 target genes (Martello et al., 2013; Niwa et al., 
2009; van Oosten et al., 2012; Ye et al., 2013) 24 h after induction of iEsrrb, iPStat3 or EVrtTA3 
in the indicated conditions, relative to iPSC-level=1. 
(C) Western blot against PStat3, Esrrb and αTubulin, after 24 h in FA or 2iLIF+dox/GCSF. 
(D–E) RT-qPCR analysis of iEsrrb (D) or EVrtTA3 (E) EpiSCs in the indicated condition +dox. 
Mean gene expression is displayed relative to Gapdh and normalised to iPSC-level=1, ±SD 
(n=3). The iEsrrb/EVrtTA3 axes are to the same scales to facilitate comparison.  
110 
 
6.2.4 Identification of endogenous BMP signalling as a route-specific mechanism 
 
In light of the above observations that signal requirements and interpretation are driver-
dependent, I interrogated RNAseq data of bulk initiation and single dGFP+ reprogramming 
intermediates for evidence of other signalling differences between iKlf2, iEsrrb and iPStat3. 
BMP signalling pathway target Id1 was upregulated in iKlf2 and iPStat3, but not iEsrrb (Figure 
6.2.4A–B). Id1 upregulation was intermediate-specific, with negligible expression in starting 
EpiSCs or destination iPSCs. BMP signalling is the key pluripotency-sustaining component in 
the serum of classical ESC cultures (Ying et al., 2003), is important for MET in serum-based 
fibroblast reprogramming (Chen et al., 2011; Samavarchi-Tehrani et al., 2010), but is not 
thought to be active in 2iLIF-cultured ESCs (Boroviak et al., 2014).  
 
I assessed BMP pathway status by PSmad1/5 immunofluorescence during EpiSC 
reprogramming in 2iLIF, finding positive staining for iKlf2 and iPStat3 but not iEsrrb (Figure 
6.2.4C). Therefore, BMP signalling is activated in a route-specific manner. Both the speed 
(Figure 6.2.4A) and strength (Figure 6.2.4C) of BMP signalling activation were greater for iKlf2 
than iPStat3. For iKlf2, Id1 was sharply upregulated at 1 hour, substantially prior to naïve gene 
expression upregulation, whereas for iPStat3 the two were more concomitant (Figure 5.2.1A). 
These differences in signalling dynamics represent additional driver-specific features of 
interest. 
 
To test whether auto/paracrine BMP signalling is required during EpiSC reprogramming, I 
applied DMH2 from day 0–4. DMH2 is a specific and well characterised BMP signalling 
inhibitor (Figure 6.2.4D) (Hao et al., 2010). DMH2 treatment abolished iKlf2- and iPStat3-
driven reprogramming in 2iLIF, but iPSC colonies still formed for iEsrrb (Figure 6.2.4E–G). 
Therefore, DMH2 treatment blocked reprogramming only in those lines exhibiting evidence of 
active BMP signalling in their intermediates. This was specific to the transition, being 




Figure 6.2.4: BMP signalling requirements for naïve pluripotency specification 
(A) Id1 expression in bulk RNAseq following reprogramming initiation in 2iLIF. 
(B) LOESS regression fit lines summarise Id1 kinetics during reprogramming, computed from 
scatter plots of log2 FPKM vs pseudotime for single cells (Fig. S2D) by Giuliano Stirparo. 
(C) Immunofluorescent staining 48 h after reprogramming induction. ESCs cultured in 
FCS+LIF provide a positive control for PSmad1/5. Representative maximum intensity 
projections of Z-stack 60x slices are presented. Scale bars: 20 µm. Technical assistance was 
provided by Andrew Malcolm. 
(D) Validation of 3 µM DMH2 efficacy. Wild-type E14 ESCs cultured in FCS+LIF were treated 
for 24 h as indicated. BMP signalling is known to be active and important for pluripotency 
maintenance in FCS+LIF (Ying et al., 2003), unlike in 2iLIF. Representative maximum intensity 
projections of Z-stack 40x slices are presented. Scale bars: 20 µm. 
(E) 3 µM DMH2 or 1:1000 DMSO was applied to reprogramming in 2iLIF+dox/GCSF from day 
0–4, then iPSC colonies were selected in 2iLIF+blasticidin from day 4–8. iPSC colonies were 
scored on day 8, presented as mean ±SD (n=3). 
(F–G) Titration of DMH2 and LDN concentrations, applied as indicated during day 0–4 of iKlf2-
driven reprogramming in 2iLIF+dox. iPSC colonies were selected in 2iLIF+blasticidin from day 
4–8, scored on day 8 and presented as mean ±SD (n=3). Representative day 8 phase and 
dGFP images are shown. Scale bars: 100 µm. LDN is a different BMP signalling inhibitor 





Figure 6.2.5: Endogenous BMP signalling is dispensable for resultant iPSCs 
(A) 3 µM DMH2 or 1:1000 DMSO was applied to ESCs or previously established iKlf2 iPSCs, 
at clonal density in 2iLIF. Naïve colonies were scored after 4 days, presented as mean ±SD 
(n=3). 
(B) Representative immunofluorescent staining of Klf4 and Oct4 expression after 48 h of 
treatment with 3 µM DMH2 or 1:1000 DMSO, for EpiSC reprogramming driven by iPStat3 in 




6.2.5 BMP signalling is required for naïve pluripotency establishment in vivo and during human 
resetting 
 
Having identified BMP signalling requirement in two routes of mouse EpiSC reprogramming, 
and given that iPStat3 reprogramming intermediates transiently acquired similarity to the early 
ICM, I explored whether endogenous BMP signalling also plays a role in other contexts of 
naïve pluripotency establishment: development of the naïve epiblast in mouse embryos, and 
resetting of primed human ESCs towards naïve pluripotency.  
 
Conventional human ESCs (hESCs) exhibit primed pluripotency, like mouse EpiSCs 
(reviewed in Davidson et al., 2015). Recently, substantial progress has been made to convert 
primed hESCs to the putative human naïve pluripotent state (Guo et al., 2017; Takashima et 
al., 2014; Theunissen et al., 2014), but the transcriptional logic and signalling cues governing 
this process remain poorly understood. Given that one method of hESC resetting is driven by 
inducible expression of Klf2+Nanog (iK2N), and that Klf2 upregulates BMP signalling in mouse 
EpiSCs (Figure 6.2.4A–C), I tested whether endogenous BMP signalling also plays a role in 
hESC resetting.  
 
DMH2 treatment led to a dramatic reduction in colony size after 7 days of induction with 
2iLIF+dox (Figure 6.2.6A–C), and no colonies remained after 1 passage (Figure 6.2.6D). Prior 
to culture collapse, DMH2-treated hESCs exhibited a reduction in naïve network expression 
(Figure 6.2.6E). Therefore, I propose that BMP signalling is required for iK2N-mediated 






Figure 6.2.6: Effect of DMH2 treatment on resetting of primed human ESCs 
(A) Resetting towards the naïve identity was initiated for human H9 iK2N.Venus primed ESCs 
by application of 2iLIF+dox ± 3 µM DMH2.  
(B–C) Size of Venus+ colonies was measured on day 7 of H9 iK2N.Venus resetting in 
2iLIF+dox ± 3 µM DMH2. Box-and-whisker plots are displayed on a log10 scale (B), together 
with representative images of merged phase and Venus channels (C). Venus+ distinguishes 
resetting H9 cells from feeders. Scale bars: 500 µm. 
(D) Mean number of Venus+ P1 colonies on day 13 is presented ±SD (n=3). Venus+ 
distinguishes resetting H9 cells from feeders. 
(E) RT-qPCR analysis of H9 iK2N.Venus after 2 days of treatment in the indicated conditions, 
which is prior to culture collapse with DMH2. Mean gene expression is displayed relative to 
Gapdh and normalised to the highest level for each gene.  
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The BMP signalling pathway is active in pre-implantation mouse embryos from the 4-cell stage 
onwards, including in the ICM (Graham et al., 2014; Reyes de Mochel et al., 2015), so 
involvement in epiblast specification is plausible. I cultured embryos ±DMH2 from the late 
morula stage, then assessed naïve network status in the mid–late blastocyst by 
immunofluorescence (Figure 6.2.7A–C). The ICM still formed in DMH2-treated embryos, 
indicated morphologically and by the cluster of Oct4-positive cells. However, expression of 
Nanog and Klf4 was dramatically reduced. Thus, BMP signalling inhibition applied from the 
late morula disrupted the induction of embryonic naïve pluripotency7. Identification of this novel 
role for the BMP pathway in vivo highlighted the power of defined reprogramming systems to 
uncover principles of identity specification. 
 
These observations were somewhat at odds with the work of Graham et al., 2014, in which 
they did not find differences in Nanog expression following dorsomorphin treatment but instead 
reported defects in extra-embryonic lineage development. However, dorsomorphin is not a 
specific BMP inhibitor, but is primarily an AMPK inhibitor (Zhou et al., 2001) and also inhibits 
VEGF signalling (Hao et al., 2010). In contrast, DMH2 selectively inhibits ALK6, ALK3 and 
ALK2 (Hao et al., 2010). It is also possible that disparities stemmed from mouse strain 
differences: in the work of Graham et al., 2014, embryos were harvested from superovulated 
C57Bl6xCBA mice, whereas my investigation was performed from normal matings of strain 
129 mice. 
 
Furthermore, I noted that the epiblast phenotype was highly sensitive to the timing of BMP 
inhibition (Figure 6.2.7D). Addition of DMH2 at the 8-cell stage caused developmental arrest, 
consistent with Reyes de Mochel et al., 2015, but precluding fair assessment of whether the 
naïve lineage specifically was compromised: at the 8-cell stage, the trophectoderm vs ICM 
decision has not yet been made. Conversely, application of DMH2 to the mid blastocyst did 
not disrupt the naïve epiblast. By this point, the epiblast vs PrE bifurcation is already underway. 
In contrast, precisely timed addition of DMH2 at cavitation onset in the late morula falls 
between these two developmental lineage bifurcations, and thus permitted assessment of the 
role of BMP signalling in naïve epiblast specification despite the multitude of BMP signalling 
roles during early development. 
  
                                               





Figure 6.2.7: Timed addition of DMH2 to embryos disrupts pluripotency induction 
(A–C) Mouse strain 129 compacted morulae were cultured with 3 µM DMH2 or 1:1000 DMSO 
from cavitation onset for 36 h. n=9. 
(A) Immunofluorescent staining against Klf4, Nanog and Oct4. Representative maximum 
intensity projections of Z-stack 40x slices are presented. Scale bars: 20 µm. 
(B) Mean cell number per embryo ±SD is shown for ICM and TRO lineages or whole embryos 
(C) Quantification of immunofluorescent signal in the ICM and trophectoderm (TRO) 
compartments.  
(D) Representative maximum intensity projections of Z-stack 40x slices for embryos to which 
3 µM DMH2 or 1:1000 DMSO was added at different timepoints. Scale bars: 20 µm. 








6.3.1 Mechanistic distinctions between reprogramming routes 
 
The results in Chapter 6 provide evidence that iKlf2, iPStat3 and iEsrrb drive reprogramming 
by mechanistically distinct routes in terms of their genetic, exogenous signal and paracrine 
signal requirements (Figure 6.3.1). Together with the differences in their transcriptional 
trajectories (Chapter 5), this demonstrated that there are multiple distinct routes by which to 
transition from EpiSC to iPSC identity. Therefore, this work supports theories of cell identities 
as multidimensional attractors (Kauffman, 1993), and reveals considerable mechanistic 
flexibility for the specification of a single identity from a single origin. To the best of my 
knowledge at the time of writing, this is the first time that mechanistic attributes have been 
included in consideration of whether cell identity attractors are multidimensional, rather than 





Figure 6.3.1: Summary of mechanistic requirements for each reprogramming route 
 
 
In addition to distinct sets of exogenous signal requirements, each EpiSC reprogramming 
driver also differentially modulated signal interpretation. Examples of this complex relationship 
included: transient induction of and dependence on BMP signalling for iPStat3 and iKlf2 but 
not iEsrrb; synergy between PD03 and Chiron in the context of PStat3 induction but PD03 
redundancy when Klf2 was driving; amplification of LIF/Stat3 input to the naïve network by 
Esrrb (Figures 6.2.2–6.2.4). iPStat3 sensitivity to Klf2 KD was partially alleviated in the 
absence of PD03 (Figure 6.2.1E), reminiscent of the ability to rescue embryo-derived Nanog-/- 
EpiSC reprogramming in Chiron+LIF but not 2iLIF (Figure 3.2.10). Notably, both Nanog and 
Klf2 are considered targets of PD03 (Silva et al., 2009; Yeo et al., 2014): it appears they are 
required to transduce its positive input to the naïve network and, in their absence, PD03 is 
actively detrimental to reprogramming. Hence, interplay between TFs and signals can 




Together, Chapters 3 and 6 exposed diverse mechanisms for amplification of exogenous LIF 
signal transduction by nuclear factors. Whilst Nanog suppressed Socs3 transcription and 
increased the amount of PStat3 (Figures 3.2.1–3.2.2), Esrrb cooperated with minute amounts 
of PStat3 to synergistically upregulate PStat3 targets (Figure 6.2.3). Whilst Esrrb is considered 
a direct target of Nanog (Festuccia et al., 2012), this point highlights that they cannot be 
considered as functionally redundant, and may shed light on their disparate reprogramming 
efficiencies (Figure 4.2.8C). 
 
The morphological changes following iKlf2, iPStat3 or iEsrrb induction were also driver-
specific (Figure 5.2.1C). This provides further evidence for distinct reprogramming routes. In 
the future, it would be interesting to re-interrogate the RNAseq data for clues as to how these 
different morphologies arise, for example by considering genes involved in regulation of the 
cytoskeleton and the extracellular matrix. These physical differences may be more than simple 
reflections of distinct intermediate transcriptomes, but could also play an active role in the 
modulation and interpretation of gene expression and signalling mechanisms.  
 
 
6.3.2 BMP signalling in naïve pluripotency establishment 
 
I found transient BMP signalling activation and requirement during reprogramming driven by 
iKlf2 and iPStat3, but not iEsrrb. This provided further evidence of route-specific mechanistic 
attributes, and formed an interesting parallel with recent work by Onishi et al., 2014 in which 
they showed that addition of BMP4 increased EpiSC reprogramming efficiency. They 
attributed the positive effect of BMP4 to facilitation of LIF signal transduction through 
GP130/LIFR and to formation of a Stat3/Smad1 protein complex together with the P300 
transcriptional coactivator. In light of the latter point, I wonder whether Esrrb-driven 
reprogramming did not require BMP signalling due to its own ability to cooperate with PStat3 
at its downstream genetic targets (Figure 6.2.3). It would be interesting to investigate whether 
Esrrb and PStat3 also form an activatory protein complex. Indeed, a very recent publication 
found that Esrrb acts as a pioneering TF during EpiSC reprogramming, binding to closed 
chromatin and recruiting P300 in a LIF/Stat3-dependent manner (Adachi et al., 2018). Local 
chromatin remodelling ensues, rendering it accessible for subsequent binding of 
Oct4/Sox2/Nanog at naïve loci. This mechanism is consistent with the findings I report here. 
 
By application of insight derived from murine EpiSC reprogramming, I found that BMP signal 
inhibition abolished resetting of primed human ESCs towards naïve pluripotency. To clarify 
whether this requirement was transition-specific in human as in the murine context, it would 
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be important to test the BMP signalling status in established naïve human iPSCs. Some 
signalling differences have already been reported between naïve human and mouse 
pluripotent cells (Guo et al., 2017; Takashima et al., 2014; Theunissen et al., 2014). Whilst 
further determination of the signals governing naïve human pluripotency maintenance was 
beyond the scope of this thesis, I am curious to see how our understanding of this is resolved 
by ongoing work in different laboratories. Similarly, I hope that the findings of Figure 6.2.7 








CHAPTER 7:  





The aforementioned differences in transcriptional trajectories, signal and genetic requirements 
demonstrated that iKlf2, iPStat3 and iEsrrb instruct reprogramming by distinct mechanisms 
(Chapters 5–6). Given that the starting and destination cellular identities were the same in all 
three cases, the extent of the route differences was surprising. Therefore, in Chapter 7 I ask 






7.2.1 Defined Oct4 level is a common feature of all routes 
 
In light of earlier observations that Oct4 drop was rescued in the Rex1::dGFP+ population of 
iK2N-driven reprogramming (Figure 4.2.3F), I checked the behaviour of Oct4 expression 
during transitions driven by iEsrrb, iPStat3 and iKlf2. I found that Oct4 was maintained at 
endogenous level throughout productive reprogramming, irrespective of the driver. In the 
scRNAseq of productive intermediates for each line, cells expressed Oct4 within a narrow 





Figure 7.2.1: Oct4 maintenance is a unifying feature of productive reprogramming 
Scatter plots of Oct4 expression in single cells vs pseudotime (Fig. S3C), fitted with LOESS 
regression lines. Regression lines are overlaid on the right for comparison. The RNAseq 
analyses were conducted in collaboration with Giuliano Stirparo.  
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Maintenance of Oct4 throughout the transitions is not to be taken for granted. Although Oct4 
is expressed at similar levels in EpiSCs and iPSCs (Figure 7.2.2A), this expression is 
supported by different transcriptional networks and is driven from different enhancer elements 
(Tesar et al., 2007; Yeom et al., 1996). Indeed, signal switch of control EpiSCs to 2iLIF 
triggered Oct4 downregulation (Figure 7.2.2B). In contrast, Oct4 was unperturbed in ESCs 
upon switch from serum+LIF to 2iLIF (Figure 7.2.2C), indicating that 2i itself did not suppress 















Figure 7.2.2: Oct4 maintenance during reprogramming is not to be taken for granted 
(A) Immunofluorescent staining of Oct4 expression in Rex1::dGFP EpiSCs and iPSCs. 
Representative maximum intensity projections of Z-stack 40x slices are presented. Scale bars: 
20 µm. 
(B) Timecourse RT-qPCR analysis of EVrtTA3 control EpiSCs in FA or 2iLIF+dox, and of 
ESCs maintained in 2iLIF. Mean Oct4 expression is displayed relative to Gapdh and 
normalised to ESC day 2, ±SD (n=3). 
(C) Timecourse RT-qPCR of ESCs previously cultured in FCS+LIF then switched to 2i±LIF. 




7.2.2 Oct4 maintenance is an active feature of productive reprogramming 
 
Timecourse RT-qPCR analysis showed that Oct4 was always expressed at or above ESC 
level in the dGFP+ reprogramming subpopulation but not always in the dGFP- (Figure 7.2.3A). 
Together, this suggested that signal-mediated collapse of the primed network prior to naïve 
network construction led to Oct4 expression loss, creating a ‘vulnerable window’ between 
different self-renewing Oct4-supporting configurations. Since 2iLIF triggered Oct4 collapse in 
control EpiSCs, I reason that the observed maintenance of Oct4 in 2iLIF during productive 
reprogramming is an active process coordinated by the driving transgene (Figures 7.2.1–
7.2.2). 
 
To evaluate the relationship between productive identity transition and Oct4 maintenance, I 
subdivided intermediate populations based on a finer gradient of dGFP level. Average Oct4 
expression positively correlated with reprogramming efficiency of the given subpopulation 
(Figure 7.2.3B). To test whether this Oct4 maintenance was required for reprogramming, I 
performed transient Oct4 KD by a single pulse of siRNA treatment at reprogramming onset. 





Figure 7.2.3: Oct4 maintenance correlates with and is required for reprogramming 
(A) Timecourse RT-qPCR analysis of Rex1::dGFP+ and dGFP- EpiSC reprogramming 
intermediate populations in 2iLIF+dox/GCSF, and Rex1::dGFP+ ESCs in 2iLIF. Mean Oct4 
expression is displayed relative to Gapdh and normalised to ESC day 2, ±SD (n=3). It is of 
interest to note that iKlf2 dGFP- cells also maintain Oct4 expression, and retain the potential 
to productively form iPSC colonies until day 4, unlike other dGFP- populations (data not 
shown). 
(B) dGFP negative, low, medium, high and bulk reprogramming intermediate populations were 
isolated by flow cytometry, analysed for mean Oct4 expression level by RT-qPCR (blue), then 
replated for clonogenicity assay in 2iLIF (green). The FACS-plot on the left shows dGFP levels 
during reprogramming, taking the example of iEsrrb 2iLIF+dox day 3. dGFP high, medium 
(med), low, and negative (neg) gates are indicated. dGFP negative and high gates were set 
according to Rex1+/dGFP EpiSCs and ESCs respectively. Low and medium gates subdivide 
the intervening levels. This was conducted in collaboration with Tim Lohoff. 
(C) Oct4 KD was performed at iPStat3 reprogramming onset with a single 16 h pulse of siRNA. 




7.2.3 Fixed Oct4 expression is sufficient for naïve instruction in minimal conditions 
 
Having demonstrated that Oct4 maintenance was observed in and required for productive 
reprogramming, next I asked whether Oct4 maintenance was sufficient. Oct4 null EpiSCs were 
generated that constitutively expressed ectopic Oct4 at endogenous level (FixedOct4) (Figure 
7.2.4A–D), according to methodology described in Radzisheuskaya et al., 2013. This 
uncoupled Oct4 expression from identity or environmental perturbations. An Oct4 null 
background was necessary to ensure maintenance of total Oct4 level, and to avoid 
overexpression of Oct4 that triggers differentiation (Niwa et al., 2000). Correspondingly, 
ectopic Oct4 expression on top of a wild-type background gave very inefficient EpiSC 
reprogramming (data not shown). 
 
Following medium switch to 2iLIF, FixedOct4 EpiSCs rapidly generated naïve iPSC colonies 
with extremely high efficiency (Figure 7.2.4B–D). FixedOct4 +LIF was the minimal requirement 
for naïve pluripotency specification (Figure 7.2.4E). In FixedOct4 reprogramming, impetus 
towards the naïve identity was provided only by exogenous signals: Oct4 is expressed equally 
in both EpiSCs and iPSCs, so there was no naïve-specific transgene. Therefore, maintenance 





Figure 7.2.4: Fixed Oct4 expression is sufficient for naïve instruction 
(A) Genotyping of Oct4-/βgeo CAG.Oct4 EpiSCs, with wild-type (+/+) and Flox (F)/βgeo 
controls. 
(B–D) Oct4-/βgeo CAG.Oct4 (FixedOct4) EpiSCs formed naïve iPSC colonies at high 
efficiency in 2iLIF, quantified by mean iPSC colonies scored on day 8 ±SD (n=3) (B), indicated 
morphologically (C), and confirmed by RT-qPCR expression analysis relative to Gapdh then 
normalised to ESC level=1 ±SD (n=3) (D). Scale bars: 100 µm. 
(E) Oct4-/βgeo CAG.Oct4 EpiSCs were plated at 2000/24well in FA. The following day, 
medium was changed to N2B27 ± Chiron ± PD03 (PD) ± LIF in all permutations (n=3). After 4 
days, G418 was applied to select for endogenous Oct4 promoter activity. Quantification of 
reprogramming efficiency was inappropriate in this case, since some conditions are 
permissive compared to 2iLIF. Instead, on day 8, each 24well was passaged in its entirety to 
2 x 6wells, one maintaining the condition +G418 and one swapped to 2iLIF+G418 to challenge 
iPSC clonogenicity in this naïve-selective condition. iPSC generation propensity was 
assessed on day 12, and representative condition +G418 phase images are shown for those 
conditions which successfully generated iPSCs. Scale bars: 100 µm. We found that FixedOct4 
+LIF was the minimal requirement for naïve pluripotency specification, with derivative iPSCs 
expandable in LIF or 2iLIF+G418 for at least 8 passages. Curiously, Chiron+LIF did not 
instruct naïve pluripotency acquisition for FixedOct4 EpiSCs despite initial emergence of 
naïve-like morphology (n=10).  
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7.2.4 Reconciliation of route differences with common Oct4 maintenance 
 
Despite the distinctions between routes in terms of their transcriptional trajectories and 
mechanistic requirements (Figures 5.3.1, 6.3.1), Oct4 maintenance was a common feature 
and I further demonstrated that this is required and sufficient for reprogramming (Figure 7.2.1–
7.2.4). Now I integrate route-specific attributes with the common denominator of Oct4 
maintenance, to address the overarching logic of the transitions.  
 
First, I assessed the ability of each factor individually to rescue the drop in Oct4 expression 
when EpiSCs are treated with 2iLIF for 24 h (Figure 7.2.5A). Klf2 induction yielded the most 
effective rescue of Oct4 drop, including on the protein level (Figure 7.2.5A–D). This Oct4 
support may explain the high efficiency of Klf2-driven reprogramming despite its paradoxical 
dearth of naïve gene induction (Figure 5.2.1A). iPStat3 somewhat maintained Oct4 





Figure 7.2.5: Immediate impact of each driver on Oct4 expression 
(A) Heatmap of Oct4 expression after 24 h of 2iLIF+dox/GCSF treatment, measured by RT-
qPCR relative to Gapdh then normalised to EpiSC-level=1. 
(B) Western blot against Oct4 and αTubulin in EVrtTA3 and iKlf2 EpiSCs, after 24 h in FA or 
2iLIF ± dox. 
(C) Immunofluorescent staining of Oct4 expression in Rex1::dGFP iKlf2, iPStat3, iEsrrb and 
EVrtTA3 EpiSCs, after 24 h in 2iLIF+dox/GCSF. Representative 20x images are presented. 
Scale bars: 100 µm. 
(D) Timecourse gene expression analysis of iKlf2, iPStat3, iEsrrb and EVrtTA3 EpiSCs 
induced in the indicated conditions +dox/GCSF. Oct4 expression is presented relative to 0 h. 




Since Klf2 was the most effective supporter of Oct4 (Figure 7.2.5), an early transcriptional 
responder to iPStat3 (Figure 6.2.1A), and since transient Klf2 KD abolished iPStat3-driven 
reprogramming (Figure 6.2.1B–D), I asked whether these observations could be conceptually 
integrated. Transient Klf2 KD at iPStat3 reprogramming onset resulted in a 50% reduction of 
Oct4 expression (Figure 7.2.6A). In contrast, Klf2 KD did not abolish reprogramming of 
FixedOct4 EpiSCs (Figure 7.2.6B), even though this was a highly LIF/Stat3-dependent 
process (Figure 7.2.4E). This places Oct4 maintenance as a functionally important 
downstream mechanism of Klf2 in reprogramming, likely to be direct due to its manifestation 
within one hour (Figure 7.2.5D). 
 
iEsrrb was the most efficient of all tested drivers (Figure 4.2.8C), yet exhibited an initial drop 
in Oct4 expression at 24 h (Figure 7.2.5) prior to recovery in the productive subpopulation by 
48 h (Figures 7.2.1, 7.2.3A). The outstanding feature of iEsrrb reprogramming initiation 
kinetics was the rapid and strong upregulation of naïve network genes in a highly 2iLIF-
dependent manner (Figures 5.2.1A, 6.2.3). To test whether this corresponded to rapid wiring 
of a coherent self-renewing naïve network, I challenged the transgene-independent 
clonogenicity of iEsrrb Rex1::dGFP+ cells at 48 h by replating single sorted cells in 2iLIF 
without dox. Strikingly, their dox-independent clonogenicity was comparable to ESCs (Figure 
7.2.6C), indicating that 48 h post-induction a functional naïve network has already formed for 
iEsrrb. Thus I propose that iEsrrb drives a rapid transition between primed and naïve networks, 
reducing the duration of the ‘vulnerable window’ for Oct4 expression loss between different 





Figure 7.2.6: Reconciliation of naïve induction logic between different routes 
(A) iPStat3 EpiSCs were treated with a single pulse of siRNA at reprogramming onset in 
2iLIF+GCSF. After 48 h, gene expression was analysed by RT-qPCR relative to Gapdh then 
normalised to iPSC-level=1. 
(B) Klf2 KD was performed at reprogramming onset of FixedOct4 EpiSCs in 2iLIF. G418 was 
applied at day 4, and iPSC colonies scored on day 8, presented as mean ±SD (n=3). 
(C) dGFP+ ESCs and iEsrrb reprogramming intermediates were isolated by FACS on day 2 
of reprogramming in 2iLIF+dox and plated for clonal assay in 2iLIF without dox. Blasticidin 
was applied on day 6 and naïve colonies scored on day 9. Mean colony number is presented 
as a percentage of ESC colonies, ±SD (n=3). 
 
 
I tested whether this Oct4-supportive role of Klf2 was conserved in human cells. As in murine 
EpiSCs, hOct4 expression dropped dramatically upon switch from primed medium to 
2iLIF+dox (Figure 7.2.7A). hOct4 drop was partially rescued by iKlf2, whereas hSox2 was 
suppressed (Figure 7.2.7A–B), suggesting a similar role of Klf2 in human and mouse 





Figure 7.2.7: Conservation of Oct4 vs Sox2 regulation between species 
RT-qPCR analysis of human H9 ESCs after 72 h of transgene induction in 2iLIF. Mean Oct4 
(A) or Sox2 (B) expression ±SD (n=3) is displayed relative to Gapdh, normalised to EV 0 h. 
This was conducted in collaboration with Tim Lohoff.  
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7.2.5 Fine-tuned Oct4 expression is a pivotal feature for somatic reprogramming 
  
To address the applicability of these findings to other cellular contexts, I derived somatic cells 
from FixedOct4 iPSCs by differentiation in chimeras (Figure 7.2.8A). Contribution of FixedOct4 
cells to chimeras was high, and their Oct4 expression persisted (Figure 7.2.8B). I confirmed 
bonafide developmental progression by loss of Nanog, expression of lineage markers in the 
appropriate locations, and histological analyses (Figure 7.2.8B–C, Appendix page 187). This 
is not so surprising as it may seem: there is precedent for Oct4-expressing cells to proceed in 
development. (Masui et al., 2007; Radzisheuskaya et al., 2013; Ramos-Mejía et al., 2005). 
 
 
Figure 7.2.8: Derivation of FixedOct4 somatic cells by differentiation in chimeras 
(A) Oct4-/βgeo CAG.Oct4.2A.Cherry iPSCs were injected into E3.5 C57BL/6 blastocysts then 
transferred to recipients. Resultant embryos were collected at E9.5. Representative phase 
and Cherry images are shown. Scale bars: 100 µm. 
(B–C) Marker expressions were analysed by immunofluorescence on 8 µm cryosections. 
Subsequently, histological analyses were performed by H&E staining. Scale bars: 200 µm. 
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I discarded a generous portion of the tail to stringently avoid germ cell contamination, then 
dissociated and cultured the anterior portion of each chimera to test reprogramming ability 
(Figure 7.2.9A). In general, reprogramming from somatic cells takes considerably longer than 
from EpiSCs, which can be explained by the need to remodel a more constrained epigenetic 
landscape. For this reason, conversion of FixedOct4 somatic cells was attempted using two 
different strategies: directly in 2iLIF, or in LIF combined with a low dose of 5-Azacytidine (aza, 
an inhibitor of DNA methyltransferase activity) prior to 2iLIF treatment.  
 
With the exception of positive control allantois (AL), iPSCs were not generated when plated 
directly in 2iLIF, consistent with previous demonstrations that, if applied from the beginning, 
2iLIF does not support somatic cell reprogramming (Silva et al., 2008). Strikingly however, 
naïve iPSCs were generated at high efficiency following culture in LIFaza then 2iLIF (Figure 
7.2.9A–G). This indicates that, as in EpiSC reprogramming (Figure 7.2.4), fine-tuned Oct4 
expression was able to drive efficient naïve pluripotency establishment from somatic cells8. 
                                               
8 In subsequent experiments, I challenged whether aza is required to overcome epigenetic barriers from 
more advanced developmental states. Aza is not essential. FixedOct4 together with Jak/Stat signalling 





Figure 7.2.9: Fine-tuned Oct4 expression is a pivotal feature for somatic reprogramming 
(A) The tail portion of E9.5 embryos was removed to strictly avoid germ cell contamination. 
The anterior portion was dissociated manually, then subdivided into quarters (2x LIFaza, 2x 
2iLIF). After 6 days, LIFaza was exchanged for 2iLIF, then on day 10 G418 was applied to all 
cultures. A chimeric allantois (AL) (Fig. S7B) was plated as a positive control (germ-cell 
containing) directly in 2iLIF. Generation of G418-resistant iPSCs is summarised in the table. 
(B) Phase and Cherry images of allantois (AL) dissected from a headfold stage embryo. 
(C) Representative phase image showing G418-resistant iPSCs in an entire 6well at 
passage 0, following LIFaza then 2iLIF treatment on 1/8th of a chimeric embryo. 
(D) Representative phase and Cherry images at passage 0 in 2iLIF+G418, following derivation 
in LIFaza then 2iLIF. Scale bars: 100 µm. This provides a closer view of the timepoint in (C). 
(E) Representative phase and Cherry images of iPSCs at passage 5 in 2iLIF+G418, following 
derivation from chimera #4 in LIFaza then 2iLIF. Scale bars: 100 µm. 
(F–G) RT-qPCR expression analysis relative to Gapdh then normalised to parental iPSC 
level=1 (F) or to pre-iPSC level=1 (G). Expression is shown after two days of treatment with 
LIF±aza on cells from chimera #1. Expression of iPSCs at passage 2 in 2iLIF+G418 is shown 
after derivation in LIFaza then 2iLIF for chimeras #1, 4–7, and after derivation directly in 2iLIF 
for the allantois (AL). Due to the iPSC-history of the cells (Radzisheuskaya et al., 2013), it was 
necessary to confirm that silenced retroviruses (r) were not reactivated. 






7.3.1 Unification of reprogramming logics 
 
During reprogramming initiation, Oct4 expression dropped as naïve signals disrupted the 
primed network (Figures 4.2.1, 4.2.2, 7.2.2, 7.2.5). However, Oct4 expression was maintained 
throughout reprogramming in the productive subpopulation, irrespective of the driving factor 
(Figures 4.2.3, 7.2.1, 7.2.3), whereas Oct4 knock-down abolished reprogramming (Figure 
7.2.3). Therefore, Oct4 drop following signal switch presented a barrier that had to be actively 
overcome by the drivers for productive reprogramming. The functional importance of this Oct4 
maintenance was validated by fixing Oct4 to endogenous level (Figure 7.2.4), which was 
sufficient for extremely efficient entry to the naïve identity under only signal instruction. 
 
Therefore, distinct routes of reprogramming (Figures 5.3.1, 6.3.1) can be thought of as 
different strategies by which to achieve the unifying, required and sufficient event of Oct4 
maintenance (Figure 7.3.1). In light of this I propose the following hypothesis: for a given 
EpiSC reprogramming driver, there is a certain probability of rescuing Oct4 expression during 
the ‘vulnerable window’ after Oct4 loses support from the collapsing primed network. I suggest 
that reprogramming efficiency correlates with this probability, which is determined by the ability 
of that factor itself to drive Oct4 expression, and the speed at which that factor orchestrates a 
coherent naïve network to support Oct4 in an alternative topology. iKlf2 and iEsrrb occupy 
opposite extremes within this model, relying solely on the former and latter methods 
respectively (Figures 7.2.5, 7.2.6). iPStat3 employs an intermediate strategy, eliciting 
moderate upregulation of naïve network genes and with Klf2 acting downstream of PStat3 to 
support Oct4 expression (Figure 7.2.5). This lends further significance to my identification of 
Klf2 as a PStat3 target in EpiSCs despite not being considered as such in ESCs (Figures 
3.2.9, 6.2.1): not only is network topology different during naïve pluripotency induction vs 
maintenance, but this has important functional consequences. 
 
The permissible time-period and level of transient Oct4 drop should be clearly delineated prior 
to its recovery at 48 h, particularly for iEsrrb (Figure 7.2.1, 7.2.3, 7.2.5). Since tagging of Oct4 
renders it dysfunctional (Silva group, unpublished), this could instead be attempted by creation 
of a destabilised reporter at an endogenous Oct4 locus, connected between the open-reading-




7.3.2 Applicability to somatic cell reprogramming 
 
Results in a somatic cell context supported my findings in EpiSCs and further demonstrated 
that identity transition to naïve pluripotency pivots on the fine-tuning of Oct4 (Figure 7.2.9). It 
was previously shown that Oct4 is sufficient to induce pluripotency from somatic cells (Kim et 
al., 2009), but this was very inefficient and protracted (0.014%, 4–5 weeks). Instead, 
fixing Oct4 expression to an ESC level resulted in efficient and rapid somatic reprogramming 
(Figure 7.2.9). Conversely, somatic reprogramming blocked in the final stage by lack of 
endogenous Oct4 was rescued by provision of ectopic Oct4 at control level (Radzisheuskaya, 
2014). Thus, precise Oct4 expression is a defining feature in distinct contexts of nuclear 
reprogramming. I suggest that correct Oct4 level creates the opportunity for transition into 






Figure 7.3.1: Convergence on precise Oct4 expression to access naïve pluripotency 
Schematic summarising the convergent feature of correct Oct4 level, which permits cells to 
transit into naïve pluripotency. Left: diverse logics by which different EpiSC reprogramming 
drivers achieve the required common feature of Oct4 maintenance in order to undergo the 
identity transition. Right: in distinct somatic cell reprogramming contexts, expression level of 
Oct4 is a key and limiting mechanism in order to access the naïve identity. From both EpiSCs 




7.3.3 Resolving the iKlf2 paradox 
 
iKlf2 is rather enigmatic as an efficient EpiSC reprogramming driver (Figure 4.2.8C). Its dearth 
of naïve gene upregulation within the first 48 h is counterintuitive, as is its highly divergent 
initiation trajectory and upregulation of mesodermal markers even in productive single cells 
(Figures 5.2.1, 5.2.5). In the first 48 h of reprogramming, the only positive impact of Klf2 on 
pluripotency genes is robust support of Oct4 expression (Figures 5.2.1, 7.2.5). Since 
FixedOct4 is sufficient for highly efficient reprogramming (Figure 7.2.4), I reason that a similar 
phenomenon happens here: iKlf2 intermediates are Oct4+ and thus remain permissive for 
reprogramming directed by signals. The slow kinetics with which naïve genes are eventually 
upregulated in productive iKlf2 cells is consistent with gradual network coordination as signal 
instruction becomes dominant (Chapter 5). I note that Oct4 expression is initially maintained 
during mesendoderm lineage entry (Downs, 2008; Thomson et al., 2011) and thus speculate 
that transient diversion can be beneficial for reprogramming if it helps to achieve the Oct4 
maintenance requirement. Conversely, Sox2 is downregulated during mesendoderm 
specification (Thomson et al., 2011). Here I report concomitant Oct4 support and Sox2 
silencing in response to iKlf2 or iK2N induction, and this is conserved between murine and 
human systems (Figures 4.2.3, 5.2.1, 7.2.5, 7.2.7). In both species, it will now be interesting 
to understand how and why Oct4 expression is maintained within the transition-permissive 







CHAPTER 8: GENERAL DISCUSSION 
 
 
8.1 General conclusions and implications 
 
8.1.1 Principles of cell identity transitions 
 
In the preceding Chapters, I showed that there are multiple routes by which the naïve identity 
can be established from EpiSCs, with the unifying feature of active Oct4 maintenance. Not 
only do these routes differ in their transcriptional trajectories (Chapter 5), but crucially also in 
their mechanistic attributes as evidenced by exogenous signal, paracrine signal and genetic 
requirements (Chapter 6). Thus, I demonstrate that there can be considerable flexibility for the 
specification of a single identity from a single origin. This adds further complexity to the 
paradigm of multicellular biology in which TFs and signals are used in different permutations 
and contexts in order to generate different cell types: they can also be used in different ways 
to generate the same cell type. I wonder whether this principle could assist organismal 
robustness and flexibility in the face of unpredictable events. 
 
This thesis supports theories that cellular identities are multidimensional attractors, occupying 
local minima of stable network states with multiple paths of approach (Section 1.1) (Huang et 
al., 2005; Kauffman, 1993). Here I provide a substantial advance on previous works, reaching 
a single destination identity via three different routes with mechanistic as well as transcriptional 
distinctions. Formally, an attractor and the transitions between them are computed on the 
basis of transcriptome signatures and underlying GRNs (Davila-Velderrain et al., 2015). Whilst 
modelling of routes through identity state space according to dynamical systems mathematics 
was beyond the scope of the thesis, I hope such analyses will be performed on our RNAseq 
data. In the meantime, it is clear from the genome-wide analyses in Chapter 5 that distinct 
transcriptional trajectories are taken. These also differ in their signal and genetic requirements 
(Chapter 6), demonstrating mechanistic distinction between transition routes. So far as I am 
aware, this is the first time that mechanistic attributes have been considered when assessing 
whether cellular attractors are multidimensional. Whilst such parameters are difficult to 
formalise in mathematical terms, in my opinion they are essential to consider from the 
biological perspective, validating that transitions occur via truly different intermediate cellular 
states. 
 
In Chapter 7, I then reveal the logic underpinning multidimensional access to the single 
attractor state: fine-tuned support of a transition factor, in this case Oct4 (Chapter 7). In line 
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with this concept, I propose that the aforementioned distinct routes of reprogramming 
represent different paths of approach towards the naïve pluripotent attractor (Figure 7.3.1). In 
such a paradigm, I speculate that appropriate Oct4 expression would allow unstable 
transitioning cells to crest energetic ridges, providing access to surrounding attractors. Having 
met this criterion, a conducive signal environment would nudge intermediates into the naïve 
valley, into which they stably settle after transgene withdrawal. Induction of naïve TFs (driver 
and targets) expedites this approach (Figure 7.2.6C), but is not strictly necessary (Figure 
7.2.4). Indeed, in the case of iKlf2 a different program is initially induced rather than that of the 
naïve identity (Chapter 5). This represents a conceptual shift, exposing expression of a 
transition factor as more important than the transcriptional program directly induced by a 
driver. Thus, transition of cellular identity does not simply require activation of the destination 
program, but instead pivots on the mechanism that permits an identity transition to occur. 
 
An extreme example is proffered by the FixedOct4 case, where opposing yet highly efficient 
identity transitions occur depending solely on the environment: induction of naïve pluripotency 
in the presence of LIF (Figures 7.2.4, 7.2.9), or re-entry to development and bonafide 
contribution to embryonic lineages in vivo (Figure 7.2.8). Oct4 also plays a transition-permitting 
role during early differentiation of several lineages (Niwa et al., 2000; Radzisheuskaya et al., 
2013), and can be briefly utilised to promote direct transdifferentiation from fibroblast to neural 
identity (Thier et al., 2012). In this light, and considering that low-Oct4 locks ESCs in self-
renewal (Radzisheuskaya et al., 2013), I am now inclined to consider Oct4 as a ‘transition’ 
rather than a ‘pluripotency’ factor. Ultimately, since the objective of pluripotency is to execute 





8.1.2 Interplay between transcription factors and environmental signals 
 
Throughout this thesis, several forms of signal/TF interplay are exemplified: 
 
Positive interactions regarding LIF/PStat3: 
1. Suppression of Socs3 and amplification of LIF signal transduction by Nanog, leading 
to increased PStat3 levels (Chapter 3). 
2. Cooperation between LIF/PStat3 and Nanog to upregulate Klf4 and its novel enhancer 
RNA, termed K4eRNA (Chapter 3). 
3. Cooperation between Esrrb and LIF to synergistically upregulate PStat3-target genes, 
even when only minute amounts of PStat3 are present (Chapter 6). 
4. Combined action of FixedOct4 and LIF suffices to induce naïve pluripotency from 
EpiSCs and somatic cells (Chapter 7). 
5. Forced activation of Stat3 boosts Sox2 expression in EpiSCs, and counteracts Nanog-
mediated Sox2-suppression (Chapter 3). 
6. Unlike in ESCs, Klf2 responds as a PStat3 target gene in EpiSCs, and this is 
functionally necessary for PStat3-driven reprogramming (Chapters 3, 6 & 7). 
 
Positive interactions regarding Chiron: 
7. Chiron from day 1–4 is required for Klf2 to drive EpiSC reprogramming (Chapter 6). 
8. Chiron increases the efficiency of Esrrb-driven EpiSC reprogramming (Chapter 6). 
 
Positive interactions regarding PD03: 
9. PD03 increases the efficiency of FixedOct4 EpiSC reprogramming, and is required if 
Chiron is also present (Chapter 7). 
 
Positive interactions regarding 2iLIF component combinations: 
10. Increase in naïve network induction kinetics in 2iLIF compared to FA for 
iNanog+iPStat3 (Chapter 4) and iEsrrb (Chapter 5). 
11. Additive effect of PD03 and Chiron on reprogramming efficiency when driven by PStat3 
or iEsrrb (Chapter 6).  
 
Positive interactions with other signals: 
12. Transient dependence on BMP signalling for iPStat3 and iKlf2 (Chapter 6). 
 
Redundancies: 




14. Rescue of Nanog-/- reprogramming in the absence of PD03 (Chapter 6). 
15. Partial alleviation of iPStat3 sensitivity to Klf2 KD in the absence of PD03 (Chapter 6). 
16. Suppression of Oct4 and Sox2 by 2iLIF treatment of EpiSCs (Chapters 4 & 6). 
17. Abolishment of FixedOct4+LIF reprogramming by the addition of Chiron (Chapter 7).  
 
Specific considerations of these findings are given in the corresponding Chapters. In a more 
general sense, these findings enrich our understanding of how the naïve pluripotent identity is 
governed by complex TF/signal interplay. This plethora of positive, negative, cooperative and 
redundant interactions is augmented by the ability of TFs and signals to fundamentally 
modulate whether and how each other is interpreted. In sum, this thesis highlights the 






8.1.3 Network differences for installation vs maintenance of naïve pluripotency 
 
An emergent theme from this work is that different regulatory principles apply during induction 
vs self-renewal of naïve pluripotency. In particular, Klf2 behaves as a PStat3-target during 
EpiSC reprogramming initiation (Chapters 3 & 6), but not during ESC maintenance (Hall et al., 
2009). Not only does this represent a difference in network topology, but it bears important 
functional consequences: Klf2 is required downstream of PStat3 during reprogramming 
(Chapter 7). I also note suppression of Sox2 by Klf2 or Nanog induction in EpiSCs (Chapters 
3 & 5). So far as I am aware, this has not been reported in ESCs.  
 
Whilst Esrrb substitutes the requirement for Chiron in 2i culture of ESCs (Martello et al., 2012), 
during EpiSC reprogramming I observe synergy of Esrrb with Chiron (Chapter 4). Chiron 
application to EpiSCs does not upregulate endogenous Esrrb in the way that it does for ESCs 
(Chapters 5 & 6). When other drivers are induced, Esrrb is not upregulated early in the 
reprogramming process, yet Chiron application is usually beneficial (Chapter 6). Therefore, it 
logically follows that Chiron plays different roles during acquisition vs maintenance of naïve 
pluripotency. In general, Chiron signal interpretation is known to be context-dependent: as a 
component of 2i, Chiron supports naïve pluripotency, whereas treatment of ESCs or EpiSCs 
with Chiron+ActivinA elicits robust mesodermal differentiation. Since EpiSCs are already 
transducing ActivinA signal, it seems reasonable that their initial response to Chiron is not 
equivalent to that of ESCs. I hypothesize that additional, as yet unknown, inputs are required 
to reactivate Esrrb expression during reprogramming.  
 
In any context, I would not tacitly assume that the rules governing identity installation and 
maintenance are the same, but rather challenge each process with an open mind.  
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8.2 Suggestions for future work 
 
8.2.1 Genomic binding and role of Oct4 during identity transitions 
 
An appropriate Oct4 level permits cells to transition between identities, both in differentiation 
and reprogramming, but the direction of the transition is instructed by other factors and signals. 
Primed vs naïve identities are characterised by different Oct4 binding configurations (Buecker 
et al., 2014). In addition to supporting Oct4 expression itself, how do other factors/signals drive 
reorganisation of Oct4 genomic binding? Is this a unifying feature between different 
reprogramming routes, or another point of mechanistic distinction? Is identity transition simply 
a matter of redirecting Oct4 from the start- to destination-identity binding sites, or is the role of 
Oct4 contingent on transition-specific events? What is the relationship between Oct4 and the 
epigenetic landscape? In the first instance, I would suggest ChIP studies to assess Oct4 
engagement with the genome following independent manipulations of TFs and signals during 
reprogramming from EpiSCs to iPSCs. In particular, the ability of PStat3 to dominantly drive 
reprogramming in FA conditions will allow controlled comparison of 2i vs TF inputs to the 
redirection and action of Oct4 (Figure 4.2.1) (van Oosten et al., 2012). 
 
Whilst the importance of Oct4 for the execution of cell identity transitions is clear, the 
mechanisms by which it achieves this remain elusive. Part of the difficulty in studying this lies 
in the very features that make the question so interesting. Oct4 performs a multitude of roles 
in an exquisitely dose- and context-dependent manner. In ESCs, Oct4 at zero, low, wild-type 
and overexpressed levels respectively trigger differentiation, locked self-renewal with inability 
to differentiate, context-appropriate self-renewal or differentiation, and forced differentiation 
(Niwa et al., 2000; Radzisheuskaya et al., 2013). Thus, even subtle manipulations can abolish 
the particular process that one is trying to study. For example, knock-down or conditional 
knock-out of Oct4 inevitably pass through an Oct4-low state, due to the time taken to degrade 
all the Oct4 protein, and this has utterly different functional consequences compared to either 
higher or lower Oct4 levels. Ongoing work (Bates et al., unpublished) may resolve this 
technical challenge by employing the rapid auxin-inducible degron (Nishimura et al., 2009). 
Similarly, a crucial benefit of our FixedOct4 system is that Oct4 is supplied at precisely the 
ESC-level, circumventing neomorphic effects which plague much of the existing literature 




8.2.2 Balancing of the naïve pluripotency network in ESCs 
 
Robust self-renewal of ESCs must be balanced with the capacity to differentiate on demand 
(Chapter 1). This implies that naïve network strength must stay within certain limits. In this 
thesis, I have identified several negative regulatory relationships that may assist in naïve 
network balancing.  
 
In EpiSCs, Sox2 is suppressed following induction of Klf2 and/or Nanog (Chapters 3–5). 
Conversely, PStat3 boosts Sox2, and together the inputs of PStat3+Nanog balance 
(Chapter 3). This may reveal a mechanism to temper the naïve pluripotent network. However, 
these relationships should now be carefully checked in ESCs, since responses in the EpiSC 
context may instead reflect onwards developmental logic. From the mid–late-streak stages, 
Sox2 and Nanog become anteriorly and posteriorly restricted respectively: the observed 
inverse relationship between Sox2 and Nanog may thus echo natural symmetry-breaking of 
the post-implantation epiblast. 
 
From Chapter 4, it is apparent that ESCs have the means to limit PStat3 levels, even when 
total Stat3 is grossly overexpressed. In agreement with the work of Tai et al., 2014, PStat3 
levels above this threshold are incompatible with long-term self-renewal of ESCs. Besides 
auto-induction of the Socs3 repressor, very little is known about the mechanisms of PStat3 
restraint in ESCs. Since Socs-insensitive GY118F-stimulated ESCs can eventually curb 
PStat3 (Figure 4.2.4C), I think it would be worth reopening investigation into other repressors 
of Jak/Stat signalling, such as the Pias and Shp protein families (Böhmer and Friedrich, 2014). 
 
As outlined above, a precise level of Oct4 expression is compatible with the choice between 
ESC self-renewal or differentiation. Levels above or below this impair one process or the other. 
How do ESCs constrain Oct4 within this narrow range? A variety of Oct4-supportive factors 
have been reported in the naïve network (Martello and Smith, 2014), yet logically they cannot 
form an endless positive feedback loop. What are the suppressors of Oct4, that ensure its 
fine-tuning? I also find it intriguing that Oct4 is expressed at the same level in FCS+LIF and 
2iLIF ESC cultures, despite weaker naïve gene expression in the former (Section 1.2). In this 
thesis, I identified Klf2 as a potent supporter of Oct4 expression (Chapter 7). Conversely, I 
observed Oct4 suppression following Tfcp2l1 induction (Figure 7.2.5A), and negative 
correlation between Tfcp2l1 and Oct4 responses (Figure 4.2.1–2). Tfcp2l1 and Klf2 are 
co-induced by 2iLIF relative to FCS+LIF (Ye et al., 2013; Yeo et al., 2014), are simultaneously 
downregulated at implantation and reactivated during diapause in vivo, throughout all of which 
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Oct4 is maintained. Therefore, I wonder whether Tfcp2l1 and Klf2 provide a coordinated 
balance, with concurrent yet opposing inputs to Oct4 gene regulation. 
 
In future studies, it should be determined whether these interactions are direct, and whether 
they are of functional significance for ESC equilibrium. This may require the implementation 
of quantitative (not Boolean) computational models and rapid knock-out technologies. 
 
 
8.2.3 Does Klf2 play a post-implantation role in mesodermal lineage specification? 
 
Paradoxically, the ability of Klf2 to reprogram EpiSCs to naïve pluripotency appears secondary 
to its ability to upregulate mesodermal markers (Chapter 5). I did not observe naïve gene 
activation until >48 h after Klf2 induction, whereas mesodermal markers were strongly 
induced. The investigation in Chapter 7 led me to conclude that the ability of Klf2 to drive 
reprogramming lies largely in its ability to maintain Oct4 expression, endowing a prolonged 
window of opportunity for 2iLIF signals to eventually induce naïve pluripotency. Interestingly, 
Oct4 is also maintained during the first stages of mesendoderm differentiation (Downs, 2008; 
Thomson et al., 2011). I wonder if these two observations are not coincidental, but rather that 
by inducing a mesodermal Oct4-expressing program, Klf2 serendipitously provides the 
opportunity for the environment to drive reprogramming.  
 
With these ideas in mind, I turned back to the literature to search for evidence as to whether 
Klf2 is re-expressed again shortly after implantation, and whether it might play a role in 
regulation of mesodermal lineage specification in vivo. An early study found Klf2 transcript at 
E7.5 (Anderson et al., 1995). More recently, Klf2 expression has been detected at E8.5 in 
endocardial and endothelial compartments, increasing to E10.5 in the heart tube loops and 
endocardial cells (Lee et al., 2006). Klf2-/- mice die between E11.5–14.5 (Chiplunkar et al., 
2013; Kuo et al., 1997). This embryonic lethality indicates an important post-implantation role 
for Klf2 that is not compensated by other Klf family members, and has been attributed to either 
haemorrhage or embryonic heart failure (Chiplunkar et al., 2013; Kuo et al., 1997; Lee et al., 
2006). Intriguingly, there is evidence implicating Klf2 as a regulator of endothelial-to-
mesenchymal transformation in the atrioventricular canal prior to E10.5 (Chiplunkar et al., 
2013). 
 
In established ESCs, Klf2 clearly has a positive role in maintaining the naïve identity (Hall et 
al., 2009; Jiang et al., 2008; Niwa et al., 2009; Yamane et al., 2018; Yeo et al., 2014). Yet, as 
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with many TFs governing naïve pluripotency, Klf2 also has expressions and roles elsewhere 
in development (Bialkowska et al., 2017), including early post-implantation. From the point of 
view of an EpiSC, a cell type on the cusp of gastrulation, why would it respond to such a factor 
according to its role in the earlier naïve network rather according to forwards developmental 
logic?  
 
In a future project, the biological questions that I would suggest to ask are as follows: does 
Klf2 actively specify particular lineages as the post-implantation epiblast progresses? In the 
absence of instructive signals, for how long are intermediates from iKlf2 EpiSCs open to both 
naïve and post-implantation fates? What is the limit after which mesodermal induction hinders 
rather than helps reprogramming? How are different roles of Klf2 computed in different 
contexts, and do they mechanistically relate? What is it about the pre-implantation vs post-
implantation context that can switch which program Klf2 directs? These questions could be 
initially explored in vitro by differentiation assays in neural, mesodermal or ‘open’ 
differentiation conditions, starting from iKlf2 EpiSCs and/or iPSCs ± dox9, and Klf2-/- cells. 
Subsequently, behaviour of labelled Klf2-/- and iKlf2 ESCs/EpiSCs could be traced in chimeric 
embryos or gastruloids. Since EpiSCs do not express Klf2 themselves, yet temporally are 
positioned between Klf2-expressing naïve and post-implantation tissues, this could provide an 
excellent paradigm for the study of factor reuse with context-dependent interpretive logics. 
 
 
8.2.4 Sox2 mRNA regulation and Oct/Sox partner swapping 
 
In counterpoint to its robust support of Oct4 expression, Klf2 silences Sox2 within one hour 
post-induction (Figure 5.2.1A). Since the half-life of Sox2 mRNA is 85-120 min (Ormsbee 
Golden et al., 2013; Sharova et al., 2009), this suggests active mRNA degradation rather than 
simply transcriptional suppression. In human mesenchymal stem cells, there is evidence for 
Sox2 mRNA degradation mediated by the 3' UTR RNA-binding protein ELAV1 together with 
RISC and miR145 (Latorre et al., 2016). miR145 has also been implicated in the suppression 
of Sox2 in human ESCs and murine neural stem cells (Morgado et al.; Xu et al., 2009). 
Unfortunately miR expressions cannot be analysed in our RNAseq data due to size-exclusion 
from the libraries, but this would be worth pursuing in the future. In a preliminary experiment I 
found that forced Sox2 expression abolished iKlf2-driven reprogramming, suggesting that 
transient Sox2 silencing is essential for this transition route. Since constitutive Sox2 was driven 
                                               
9 In a preliminary experiment, iKlf2 cells +dox dominantly differentiated into a ‘motile mesoderm’ 
morphology, even in strongly pro-neural N2B27+A8301 conditions. 
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from a CAG promoter and lacked the endogenous 3' UTR, further work will be required to 
distinguish between the functional importance of transcriptional vs post-transcriptional 
silencing, and the mechanisms thereof. 
 
Pou and Sox family proteins usually bind DNA in cooperation with partner factors. This 
partnering is required for transcriptional regulation, and different partnerships bind different 
gene targets. There is extensive precedent for Pou/Sox partner swapping as a critical regulator 
of lineage specification (Aksoy et al., 2013; Kondoh and Kamachi, 2010). I wonder whether 
Sox2 silencing reflects a mechanism by which Klf2 influences identity transitions, by altering 
Oct4 partnering. Several Pou/Sox family members are rapidly modulated following Klf2 
induction in EpiSCs, as is Oct4-partner Otx2 (Figure 8.2.1). In the first instance, these 
transcriptional trends should be confirmed on the protein level. Then, during both 
reprogramming and differentiation of iKlf2 EpiSCs, Oct4 immunoprecipitation could ascertain 
whether its partners do indeed swap from Oct4/Sox2 and Oct4/Otx2 to Oct4/Sox7 or other 




Figure 8.2.1: Pou/Sox family responses to Klf2 induction in EpiSCs 
Timecourse gene expression analysis of iKlf2 EpiSCs induced with dox in the indicated 
conditions. Gene expressions are presented as FPKM from RNAseq. 
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8.2.5 Transition factors during regenerative fate transitions in vivo? 
 
In this thesis, I found that appropriate expression of Oct4 is the pivotal feature for transition 
into the naïve pluripotent identity. Indeed, maintenance of this transition factor appears to be 
more important than the transcriptional program directly induced by the reprogramming driver, 
as exemplified by the case of Klf2 where induction of mesodermal rather than naïve genes is 
ultimately compatible with efficient reprogramming, thanks to the interim robust support of 
Oct4 expression. Does this concept extrapolate to establishment of other cellular identities? 
Are there other cases whereby multiple routes of identity change converge on a unifying 
transition factor? Intuitively, this could provide benefits when responding to unpredictable 
events such as injury, balancing flexibility with fidelity of cell identity regeneration. 
 
Compared to the tractable in vitro systems employed in this thesis, answering these questions 
in a variable-controlled manner during in vivo identity transitions will be far more challenging. 
Ongoing advances in our understanding and manipulation of regenerative events may open 
this avenue in the near future. For example, induction of progenitors in response to liver 
damage is increasingly well defined thanks to the published and ongoing work of Meri Huch 
(Huch et al., 2013). In response to Wnt signalling, differentiated duct cells undergo 
dedifferentiation and epigenetic reprogramming to yield proliferative Lgr5+ bipotent liver 
progenitors. The ability of single Lgr5+ progenitors to form in vitro liver organoids provides a 
clear confirmation of destination molecular signature and functionality. Therefore, it could now 
be feasible to study fate transition into the liver progenitor identity from a variety of starting 
liver positions or damage types.  
 
Recent work on Axolotl limb regeneration has also highlighted and clarified a process of tissue 
dedifferentiation (Tanaka group, in press). During this reprogramming there is a marked 
reduction in cellular heterogeneity, indicative of a transient convergence of cellular identities 
prior to redifferentiation. Does a transition factor regulate entry to this putative attractor state? 
What determines the relative ease with which the Axolotl can re-access this? Thanks to 
genomic sequencing and molecular tools for Axolotl manipulation (Nowoshilow et al., 2018), 
we are now in a position to tackle these fascinating questions. 
 
As a community, I hope we will continue to identify the transition factors and supporting logic 
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To decipher how cellular identity is instructed 
by interplay between transcription factors and 
signals, we employ defined reprogramming 
systems in which genetic and signalling pa-
rameters can be independently varied and 
successfully transitioning cells isolated. We 
show that naïve pluripotency can be induced 
from EpiSCs along transcriptionally and 
mechanistically distinct routes. Relative to de-
velopment, one route moves forward, with 
productive cells acquiring mesodermal signa-
ture prior to naïve pluripotency induction. In 
contrast, another route overshoots back-
wards, transcriptionally resembling the earlier 
embryo and gaining its greater developmental 
potency. Nevertheless, these distinct trajecto-
ries reach the same endpoint, demonstrating 
surprising flexibility for the establishment of a 
single identity from a single origin. We recon-
cile route differences, revealing precise Oct4 
expression as a unifying, essential and suffi-
cient feature. We propose that fine-tuned reg-
ulation of this ‘transition factor’ underpins mul-
tidimensional access to the naïve identity. 
This offers a conceptual framework for the un-
derstanding of cell identity transitions. 
 
Introduction 
Differential use of the same genome gener-
ates the spectacular diversity of biological 
form and function in multicellular animals. A 
finite number of transcription factors (TFs) 
and signalling pathways are used and re-
used in different combinations and contexts in 
order to generate this array of distinct cellular 
identities. But how is interplay between exter-
nal signals and internal TF networks com-
puted by the cell to instruct identity? Are there 
multiple routes by which a given identity can 
be established, or must it always follow the 
same progression of mechanistic steps? 
These are fundamental questions of wide in-
terest, answers to which will underpin our un-
derstanding of multicellular biology. 
A cellular identity with a stable gene regu-
latory network can be thought of as an attrac-
tor, occupying a local minimum in an ‘ener-
getic’ landscape of cell states (Kauffman, 
1993; reviewed in Enver et al., 2009). But is 
an attractor multidimensional, with multiple 
ways by which it can be approached, or do 
identity transitions follow a set path through 
an energetic ’valley’? Empirical evidence sup-
porting theories of cellular identity as a multi-
dimensional attractor was provided in a land-
mark work by Huang et al., 2005. They 
showed two transcriptionally distinct routes of 
promyelocytic HL60 cell differentiation into 
neutrophils, although they noted some dispar-
ity in the resulting neutrophil identities. A limi-
tation for the further understanding of the prin-
ciples governing cell identity change has 
been a lack of suitable in vitro cell types and 
of defined, tractable systems to study the 
transitions occurring between these. 
Here we investigate the principles under-
pinning cell identity transitions. To address 
this we chose reprogramming to naïve plu-
ripotent stem cells (nPSCs) as a model. 
nPSCs have an unbiased potential to 
make all lineages of the developed organism, 
including the germ lineage. This fascinating 
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tion mammalian epiblast, and can be cap-
tured in vitro as embryonic stem cells (hereaf-
ter referred to as nPSCs), or generated by re-
programming of differentiated cells back into 
induced nPSCs (inPSCs) (Takahashi & 
Yamanaka, 2006). Murine naïve pluripotency 
can be maintained in culture by dual inhibition 
(2i) of Mek/Erk by PD03 and Gsk3 by Chiron, 
together with Stat3-agonist LIF (Ying et al., 
2008). Core members of the TF network reg-
ulating the naïve identity include Oct4, Sox2, 
Nanog, Esrrb, Klf2, Klf4, Klf5, Stat3 and 
Tfcp2l1, and multiple inputs have been identi-
fied between the 2iLIF signal components 
and this network (reviewed in Martello & 
Smith, 2014). 
In the post-implantation epiblast, the plu-
ripotent cells have progressed to the primed 
state. This distinct identity exhibits markedly 
different transcriptional, epigenetic and meta-
bolic profiles, and no longer gives rise to the 
germ lineage (reviewed in Morgani et al., 
2017). These cells can be captured in culture 
as epiblast stem cells (EpiSCs) and require 
FGF stimulation rather than inhibition of 
Mek/Erk signalling, together with the addition 
of ActivinA (FA) (Brons et al., 2007; Tesar et 
al., 2007). 
Reprogramming of EpiSCs to inPSCs pro-
vides several advantages as a model system 
to study cell identity transitions. The destina-
tion naïve identity is extremely well defined in 
terms of its molecular signature, while func-
tional assays such as clonogenic expansion 
and chimeric contribution leave no doubt as 
to whether the identity in question has indeed 
been generated. Reprogramming of EpiSCs 
requires only one driving naïve factor, com-
bined with defined modulation of the signal-
ling environment (Guo et al., 2009; van 
Oosten et al., 2012). This is in stark contrast 
to somatic cell reprogramming, which re-
quires multiple genetic and signal variables to 
be introduced simultaneously in order to 
achieve reprogramming, prohibiting causal 
ascription of changes to individual inputs 
(reviewed in Smith, Sindhu & Meissner, 
2016). Furthermore, rapid naïve gene expres-
sion responses follow transgene induction in 
EpiSCs, even while maintaining EpiSC FA 
culture conditions (Stuart et al., 2014). Thus, 
in this system we can disentangle the contri-
butions of TFs and the environment to identity 
induction mechanisms and kinetics. 
By use of individual, inducible factors cou-
pled with independent manipulation of envi-
ronmental parameters, we interrogated how 
the naïve pluripotent identity is instructed by 
interplay between TFs and signals. As a re-
sult we defined principles and new mecha-
nisms governing naïve pluripotency establish-
ment, which were also applicable to other 
contexts including embryonic development 
and somatic cell reprogramming. Importantly, 
we provide explicit evidence for cellular iden-
tity as a multidimensional attractor state, with 
mechanistically as well as transcriptionally 
distinct pathways to transit between the same 




Reprogramming initiation is driver- 
dependent 
In order to causally ascribe independent ge-
netic and signal variables to reprogramming 
events, use of single drivers is necessary. 
Therefore, we tested reprogramming efficacy 
of individual naïve factors in embryo-derived 
Rex1+/dGFP.IRES.bsd (Rex1::dGFP) EpiSCs (Fig-
ure 1A–C). Dox-inducible (i) transgenes were 
used for Esrrb, Klf2, Klf4, Nanog, Tfcp2l1 and 
Klf5. Stat3 activation by phosphorylation (iP-
Stat3) was elicited by GCSF-stimulation of 
the GY118F receptor transgene (Burdon et 
al., 1999), since LIF signal transduction of 
EpiSCs is limited (Yang et al., 2010). iEsrrb, 
iPStat3 and iKlf2 were the three most efficient 
single drivers in 2iLIF (Fig 1C). Interestingly, 
each inputs to the naïve network along a dif-
ferent regulatory axis (Fig 1D), that of Chiron, 
LIF and PD03 respectively (Martello et al., 
2012; Niwa et al., 1998; Yeo et al., 2014). 
inPSCs established from these lines were 
transcriptionally indistinguishable (Fig 1E, 
S1A) and were chimera and germline compe-
tent (Fig 1F), demonstrating molecular and 
functional equivalency. Therefore, we took 
iEsrrb, iPStat3 and iKlf2 as a complementary 
model set of single reprogramming drivers for 
mechanistic study. 
We analysed the initial transcriptional re-
sponse to each driver from 1–48h (Fig 1G). In 
2iLIF, naïve gene upregulation by iPStat3 
was moderate, by iEsrrb was substantially 
faster and stronger, while iKlf2 surprisingly 
did not upregulate naïve genes and even si-
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Figure 1: Reprogramming initiation is driver-dependent 
(A) Reprogramming protocol for Rex1+/dGFP.IRES.bsd (Rex1::dGFP) EpiSCs with individual, inducible driver genes of 
interest (iGOI). Bsd=blasticidin. (B) Phase images of iEsrrb and EmptyVector+rtTA3 (EVrtTA3, negative control) 
wells on day 8. Scale: 500µm. (C) Mean number of inPSC colonies on day 8 ±SD (n=3) per 2000 cells plated. (D) 
Inputs of Esrrb, PStat3 and Klf2 to the naïve network. Signals: PD=PD03, CH=Chiron. (E) Unsupervised hierar-
chical cluster of scRNAseq, computed with Ward.D2 agglomeration method and Euclidean distances for all ex-
pressed genes (FPKM>0). (F) Blastocyst injection of inPSCs (agouti) yielded high-contribution adult chimeras, 
capable of germline transmission (agouti pups). (G) Heatmap of mean gene expressions from 0–48h, measured 
by RT-qPCR relative to Gapdh then normalised to nPSCs. (H) PCA based on variable genes (log2 FPKM>1, 
CV2>0.5 calculated for each driver then merged to a single list). (I) Expression of mesodermal markers following 
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are further reflected by the rates of  
Rex1::dGFP upregulation and the rates of for-
mation of transgene-independent inPSCs 
from day 2 onwards (Fig S1B–C), yet are not 
attributable to differences in the kinetics or 
levels of transgene induction (Fig S1D–E). 
We compared transgene induction in 
2iLIF or FA conditions from 1–48h, to assess 
the contribution of and interplay between ge-
netic and signal variables. For iPStat3 and 
iKlf2, responses were similar in EpiSC FA and 
2iLIF conditions (Fig 1G). However, for iEsrrb 
the response was highly condition-depend-
ent, suggesting that Esrrb and 2iLIF work in 
synergy to rapidly induce naïve genes. In-
deed, iEsrrb and 2iLIF components interact to 
elicit a transcriptional trajectory distinct from 
that of iEsrrb in EpiSC FA conditions (Fig 
S1F). The signalling environment did not play 
a strong role in the early transcriptional be-
haviour of iKlf2, with more similarity between 
timepoints than conditions (Fig S1F). 
Considering that Klf2 is a potent repro-
gramming driver (Fig 1C), its initial lack of na-
ïve gene induction presented a fascinating 
conundrum. Principle component analysis 
(PCA) showed a remarkable transcriptional 
divergence following Klf2 induction, corrobo-
rated by k-means cluster analysis (Fig 1H, 
S1G). We asked which genes could cause 
such a transcriptional divergence, and found 
robust upregulation of mesodermal markers 
in a Klf2-specific manner (Fig 1I). This indi-
cates initial instigation of a different program 
downstream of Klf2, rather than simply a de-
layed naïve induction kinetic. 
Together, expression analyses revealed 
that the pattern and kinetics of naïve network 
reactivation were driver-dependent, and that 
signal contribution was modulated by the 
driver. Morphological changes during repro-
gramming initiation were also driver-specific 
(Fig 1J). Nonetheless, these divergent pro-
cesses ultimately re-converged on the same 
naïve pluripotent destination identity (Fig 1E–
F, S1A). 
 
Single-cell RNAseq defines distinct  
productive trajectories 
Since reprogramming to naïve pluripotency is 
heterogeneous and asynchronous, cells un-
dergoing the change of interest must be re-
solved from the average in order to study tran-
sition mechanisms (Fig 2A) (reviewed in 
Buganim et al., 2013). Therefore, we tested 
isolation of productively transitioning interme-
diates based on activation of Rex1::dGFP re-
porter. Rex1 is silent in EpiSCs, increases in-
crementally during reprogramming (Stuart et 
al., 2014), and is extensively characterised as 
a sensitive proxy of naïve network strength 
(Kalkan et al., 2017). When replated in 
2iLIF+dox/GCSF, we found that emergent 
dGFP+ reprogramming intermediates were 
destined to form naïve colonies with efficiency 
comparable to nPSCs (Fig 2B). 
We performed single-cell (sc)RNAseq at 
12 and 24h (all cells), on dGFP-/low/+ at 72h, 
and on dGFP+ at 48, 72 and 96h (Fig 2C). 
With the former we capture early differences 
and trajectory overviews, while the 48–96h 
dGFP+ resolves cells undergoing productive 
progression to naïve pluripotency. PCA re-
vealed that, for iEsrrb and iPStat3, the start 
EpiSCs and end inPSCs represent the ex-
tremes of identity along PC1. In contrast, in 
the first 12–24h, iKlf2 shows a marked diver-
sion, away from both EpiSC and inPSC along 
PC1 (Fig 2D) and corroborated by unsuper-
vised hierarchical clustering (Fig S2A). To in-
vestigate the molecular features of this early 
diversion, we performed Gene Ontology (GO) 
analysis (Table S1). There was significant GO 
enrichment for processes involved in cell mo-
tility and development, consistent with initial 
diversion of iKlf2 in a mesodermal direction. 
To further investigate the trajectory dis-
tinctions, we performed differential gene ex-
pression (DE) analysis. We compared each 
sample with the start EpiSCs, to see how the 
expression signatures changed over time for 
each driver, and, by using a common refer-
ence, to assess similarities vs differences be-
tween drivers. We plotted Venn diagrams to 
find the numbers of DE genes that are unique 
to or shared between drivers at each 
timepoint (Fig S2B) and summarise these DE 
numbers in Fig 2E. These clearly show that 
drivers initially diverge, in particular with iKlf2 
exhibiting 2985 unique DE genes at 12h. 
Over time, the drivers then reconverge, indi-
cated by the increasing proportion of shared 
DE genes. At 72h, there is positive correlation 
between dGFP level and the proportion of 
shared DE genes, consistent with approach 
of distinct trajectories to the common destina-
tion identity.  
The initial divergence of iKlf2 cannot 
simply be attributed to an unproductive off-
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Figure 2: Single-cell RNAseq defines distinct productive trajectories 
(A) A method is required to isolate productive intermediates for mechanistic study. (B) Rex1::dGFP+ cells were 
isolated by FACS at 48/72h and plated for clonal assay: reprogramming intermediates were plated in 2iLIF+dox, 
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near the EpiSCs, not at the end of a different 
trajectory (Fig 2D). By live-imaging we con-
firmed that iKlf2 cells at 12/24h are not under-
going cell death (Video S1). It logically follows 
that iKlf2 cells start on a divergent trajectory, 
prior to acquisition of naïve pluripotency. 
To connect early trajectory divergence 
with subsequent acquisition of naïve pluripo-
tency, we analysed the 48–96h dGFP+ cells 
in more detail. Intermediate identity was con-
firmed by naïve vs EpiSC marker expression 
profiles (Fig 2F). Sample relationships deter-
mined by t-distributed Stochastic Neighbour 
Embedding (t-SNE) dimensionality reduction 
and by hierarchical clustering revealed that 
dGFP+ sorted intermediates arranged by 
driver rather than timepoint (Fig 2G–H). This 
demonstrates that reprogramming routes are 
transcriptionally distinct throughout the pro-
ductive transitions, not only during initiation. 
Again, the iKlf2 route was transcriptionally 
more different from those of iPStat3 and 
iEsrrb (Fig 1H, 2H, S2A). 
We then examined the kinetics of naïve 
network activation in single dGFP+ cells. In 
order to deconvolute the asynchronous na-
ture of reprogramming, we ordered the cells 
by fraction of similarity to origin EpiSCs and 
destination inPSCs to assign pseudotime co-
ordinates (Fig S2C). iEsrrb exhibited the fast-
est kinetics of naïve network orchestration for 
the majority of naïve genes, while iKlf2 was 
slowest (Fig 2I, S2D). This is in agreement 
with the different kinetics observed in bulk 
analyses from 0–48h (Fig 1G), now extended 
to 48–96h and within dGFP+ single cells. 
 
iKlf2 reprogramming proceeds via a  
mesoderm-like state 
For iKlf2, the upregulation of mesodermal 
markers observed during bulk initiation per-
sisted in productive Rex1::dGFP+ single-cells 
(Fig 1I, 3A, S3A). This suggests that transient 
activation of mesodermal markers was not 
due to differentiation of a population of unpro-
ductive cells, but was a transcriptional re-
sponse occurring during productive establish-
ment of naïve pluripotency when driven by 
Klf2. T is specifically expressed in and essen-
tial for nascent mesoderm formation. To de-
termine the proportion of iKlf2 intermediates 
expressing T on the protein level, we per-
formed and quantified immunofluorescence 
staining following iKlf2 induction (Fig 3B). By 
48h, we observe robust expression of T pro-
tein in 60% of iKlf2 cells, indicating that these 
are a major population. 
To trace the outcome of these T+ interme-
diates through the reprogramming process, 
we generated T/Rex1 double-reporter 
EpiSCs (Fig 3C). Into T::GFP reporter nPSCs 
(T+/GFP, Fehling et al., 2003), we knocked 
mKO2 (Orange) into the Rex1 locus (Fig 
S3B). We obtained T/Rex1 double-reporter 
EpiSCs (TGRO) by differentiation for 10 pas-
sages in FA, into which we transfected iKlf2 
reprogramming driver. We confirmed that 
these EpiSCs upregulate T in response to 
iKlf2 induction, and verified that T and GFP 
expressions are in agreement (Fig 3D, S3C). 
By live-imaging, we traced the activity of T 
and Rex1 during iKlf2-driven reprogramming 
of these double-reporter EpiSCs (Fig 3E, 
Video S2). We observe that T+ colonies 
emerge around day 2. Strikingly, these T+ 
colonies then convert into Rex1+ colonies 
around day 4. The largely sequential nature 
of T then Rex1 reporter activation is con-
sistent with the low % of T+ cells captured by 
scRNAseq of Rex1+ intermediates (Fig 3A). 
Together, this provides direct evidence that 
productive iKlf2 reprogramming proceeds via 
a T+ state on the protein level, demonstrating 
diversion towards mesoderm prior to acquisi-
tion of naïve pluripotency. 
 
iPStat3 reprogramming proceeds via an 
early ICM-like state 
To place the reprogramming trajectories in 
the context of development, we compared 
scRNAseq of productive Rex1::dGFP+ inter-
mediates with E2.5–E6.5 embryos (Deng et 
al., 2014; Mohammed et al., 2017). Single-
cell transcriptome analyses revealed that iP-
Stat3 reprogramming intermediates transi-
ently acquired significant similarity to the early 
inPSC colonies ±SD (n=3) scored on day 9 are indicated as % of nPSC colonies for each experiment. (C) Sche-
matic summarising RNAseq datasets. sc: single-cell. (D) PCA based on variable genes (log2 FPKM>1, CV2>0.5). 
(E) Numbers of unique and shared differentially expressed (DE) genes for each driver compared to EpiSCs. (F) 
Expression scatter plots of EpiSC markers (Otx2, Utf1) and naïve markers (Dazl, Nr0b1). (G) t-SNE plot showing 
relationships between single cell transcriptomes. (H) Unsupervised hierarchical cluster computed with Ward.D2 
agglomeration method and Euclidean distances. (I) LOESS regression fit lines summarise expression kinetics, 
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inner cell mass (ICM) (Fig 4A–B) and exhib-
ited a Nanog+Gata6+ double-positive signa-
ture (Fig 4C, S4A). Nanog+Gata6+ co-ex-
pression is a hallmark of the early ICM (Plusa 
et al., 2008), prompting the hypothesis that 
iPStat3-driven reprogramming goes further 
back to an early ICM-like state, then forwards 
into the consolidated naïve identity. Indeed, 
the temporal sequence of naïve gene activa-
tion in iPStat3 intermediates emulates that of 
the embryo (Fig S4B). 
In order to functionally test the properties 
of Gata6+ iPStat3 reprogramming intermedi-
ates, we generated Gata6 reporter EpiSCs by 
differentiation from Gata6+/H2BVenus nPSCs 
(Freyer et al., 2015). We confirmed that re-
sultant EpiSCs upregulate Gata6 in response  
Figure 3: iKlf2 reprogramming proceeds via a mesoderm-like state 
(A) Expression scatter plots of mesodermal markers vs Nanog. (B) Immunofluorescence staining for T and Nanog 
was quantified 24/48h after iKlf2 induction in the original Rex1::dGFP EpiSCs, on a total of 3675 cells. To determine 
% of T+ cells a stringent threshold was calculated: mean of EpiSC values +2SD (standard deviations). 
Scale: 100µm. (C) Strategy to generate T/Rex1 double-reporter (TGRO) iKlf2 EpiSCs. (D) RT-qPCR analyses fol-
lowing reprogramming induction of TGRO iKlf2 EpiSCs. T::GFP+ (G+) and T::GFP- (G-) populations were both 
Rex1::mKO2- (O-) at 48h. Mean expressions are displayed ±SD (n=3). (E) Live imaging of TGRO iKlf2 EpiSC 
reprogramming. On day 4, iKlf2 induction was withdrawn and blasticidin added to select for inPSCs with active 
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Figure 4: iPStat3 reprogramming proceeds via an early ICM-like state 
(A) PCA based on variable genes (log2 FPKM>1, CV2>0.5) for reprogramming intermediates and embryo single 
cells. Mor: compacted morula. ICM: inner cell mass. Epi: epiblast. PrE: primitive endoderm. PC1 separates in vivo 
vs in vitro datasets; PC2 portrays developmental progression. (B) Fraction of similarly to signature embryo datasets 
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to iPStat3 induction, that Gata6 and Venus 
expressions are in agreement, and that 
Nanog+Gata6+ double-positive cells are pre-
sent on the protein level (Fig 4D–E, S4C). By 
live-imaging, we observed that Gata6+ cells 
emerge at day 2–3 (Fig 4F, Video S3). These 
subsequently gave rise to inPSCs by the end-
point, providing direct evidence that Gata6+ 
iPStat3 reprogramming intermediates are 
productive. 
The defining functional property of the 
early ICM is the potential to generate primitive 
endoderm (PrE) as well as pluripotent epi-
blast. To test whether they acquire this 
greater potency, we injected Gata6+ iPStat3 
reprogramming intermediates into 8-cell 
stage embryos, then cultured these to the late 
blastocyst stage by which time PrE and epi-
blast lineages are fully segregated. Chimeric 
embryos were fixed and analysed for contri-
bution of injected cells to the epiblast (Sox2+), 
PrE (Gata4+) and trophectoderm (Cdx2+) 
(Fig 4G). Remarkably, the Gata6+ population 
contributed to both epiblast and PrE, con-
sistent with a gain of potency equivalent to 
that of the early ICM (Fig 4H–I). The Gata6+ 
intermediates were Sox2+Gata4– prior to in-
jection, as the early ICM would be, then could 
subsequently become either Sox2+Gata4– 
epiblast or Sox2–Gata4+ PrE in the embryo 
(Fig S4D). As expected, established inPSCs 
contributed only to epiblast, and EpiSCs did 
not contribute at all (data not shown). 
In sum, the iPStat3 reprogramming popu-
lation transiently gains resemblance to the 
early ICM both in terms of its molecular sig-
nature and its developmental potency. 
 
Routes have distinct genetic and signal  
requirements 
To test whether the divergent transcrip-
tional trajectories are indicative of mechanis-
tic differences, we assessed the routes’ ge-
netic and signal requirements. Putative down-
stream genetic mediators were identified by 
examining expression of known reprogram-
ming drivers 24h after induction of iEsrrb, iKlf2 
or iPStat3 (Fig 5A). Endogenous Esrrb was 
not strongly upregulated by either iKlf2 or iP-
Stat3 by 24h, and correspondingly its knock-
down (KD) did not prevent reprogramming 
(Fig S5A–B). In contrast, endogenous Klf2 
reached 50% and 20% of nPSC-level in iP-
Stat3 and iEsrrb respectively. Given this early 
response, we tested whether Klf2 is a media-
tor of iPStat3- or iEsrrb-driven reprogram-
ming. We found that transient Klf2 KD abol-
ished reprogramming driven by iPStat3 but 
not iEsrrb (Fig 5B, S5A–B). This implicates 
Klf2 as a critical mediator of reprogramming 
initiation by iPStat3. Klf2 is not considered a 
PStat3 target in nPSCs, implying different 
network topologies during establishment ver-
sus maintenance of naïve pluripotency. Curi-
ously, iPStat3 sensitivity to Klf2 KD was con-
text-dependent, partially alleviated in the ab-
sence of PD03 (Fig S5C). 
To assess differences between routes in 
terms of exogenous signal requirements, we 
challenged the first 4 days of reprogramming 
with different 2iLIF signal permutations (Fig 
5C). iPStat3 yielded inPSCs in the absence of 
both PD03 and Chiron, but together PD03 
and Chiron synergistically boosted the effi-
ciency. However, the impact of PD03 and Chi-
ron was driver-dependent: Chiron was essen-
tial for iKlf2-driven reprogramming, with no 
benefit from additional supplementation with 
PD03. Functional redundancy between Klf2 
and PD03 has been previously noted (Yeo et 
al., 2014), and the inability of iKlf2 to drive re-
programming without direction from an exog-
enous signal is in agreement with the obser-
vation that iKlf2 does not directly induce naïve 
gene expression (Fig 1G). Unlike iKlf2, repro-
gramming driven by iEsrrb was highly LIF-de- 
  
(C) Scatter plots of Gata6 vs Nanog for iPStat3 reprogramming, E3.5 and E4.5 embryos. (D) Strategy to generate 
Gata6-reporter iPStat3 EpiSCs. (E) RT-qPCR analyses following reprogramming induction of Gata6::H2BVenus 
iPStat3 EpiSCs. Mean expression is displayed ±SD (n=3). (F) Live imaging of Gata6::H2BVenus iPStat3 EpiSC 
reprogramming. On day 4, iPStat3 induction was withdrawn. Merge snapshots are shown from Video S3. Endpoint 
staining identified inPSC colonies. (G) Gata6::H2BVenus+ iPStat3 day 2.5 reprogramming intermediates were in-
jected into 8-cell stage embryos then traced in resultant late blastocyst chimeras. (H) Maximum intensity Z-projec-
tions for a stained chimeric blastocyst. Scale: 20µm. Zooms are shown of indicated regions and slices. Upper: 
contribution of injected cells to Sox2+Gata4- epiblast is apparent. Although Gata6 is no longer expressed in E4.5 
epiblast, Venus has a long half-life allowing us to trace the contribution 2 days after injection of positive cells. Lower: 
region with contribution of Venus+ cells to Sox2-Gata4+ PrE. Since Gata6 is still expressed in E4.5 PrE, contrib-
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Figure 5: Routes have distinct genetic and signal requirements 
(A) Gene expression after 24h relative to inPSCs. y-axis iEsrrb: Esrrb=3.32. iKlf2: Klf2=8.30. (B) KD was performed 
at reprogramming onset with a single pulse of siRNA. Mean inPSC colonies scored on day 8 are presented ±SD 
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pendent (Fig 5C–D). iEsrrb induction in LIF 
led to greater upregulation of canonical 
PStat3 targets than induction of iPStat3 itself 
(Fig 5E). This was not due to elevation of 
PStat3 protein by Esrrb (Fig S5D) and thus 
demonstrates downstream synergy between 
Esrrb and PStat3. To identify when the syn-
ergy between Esrrb and PStat3 became ef-
fective, we performed timecourse expression 
analyses. A turning point occurred 6h after 
Esrrb induction: from 0–6h, Klf2 was upregu-
lated similarly in 2i±LIF for both iEsrrb and 
negative control EpiSCs; after 6h, Klf2 ex-
pression continued to increase in 
iEsrrb+2iLIF, but collapsed in iEsrrb+2i and 
all control conditions (Fig 5F, S5E). Klf4 up-
regulation also launched in earnest after 6h 
with iEsrrb+2iLIF. 
In light of the above observations that sig-
nal requirement and interpretation is driver-
dependent, we interrogated Rex1::dGFP+ 
48–96h scRNAseq data for evidence of other 
signalling differences between iKlf2, iEsrrb 
and iPStat3 productive intermediates. BMP 
signalling pathway target Id1 is upregulated in 
iKlf2 and iPStat3, but not iEsrrb (Fig 5G). Id1 
upregulation is intermediate-specific, with 
negligible expression in starting EpiSCs or 
destination inPSCs. BMP signalling is the key 
pluripotency-sustaining component in the se-
rum of classical nPSC cultures (Ying et al., 
2003), is important for MET in serum-based 
fibroblast reprogramming (Samavarchi-
Tehrani et al., 2010), but is not thought to be 
active in 2iLIF-cultured nPSCs (Boroviak et 
al., 2014). We assessed BMP pathway status 
by PSmad1/5 immunofluorescence during 
EpiSC reprogramming in 2iLIF, finding posi-
tive staining for iKlf2 and iPStat3 but not 
iEsrrb (Fig S5F). Therefore, BMP signalling is 
activated in a route-specific manner. 
To test whether auto/paracrine BMP sig-
nalling is required during EpiSC reprogram-
ming, we applied BMP inhibitor from day 0–4. 
DMH2 is a specific and well-characterised 
BMP receptor inhibitor (Fig S5G) (Hao et al., 
2010), and we also verified key findings with 
a different inhibitor LDN193189 (LDN) (Cuny 
et al., 2008). BMP inhibition abolished iKlf2- 
and iPStat3-driven reprogramming in 2iLIF, 
but inPSC colonies still formed for iEsrrb (Fig 
5H). Therefore, BMP inhibition blocked repro-
gramming only in those lines exhibiting evi-
dence of active BMP signalling in their inter-
mediates. This was specific to the transition, 
being dispensable for maintenance of result-
ant inPSCs in 2iLIF (Fig 5I, S5H). 
Together, these results demonstrate that 
iKlf2, iPStat3 and iEsrrb drive reprogramming 
by mechanistically distinct routes in terms of 
their genetic and signal requirements, and 
their differential modulation of exogenous and 
endogenous signal transduction. 
 
BMP signalling is required for naïve  
pluripotency establishment in vivo 
Having identified BMP signalling requirement 
in two routes of reprogramming, and given 
that iPStat3 reprogramming intermediates 
transiently acquired similarity to the early 
ICM, we explored whether endogenous BMP 
signalling also plays a role in naïve pluripo-
tency establishment in vivo. The BMP signal-
ling pathway is active in pre-implantation 
mouse embryos from the 4-cell stage on-
wards, including in the ICM (Graham et al., 
2014; Reyes de Mochel et al., 2015), so in-
inPSC colonies scored on day 8 are presented as mean ±SD (n=3). PD=PD03; CH=Chiron; 2i=PD+CH. (D) Phase 
images of iEsrrb on day 8 in 2iLIF+blasticidin, after reprogramming from day 0–4 in 2iLIF+dox or 2i+dox as indi-
cated. White arrow indicates an inPSC colony. (E) Expression of LIF/Stat3 target genes 24h after driver induction 
in the indicated conditions. (F) Timecourse RT-qPCR analyses of iEsrrb EpiSCs in the indicated conditions +dox. 
Mean expressions are displayed ±SD (n=3). (G) LOESS regression fit lines summarise Id1 kinetics during repro-
gramming, computed from log2 FPKM vs pseudotime for single cells (Fig S2C). (H) 3µM DMH2, 0.6µM LDN or 
DMSO were applied to reprogramming in 2iLIF+dox/GCSF from day 0–4, then inPSCs were selected in 2iLIF+blas-
ticidin. inPSC colonies scored on day 8 are presented as mean ±SD (n=3). (I) Immunofluorescent staining after 
48h of inhibitor treatment, for iPStat3 reprogramming in 2iLIF+GCSF or for previously established iPStat3 inPSCs 
in 2iLIF. Scale: 20µm. (J) Schematic summarising BMP inhibitor treatment of pre-implantation embryos. (K) Quan-
titative nPSC-derivation following embryo treatment with DMSO or 3µM DMH2. nPSC colonies were scored per 10 
single ICM cells. Black line=mean. DMSO n=7, DMH2 n=8 embryos. (L–N) Late blastocysts were stained for Cdx2, 
Gata4 and Oct4, following treatment with DMSO, 3µM DMH2 or 0.3µM LDN. (L) Mean cell number per lineage ± 
SD, presented as a proportion of the total cells per embryo. DMSO n=23, DMH2 n=18, LDN n=7 embryos. (M) 
Representative maximum intensity Z-projections. Scale: 20µm. (N) Quantification of immunofluorescent signal for 
Oct4 in Epi nuclei and Gata4 in PrE nuclei, presented as box-and-whisker plots. DMSO n=23, DMH2 n=18, LDN 
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volvement in epiblast specification is plausi-
ble. We applied BMP inhibitor to the late mor-
ula, cultured the embryos to the late blasto-
cyst stage, then analysed the impact on each 
lineage and performed quantitative nPSC 
derivation (Fig 5J). Per cell, we observed a 4-
fold reduction in nPSC derivation efficiency 
from embryos that had previously been 
treated with BMP inhibitor (p=9.1x10-5), 
demonstrating that BMP inhibition had dis-
rupted pluripotency establishment in the em-
bryo (Fig 5K, S5I). 
By analysis of immunofluorescence stain-
ing, we counted the number of cells in the Epi, 
PrE and trophectoderm (TE) lineages, and 
quantified the intensity of lineage marker ex-
pression (Fig 5L–N, S5J–L). The proportions 
of cells assigned to each lineage were unaf-
fected by BMP inhibition (Fig 5L). PrE and TE 
exhibited either mildly reduced (DMH2) or un-
affected (LDN) lineage marker expression, 
whereas Oct4 expression in the Epi lineage 
was dramatically reduced by both inhibitors 
(p=4.3x10-110 for DMH2; p=6.7x10-55 for LDN) 
(Fig 5M–N, S5K). We also performed Nanog 
staining on a subset of embryos, and ob-
served significant reduction in the Epi for both 
inhibitors (Fig S5L). 
In sum, we found that BMP inhibition gave 
a specific impact on naïve pluripotency estab-
lishment in the embryo, dramatically reducing 
Epi marker expression and the functional abil-
ity to yield nPSCs, despite a normal propor-
tion of cells being allocated to the Epi com-
partment. Identification of this novel role for 
the BMP pathway in vivo highlights the power 
of our defined reprogramming systems to un-
cover principles of identity specification. 
 
Defined Oct4 level is a common feature of 
all routes 
The aforementioned differences in transcrip-
tional trajectories, signal and genetic require-
ments demonstrate that iKlf2, iPStat3 and 
iEsrrb instruct reprogramming by distinct 
mechanisms (Fig 6A). Given that the starting 
and destination cellular identities are the 
same in all three cases (Fig 1E–F), the extent 
of the route differences was surprising. 
Therefore, we asked whether there was a 
common feature that could reconcile the dis-
parate transition logics. 
From 48–96h in Rex1::dGFP+ single 
cells, we found that Oct4 is expressed at en-
dogenous pluripotent level, irrespective of the 
driver (Fig 6B). Maintenance of Oct4 through-
out the transitions is not to be taken for 
granted. Although Oct4 is expressed at simi-
lar levels in EpiSCs and inPSCs (Fig S6A), 
this expression is supported by different tran-
scriptional networks and is driven from differ-
ent enhancer elements (Tesar et al., 2007; 
Yeom et al., 1996). Indeed, signal switch of 
control EpiSCs to 2iLIF triggered Oct4 down-
regulation (Fig 6C). In contrast, Oct4 was un-
perturbed in nPSCs upon switch from se-
rum+LIF to 2iLIF (Fig 6D), indicating that 2i 
itself did not suppress Oct4 in a context where 
cellular identity was constant. Timecourse 
RT-qPCR analyses showed that Oct4 was ex-
pressed at or above pluripotent stem cell 
(PSC) level in the dGFP+ reprogramming 
subpopulation from 48h onwards but not al-
ways in the dGFP– (Fig S6B). Together, this 
suggests that signal-mediated collapse of the 
primed network prior to naïve network con-
struction leads to Oct4 expression loss, creat-
ing a ‘vulnerable window’ between different 
self-renewing Oct4-supporting configura-
tions. Since 2iLIF triggered Oct4 collapse in 
control EpiSCs (Fig 6C), we reason that the 
observed maintenance of Oct4 in 2iLIF during 
productive reprogramming is an active pro-
cess coordinated by the driving transgene 
(Fig 6B). 
To evaluate the relationship between Oct4 
level and productive reprogramming, we sub-
divided intermediate populations based on a 
finer gradient of Rex1::dGFP, measured Oct4 
expression and replated for clonogenicity as-
say in 2iLIF. Average Oct4 expression posi-
tively correlated with the subsequent repro-
gramming efficiency of a given subpopulation 
(Fig 6E, S6C). To test whether this Oct4 
maintenance is required for reprogramming, 
we performed transient Oct4 KD by a single 
pulse of siRNA treatment at reprogramming 
onset. inPSC formation was abolished (Fig 
6F, S6D). 
 
Fixed Oct4 expression is sufficient for  
naïve instruction in minimal conditions 
Having demonstrated that Oct4 maintenance 
is observed in and required for productive re-
programming, next we asked whether Oct4 
maintenance is sufficient. We generated Oct4 
null EpiSCs that constitutively express ec-
topic Oct4 at endogenous PSC level (Fixe-
dOct4) (Fig 6G–I, S6E), according to method-
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Figure 6: EpiSC reprogramming converges on the fine-tuning of Oct4 expression 
(A) Summary of transcriptional trajectories and mechanistic requirements for each driver. (B) Scatter plots of Oct4 
expression in single cells vs pseudotime (Fig S2C), fitted with LOESS regression lines. (C–D) Timecourse RT-
qPCR analyses of mean Oct4 expression, displayed relative to Gapdh and normalised to nPSCs ±SD (n=3). (C) 
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2013. This uncouples Oct4 expression from 
identity or environmental perturbations, i.e. 
prevents the loss of Oct4 upon switch of 
EpiSCs to 2iLIF. An Oct4 null background 
was necessary to ensure maintenance of total 
Oct4 level, and to avoid overexpression of 
Oct4 that triggers differentiation (Niwa et al., 
2000). Correspondingly, ectopic Oct4 expres-
sion on top of a wild-type background gives 
very inefficient EpiSC reprogramming (Guo 
and Smith, 2010; Yang et al., 2019). 
Following medium switch to 2iLIF, Fixe-
dOct4 EpiSCs rapidly generated inPSC colo-
nies with extremely high efficiency (Fig 6H–I). 
The initial transcriptional response of Fixe-
dOct4 reprogramming initiation in 2iLIF has 
aspects in common with each of the other 
drivers, but is overall most similar to iPStat3 
(Fig 1G, S6F). We tested the signal depend-
encies of FixedOct4 reprogramming, and 
found that LIF was the minimal requirement 
for naïve pluripotency induction (Fig S6G–H). 
In FixedOct4 reprogramming, impetus to-
wards the naïve identity is provided only by 
exogenous signals: Oct4 is expressed equally 
in both EpiSCs and inPSCs, so there is no na-
ïve-specific transgene. Therefore, mainte-
nance of Oct4 permits the identity transition, 
while signals such as LIF specify the direc-
tion. 
 
Reconciliation of route differences with 
common Oct4 maintenance 
Despite the distinctions between routes in 
terms of their transcriptional trajectories and 
mechanistic requirements (Fig 6A), Oct4 
maintenance is a common feature and we fur-
ther demonstrated that this is required and 
sufficient for reprogramming (Fig 6F–I). Now 
we reconcile route-specific attributes with the 
common denominator of Oct4 maintenance. 
First, we assessed the ability of each fac-
tor individually to rescue the drop in Oct4 ex-
pression when EpiSCs are treated with 2iLIF 
for 24h (Fig 6J). Klf2 induction yielded the 
most effective rescue of Oct4 drop, including 
on the protein level (Fig S6I–K). This Oct4 
support could explain the high efficiency of 
Klf2-driven reprogramming despite its para-
doxical dearth of naïve gene induction (Fig 
1G). iPStat3 also maintained Oct4 expression 
(Fig 6J). However, the remaining drivers 
failed to rescue Oct4 drop in bulk populations. 
Since Klf2 is the most effective supporter 
of Oct4 (Fig 6J) and is an early transcriptional 
responder to iPStat3 (Fig 5A), we asked 
whether these observations can be conceptu-
ally integrated. Transient Klf2 KD at iPStat3 
reprogramming onset resulted in a 65% re-
duction of Oct4 expression (Fig 6K) and abol-
ished iPStat3-driven reprogramming (Fig 5B). 
In contrast, Klf2 KD did not abolish repro-
gramming of FixedOct4 EpiSCs (Fig S6L), 
even though this is a highly LIF/Stat3-de-
pendent process (Fig S6G–H). This places 
Oct4 maintenance as a functionally important 
downstream mechanism of Klf2 in reprogram-
ming, likely to be direct due to its manifesta-
tion within 1h (Fig 6L). 
iEsrrb was the most efficient of all tested 
drivers (Fig 1C), yet exhibited an initial drop in 
Oct4 expression at 24h (Fig 6J, S6J–K) prior 
to recovery in the productive subpopulation 
by 48h (Fig 6B, S6B,K). The outstanding fea-
ture of iEsrrb reprogramming initiation was 
the rapid and strong upregulation of naïve 
genes in a highly 2iLIF-dependent manner 
(Fig 1G, 5E–F). To test whether this corre-
sponded to rapid wiring of a coherent self-re-
newing naïve network, we challenged the 
transgene-independent clonogenicity of 
iEsrrb Rex1::dGFP+ cells at 48h by replating 
single sorted cells in 2iLIF without dox. Strik-
ingly, their dox-independent clonogenicity 
was comparable to nPSCs (Fig 6M), indicat-
ing that 48h post-induction a functional naïve 
network has already formed for iEsrrb. Thus 
FCS+LIF then switched to 2iLIF. (E) Rex1::dGFP negative, low, medium, high and bulk reprogramming intermedi-
ates were isolated by flow cytometry, analysed for average Oct4 expression level by RT-qPCR (blue), then replated 
for clonogenicity assay in 2iLIF (green). Means are presented ±SD (n=3). (F) Oct4 KD was performed at repro-
gramming onset with a single pulse of 10µM siRNA. inPSC colonies scored on day 8 are presented as mean ±SD 
(n=3). P=Pool. (G–I) FixedOct4 EpiSCs formed inPSC colonies at high efficiency in 2iLIF, indicated morphologically 
(scale 100µm) (G), by mean inPSC colonies scored on day 8 ±SD (n=3) (H), and by RT-qPCR analyses (I). (J) 
Heatmap of Oct4 expression after 24h of 2iLIF+dox/GCSF, measured by RT-qPCR relative to Gapdh then normal-
ised to EpiSCs. (K) Oct4 or Klf2 KD was performed at iPStat3 reprogramming onset. After 48h, expressions were 
analysed by RT-qPCR. (L) Timecourse Oct4 expression analyses for EpiSCs induced in the indicated conditions, 
relative to 0h. (M) Rex1::dGFP+ iEsrrb reprogramming intermediates (2iLIF+dox) and nPSCs (2iLIF) were isolated 
by FACS at 48h and plated for clonal assay in 2iLIF without dox. Blasticidin was applied on day 6. Mean naïve 
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we propose that iEsrrb drives a rapid transi-
tion between primed and naïve networks, res-
cuing Oct4 expression within the ‘vulnerable 
window’ between different self-renewing 
states. 
Together, these results indicate that, irre-
spective of the mechanism used by the differ-
ent routes, achieving a PSC-level of Oct4 is 
the common feature of successful reprogram-
ming. This event creates the opportunity for 
transition into naïve pluripotency, which is ef-
fected provided there is a conducive signal 
environment. 
 
PSC-level of Oct4 is sufficient for somatic 
cell reprogramming 
To address the applicability of our findings 
to other cellular contexts, we derived somatic 
cells from FixedOct4 nPSCs by differentiation 
in chimeras (Fig 7A). Extensive analysis of 
E9.5 chimera cryosections confirmed bo-
nafide development, with widespread contri-
bution of FixedOct4 cells to all germ lineages, 
expressing appropriate tissue-specific mark-
ers together with Oct4 (Fig 7B, S7A–D). Fixe-
dOct4 nPSCs were also capable of perform-
ing tetraploid complementation, a stringent 
assay for developmental contribution (Fig 
S7E). 
Having verified the contribution of Fixe-
dOct4 cells to downstream lineages in E9.5 
chimeras, we then tested whether they could 
reprogram and if signal instruction was suffi-
cient. After discarding a generous portion of 
the tail to stringently avoid germ cell contami-
nation, we dissociated and cultured the ante-
rior portion of each chimera to test reprogram-
ming ability using three different conditions 
(Fig 7C): directly in 2iLIF, in LIF only, or in LIF 
combined with a low dose of 5-Azacytidine 
(aza, an inhibitor of DNA methyltransferase 
activity, in case assistance was required to re-
model a more constrained epigenetic land-
scape). After 6 days, all conditions were 
swapped to 2iLIF (Fig 7C). With the exception 
of positive control allantois, inPSCs were not 
generated when plated directly in 2iLIF, con-
sistent with our previous demonstration that, 
if applied from the beginning, 2iLIF does not 
support somatic cell reprogramming (Silva et 
al., 2008). However, inPSCs were generated 
from 16/17 chimeras following culture in 
LIF+aza, and from 7/9 chimeras after LIF only 
(Fig 7C–F, S7F). Therefore, LIF is sufficient 
to induce reprogramming of FixedOct4 cells 
from E9.5 states, as well as from EpiSCs (Fig 
S6G–H). 
To test more developmentally advanced 
starting material, we derived FixedOct4 fibro-
blasts from E12.5 chimeras and investigated 
whether they could reprogram under signal 
instruction alone (Fig 7G–J). E12.5 is a stand-
ard stage for murine embryonic fibroblast 
(MEF) derivation as the starting material for 
somatic cell reprogramming. FixedOct4 
MEFs exhibited normal MEF morphology (Fig 
7I) and expressed both Oct4 and MEF mark-
ers (Fig 7J). Since MEF reprogramming usu-
ally takes longer than from EpiSCs and has 
different signal requirements in the early 
stages, we tried various conditions in the first 
week (Fig 7G–H). On day 7, we swapped all 
conditions to 2iLIF, then on day 14 applied 
G418 to select for inPSC colonies. As ex-
pected, direct application of 2iLIF did not yield 
inPSCs from MEFs but did allow derivation of 
naïve pluripotent colonies from genital ridges 
(positive control). Unlike from FixedOct4 
EpiSCs and E9.5 cells, LIF alone was insuffi-
cient to reprogram MEFs. Since MEFs may 
not effectively transduce LIF signal, we added 
IL6 and soluble IL6 receptor to assist Jak/Stat 
pathway activation. We also tested addition of 
FGF2 and Chiron, since there is precedent for 
a positive role of these signals in fibroblast re-
programming (Giulitti et al., 2019; Li et al., 
2011). We successfully obtained inPSCs from 
IL6+IL6R+LIF+FGF2+Chiron (ILFC), and 
IL6+IL6R+LIF (IL) (Fig 7H–J). Whilst ILFC 
was more efficient, IL represents the mini-
mum requirement for MEF reprogramming. 
Together, this defines fine-tuned Oct4 ex-
pression together with Jak/Stat signalling as 
sufficient for naïve pluripotency induction 
from a range of cell types: EpiSCs, E9.5 cells, 
and E12.5 MEFs. 
 
Discussion 
We show that there are multiple routes by 
which the naïve pluripotent identity can be es-
tablished from EpiSCs, with the unifying fea-
ture of active Oct4 maintenance. Not only do 
these routes differ in their transcriptional tra-
jectories, but crucially also in their mechanis-
tic attributes of genetic and signal require-
ments (Fig 6A). Nevertheless, molecular and 
functional equivalency of the resultant 
inPSCs demonstrates that these routes ulti-
mately converge to a single identity (Fig 1E–
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Figure 7: PSC-level of Oct4 is sufficient for somatic cell reprogramming 
(A) FixedOct4 nPSCs were injected into E3.5 C57BL/6 blastocysts then transferred to recipients. Resultant em-
bryos were collected at E9.5. Images are shown of 5 chimeras & 1 negative control from the same litter. (B) Con-
tribution of FixedOct4 cells to E9.5 chimeras was assessed by immunostaining of 8µm cryosections. Zooms are 
shown of the indicated regions. Scale: 100µm. NT=neural tube; FP=floor plate; FG=foregut; HB=hepatic bud; 
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the specification of a single identity from a sin-
gle origin. This adds further complexity to the 
paradigm of multicellular biology by which 
TFs and signals are used in different permu-
tations and contexts in order to generate dif-
ferent cell types: they can also be used in dif-
ferent ways to generate the same cell type. 
We relate our reprogramming routes to 
development by transcriptome comparison, 
reporter live-imaging, and in vivo lineage trac-
ing. iPStat3 intermediates transcriptionally re-
semble the early embryo ICM and, remarka-
bly, gain its greater developmental potency 
(Fig 4). In contrast, the iKlf2 route acquires 
mesodermal signature prior to naïve pluripo-
tency induction (Fig 3). Therefore, initially 
moving backwards or forwards in develop-
mental time can be compatible with success-
ful reprogramming, provided key mechanistic 
criteria are met (Fig 6). 
 Adachi et al., 2018 recently reported that 
Esrrb acts as a pioneer TF during EpiSC re-
programming, binding to closed chromatin 
and recruiting the P300 transcriptional coacti-
vator in a LIF/Stat3-dependent manner. This 
is consistent with our observation that Esrrb-
driven reprogramming is highly LIF-depend-
ent (Fig 5C–F). Meanwhile, Stat3 and Smad1 
have been reported to form a protein complex 
together with P300 under conducive signal-
ling conditions (Onishi et al., 2014), which is 
compatible with our finding that iPStat3-
driven reprogramming is blocked by BMP sig-
nalling inhibition (Fig 5H). Based on this, we 
speculate that different reprogramming driv-
ers engage with P300 via different partners, 
and that this might underpin their different 
mechanistic requirements (Fig 6A). 
iKlf2 is enigmatic as an efficient EpiSC re-
programming driver. Its dearth of naïve gene 
upregulation within the first 48h is counterin-
tuitive, as is its highly divergent initiation tra-
jectory (Fig 1–3). In the first 48h of reprogram-
ming, the only positive impact on pluripotency 
genes is robust support of Oct4 expression 
(Fig 6). Since FixedOct4 is sufficient for highly 
efficient reprogramming, we reason that a 
similar phenomenon happens here: iKlf2 in-
termediates are Oct4+ and thus remain per-
missive for reprogramming directed by sig-
nals. We note that Oct4 is initially maintained 
during mesendoderm lineage entry (Downs, 
2008; Thomson et al., 2011) and thus reason 
that transient lineage diversion can benefit re-
programming if it helps to achieve the Oct4 
maintenance requirement. This signifies a 
conceptual shift, exposing expression of a 
transition factor as more important than the 
transcriptional program directly induced by a 
driver. Thus, identity change does not simply 
require activation of the destination program, 
but instead pivots on the mechanism that per-
mits a transition to occur. 
Ultimately, successful reprogramming 
routes can be thought of as different strate-
gies that converge on the unifying, required 
and sufficient feature of fine-tuned Oct4 ex-
pression (Fig 6). In light of this we propose the 
following hypothesis: for a given EpiSC repro-
gramming driver, there is a certain probability 
of rescuing Oct4 during the ‘vulnerable win-
dow’ after Oct4 loses support from the col-
lapsing primed network. We suggest that re-
programming efficiency correlates with this 
probability, which is determined by the ability 
of that factor itself to drive Oct4 expression 
and the speed at which that factor orches-
trates a coherent naïve network to support 
Oct4 in an alternative topology. iKlf2 and 
iEsrrb occupy opposite extremes within this 
model, relying solely on the former and latter 
methods respectively (Fig S7G). 
Results from other cell contexts further 
demonstrate that identity transition to naïve 
pluripotency pivots on precise Oct4 expres-
sion. PSC-level of Oct4 is the minimal require-
ment for naïve pluripotency induction not only 
from EpiSCs but also from developmentally 
more advanced cell types including MEFs 
(Fig 7). We suggest that correct Oct4 level 
MEFs. (C) Anterior portion of each E9.5 chimera was dissociated manually, subdivided into quarters then cultured 
in the indicated conditions in duplicates. Generation of inPSCs is summarised in the table. L=LIF; Z=aza; A=allan-
tois. (D) inPSCs at P0, following reprogramming of 1/8th of an E9.5 chimera in a 6well. (E) inPSCs at P5. Scale: 
100µm. (F) RT-qPCR analyses of inPSCs at P2, after reprogramming from E9.5 in LIF (L) or LIFaza (LZ), followed 
by 2iLIF. Mean expressions are shown ± SD (2 technical replicates per embryo). (G) Reprogramming protocol for 
FixedOct4 MEFs, after derivation from E12.5 chimeras. (H) Conditions tested during the first week of MEF repro-
gramming. Number of inPSC colonies scored at day 21 is shown as mean ± SD (n=3), per 5000 MEFs plated. (I) 
FixedOct4 MEFs, an inPSC colony at day 21, and P3 inPSCs. Scale: 100µm. (J) RT-qPCR analyses of FixedOct4 
and wild-type MEFs, FixedOct4 MEF-derived inPSCs after reprogramming in IL or ILFC followed by 2iLIF, and after 
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creates the opportunity for transition into na-
ïve pluripotency, which is effected provided 
there is a conducive environment. In agree-
ment with this, Liu et al., 2018 recently re-
ported that CRISPR-based chromatin remod-
elling of the Oct4 locus is sufficient to repro-
gram MEFs, using the acetyltransferase do-
main of P300 to activate endogenous Oct4. 
Thus, precise Oct4 expression is the defining 
feature in distinct contexts of nuclear repro-
gramming. It will now be interesting to explore 
how our findings relate to other advances 
made towards the optimisation and under-
standing of induced pluripotency. 
Whilst Oct4 expression at PSC-level is re-
quired and sufficient for reprogramming under 
signal instruction, it is also compatible with 
bonafide development when returned to the 
embryo. In our FixedOct4 system, opposing 
yet highly efficient identity transitions occur 
depending solely on the environment: induc-
tion of naïve pluripotency in the presence of 
LIF (Fig 6), or re-entry to development in vivo 
(Fig 7). Oct4 plays a transition-permitting role 
during early differentiation of several lineages 
(Niwa et al., 2000; Radzisheuskaya et al., 
2013), and can be briefly utilised to promote 
direct transdifferentiation from fibroblast to 
neural identity (Thier et al., 2012). In this light, 
and considering that low-Oct4 traps nPSCs in 
self-renewal (Karwacki-Neisius et al., 2013; 
Radzisheuskaya et al., 2013), we now define 
Oct4 as a ‘transition factor’, permitting identity 
change in various directions depending on 
the context. 
Our work supports theories that cell iden-
tities are multidimensional attractors, occupy-
ing local minima of stable network states 
(Huang et al., 2005; Kauffman, 1993). Here, 
we provide a substantial advance on previous 
works, reaching a single destination identity 
via three different trajectories. Mechanistic as 
well as transcriptional differences verify that 
transitions occur via truly distinct intermediate 
states. Furthermore, we reveal the logic un-
derpinning multidimensional access to the 
single attractor: fine-tuned support of a transi-
tion factor, in this case Oct4. This provides a 
conceptual framework for the understanding 
of cell identity transitions. In the future, it will 
be of interest to continue identifying the tran-
sition factors and supporting logic for the mul-
titude of developmental, regenerative and 
pathological cell identity transitions. 
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Supplemental Figure Legends 
 
Figure S1: Reprogramming initiation is driver-dependent 
(A) Gene expression of established inPSCs at passage 5, together with control EpiSCs and 
nPSCs. Means are shown from scRNAseq. Greys: primed markers. Blues: core pluripotency 
markers. Oranges: naïve markers. Together with Fig 1E, this shows that inPSCs derived with 
each driver do not differ in their molecular signatures. 
(B) Percentage of Rex1::dGFP+ cells is shown for each driver after reprogramming induction 
in 2iLIF+dox (iEsrrb, iKlf2) or 2iLIF+GCSF (iPStat3), from days 2–5. Note that in standard re-
programming assays we would normally withdraw dox/GCSF at day 4 and add blasticidin to 
select for Rex1 reporter activity. However, in this instance we continued in 2iLIF+dox/GCSF 
until day 5 and never added blasticidin, so that the % of dGFP+ cells was not confounded. 
Parental Rex1::dGFP EpiSCs in FA (0.00% dGFP+) and Rex1::dGFP nPSCs in 2iLIF (99.50% 
dGFP+) provided negative and positive controls respectively. Example: FACS-plot showing 
emergence of Rex1::dGFP expression during reprogramming of iEsrrb in 2iLIF+dox at day 4. 
(C) Reprogramming of iEsrrb, iPStat3 and iKlf2 EpiSCs was induced at day 0 in 2iLIF+dox 
(iEsrrb, iKlf2) or 2iLIF+GCSF (iPStat3). Transgene induction by dox/GCSF was withdrawn on 
either day 1, 2, 3 or 4, with concomitant addition of blasticidin (bsd) to select for Rex1 reporter 
activity. Naïve colonies were scored on day 8, and are presented as mean ±SD (n=3), relative 
to day 4. iEsrrb is the fastest to yield transgene-independent inPSCs, while iKlf2 is the slowest, 
consistent with their differing rates of Rex1::dGFP induction (Fig S1B) and their differing kinet-
ics of naïve gene expression induction (Fig 1G). 
(D) Timecourse of driver protein induction from 0–48h. Western blots are shown against 
PStat3, Klf2 and Esrrb, with αTubulin providing loading control. Induction is robust from 1h 
onwards for all drivers. Therefore, differences in naïve network induction kinetics are due to 
the downstream responses, rather than due to delays in transgene induction itself. 
(E) Immunofluorescent staining was performed and quantified 24h after transgene induction, 
on a total of 5956 cells. EpiSC and nPSC samples provide negative and positive controls re-
spectively. To determine the % of driver-positive cells, a stringent threshold was calculated: 
the mean of EpiSC values plus three standard deviations (3SD), indicated on the plots. Quan-
tification of driver proteins in single cells shows efficient inductions (93–98%) to expression 
levels comparable to those of the endogenous proteins in nPSCs, which is the biologically 
relevant reference. DAPI+ area is plotted on the y-axis simply to assist in data visualisation.  
(F) RNAseq was performed on bulk samples after driver induction in 2i±LIF and in FA. Principle 
component analyses (PCA) based on expressed genes (FPKM>0) are shown for iEsrrb 
(above) and iKlf2 (below). 
(G) k-means clustering of bulk RNAseq samples, based on expressed genes (FPKM>0). Op-
timal k cluster number was computed using the elbow method. 
 
Figure S2: Single-cell RNAseq defines distinct productive trajectories 
(A) Unsupervised hierarchical clustering, computed based on all genes with the Ward.D2 ag-
glomeration method and Euclidean distances. iKlf2 12/24h cells cluster in a separate branch 
‘a’ from all other samples, indicating that they are more different to the rest than even EpiSC 
(start) vs nPSC/inPSC (end) samples are to each other. This is consistent with an initial diver-
sion in the iKlf2 trajectory. The remainder of the samples clustered into indicated branches b 
and c. Branch b subclustered into: b(i), comprised of EpiSCs and mostly 12h iPStat3 and 
iEsrrb; b(ii), mostly 24h iPStat3 and iEsrrb; b(iii), a mixture of early and mostly 72h dGFP- 
samples. Branch c subclustered into: c(i), comprised of nPSC/inPSCs; and c(ii), mostly 72h 
dGFPlow and dGFP+ samples for all drivers. Overall, this indicates that early timepoints and 
less productive populations are more similar to EpiSCs (start identity) whereas later and higher 
dGFP samples are more similar to nPSC/inPSCs (end identity). Importantly, within groups b 
and c, cells cluster according to driver rather than according to timepoint or dGFP status, 
demonstrating that routes are transcriptionally distinct throughout. 
(B) Differential expression (DE) analysis was performed on each sample set relative to start 
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DE genes that are unique to or shared between drivers at each timepoint. Examples of the 
Venn diagrams are shown here, and the DE numbers are summarised in main Fig 2E. 
(C) Computation of fraction of similarity between each single cell vs EpiSCs in FA and inPSCs 
in 2iLIF. Signature EpiSC and inPSC datasets were generated by averaging of bulk RNAseq 
samples. Single cells were ordered from lowest to highest inPSC/EpiSC identity fractions to 
generate pseudotime coordinates from reprogramming start to end. Pseudotime coordinates 
largely agreed with real-time. 
(D) Scatter plots of expression in single cells vs pseudotime, fitted with LOESS regression 
lines. 
 
Figure S3: iKlf2 reprogramming proceeds via a mesoderm-like state 
(A) Scatter plots of mesodermal markers (Fgf8, Mesp1, Lefty1, T) against Nanog expression 
in iEsrrb and iPStat3 reprogramming intermediates, EpiSC (start) and nPSC/inPSC (end) iden-
tity controls. The y-axes are to the same scales as Fig 3A to facilitate comparison. 
(B) Upper: Knock-in strategy for the Rex1::mKO2 fusion cassette, which was constructed by 
replacing the dGFP cassette of the Rex1::dGFP targeting vector (Kalkan et al., 2017). E4/5 = 
exon 4/5; H = helical linker (Arai et al., 2001); mKO2 = monomeric Kusabira Orange 2; bsd 
confers resistance to blasticidin if Rex1 is expressed. Lower: resulting bsd-resistant clones 
were genotyped by PCR using the indicated F1/R1 or F2/R2 primers. TG is the T+/GFP parental 
nPSC line (Fehling et al., 2003). TGHRO are targeted with the helical linker (H) construct 
whereas TGGRO clones contained a glycine-serine linker. Correct targeting was obtained in 
nPSC clones TGHRO6&8, and TGHRO6 was used for subsequent experiments (simply de-
noted as TGRO in main figure panels).  
(C) Immunofluorescent staining against GFP and T proteins, following induction of iKlf2 in 
TGHRO6 (TGRO) EpiSCs. Scale bars: 100µm. 
 
Figure S4: iPStat3 reprogramming proceeds via an early ICM-like state 
(A) Scatter plots of Gata6 vs Nanog expression in iEsrrb and iKlf2 reprogramming intermedi-
ates, EpiSC (start) and nPSC/inPSC (end) identity controls. The y-axes are to the same scales 
as Fig 4C to facilitate comparison. 
(B) Scatter plots of Gata6 vs earlier or later ICM markers in iPStat3 reprogramming intermedi-
ates, E3.5 and E4.5 embryos. ICM: inner cell mass. Epi: epiblast. PrE: primitive endoderm. 
There is a temporal sequence of naïve gene activation in the embryo (Boroviak et al., 2015). 
Earlier markers (Klf2, Tfcp2l1) are expressed in Nanog+Gata6+ early ICM. In contrast, later 
markers (Gbx2, Nr0b1) are not activated until after Nanog+Gata6- naïve epiblast has segre-
gated from Nanog-Gata6+ primitive endoderm. iPStat3 reprogramming intermediates emulate 
this in vivo progression: Klf2 and Tfcp2l1 are turned on earlier and are co-expressed with 
Gata6, whereas Gbx2 and Nr0b1 are activated later in Gata6- cells.  
(C) iPStat3 was induced to reprogram Gata6::H2BVenus EpiSCs. Immunofluorescent staining 
against Gata6 and Nanog was performed at day 2.5. H2BVenus signal persisted without need 
for counterstaining. Scale bars: 20µm. 
(D) Immunofluorescent staining against Gata4 and Sox2, 2.5 days after iPStat3 reprogram-
ming induction, i.e. at the timepoint of sorting for injection. Scale bars: 20µm.  
 
Figure S5: Routes have distinct genetic and signal requirements 
(A) Western blots against Esrrb and Klf2, after siRNA treatment of nPSCs in 2iLIF. αTubulin 
provides loading control. siRNAs were applied from 0–16h, and samples harvested at 48h. 
Individual siRNAs were used at 10µM, whereas pools were comprised of 4x 2.5µM. 
(B) siRNA treatment was performed in a single 16h pulse at reprogramming onset, with indi-
vidual 10µM siRNAs as well as pools (P) of 4x 2.5µM. Reprogramming was induced with 
2iLIF+dox (iEsrrb, iKlf2) or 2iLIF+GCSF (iPStat3). Selection was performed from day 4 with 
2iLIF+blasticidin and inPSC colonies were scored at day 8, presented as mean ± SD (n=6) 
relative to siNeg. Pools of 4 siRNAs, each at a quarter concentration and targeting a different 
region of the mRNA, are expected to minimise off-target effects. With the exception of ineffi-
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driven reprogramming is dependent on early Klf2 expression, whereas iEsrrb is not (Fig 5B); 
Esrrb KD at reprogramming onset does not abolish reprogramming by any driver. This is con-
sistent with lack of Esrrb expression by any other driver at 24h (Fig 5A, S5D). 
(C) Klf2 KD was performed at iPStat3-driven reprogramming onset with a single 16h pulse of 
siRNA pool, in the indicated conditions +GCSF from day 0–4, then inPSC colonies were se-
lected from day 4–8 in 2iLIF+blasticidin. inPSC colonies were scored on day 8, presented as 
mean ±SD (n=3) relative to siNeg. PD=PD03; CH=Chiron; 2i=PD+CH. iPStat3 sensitivity to 
Klf2 KD is alleviated in the absence of PD03, reminiscent of the ability to rescue embryo-de-
rived Nanog-/- EpiSC reprogramming in Chiron+LIF but not 2iLIF (Stuart et al., 2014). Notably, 
both Nanog and Klf2 are considered targets of PD03 (Silva et al., 2009; Yeo et al., 2014): it 
appears they are required to transduce its positive input to the naïve network and, in their 
absence, PD03 is actively detrimental to reprogramming. Hence, interplay between TFs and 
signals can fundamentally modulate each other’s role in identity specification. 
(D) Western blots against PStat3 and Esrrb, after 24h in FA or 2iLIF+dox/GCSF. αTubulin 
provides loading control. 
(E) RT-qPCR analysis of EVrtTA3 EpiSCs in the indicated condition +dox. Mean gene expres-
sion is displayed relative to Gapdh and normalised to inPSCs, ±SD (n=3). The axes are to the 
same scales as Fig 5F to facilitate comparison. 
(F) Immunofluorescent staining 48h after reprogramming induction. nPSCs cultured in 
FCS+LIF provide a positive control for PSmad1/5. Maximum intensity projections of Z-stack 
slices are presented. Scale bars: 20µm. 
(G) Validation of 3µM DMH2 efficacy. Wild-type nPSCs cultured in FCS+LIF were treated for 
24h as indicated. BMP signalling is known to be active and important for pluripotency mainte-
nance in FCS+LIF (Ying et al., 2003), unlike in 2iLIF. Maximum intensity projections of Z-stack 
slices are presented. Scale bars: 20µm. 
(H) 3µM DMH2 or 1:1000 DMSO was applied to nPSCs or previously established iKlf2 inPSCs, 
at clonal density in 2iLIF. Naïve colonies were scored after 4 days, as mean ±SD (n=3). 
(I–K) Mouse blastocysts were cultured with DMSO or BMP signalling inhibitor from cavitation 
onset until the late blastocyst stage, by which point the epiblast (Epi) and primitive endoderm 
(PrE) lineages are fully segregated, thus allowing us to study the impact on each lineage. 
(I) Quantitative nPSC-derivation was performed from late blastocysts, following treatment with 
either DMSO or 3µM DMH2. Immunosurgery was performed to remove the trophectoderm 
(TE), then the inner cell mass (ICM, comprising Epi+PrE) was dissociated to single cells. 10 
single cells were manually transferred to each 96well and cultured in feeder-free 2iLIF condi-
tions, without any further DMSO/DMH2 treatment so that we could assess whether the Epi of 
the embryo was already affected. By plating 10 single cells per well, we could measure abso-
lute nPSC-derivation efficiency independently of embryo size. The number of nPSC colonies 
was scored on day 6, and is presented per 10 single cells (main Fig 5K) and as mean per 
embryo ±SD (here). DMSO n=7; DMH2 n=8. nPSC-identity was subsequently confirmed by 
RT-qPCR (data not shown).  
(J) Mean number of total cells per embryo ± SD. DMSO n=23, DMH2 n=18, LDN n=7 embryos. 
Note that the lower cell number per DMH2-treated embryo was not due to developmental re-
tardation: Epi and PrE endoderm lineages segregated, the proportion of cells per lineage was 
unchanged (Fig 5L), and expression of Gata4 indicates late PrE (Artus et al., 2011). 
(K) Late blastocysts were fixed and stained for Cdx2, Gata4 and Oct4, following treatment with 
1:1000 DMSO, 3µM DMH2 or 0.3µM LDN. Mean signal intensity was quantified for each nu-
cleus, and is presented as box-and-whisker plots for Cdx2 in TE cells (DMSO n=23, DMH2 
n=18, LDN n=7 embryos). Oct4 and Gata4 results are presented in main Fig 5N. 
(L) A subset of embryos was also stained for Nanog. Mean signal intensity was quantified for 
each nucleus, and is presented as box-and-whisker plots for Nanog in Epi cells (DMSO n=9, 
DMH2 n=11, LDN n=4). 
 
Figure S6: EpiSC reprogramming converges on the fine-tuning of Oct4 expression 
(A) Immunofluorescent staining of Oct4 expression in Rex1::dGFP EpiSCs and inPSCs. Max-
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(B) Timecourse RT-qPCR analyses of Rex1::dGFP+ and dGFP- EpiSC reprogramming inter-
mediates in 2iLIF+dox/GCSF, and of Rex1::dGFP+ nPSCs in 2iLIF. Mean Oct4 expression is 
displayed relative to Gapdh and normalised to nPSC day 2, ±SD (n=3). 
(C) FACS-plot showing Rex1::dGFP levels during reprogramming. The example here is iEsrrb 
2iLIF+dox day 3. Rex1::dGFP high, medium (med), low, and negative (neg) gates are indi-
cated. Rex1::dGFP negative and high gates were set according to Rex1::dGFP EpiSCs and 
nPSCs respectively. Low and medium gates subdivide the intervening levels. 
(D) Western blot against Oct4, after siRNA treatment of nPSCs in 2iLIF. αTubulin provides 
loading control. siRNAs were applied from 0–16h, and samples harvested at 48h. Individual 
siRNAs were used at 10µM, whereas pool was comprised of 4x 2.5µM. Whilst other genetic 
requirements at reprogramming onset are driver-specific (Fig S5B), Oct4 KD at reprogramming 
onset abolished reprogramming for iKlf2, iEsrrb and iPStat3 (Fig 6F). 
(E) Genotyping of Oct4-/βgeo CAG.Oct4 EpiSCs (FixedOct4), with Oct4+/+ and Oct4F/βgeo controls. 
F=flox allele. The βgeo allele confers resistance to G418 if Oct4 promoter is active. 
(F) Gene expression analyses by RT-qPCR of FixedOct4 EpiSCs following reprogramming 
induction by 2iLIF. Mean gene expression is displayed relative to Gapdh and normalised to 
inPSCs, ±SD (n=3). The initial transcriptional response of FixedOct4 to 2iLIF has features in 
common with each of the other drivers: rapid upregulation of Klf2 (as also observed for iPStat3 
& iEsrrb); moderate upregulation of Tfcp2l1 (iPStat3 & iEsrrb); poor upregulation of Klf4 (iP-
Stat3 & iKlf2); poor upregulation of Klf5 (iEsrrb & iKlf2); poor upregulation of iEsrrb (iPStat3 & 
iKlf2). Thus, besides the Klf5 discrepancy, FixedOct4 initiation is most similar to iPStat3, con-
sistent with its reprogramming impetus coming from the environment including LIF. 
(G–H) Oct4-/βgeo CAG.Oct4 EpiSCs were plated at 2000/24well in FA. The following day, me-
dium was changed to N2B27 ± Chiron ± PD03 (PD) ± LIF in all permutations (n=3). After 4 
days, G418 was applied to select for endogenous Oct4 promoter activity. Quantification of 
reprogramming efficiency was inappropriate at this point, since some conditions are permissive 
compared to 2iLIF. Instead, on day 8, each 24well was passaged in its entirety to 2 x 6wells, 
one maintaining the condition +G418 and one swapped to 2iLIF+G418 to challenge inPSC 
clonogenicity in this naïve-selective condition. P1 inPSC colonies were scored on day 12 in 
2iLIF+G418, presented as mean ± SD (n=3) (G). Condition +G418 phase images are shown 
for those conditions which successfully generated inPSCs (H). Scale bars: 100µm. We found 
that FixedOct4 +LIF was the minimal requirement for naïve pluripotency specification, with 
derivative inPSCs expandable in LIF+G418 or 2iLIF+G418 for at least 8 passages. Curiously, 
Chiron+LIF did not instruct naïve pluripotency acquisition for FixedOct4 EpiSCs despite initial 
emergence of naïve-like morphology. 
(I) Western blot against Oct4 in EVrtTA3 and iKlf2 EpiSCs, after 24h in FA or 2iLIF ± dox. 
αTubulin provides loading control. 
(J) Immunofluorescent staining of Oct4 expression in Rex1::dGFP iKlf2, iPStat3, iEsrrb and 
EVrtTA3 EpiSCs, after 24h in 2iLIF+dox/GCSF. Scale bars: 100µm. 
(K) Quantification of Oct4 immunofluorescent staining during EpiSC reprogramming, on a total 
of 14,736 single cells. Samples included all cells and were not sorted according to Rex1::dGFP 
reporter, i.e. productive and unproductive cells are present to capture all events unbiasedly. 
Tfcp2l1 co-staining indicates progression towards the naïve pluripotent identity. Oct4 protein 
is lost in negative control EVrtTA3 EpiSCs following medium switch, but this can be rescued 
by the reprogramming drivers. Oct4 is maintained on the protein level in cells progressing to-
wards naïve pluripotency. Conversely, there is no evidence of naïve acquisition if Oct4 protein 
is lost. 
(L) To address the role of endogenous Klf2, Esrrb and PStat3 during FixedOct4 EpiSC repro-
gramming, Klf2 and Esrrb KD were performed at reprogramming onset with a single 16h pulse 
of individual (10µM) or pooled (4x 2.5µM) siRNAs. Reprogramming was induced with 2iLIF, 
selection was performed from day 4 with 2iLIF+G418, then inPSC colonies were scored at day 
8, presented as mean ± SD (n=6) relative to siNeg. To address the role of PStat3, we instead 
conducted experiments in the absence of LIF (L) and/or in the presence of Jak inhibitor (Ji), to 
ensure that Stat3 was not activated. Overall, LIF/Stat3 signal inhibition had the greatest impact 
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Figure S7: PSC-level of Oct4 is sufficient for somatic cell reprogramming 
(A–D) Differentiation of FixedOct4 cells in E9.5 chimeras was analysed by immunostaining of 
8µm cryosections, taken in various sectioning planes. This extensively demonstrates bonafide 
contribution of FixedOct4 cells to downstream lineages in the embryo, as evidenced by con-
tinued Oct4 expression together with appropriate lineage markers. 
(A) Cherry and brightfield (BF) images were acquired on rehydrated sagittal slice, prior to im-
munofluorescent staining against Oct4 and Nanog. Contribution of FixedOct4 cells was high 
and widespread, visualised by Cherry signal from the CAG.Oct4.2A.Cherry transgene. Im-
portantly, Cherry signal agreed with Oct4 counter-stain, whereas Nanog expression was not 
detected. This confirms that the cells had exited pluripotency yet maintained transgenic Oct4 
expression. Subsequently, H&E staining was performed on the same slice. Contribution of 
FixedOct4 cells to various tissues is evident from H&E histological analyses. Scale bars: 
200µm. 
(B) Immunofluorescent staining against Oct4 and Sox1 on sagittal slice (midline section). 
Zoom of the indicated region shows the developing brain. Scale bars: 100µm. 
(C) Immunofluorescent staining against Oct4 and T on coronal slice. Zoom of the indicated 
region shows the notochord. Scale bars: 100µm. GE=gut endoderm; NT=neural tube; a=ante-
rior; p=posterior. 
(D) Immunofluorescent staining against Oct4 and Sox17 on a sagittal slice. Zoom of the indi-
cated region shows intersomitic blood vessels. Scale bars: 100µm. 
(E) Tetraploid C57BL/6 embryos were generated by cell fusion at the 2-cell stage, then cultured 
to the 8-cell stage. Oct4-/βgeo CAG.Oct4.2A.Cherry nPSCs were injected into tetraploid 8-cell 
embryos, then transferred to recipients. Resultant embryos were collected at E8.5. Phase and 
Cherry images are shown, of 3 tetraploid complementations and 3 stage-matched wild-type 
embryos from a different litter. Scale bars: 100µm. This shows that FixedOct4 cells are capable 
of performing tetraploid complementation, a stringent assay for developmental contribution. 
(F) Differentiated FixedOct4 cells were derived from E9.5 chimeras, then reprogrammed in 
LIFaza (LZ) or LIF only (L) from day 0–6, followed by 2iLIF until day 10 (Fig 7C). RT-qPCR 
expression analyses are shown after two days of treatment with L or LZ on cells from chimera 
1, for inPSCs at passage 2 in 2iLIF+G418 after derivation in LZ then 2iLIF from chimeras 1–7, 
and after derivation directly in 2iLIF for a chimeric allantois (A1). Mean expressions ± SD (2 
technical replicates per embryo) are presented relative to Gapdh then normalised to parental 
nPSCs. 
(G) Schematic summarising the unifying, required and sufficient feature of correct Oct4 level, 
which permits cells to transit into naïve pluripotency. Left: diverse logics by which different 
EpiSC reprogramming drivers achieve correct Oct4 expression. When control EpiSCs are ex-
posed to naïve signals, Oct4 expression drops as the primed network is disrupted. Reprogram-
ming drivers must actively overcome this in order to undergo the identity transition. Although 
iKlf2, iPStat3 and iEsrrb drive reprogramming by transcriptionally and mechanistically distinct 
routes (Fig 6A), all ultimately achieve the convergent feature of correct Oct4 level and thus can 
reach the same naïve pluripotent destination. Right: the functional importance of precise Oct4 
expression was confirmed by transient KD, which abolishes reprogramming by all drivers. Con-
versely, fixing Oct4 to PSC level is sufficient for reprogramming under only signal instruction, 
from EpiSCs and from developmentally more advanced cell types including MEFs. Therefore, 
appropriate Oct4 expression is the pivotal feature for transition into the naïve pluripotent iden-
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Supplemental Tables 
 
GO biological process p value 
supramolecular fiber organization (GO:0097435) 4.66E-08 
cytoskeleton organization (GO:0007010) 3.89E-06 
regulation of cellular component movement (GO:0051270) 4.52E-06 
cellular component organization (GO:0016043) 5.00E-06 
cellular component organization or biogenesis (GO:0071840) 2.56E-05 
regulation of actin filament-based process (GO:0032970) 2.93E-05 
regulation of localization (GO:0032879) 5.97E-05 
regulation of biological quality (GO:0065008) 6.72E-05 
regulation of multicellular organismal process (GO:0051239) 1.08E-04 
regulation of supramolecular fiber organization (GO:1902903) 1.48E-04 
regulation of cell motility (GO:2000145) 4.25E-04 
actin cytoskeleton organization (GO:0030036) 4.72E-04 
regulation of cell migration (GO:0030334) 5.01E-04 
regulation of locomotion (GO:0040012) 6.52E-04 
actin filament organization (GO:0007015) 7.41E-04 
regulation of developmental process (GO:0050793) 1.04E-03 
negative regulation of biological process (GO:0048519) 1.75E-03 
anatomical structure development (GO:0048856) 1.99E-03 
actin filament-based process (GO:0030029) 2.92E-03 
negative regulation of cellular process (GO:0048523) 3.46E-03 
regulation of system process (GO:0044057) 3.81E-03 
protein localization to plasma membrane (GO:0072659) 4.32E-03 
developmental process (GO:0032502) 5.19E-03 
regulation of cell differentiation (GO:0045595) 5.80E-03 
cellular process (GO:0009987) 8.64E-03 
system development (GO:0048731) 9.78E-03 
regulation of cytoskeleton organization (GO:0051493) 1.51E-02 
regulation of actin cytoskeleton organization (GO:0032956) 1.84E-02 
regulation of biological process (GO:0050789) 1.96E-02 
regulation of cellular component organization (GO:0051128) 1.99E-02 
animal organ development (GO:0048513) 2.90E-02 
biological regulation (GO:0065007) 3.62E-02 
regulation of cell population proliferation (GO:0042127) 4.60E-02 
 
Table S1: Gene ontology enrichment for genes contributing to initial iKlf2 diversion. 
Gene ontology (GO) analysis for biological processes enriched in the gene list contributing 
to –PC1 dimension on the iKlf2 PCA plot (main Fig 2D left panel) (contribution score <–0.5). 
GO analysis was conducted using the PANTHER Overrepresentation Test with Bonferroni 
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Materials & Methods 
 
Tissue culture 
nPSCs and inPSCs were cultured in N2B27+2i+LIF (2iLIF). EpiSCs were cultured in N2B27+ 
XAV+FGF2+ActivinA (FA). N2B27 medium comprised 1:1 DMEM/F-12 and Neurobasal 
(Gibco), 2 mM L-glutamine (Gibco), 1x penicillin-streptomycin (Sigma), 0.1 mM 2-mercaptoeth-
anol (Gibco), 1% B27 (Gibco) and 0.5% N2 (homemade). As required, N2B27 was supple-
mented with 20 ng/ml murine LIF (homemade), 3 μM CHIR99021 (Chiron; CH) and 1 μM 
PD0325901 (PD03; PD) (Stewart lab, Dresden), 12.5 ng/ml FGF2 and 20 ng/ml ActivinA 
(homemade), 6.25 µg/ml XAV 939 (Tocris), 3 µM DMH2 (Tocris), or 0.6 µM LDN193189 
(Sigma). For nPSCs and inPSCs, tissue-culture flasks were coated with 0.15% gelatin (Sigma) 
in PBS (Sigma) and incubated in 7% CO2. For EpiSC culture and reprogramming experiments, 
tissue-culture flasks were coated with 10 µg/ml fibronectin (Millipore) in PBS (Sigma) and in-
cubated in 7% CO2 and 5% O2. nPSCs, inPSCs and EpiSCs were dissociated with accutase 
(Millipore) during passaging. For optimal performance of EpiSCs, lines were maintained by 
plating 25000 cells/cm2 every other day (usually 1:6 split ratio) following gentle accutase treat-
ment for less than 3 minutes at room temperature. For Figures S5F–G and 6D, nPSCs were 
cultured in FCS+LIF medium containing GMEM (Sigma), 10% fetal calf serum (FCS) (Gibco), 
1x non-essential amino acids (Gibco), 1 mM sodium pyruvate (Sigma), 2 mM L-glutamine 
(Gibco), 1x penicillin-streptomycin (Sigma), 0.1 mM 2-mercaptoethanol (Gibco), 20 ng/ml mu-
rine LIF (Hyvonen lab, Cambridge), and 10 ng/ml BMP4 (Miltenyi Biotec) was supplemented 
as indicated. 
 
Rex1::dGFP EpiSCs  
Rex1dGFP.IRES.bsd/dGFP.IRES.bsd homozygous 129 studs (Kalkan et al., 2017) were crossed with wild-
type 129 females and heterozygous Rex1+/dGFP.IRES.bsd EpiSCs (referred to as Rex1::dGFP re-
porter) were derived from resultant E6.5 embryos. Epiblasts were manually dissected from 
extra-embryonic tissues and plated on fibronectin-coated plates in FA medium. After 5–7 days 
of culture, regions of the explant exhibiting EpiSC morphology were manually passaged to a 
fresh plate. Subsequent passages were performed using accutase (Millipore). 
 
Cell transfection 
For transgene integration transfections, 1 μg PiggyBac (PB) vectors of interest, 0.5 μg PBase 
expression vector (CAG.PBase) and 10 μl Lipofectamine-2000 (Invitrogen) were incubated for 
20 min in 500 ml DMEM (Gibco), then applied to 500,000 cells/6well in 3 ml medium for 18 
hours. Selection was applied to transfectants for at least 5 passages prior to use: 50 μg/ml 
hygromycin-B (Life Technologies) for PB.TetO.GOI.PGK.hph or PB.CAG.GY118F.PGK.hph, 
and 0.33 µg/ml puromycin (ThermoFisher) for PB.CAG.rtTA3.PGK.pac. siRNA transfections 
were performed using RNAiMAX transfection reagent (Invitrogen) and FlexiTube siRNAs 




EpiSCs were plated in FA without selection at a density of 2000/24well or equivalent. For 
siRNA experiments, 10000/24well or equivalent was used instead to compensate for transfec-
tion toxicity. The following day, reprogramming was induced by medium change to 2iLIF or 
subset components thereof as indicated. GY118F transgenic receptor was stimulated with 
30 ng/ml human GCSF (Peprotech), whereas expression of other transgenes was induced 
with 1 µg/ml doxycycline (MP Biomedicals). After 4 days, transgene induction was withdrawn 
and 20 μg/ml blasticidin (Gibco) was applied to select for Rex1::dGFP.IRES.bsd activity. On 
day 8, 4x images were acquired using CellSens software and an X-51 Olympus microscope 
system with motorized stage and camera. inPSC colonies with active Rex1 reporter were 
counted manually. Rex1 reporter activity confers both dGFP expression and blasticidin re-
sistance, and is a well-characterised naïve marker (Kalkan et al., 2017). We confirmed that 
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transgene induction is a stringent test of driver efficacy; we note that more colonies emerged 
when induced for longer, including for weaker drivers iNanog and iTfcp2l1 (data not shown). 
No colonies ever emerged from any EVrtTA3 reprogramming experiments, confirming that our 
lines represent “late-stage” EpiSCs (Han et al., 2010). Where indicated, reprogramming ex-
periments were treated with 3 µM DMH2 (Tocris), 0.6 µM LDN (Sigma), or 1 µM Jak inhibitor 
(Merck-Millipore) from days 0–4. Unless stated otherwise, reprogramming data presented are 
the mean of 3 biological replicates. 
 
FixedOct4 EpiSCs 
FixedOct4 EpiSCs were generated from Oct4-/βgeo CAG.Oct4wt.2A.mCherry nPSCs 
(Radzisheuskaya et al., 2013) by differentiation in FA for 10 passages. Oct4F/βgeo CAG.Emp-
tyVector EpiSCs were generated as a control from the same parental line. Reprogramming 
was conducted in N2B27+2iLIF as above. 200 μg/ml G418 (Invitrogen) was applied to select 
for endogenous Oct4 promoter activity after 4 days of reprogramming. 
 
Gata6::H2BVenus EpiSCs 
Gata6+/H2BVenus nPSCs (Freyer et al., 2015) were kindly shared by Christian Schröter. By differ-
entiation for 10 passages in FA, we obtained Gata6::H2BVenus reporter EpiSCs. 
 
T::GFP Rex1::mKO2 EpiSCs 
T+/GFP nPSCs (Fehling et al., 2003) were kindly shared by Gordon Keller. Rex1-mKO2 fusion 
cassette was constructed by replacing the dGFP cassette of the Rex1-dGFP targeting vector 
(Kalkan et al., 2017) (Figure S3B). We linearized the vector with BspH1, then electroporated it 
into T+/GFP nPSCs using Gene Pulser (BioRad) at 230V, 500µF. Correct targeting results in a 
Rex1-mKO2 fusion protein and confers blasticidin resistance when Rex1 is expressed. nPSCs 
were selected with 10 µg/ml blasticidin, then clones were genotyped by PCR. PCR primers for 
5’ side are TCGTGTGACTCTGCATCTGT and CTGCCTCTTTAGCTGCGG, and for 3’ side 
are ATTCGTGAATTGCTGCCCTC and GAGGCAGAGGAACAGGACTT. Correctly targeted 
nPSC clone TGHRO6 (subsequently referred to as TGRO) was differentiated to EpiSCs by 10 
passages in FA, resulting in T::GFP Rex1::mKO2 double-reporter EpiSCs. 
 
Live imaging 
Live imaging was performed using IncuCyte system, with phase and H2BVenus images taken 
every 60 min for Gata6 reporter, or phase, GFP and mKO2 images taken every 45 min for 
T/Rex1 double-reporter. For Gata6 reporter, the endpoint was fixed, stained for Tfcp2l1 
(AF594) and Oct4 (AF647), then re-imaged with the same positional registration for AF594. 
Co-expression of Tfcp2l1+Oct4+ in endpoint inPSCs was confirmed on a separate microscope 
capable of detecting AF647 as well (data not shown). 
 
Microinjection to generate chimeras 
Chimeras were generated from strain 129 (agouti) male inPSCs by standard microinjection 
methodology using host blastocysts of strain C57BL/6 (black), followed by gestation in pseudo-
pregnant recipient females. Germline-competence of male chimeras was tested by crossing 
them to C57BL/6 (black) females and checking for agouti pups. For Figure 4G–I, host embryos 
were injected at the 8-cell stage, cultured in Blast medium (Origio) until blastocysts formed, 
then cultured to the late blastocyst stage in N2B27. For Figure S7E, tetraploid host embryos 
were generated by cell fusion at the 2-cell stage, cultured to the 8-cell stage in Cleav medium 
(Origio), injected then transferred to pseudo-pregnant recipients for gestation. All animal work 
was performed in accordance with Home Office guidelines and regulations at the University of 
Cambridge, UK. 
 
Reprogramming from FixedOct4 E9.5 chimeras 
E9.5 chimeras were generated by blastocyst injection of Oct4-/βgeo CAG.Oct4wt.2A.mCherry 
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moved to strictly avoid germ cell contamination in the cultures. The anterior portion was disso-
ciated manually, then subdivided into quarters (2x LIFaza, 2x 2iLIF or LIF only as indicated). 
Aza = 1 μM 5-Azacytidine (Sigma). After 6 days, LIF or LIFaza was exchanged for 2iLIF, then 
on day 10 G418 was applied to all cultures (200 μg/ml). Chimeric allantois samples were dis-
sociated manually, a portion taken for expression analysis, and the remainder plated as posi-
tive control (germ-cell containing). 
 
Derivation and reprogramming of FixedOct4 MEFs 
E12.5 chimeras were generated by blastocyst injection of Oct4-/βgeo CAG.Oct4wt.2A.mCherry 
nPSCs (Radzisheuskaya et al., 2013). The heads and all internal organs were removed, taking 
particular care to fully remove the genital ridges. Carcasses were dissociated in trypsin (Life 
Technologies), then cultured in FCS medium. Hygromycin was applied to select for 
CAG.Oct4wt.2A.mCherry transgene. MEFs were passaged using trypsin, and used from pas-
sage 3–5 for reprogramming assays. For reprogramming, MEFs were plated at 5000/24well in 
FCS medium on 0.15% gelatin. The following day, medium was changed to 
N2B27+LIF±IL6&IL6R±FGF2±CH±PD as indicated for the first week (20 ng/ml LIF; 50 ng/ml 
IL6 and 10 ng/ml soluble IL6R; 12.5 ng/ml FGF2; 3 μM CH; 1 μM PD). On day 7, all were 
swapped to N2B27+2iLIF, then on day 14 G418 was added (200 μg/ml) to select for inPSC 
colonies. We would like to highlight that all medium was N2B27-based, i.e. MEF reprogram-
ming occurred in the absence of serum, KSR/ascorbic acid, or any small molecule epigenetic 
modulators. 
 
BMP inhibitor treatment of embryos 
Wild-type 129 mice were crossed and embryos flushed from oviducts at 2.75 dpc using M2 
medium (Millipore). Embryos were subsequently incubated in Blast medium (Origio) and peri-
odically inspected. At cavitation onset, embryos were randomly divided into Blast medium sup-
plemented either with 3 µM DMH2 (Tocris), 0.3 µM LDN (Sigma) or 1:1000 DMSO. Once blas-
tocysts had fully formed, they were transferred to N2B27 medium continuing 
DMH2/LDN/DMSO treatment as before. At the late blastocyst stage, embryos were fixed and 
immunostaining was performed. Embryos were permeabilized in 0.25% Triton X-100 (Sigma) 
in PBS for 30 min, then blocked in 3% donkey serum (Sigma), 0.1% BSA (Sigma) and 0.01% 
Tween-20 (Sigma) for 30 min at room temperature. Embryos were incubated overnight at 4°C 
in blocking buffer with the following primary antibodies: Cdx2 (1:500, mouse mAb, BioGenex); 
Gata4 (1:300, goat pAb, Santa Cruz); Nanog (1:300, rat mAb, eBioscience); Oct4 (1:300, rabbit 
mAb, Cell Signaling). The following day, washes were performed in blocking buffer. AlexaFluor 
secondary antibodies (Life Technologies) were used against the appropriate species at 1:1000 
in blocking buffer. Embryos were gradually acclimatised then mounted in Fluoromount-G 
(Southern Biotech) and images were taken with a Zeiss 710 LSM confocal microscope. Pre-
sented images are maximum intensity projections of Z-stack slices processed with ImageJ. 
Staining quantification was carried out with Imaris: nuclei were identified in the DAPI channel 
and the fluorescence of each other channel recorded. Cells were assigned to each lineage 
based on position and marker staining. We note that the phenotype was highly time-sensitive: 
addition of BMP inhibitor at the 8-cell stage caused developmental arrest, consistent with 
Reyes de Mochel et al., 2015 but precluding fair assessment of whether the naïve lineage 
specifically is compromised. At the 8-cell stage, the trophectoderm (TE) vs inner cell mass 
(ICM) decision has not yet been made. Conversely, application of BMP inhibitor to the mid 
blastocyst did not disrupt the naïve epiblast (data not shown). By this point, the epiblast vs 
primitive endoderm (PrE) bifurcation is already underway. In contrast, precisely timed inhibitor 
addition at cavitation onset in the late morula falls between these two developmental lineage 
bifurcations, and thus permits assessment of the role of BMP signalling in naïve epiblast es-
tablishment despite the multitude of BMP signalling roles during early development. 
 
Quantitative nPSC derivation 
Following BMP inhibitor treatment from cavitation onset as above, quantitative nPSC-deriva-
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Briefly, immunosurgery was performed to remove the TE, then the ICM (comprising epi-
blast+PrE) was dissociated to single cells using accutase. 10 single cells were manually 
transferred to each 96well and cultured in feeder-free N2B27+2iLIF conditions on gelatin, 
without any further DMSO/DMH2 treatment so that we could assess whether the epiblast of 
the embryo was already affected. The number of nPSC colonies was scored after 6 days, 
and nPSC identity confirmed by RT-qPCR (data not shown). 
 
Flow cytometry 
Flow cytometry was performed using a BD LSRFortessa analyser with subsequent data anal-
ysis using FlowJo software. Cell sorting was performed using a MoFlo Legacy Cell Sorter 
(Beckman) or an S3 Cell Sorter (BioRad). dGFP was excited using a 488 nm laser and de-
tected using a 530/30 filter. Rex1::dGFP EpiSCs and nPSCs were used to determine negative 
and positive dGFP gates respectively. After sorting of reprogramming intermediates, number 
of inPSC colonies are quantified relative to the number of nPSC colonies, because replating 
of sorted nPSCs provides a control for cell death due to the stress of sorting. nPSCs already 
stably occupy the destination naïve pluripotent identity, and are thus the appropriate functional 
control. When we replated Rex1::dGFP+ reprogramming intermediates for clonogenicity as-
say, we later applied blasticidin as an additional control to prove that the Rex1 promoter was 




Cultured cells were fixed with 4% paraformaldehyde (Sigma) in PBS for 10 min at room tem-
perature. E9.5 embryos were fixed with 4% paraformaldehyde (Sigma) in PBS for 4 hours at 
4°C, gradually adjusted to 20% sucrose over 2 days, mounted in O.C.T. (TissueTek), snap 
frozen on liquid nitrogen, cryosectioned (8 µm), stored at -80°C, then rehydrated in PBS. For 
both cultured cells and embryo cryosections, permeabilization was performed in 0.4% Triton 
X-100 (Sigma) in PBS, then samples were blocked in 5% donkey serum (Sigma) and 0.1% 
Triton X-100 in PBS. Samples were incubated overnight at 4°C in blocking buffer with the 
following primary antibodies: Cardiac troponin (1:300, mouse mAb, Abcam); Esrrb (1:300, 
mouse mAb, Perseus Proteomics); FoxA2 (1:300, goat pAb, R&D); Gata4 (1:300, goat pAb, 
Santa Cruz); Gata6 (1:300, goat Santa Cruz); GFP (1:300, rat mAb, Nacalcai); Klf2 (kind gift 
from Hitoshi Niwa (1:300, mouse mAb, Yamane et al., 2018)); Klf4 (1:300, goat pAb, R&D); 
Nanog (1:300, rat mAb, eBioscience); Oct4 (1:300, rabbit mAb, Cell Signaling); Oct4 (1:100, 
mouse mAb, Santa Cruz); PSmad1/5 (1:100, rabbit mAb, Cell Signaling); P-Y705-Stat3 (1:300, 
rabbit mAb, Cell Signaling); Sox1 (1:300, goat pAb, R&D); Sox2 (1:300, rat mAb, eBioscience); 
Sox17 (1:300, goat pAb, R&D); T (1:300, goat pAb, R&D); Tfcp2l1 (1:300, goat pAb, R&D). 
The next day, washes were performed with 0.1% Triton X-100 in PBS, and samples incubated 
with DAPI (ThermoFisher) and AlexaFluor secondary antibodies against the appropriate spe-
cies at 1:1000 (Life Technologies). For PSmad1/5 and PStat3 stainings, TBS was used at all 
steps instead of PBS. Samples were mounted in Fluoromount-G (Southern Biotech) and im-
aged using Leica DMI6000, Nikon Eclipse Ti Spinning Disk confocal or Zeiss ApoTome micro-
scope. Staining quantification was carried out with CellProfiler: nuclei were identified in the 
DAPI channel and the fluorescence of each other channel recorded. Confocal images are pre-
sented as maximum intensity projections of Z-stack slices processed with ImageJ. Embryo 
sections were imaged using the Zeiss ApoTome microscope at 20x then tiled. After imaging, 
H&E histological staining was performed on the same sections according to standard method-
ologies. These sections were then re-imaged in the same pipeline. 
 
Western blotting 
Cells were lysed in RIPA buffer (Sigma) containing Complete-ULTRA protease-inhibitor and 
PhoStop phosphatase-inhibitor cocktails (Roche), and sonicated with Bioruptor200 (Dia-
genode) at high frequency, alternating 30 s on/off for 3 min. SDS-PAGE electrophoresis was 
performed using Bolt 10% Bis-Tris Plus gels (ThermoFisher) in a Novex MiniCell (Ther-
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and iBlot Transfer Stacks (ThermoFisher). The following primary antibodies were used: Esrrb 
(1:1000, mouse mAb, R&D); Klf2 (kind gifts from Huck-Hui Ng (1:500, rabbit serum, Yeo et al., 
2014) and Hitoshi Niwa (1:1000, mouse mAb, Yamane et al., 2018)); Oct4 (1:1000, rabbit mAb, 
Cell Signaling); P-Y705-Stat3 (1:1000, rabbit mAb, Cell Signaling); αTubulin (1:10000, mouse 
mAb, Abcam). Detection was achieved using HRP-linked secondary antibodies at 1:10000 
against the appropriate species (GE Healthcare) and ECL Plus Western Blotting Detection 
System (GE Healthcare). 
 
Genotyping  
Genotyping to distinguish between Oct4-/βgeo, Oct4F/βgeo and Oct4+/+ cells was conducted using 
Taq DNA Polymerase (Qiagen) according to manufacturer’s instructions and the following ther-
mocycler program: 95°C 3 min; 30x 94°C 15 s, 60°C 30 s, 72°C 60 s; 72°C 10 min. Primer 
GAGCTTATGATCTGATGTCCATCTCTGTGC binds in the Oct4 final intron, which is present 
in both wild-type and Flox (F) alleles. Primer GGGCTGACCGCTTCCTCGTGCTTTACG binds 
in the βgeo allele. Primer GCCTTCCTCTATAGGTTGGGCTCCAACC binds 3' downstream of 
Oct4 and is common to all alleles. 
 
Plasmids 
PiggyBac expression vector was modified to contain TetO rather than CAG promoter. Genes 
of interest (Esrrb, Klf2, Klf4, Klf5, Nanog, Tfcp2l1) were cloned into the resultant vector using 
Gateway technology (ThermoFisher) according to manufacturer’s instructions, producing in-
ducible expression vectors in the form PB.TetO.GOI.PGK.hph. GY118F and rtTA3 expression 
vectors were generated in the same manner, but retaining CAG instead of TetO promoters 
and thus yielding PB.CAG.GY118F.PGK.hph and PB.CAG.rtTA3.PGK.pac respectively. 
PB.CAG.GY118F.PGK.bsd was used in the Gata6::H2BVenus reporter line. 
 
RT-qPCR 
Total RNA was extracted using RNeasy kits, according to manufacturer’s spin protocol, includ-
ing on-column DNaseI digest (Qiagen). cDNA was produced from 1 μg RNA using Super-
scriptIII VILO cDNA synthesis kit, following the recommended protocol including RNaseH treat-
ment (Invitrogen). RT-qPCR reactions were performed using StepOnePlus Real Time PCR 
System with recommended thermocycler settings (Applied Biosystems) and TaqMan Fast Uni-
versal PCR Master Mix (Applied Biosystems). Gene expression relative to Gapdh in each well 
was determined using FAM-labelled TaqMan assay probe together with VIC-labelled Gapdh 
probe (Applied Biosystems). 
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Bulk RNAseq library preparation 
Sequencing libraries were prepared according to the SmartSeq2 protocol (Picelli et al., 2014) 
with the following amendments: purified RNA was used diluted to 5 ng/µl; ERCC spike-ins 
(Invitrogen) were added at 1 µl of 1:10000 dilution per 5 ng; 13 cycles of amplification were 
used to obtain cDNA (rather than 21 cycles used for single-cells). Nextera XT reactions were 
scaled-down by half, using 0.4ng cDNA input per reaction. Pooled libraries were sequenced 
on the Illumina HiSeq 4000 (paired-end 150bp reads). 
 
scRNAseq library preparation 
Single cells were index-sorted individually by FACS (BD Influx 5) into wells of a 96-well PCR 
plate containing lysis buffer. scRNAseq was performed as previously described (Nestorowa et 
al., 2016; Picelli et al., 2014; Wilson et al., 2015) for a total of 1152 single cells. The Illumina 
Nextera XT DNA kit was used to prepare libraries. Pooled libraries were sequenced on the 
Illumina HiSeq 4000 (single-end 125bp reads). Samples from all cell lines were included in 




GENCODE M12 mouse gene annotation from Ensembl release 87 was used for read align-
ment (Yates et al., 2016) and splice junction donor/acceptor overlap settings were tailored to 
the read length of each dataset. Alignments to gene loci were quantified with HTSeq-count 
(Anders et al., 2015) based on annotation from Ensembl release 87. Sequencing libraries with 
fewer than 500,000 mapped reads were excluded from subsequent analyses. Read distribution 
bias across gene bodies was computed as the ratio between the total reads spanning the 50th 
to the 100th percentile of gene length, and those between the first and 49th. Samples with ratio 
>2 were not considered further. 
 
Published embryo scRNAseq datasets 
Sequencing data of single-cell mouse embryo profiling studies SRP110669 (Mohammed et al., 
2017; E3.5, E4.5, E6.5) and SRP020490 (Deng et al., 2014; compacted morula) were down-
loaded from the European Nucleotide Archive (Toribio et al., 2017) and aligned as above. 
 
Transcriptome analysis  
Principal component and cluster analyses were performed based on log2 FPKM values and 
were computed with the Bioconductor packages DESeq2 (Love et al., 2014), Sincell (Juliá et 
al., 2015) or FactoMineR (Lê et al., 2008) in addition to custom scripts. Default parameters 
were used unless otherwise indicated. For global analyses, genes that registered zero counts 
in all single-cell samples were omitted. Euclidean distance and average agglomeration meth-
ods were used for cluster analyses unless otherwise indicated. t-SNE analysis was computed 
using Rtsne R package (Krijthe, 2015) with default parameters. k-means hard clustering was 
performed using the Mfuzz R package (Futschik and Carlisle, 2005) and the optimal number 
of k clusters were selected using the elbow method. 
 
Selection of high-variability genes  
Genes exhibiting the greatest expression variability (and thus contributing substantial discrim-
inatory power) were identified by fitting a non-linear regression curve between average log2 
FPKM and the square of coefficient of variation. Indicated specific thresholds were applied 
along the x-axis (average log2 FPKM) and y-axis (CV2) to identify the most variable genes. 
 
Quadratic programming  
Fractional identity of single cells was computed using R package DeconRNASeq (Gong and 
Szustakowski, 2013). This package utilises quadratic programming to estimate the proportion 
of distinctive cell types. The average expression of bulk RNAseq samples (EpiSCs or inPSCs, 
Fig S2C) or the average expression of scRNAseq samples (embryo stages, Fig 4B) were used 
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was computed using the whole transcriptome. Reprogramming pseudotimes for single cells 
were assigned by ordering cells based on their fraction of similarity to EpiSCs (origin) and 
inPSCs (destination) (Fig S2C), as previously described (Treutlein et al., 2016). 
 
LOESS regression 
Smooth curve local regression (LOESS) lines were fitted to scatter plots of log2 FPKM vs 
pseudotime using the R stats package (R Core Team, 2016). Smoothness parameter of 1/3 
and 2 degrees of local polynomial were used for curve fitting. 
 
Differential gene expression 
Differential expression (DE) analysis was performed on each sample set relative to start 
EpiSCs, using the R package “scde" (Kharchenko et al., 2014) which fits individual error mod-
els for assessment of differential expression between groups of single cells. 
 
Statistical analyses 
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Summary
Reprogramming of a differentiated cell back to a naive
pluripotent identity is thought to occur by several indepen-
dent mechanisms. Two such mechanisms include NANOG
and activated STAT3 (pSTAT3), known master regulators of
naive pluripotency acquisition [1–5]. Here, we investigated
the relationship between NANOG and pSTAT3 during the
establishment and maintenance of naive pluripotency. Sur-
prisingly, we found that NANOG enhances LIF signal trans-
duction, resulting in elevated pSTAT3. This is mediated, at
least in part, by suppression of the expression of the
LIF/STAT3 negative regulator SOCS3. We also discovered
NANOG to be limiting for the expression of KLF4, a canonical
‘‘Yamanaka’’ reprogramming factor [6] and key pSTAT3
target [2, 7, 8]. KLF4 expression resulted from the codepen-
dent and synergistic action of NANOGand pSTAT3 in embry-
onic stem cells and during initiation of reprogramming.
Additionally, within 48 hr, the combined actions of NANOG
and pSTAT3 in a reprogramming context resulted in reacti-
vation of genes associated with naive pluripotency. Impor-
tantly, we show that NANOGcan be bypassed during reprog-
ramming by exogenous provision of its downstream
effectors, namely pSTAT3 elevation and KLF4 expression.
In conclusion, we propose that mechanisms of reprogram-
ming are linked, rather than independent, and are centered
on a small number of genes, including NANOG.Results
NANOG Amplifies STAT3 Activation
We first investigated the effect of NANOG on STAT3 activation
in embryonic stem cells (ESCs), since the pluripotency
network is established and functional in this cellular context.
Although NANOGand STAT3 are essential for embryonic naive
pluripotency establishment [4, 9], they promote but are not
required for in vitro ESC maintenance [10–14]. This permits*Correspondence: jcs64@cscr.cam.ac.uk
This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution,
and reproduction in any medium, provided the original author and source
are credited.the study ofNanog2/2 and Stat32/2 ESCs and suggests differ-
ences between network requirements for naive pluripotency
establishment versus maintenance.
Active pSTAT3 lies downstream of a LIF-stimulated tyrosine
kinase signaling cascade [1] (Figure S1A available online).
Wild-type,Nanog2/2, and constitutively NANOG-overexpress-
ing ESCs were harvested from steady-state and LIF-induction
cultures. Western blotting revealed that higher NANOG both
increased steady-state pSTAT3 levels (Figures 1A and S1B)
and enhanced ESC sensitivity to LIF stimulation (Figure 1B).
To explain how NANOG drives pSTAT3 elevation without
directly binding the STAT3 protein or gene [17, 18], we exam-
ined the effect of NANOG on components of the LIF/STAT3
signaling pathway (Figure S1A). By quantitative RT-PCR
(qRT-PCR), no correlation was reliably found between NANOG
and transcript levels of the positive signal transducers Lif, Lifr,
Gp130, Jak2, and Stat3 (data not shown), despite NANOG
binding to Lif, Lifr, and Gp130 gene regulatory sequences in
ESCs according to published chromatin immunoprecipitation
sequencing data [18]. However, NANOG also binds the
Socs3 gene (Figure S1C), which is a negative regulator of
STAT3 activation [19, 20]. This prompted our hypothesis that
NANOG represses Socs3 transcription.
Since Socs3 transcription is upregulated by pSTAT3 to form
a classic negative feedback loop [20, 21], determination of
whether NANOG causes Socs3 repression is obfuscated by
the effect of pSTAT3 on Socs3. To disentangle the opposing
yet interconnected influences of NANOG and pSTAT3 on
Socs3 expression, we designed experiments in which the
pSTAT3 level is not significantly influenced by NANOG. ESCs
can be maintained without exogenous LIF by 2i medium [10],
which contains small molecules CHIR99021 (chiron) and
PD0325901 (PD03) that inhibit GSK3 and MEK, respectively.
In the absence of LIF-stimulated Socs3 activation, the effect
of NANOG on Socs3 transcription can be assessed. From
qRT-PCR analysis of wild-type, Nanog2/2, and constitutively
NANOG-overexpressing ESCs cultured in 2i, a strong negative
correlation was evident betweenNanog and Socs3 expression
levels (Figure 1C). Furthermore, in the absolute absence of
pSTAT3 in Stat32/2 ESCs, those constitutively overexpressing
NANOG exhibited a lower Socs3 level (Figure 1C).
STAT3 can be specifically activated by GCSF stimulation of
the GY118F receptor transgene [22–24] (Figure S1A). When
GCSF/GY118F are used in the absence of LIF, Socs3 downre-
gulation by NANOG should have little or no effect on pSTAT3
levels; GY118F is insensitive to SOCS3 repression, and nearly
all STAT3 activation will be attributable to GY118F rather than
LIFR-GP130. In addition, we generated a doxycycline (dox)-
inducible Nanog transgene (iNANOG) (Figure S1D). Dox induc-
tion of NANOG expression rapidly led to enriched NANOG
binding at the Socs3 gene in ESCs, consistent with direct tran-
scriptional regulation (Figure S1C). InNanog2/2 ESCs contain-
ing both iNANOG and GY118F, NANOG expression and STAT3
activation were induced separately and in combination in 2i.
Induction of NANOG alone caused Socs3 repression, while
Socs3 induction in response to STAT3 activation was reduced
by 60% when NANOG was also induced (Figure 1D). This sug-
gests that Socs3 repression is a mechanism by which NANOG
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Figure 1. NANOG Amplifies STAT3 Activation
(A) Western blot analysis of pSTAT3, total STAT3, and KLF4 protein expression in Nanog2/2 and constitutively NANOG-overexpressing ESCs cultured in
steady-state serum+LIF conditions and harvested on two separate days (i and ii). OCT4 expression confirmed undifferentiated status.
(B) Western blot analysis of pSTAT3 and total STAT3 protein expression in wild-type, constitutively NANOG-overexpressing, and Nanog2/2 ESCs in
response to LIF stimulation for 0, 2, and 12 hr. Positive feedback of pSTAT3 induction on STAT3 and NANOG expression was observed, in accordance
with previous work [2, 7, 15]. Selection for pluripotent cells was maintained throughout. Left: LIF was withdrawn from serum+LIF culture for 36 hr prior
to readdition. Right: ESCs were cultured in 2i for at least 7 days prior to LIF addition. Different conditions were used to provide the most informative com-
parisons, since 2i boosts the expression of endogenous NANOG compared to serum conditions [16].
(C and D) qRT-PCR analysis of gene expression, relative toGapdh and normalized either to the highest value (C) or to serum+LIF ESC level (D). Data shown
are the mean of three technical replicates and are from one of two representative experiments. Error bars indicate 6SD.
(C) Nanog and Socs3 expression in ESCs cultured in 2i without LIF for at least 7 days. Top: Nanog2/2, wild-type, and constitutively NANOG-overexpressing
ESCs. Bottom: control and NANOG-overexpressing Stat32/2 ESCs.
(D) Top left: Socs3 expression in Nanog2/2 iNANOG+GY118F ESCs after induction with dox and/or GCSF in 2i. Top right: Socs3 expression in Nanog2/2
iNANOG+GY118F EpiSCs after induction with dox and/or GCSF in FGF2+ActivinA. Bottom: zoomed-in view of the respective dox inductions.
See also Figure S1.
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341augments LIF signal transduction in ESCs, resulting in higher
levels of active pSTAT3. The same trends were observed in
Nanog2/2 iNANOG+GY118F postimplantation epiblast stem
cells (EpiSCs) in standard FGF2+ActivinA conditions (Fig-
ure 1D), demonstrating that NANOG-mediated Socs3 repres-
sion is not restricted to ESCs and may be of functional
relevance during NANOG-driven reprogramming.
NANOG and pSTAT3 Synergistically Upregulate KLF4
To further explore our newfound mechanistic link between
NANOG and LIF/STAT3 signaling, we investigated the effect
of NANOG on expression of LIF/STAT3 targets in ESCs. Inthe steady-state presence of LIF, we found strong positive cor-
relation between levels of NANOG and KLF4, a canonical
pSTAT3 target [2, 7, 8] (Figures 1A and S1B). Interestingly, in
response to LIF stimulation, Klf4 upregulation required
NANOG to be present, while NANOG overexpression cooper-
ated with LIF to substantially increase the rate and levels of
Klf4 induction (Figures 2A and 2B). In agreement with previous
work [8], modest upregulation of NANOG was found in
response to LIF (Figures 1B and S2A).
The correlation between NANOG and Klf4 was abrogated
in the absence of pSTAT3 in Stat3+/+ ESCs without LIF and
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Figure 2. NANOG and pSTAT3 Synergistically Upregulate KLF4
qRT-PCR analysis of gene expression relative to Gapdh and normalized to the highest value. Data shown are the mean of three technical replicates and are
from one of two representative experiments. Error bars indicate 6SD.
(A) Klf4 andK4eRNA expression inNanog2/2, wild-type, and constitutively NANOG-overexpressing ESCs in response to LIF stimulation. LIF was withdrawn
from serum culture for 36 hr prior to readdition. Selection for pluripotent cells was maintained throughout.
(B) Klf4 expression in Stat32/2, Nanog2/2, and wild-type ESCs in response to LIF stimulation. LIF was added after at least 7 days in 2i without LIF.
(C) Top: Klf4 and K4eRNA expression in NANOG-overexpressing Stat32/2, NANOG-overexpressing Stat3+/+, and STAT3-hyperactivated (GCSF/GY118F)
Nanog2/2 ESCs in basic conditions with or without LIF. Socs3 expression indicates STAT3 activation as appropriate. Bottom: Klf4 and K4eRNA expression
in Nanog2/2, wild-type, and constitutively NANOG-overexpressing ESCs cultured in steady-state serum+LIF.
(D) Klf4 and K4eRNA expression in Nanog2/2 iNANOG+GY118F ESCs after induction with dox and/or GCSF in 2i.
See also Figure S2.
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342Klf4 upregulation was pSTAT3 dependent. However, the
effect of NANOG on Klf4 transcription was not solely attribut-
able to pSTAT3 elevation, since STAT3 hyperactivation in
the absence of NANOG could not rescue Klf4 expression
(Figure 2C).
The relationship betweenNANOG, pSTAT3, andKlf4 expres-
sion was further dissected using Nanog2/2 iNANOG+GY118F
ESCs in 2i without LIF. Together, induction of NANOG expres-
sion and STAT3 activation elicited Klf4 upregulation in a syner-
gistic manner compared to induction of either factor alone
(Figure 2D). This synergistic action of NANOG and pSTAT3 is
specific to Klf4: other pluripotency factors did not respond in
this striking manner, including NANOG-target Esrrb [25] and
pSTAT3-target Klf5 [7, 8] (Figure S2B).
Since NANOG and pSTAT3 both bind the Klf4 enhancer (Fig-
ure S2C), it is likely that they regulate Klf4 transcription
directly. The Klf4 enhancer lies around 60 kb downstream of
the Klf4 transcription start site and was recently identified as
an archetypal ‘‘super-enhancer’’ [26]. We found novel noncod-
ing RNA to be expressed from the Klf4 enhancer in ESCs, andwe termed it K4eRNA (Figure S2C). Given that K4eRNA
expression positively correlates with Klf4, responding to
NANOG and LIF/STAT3 in the same synergistic manner (Fig-
ures 2A, 2C, and 2D), we hypothesize thatK4eRNA is a cis acti-
vator of Klf4 transcription.
NANOG and pSTAT3 Induce Rapid and Efficient
Reactivation of Naive Genes
EpiSC reprogramming requires reversion from primed to naive
pluripotency and thus provides an excellent system inwhich to
study naive pluripotency acquisition. Conversion of EpiSCs to
iPSCs does not occur simply in naive-state culture conditions,
but can be driven by a minimum of one factor [27]. It is known
that NANOG overexpression and STAT3 hyperactivation
together increase EpiSC reprogramming efficiency in a syner-
gistic manner [1]. Since we have mechanistically linked
NANOG and pSTAT3 in ESCs where the pluripotency network
is fully operational, we turned to EpiSCs to study the role of
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Figure 3. NANOG and pSTAT3 Induce Rapid and Efficient Reactivation of Naive Genes
(A) qRT-PCR analysis of Nanog2/2 and Nanog+/Flox (Nanog+/F) EpiSCs derived from Nanog2/F and Nanog+/F littermate embryos, cultured in FGF2+ActivinA
(F+A), compared to wild-type ESCs in 2i+LIF. Lack ofNanog expression inNanog2/2 EpiSCs confirmed the null genotype, while their expression ofOct4 and
Fgf5 but notRex1 or Klf4 confirmed their EpiSC identity. Gene expression wasmeasured relative toGapdh and normalized to the highest value. Data shown
are the mean of three technical replicates and are from one of two representative experiments. Error bars indicate 6SD.
(B) Representative phase and Nanog-GFP images of the Nanog2/2 EpiSCs derived from Nanog2/F embryos, in FGF2+ActivinA conditions. GFP reporter is
under the endogenous Nanog promoter of the floxed null allele (Figure S3A). Images are 1122 mm by 839 mm.
(C) qRT-PCR analysis of Klf4, K4eRNA, Klf5, Tfcp2l1, Esrrb, and Rex1 expression in Nanog2/2 iNANOG+GY118F EpiSCs after induction with dox and/or
GCSF in FGF2+ActivinA. Gene expression was measured relative to Gapdh and normalized to serum+LIF ESC level = 1. Data shown are the mean of three
technical replicates and are from one of two representative experiments. Error bars indicate 6SD.
See also Figure S3.
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343The iNANOG+GY118F system provides a powerful platform
for the quantitative dissection of NANOG and pSTAT3 mecha-
nisms, as they can be induced separately and in combination
within a single cell line. We generated Nanog2/2 background
EpiSCs (Figure 3A, 3B, and S3A–S3C) to eliminate confounding
endogenous Nanog expression, and maintained EpiSC
FGF2+ActivinA culture conditions so that putative reprogram-
ming kinetics could be ascribed exclusively to transgene
induction. Strikingly, NANOG and pSTAT3 codependently
reactivated Klf4 and K4eRNA in this distinct cellular and envi-
ronmental context (Figure 3C). This demonstrates that their
effect on Klf4 is not an ESC-specific phenomenon and may
be of functional relevance for NANOG/pSTAT3-driven reprog-
ramming. We observed activation of naive pluripotency
marker Rex1 at 48 hr (Figure 3C). Since Rex1 did not respond
to NANOG/pSTAT3 in this manner in ESCs (Figure S2B),
we believe Rex1 induction in EpiSCs to be indirect, indicating
identity changes toward iPSCs within the population.
Interestingly, Rex1 activation positively correlates with Klf4
expression.
Known NANOG-target Esrrb [25] responded to dox induc-
tion of NANOG expression in EpiSCs (Figure 3C). Similarly,
known pSTAT3 targets Klf5 [7, 8] and Tfcp2l1 [15, 28] were up-
regulatedafterGCSF inductionofSTAT3activation (Figure 3C).
However, the synergistic response of Klf4 to NANOG and
pSTAT3 remains unique. In total, NANOG and pSTAT3 rapidly
reactivated many key components of the naive pluripotencynetwork to near ESC level, shedding light on their ability to
drive fast and efficient reprogramming. This is even more
remarkable when taking into account that the assay used
EpiSC culture conditions instead of conditions promoting re-
programming or ESC self-renewal.
Combined pSTAT3 and KLF4 Bypass NANOG in
Reprogramming
Although NANOG is dispensable for pluripotencymaintenance
[11], it is required for establishment of the pluripotent
epiblast during preimplantation embryonic development [4].
Correspondingly, NANOG is essential for naive pluripotency
establishment during conventional in vitro reprogramming ex-
periments [4]. Rescue of Nanog2/2 reprogramming thus pro-
vides a means of functionally testing proposed downstream
mechanisms of NANOG.
We have described two new NANOG mechanisms: pSTAT3
elevation by SOCS3 repression and KLF4 upregulation in
cooperation with pSTAT3. Therefore, we investigated the abil-
ity of pSTAT3 and KLF4 to rescue reprogramming ofNanog2/2
EpiSCs. We also tested ESRRB, since it has previously been
reported as a NANOG downstream target able to bypass
NANOG in reprogramming of ESC-derived EpiSCs [25].
Expression of GFP and bgeo under the control of endogenous
Nanog promoters provide visual and selective reporters in our
system, since EpiSCs cannot survive long-term in the reprog-
ramming culture conditions (Figure 4A).
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Figure 4. Combined pSTAT3 and KLF4 Bypass NANOG in Reprogramming
(A) Schematic depicting the protocol for reprogramming of Nanog2/2 EpiSCs containing bgeo and GFP reporters under the endogenous Nanog promoters
(Figure S3A). EpiSCs were plated in FGF2+ActivinA (F+A) and, after 1 day, medium was switched to chiron+LIF or 2i+LIF to prompt reprogramming. On
day 7, G418, FGFR inhibitor, and ALK inhibitor were added to select for emergent iPSCs. On day 12, iPSCs were passaged into 2i+LIF.
(B) Representative phase and Nanog-GFP images taken on day 12 of reprogramming in 2i+LIF. The mean number of GFP+ iPSC colonies is indicated as the
percentage of cells initially plated, 6SD (n = 3 biological replicates). Nanog2/2 iNANOG+GY118F EpiSCs generated GFP+ iPSCs in 2i+LIF only if dox or
dox+GCSF were supplied during reprogramming, to induce NANOG expression and STAT3 activation, respectively. Nanog2/2 EpiSCs with activated
STAT3 (GCSF/GY118F) and constitutive ESRRB or KLF4 expression did not generate GFP+ iPSCs in 2i+LIF.
(C) Representative phase and Nanog-GFP images taken on day 12 of reprogramming in chiron+LIF. Quantification of reprogramming efficiency by GFP+
colony counting was inappropriate in this case, since chiron+LIF is a permissive medium compared to 2i+LIF and yielded some GFP+ colonies that were
not true iPSCs. After passaging in 2i+LIF, clean GFP+ iPSC lines were obtained as indicated.
(D) qRT-PCR analysis of gene expression in chiron+LIF-derived Nanog2/2 iPSCs after passaging in 2i+LIF, compared to parental EpiSC lines in FGF2+
ActivinA (F+A) and wild-type and Nanog2/2 ESCs in 2i+LIF. Expression patterns of Nanog, Esrrb, and Klf4 verified the genotypes. Reprogramming to naive
iPSCs was confirmed by reactivation of naive genes, maintenance of Oct4, and repression of Fgf5 expression. Gene expression was measured relative to
Gapdh and normalized to wild-type ESC level, except Fgf5, which was normalized to control EpiSCs. Data shown are the mean of three technical replicates
and are from one of two representative experiments. Error bars indicate 6SD.
(E) Chimericmouse obtained after injection of pSTAT3+KLF4 EpiSC-derivedNanog2/2 iPSCs intoC57/BL6 blastocysts. Agouti coat color indicates chimeric
contribution (MF1/129 background).
See also Figure S4.
Current Biology Vol 24 No 3
344Forced expression of NANOG, ESRRB, KLF4 or pSTAT3
individually can drive reprogramming of Nanog+/+ EpiSCs in
2i+LIF conditions [1, 4, 25, 27]. We verified the ability of our
Nanog2/2 EpiSCs to generate iPSCs in 2i+LIF when rescuedby NANOG expression and confirmed that STAT3 activation
in conjunction with NANOG expression drives rapid reprog-
ramming at high efficiency (Figure 4B). However, in the
absence of NANOG, individual and combined overexpression
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345of ESRRB, KLF4, and pSTAT3 could not rescue reprogram-
ming in 2i+LIF (Figure 4B).
In parallel, we tried to rescue Nanog2/2 reprogramming with
individual and combined overexpression of ESRRB, KLF4, and
pSTAT3 in chiron+LIF (Figure 4C) and in serum+LIF (data not
shown). To our surprise, we found that ESRRB overexpression
was unable to drive Nanog2/2 EpiSC reprogramming in any
condition. We speculate that this is due to differences in re-
programming propensity between our EpiSCs derived from
Nanog2/F embryos and ESC-derived secondary EpiSC sys-
tems [25]. Individually, KLF4 and pSTAT3 also failed to yield
iPSCs. Although they initially generated GFP+ colonies in
chiron+LIF (Figure 4C), these lacked the capacity to self-renew
after passaging into 2i+LIF, suggesting that reprogramming
was incomplete.
In combination, pSTAT3+ESRRB and pSTAT3+KLF4 yielded
Nanog2/2 GFP+ iPSCs in chiron+LIF conditions (Figure 4C).
Reprogramming occurred with the highest rate and efficiency
with pSTAT3+KLF4. Although Nanog2/2 iPSCs could not be
established in 2i+LIF, once naive pluripotency was established
in chiron+LIF, Nanog2/2 iPSCs could be passaged indefinitely
in 2i+LIF, consistent with known discrepancies between
NANOG requirement in pluripotency establishment versus
maintenance. After passaging in 2i+LIF, the gene expression
profile and observed chimeric competence ofNanog2/2 iPSCs
formally demonstrated their reacquisition of a naive pluripo-
tent program (Figures 4D and 4E). This highlights pSTAT3
activation as a key functional mechanism acting downstream
of NANOG, which, in conjunction with overexpression of
either NANOG-target KLF4 or ESRRB, can efficiently rescue
Nanog2/2 reprogramming. It is of interest to note that KLF4
but not NANOG overexpression can drive EpiSC reprogram-
ming in the presence of JAK inhibitor [1], further supporting
the placement of NANOG upstream and KLF4 downstream
of STAT3 activation during reprogramming.
NANOG is dispensable for the initial formation of repro-
gramming intermediates (pre-iPSCs) from somatic cells,
but is essential for pre-iPSCs to transit to naive pluripotency
in 2i+LIF [4] (confirmed in Figures S4A and S4B). Since
Nanog2/2 EpiSCs were able to reprogram in chiron+LIF but
not 2i+LIF, we tested whether Nanog2/2 pre-iPSCs could
also reprogram in alternative conditions. From these, we suc-
cessfully obtained Nanog2/2 iPSCs in chiron+LIF and
KSR+LIF conditions, albeit with low speed and efficiency (Fig-
ures S4C–S4E). Microarray analysis revealed that pre-iPSC-
derived and EpiSC-derived Nanog2/2 iPSCs clustered closely
with both wild-type and Nanog2/2 ESCs, demonstrating re-
programming to a naive pluripotent identity (Figure S4F). It
should be noted that retroviral Klf4 and exogenous LIF pro-
vided the reprogramming impetus for these pre-iPSCs, again
implicating pSTAT3 and KLF4 in the rescue of Nanog2/2
reprogramming.
Discussion
We connect NANOG with the activation of STAT3, two major
mechanisms for the establishment and maintenance of naive
pluripotency. Our finding that NANOGmodulates signal trans-
duction of extracellular cues adds a new dimension to the
interplay between external environment and nuclear control
networks to instate and reinforce cellular identity. We also pro-
vide mechanistic insight into the process of induced pluripo-
tency by showing that expression of KLF4, a canonical ‘‘Yama-
naka’’ factor, results from codependent and synergistic actionbetween NANOG and pSTAT3. Interestingly, the only remain-
ing factor to be used by all reprogramming protocols is LIF
and consequently STAT3 activation, now linked to NANOG.
The role of NANOG is thus to build a naive pluripotent
transcriptional network by concurrently inducing the expres-
sion of ESRRB, enhancing LIF/STAT3 signal transduction,
and inducing KLF4 expression in cooperation with pSTAT3
(Figure S4G). Ultimately, combinations of these factors allow
in vitro bypassing of NANOG for the establishment of a naive
pluripotent cell state. However, the observed slower kinetics
and reduced efficiency of Nanog2/2 somatic cell reprogram-
ming imply the existence of further mechanisms by which
NANOG operates. These may include additional downstream
effectors of reprogramming and the activities of NANOG co-
factors such as TET1/2 [29]. In this light, it is interesting to
note that bypass of NANOG in reprogramming was enhanced
by KSR medium (Figure S4C), which contains ascorbic acid, a
powerful coactivator of dioxygenases such as the jumonji
histone demethylases and TETs [30–34]. Additionally, it will
be of future interest to ascertain why 2i conditions are detri-
mental to Nanog2/2 reprogramming.
Successful induction of naive pluripotency can be achieved
by the combined actions of different culture environments with
different sets of transgenes. This has led to the notion that
iPSCs can be generated by different, independent reprogram-
ming mechanisms acting in an additive, linear manner. In
contrast to this, our newfound cooperative relationship be-
tween NANOG and STAT3 activity raises the possibility of an
integrated reprogrammingmechanism. Therefore, we propose
that allegedly independent mechanisms of naive pluripotency
inductionmay instead be linked and centered on a small group
of genes including NANOG.Accession Numbers
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Figure S1: NANOG amplifies STAT3 activation (Related to Figure 1) 
(A) Simplified schematic comparing LIF/LIFR-GP130 and GCSF/GY118F signal transduction 
pathways. Left: LIF ligand binds the extracellular domains of LIFR and GP130, triggering 
phosphorylation and activation of JAK2 associated with the intracellular domain of GP130. 
JAK2 phosphorylates the intracellular domain of GP130, causing recruitment of latent 
cytoplasmic STAT3 to GP130 via the STAT3 SH2 phosphotyrosine-binding domain. JAK2 then 
phosphorylates tyrosine-705 of STAT3 (pSTAT3), allowing SH2-mediated homodimerization of 
pSTAT3, nuclear translocation and transcriptional activation of multiple target genes [S1-5]. 
Socs3 transcription is rapidly and strongly induced by pSTAT3. SOCS3 binds to GP130-JAK2 
complexes, prevents STAT3 binding to JAK2, and thus inhibits STAT3 phosphorylation and 
activation [S6, S7], forming a classic negative feedback loop in which pSTAT3 and SOCS3 levels 
oscillate in antiphase [S8]. Additionally, LIF signalling leads to activation of the MAPK/ERK and 
PI3-kinase pathways [S9, S10]. Right: Specific and sustained STAT3 activation can be achieved 
by supplying GCSF to cells expressing GY118F, a chimeric transmembrane receptor [S11-13]. 
The GY118F extracellular domain is that of the human GCSF receptor, whereas the 
transmembrane and intracellular domains are based on murine GP130, with a point mutation 
of tyrosine-118 to phenylalanine. The Y118F mutation prevents activation of MAPK/ERK and 
PI3-kinase pathways, and blocks SOCS3-mediated negative feedback by eliminating the SOCS3 
binding site on GP130. 
(B) RT-qPCR analysis of gene expression in Nanog-/-, wild-type and constitutively NANOG-
overexpressing ESCs cultured in steady-state serum+LIF conditions and harvested on 2 separate 
days (i and ii). Expression was measured relative to Gapdh and normalized to the appropriate 
wild-type sample. Oct4 expression confirmed undifferentiated status. Rex1, Klf2, and Nr0b1 
expression patterns confirmed that the strong positive correlation observed between Nanog 
and Klf4 was specific. Data shown are the mean of 3 technical replicates. Error bars indicate 
± s.d. 
(C) Upper: Published ESC ChIP-seq data [S14] reveal that NANOG binds the upstream 
regulatory region of the Socs3 gene. Arrow indicates the direction of Socs3 transcription. 
Lower: ChIP analysis of NANOG binding at the regulatory region of Socs3. Proximal and distal 
NANOG binding sites are as indicated above. NANOG expression was dox-induced in Nanog-/- 
iNANOG ESCs in 2i culture and samples were harvested at t=0 and 3 hours. Data shown are the 
mean of 3 technical replicates from each of 2 experiments (i and ii). Error bars indicate ± s.d.  
(D) Western blot analysis of NANOG protein expression in Nanog-/- iNANOG ESCs following dox 
induction in serum+LIF, compared to wild-type ESCs cultured in serum+LIF. FLAG- and biotin-
tagged (FB) NANOG expressed from iNANOG was detected at a higher molecular weight than 














+LIF (h) 0 2 12 
Nanog-/- 
0 2 12 
WT 




























Time (h) after induction of Nanog-/- iNANOG+GY118F ESCs with DOX/GCSF 
GCSF GCSF+DOX DOX 



























Figure S2: NANOG and pSTAT3 synergistically upregulate KLF4 (Related to Figure 2) 
(A) RT-qPCR analysis of Oct4 and Nanog expression, relative to Gapdh and normalized to the 
highest value. LIF was withdrawn from serum culture of Nanog-/-, wild-type and constitutively 
NANOG-overexpressing ESCs for 36 hours prior to re-addition. Selection for pluripotent cells 
was maintained throughout, and Oct4 expression indicated undifferentiated status. Data 
shown are the mean of 3 technical replicates and are from 1 of 2 representative experiments. 
Error bars indicate ± s.d. 
(B) RT-qPCR analysis of Esrrb, Klf5, Oct4 and Rex1 expression in Nanog-/- iNANOG+GY118F 
ESCs following induction with dox and/or GCSF in 2i. Gene expression was measured relative to 
Gapdh and normalized to the highest value. Data shown are the mean of 3 technical replicates 
and are from 1 of 2 representative experiments. Error bars indicate ± s.d. 
(C) The Klf4 gene locus shown on assembly mm9. Upper: Analysis of published ESC ChIP-seq 
data revealed pSTAT3, NANOG and Mediator (MED12) binding to the Klf4 downstream 
enhancer. RNA PolII binding and H3K27ac enrichment suggest active transcription from this 
enhancer. Furthermore, a ‘K4-K36 domain’ is predicted here, which, in the absence of a known 
protein-coding gene, is thought to demarcate PolII-transcribed non-coding RNA [S15]. We 
found novel non-coding RNA to be expressed from the Klf4 enhancer in ESCs, termed K4eRNA, 
the position of which is marked by the purple box. Arrows indicate the directions of K4eRNA 
and Klf4 transcription. Lower: Published RNA-seq [S16] indicates bidirectional transcription 
from the Klf4 downstream enhancer in wild-type ESCs in 2i+LIF, confirmed here by RT-PCR 
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Figure S3: NANOG and pSTAT3 induce rapid and efficient reactivation of naïve genes (Related 
to Figure 3) 
(A) Simplified schematic of the strategy used to generate Nanog-/- EpiSCs, not to scale. All 
alleles are under control of the endogenous Nanog promoter, and the Nanog 5’ UTR is 
unchanged. We crossed NanogF/F [S17] and Nanog+/- [S18] mice and derived EpiSCs from the 
resulting Nanog-/F and Nanog+/F post-implantation embryos. We treated Nanog-/F EpiSCs 
with TAT-CRE, to excise LoxP-flanked Nanog exons and bring GFP under control of the Nanog 
promoter. This resulted in Nanog-/- EpiSCs with Nanog-promoter-driven βgeo and GFP 
expression. Key: floxed-Nanog (F); wild-type Nanog (+); deleted Nanog (-); endogenous Nanog 
exons (1,2,3,4); splice-acceptor (SA); internal ribosome entry site (IRES); geneticin resistance 
(βgeo); stop codon (S); LoxP site (L); puromycin resistance (Pac); GFP coding sequence without 
a promoter (GFP).  
(B) Genotyping PCR was conducted with 3 primers, 1 of which is common to F, + and βgeo 
alleles. 1 primer recognizes both F and + alleles, to give an 800 bp product. 1 primer anneals to 
the βgeo allele, yielding a 600 bp product. L denotes a molecular weight ladder.  
Left: Genotyping of embryo-derived EpiSCs revealed that #2 was Nanog-/F. Right: Nanog-/- 
clonal EpiSC lines (2cre02, 11, and 15) were obtained after treating #2 Nanog-/F EpiSCs with 
TAT-CRE. Nanog-/- ESC samples containing different knock-out alleles were included as 
negative controls (–), while #2 Nanog-/F and #4 Nanog+/F EpiSCs provided positive controls. 
Nanog-/- 2cre15 EpiSCs were used in all subsequent experiments. 
(C) RT-qPCR analysis of Nanog and Oct4 expression in Nanog-/- iNANOG+GY118F EpiSCs 
following induction with dox (D) and/or GCSF (G) in FGF2+ActivinA. Wild-type ESCs in 2i+LIF 
(2i+L), and Nanog-/- and Nanog+/F EpiSCs in FGF2+ActivinA conditions were included as 
controls. Gene expression was measured relative to Gapdh and normalized to the highest 
value. Data shown are the mean of 3 technical replicates and are from 1 of 2 representative 
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Figure S4: Bypass of NANOG in reprogramming (Related to Figure 4) 
(A–E) Constitutively GFP+ (CAG-GFP) Nanog-/- NSCs were derived from chimerae, then 
converted to pre-iPSCs by retroviral transduction with Klf4, Oct4 and c-Myc in serum+LIF, as 
previously described [S19]. Pre-iPSCs are non-pluripotent, transgene-dependent, proliferative 
reprogramming intermediates [S20]. NANOG is dispensable for the initial formation of 
pre-iPSCs, but is essential for pre-iPSCs to transit to naïve pluripotency in 2i+LIF [S19] 
(confirmed in A, B). Since Nanog-/- EpiSCs were able to reprogram in chiron+LIF but not 2i+LIF 
(Figure 4), we tested whether Nanog-/- pre-iPSCs could also reprogram in alternative 
conditions. 
(A) Nanog-/- pre-iPSCs with constitutive NANOG-overexpression or control transgenes were 
plated in serum+LIF (S+L) and, after 2 days, medium was switched to 2i+LIF (2i+L) to prompt 
reprogramming. On day 7, G418 was added to select for emergent iPSCs, since βgeo is under 
control of an endogenous Nanog promoter. On day 11, representative phase and CAG-GFP 
images were taken and iPSC colonies were counted. The mean number of iPSC colonies is 
indicated as % of pre-iPSCs initially plated, ± s.d. (n=3 biological replicates). 
(B) RT-qPCR analysis of gene expression in 2i+LIF-derived NANOG-rescue iPSCs, compared to 
parental and control pre-iPSCs in serum+LIF and wild-type ESCs in 2i+LIF. Reprogramming to 
naïve iPSCs was confirmed by reactivation of endogenous pluripotency genes and retroviral 
factor silencing. Gene expression was measured relative to Gapdh and normalized to the 
highest value. Data shown are the mean of 3 technical replicates and are from 1 of 2 
representative experiments. Error bars indicate ± s.d. 
(C) Nanog-/- pre-iPSCs were plated in serum+LIF (S+L) and, after 1 day, medium was switched 
to chiron+LIF (Ch+L) or KSR+LIF (KSR+L) to prompt reprogramming. On day 8, G418 was added 
to select for emergent iPSCs, since βgeo is under control of an endogenous Nanog promoter. 
On day 20, medium was switched to 2i+LIF (2i+L) to further select for naïve iPSCs. On day 26, 
representative phase and CAG-GFP images were taken and iPSC colonies were counted. The 
mean number of iPSC colonies is indicated as % of pre-iPSCs initially plated, ± s.d. (n=3 
biological replicates). We successfully obtained Nanog-/- iPSCs in chiron+LIF and KSR+LIF 
conditions, albeit with low speed and efficiency. Like those generated from EpiSCs, the 
Nanog-/- iPSCs derived from pre-iPSCs could be maintained in 2i+LIF after naïve pluripotency 
establishment. 
(D) RT-qPCR analysis of gene expression in chiron+LIF- and KSR+LIF-derived Nanog-/- iPSCs 
after passaging in 2i+LIF, compared to Nanog-/- pre-iPSCs in serum+LIF and wild-type ESCs in 
2i+LIF. Reprogramming to naïve iPSCs was confirmed by reactivation of endogenous 
pluripotency genes and retroviral factor silencing. Gene expression was measured relative to 
Gapdh and normalized to wild-type ESC level. Data shown are the mean of 3 technical 
replicates and are from 1 of 2 representative experiments. Error bars indicate ± s.d. 
(E) Contribution of constitutively GFP+ pre-iPSC-derived Nanog-/- iPSCs to mid-gestation 
chimerae, formally demonstrating their reacquisition of developmental pluripotency. 
(F) Correlation heatmap of global gene expression between: wild-type ESCs, Nanog-/- ESCs, 
pre-iPSC-derived Nanog-/- iPSCs, pSTAT3+KLF4 EpiSC-derived Nanog-/- iPSCs all in 2i+LIF; 
parental Nanog-/- pre-iPSCs in serum+LIF; parental Nanog-/- EpiSCs in FGF2+ActivinA. 
2 technical replicates were included for each cell line. 
(G) Simplified schematic depicting the newfound role of NANOG in the modulation of LIF/STAT3 
signal transduction. Left: Existing model of the LIF/STAT3 pathway (see Figure S1A for details). 
Klf4 is a known target of active pSTAT3 [S5, S21, S22]. Right: We discovered that NANOG 
represses Socs3 and amplifies LIF signal transduction, resulting in higher levels of active 
pSTAT3. Furthermore, we found that NANOG and pSTAT3 upregulate Klf4 in a co-dependent 
and synergistic manner. Functionally, pSTAT3 elevation and KLF4 expression allowed us to 




Supplemental Experimental Procedures 
 
Cell culture 
The following established cell lines were used: wild-type E14TG2A ESCs; E14TG2A-derived 
Nanog-/- BT12 and 44cre6 ESCs [S23]; E14TG2A-derived constitutively NANOG-overexpressing 
RHN ESCs [S24]; Stat3-/- and littermate-derived Stat3+/+ ESCs [S25]; Nanog-/- pre-iPSCs [S19]. 
ESCs and iPSCs were cultured in 2i±LIF or serum+LIF as indicated, pre-iPSCs were cultured in 
serum+LIF, and EpiSCs were cultured in FGF2+ActivinA. 2i medium [S25] was composed of 
N2B27, 3 μM CHIR99021 and 1 μM PD0325901 (Stewart lab, Dresden). N2B27 medium 
comprised 1:1 DMEM/F-12 and Neurobasal (Gibco), 2 mM L-glutamine (Gibco), 1x penicillin-
streptomycin (Sigma), 0.1 mM 2-mercaptoethanol (Gibco), 1% B27 (Gibco) and 0.5% N2 
(homemade). Serum medium contained GMEM (Sigma), 10% fetal bovine serum (Gibco), 
1x non-essential amino acids (Gibco), 1 mM sodium pyruvate (Sigma), 2 mM L-glutamine 
(Gibco), 1x penicillin-streptomycin (Sigma) and 0.1 mM 2-mercaptoethanol (Gibco). 
FGF2+ActivinA medium was composed of N2B27, 12.5 ng/ml FGF2 and 20 ng/ml ActivinA 
(Hyvonen lab, Cambridge). During reprogramming, chiron+LIF and KSR+LIF were used when 
indicated. Chiron+LIF was the same as N2B27-based 2i+LIF, but without PD0325901. KSR 
medium contained GMEM (Sigma), 10% KnockOut Serum Replacement (Invitrogen), 1% fetal 
bovine serum (Gibco), 1x non-essential amino acids (Gibco), 1 mM sodium pyruvate (Sigma), 
2 mM L-glutamine (Gibco), 1x penicillin-streptomycin (Sigma) and 0.1 mM 2-mercaptoethanol 
(Gibco). As required, media were supplemented with 20 ng/ml murine LIF (Hyvonen lab, 
Cambridge), 30 ng/ml human GCSF (Peprotech), or 1 µg/ml doxycycline (MP Biomedicals). For 
ESCs, iPSCs and pre-iPSCs, tissue-culture flasks were coated with 0.15% gelatin (Sigma) in PBS 
(Sigma). For EpiSCs, tissue-culture flasks were coated with 10 µg/ml fibronectin (Millipore) in 
PBS (Sigma). During expansion of cell lines, selection with 150 μg/ml hygromycin-B (Life 
Technologies), 20 μg/ml blasticidin (Gibco), 200 μg/ml G418 (Invitrogen) or 100 μg/ml zeocin 
(Invitrogen) was applied as appropriate. Note that G418 selects for endogenous Nanog 
promoter activity in Nanog-/- BT12 and 44cre6 ESCs [S23]. Colonies were dissociated with 
accutase (Millipore) during passaging.  
 
Cell transfection 
For transfections, 1 μg PiggyBac (PB) vector, 2 μg PBase expression vector (pCAGPBase) and 
10 μl Lipofectamine-2000 (Invitrogen) were incubated for 20 min in 500 ml DMEM (Gibco), 
then applied to 500,000 cells/10 cm2 well in 3 ml medium for 24 hours. Selection was applied 
to transfectants for at least 5 passages prior to use. PB-vectors stably integrate into host 
genome TTAA-sites in the presence of PBase transposase; pCAGPBase does not integrate and is 
lost with passaging (Cambridge Bioscience). Existing PB vectors were used to drive constitutive 
expression of: NANOG (CAG-Nanog-PGK-Hph); GY118F (CAG-DsRed-IRES-Hph-CAG-Gy118f, 
coding sequence as described in Niwa et al, 1998); KLF4 (CAG-Klf4-IRES-Zeo); ESRRB 
(CAG-Esrrb-IRES-Zeo); Control (CAG-empty-PGK-Hph). A selective reporter for naïve 
pluripotency was provided when necessary by O4GIP PB vector 
(Oct4-distal-enhancer-GFP-IRES-puro). 
 
Derivation of EpiSCs from post-implantation embryos 
EpiSCs were derived from E6.5 embryos carrying the modified alleles shown in Figure S3A. 
Epiblasts were manually dissected from extra-embryonic tissues and plated on fibronectin-
coated plates in FGF2+ActivinA medium. After 5–7 days of culture, regions of the explant 
exhibiting EpiSC morphology were manually passaged to a fresh plate. Subsequent passages 
were performed using accutase. 
  
Genotyping 
Genomic DNA was extracted by incubation at 95°C for 20 min in 25 mM NaOH + 0.2 mM EDTA, 
followed by addition of an equal volume of 40 mM Tris HCl and vortexing. Genotyping PCR was 
conducted on the genomic DNA using Taq DNA polymerase (Qiagen) and the following thermal 
cycler settings: 94°C for 5 min, 35 cycles of (94°C for 10 s, 60°C for 20 s, 72°C for 60 s), and 72°C 
for 3 min. An equal mix of 3 primers was used: βgeo AATGGGCTGACCGCTTCCTC; 
S5 ACCTCAGCCTCCAGCAGATG; A53 CAGAATGCAGACAGGTCTACAGCCCG.  An 800 bp product is 




Chimerae were generated by standard microinjection methodology using host blastocysts of 
strain C57BL/6. All animal work was performed in accordance with Home Office guidelines and 
regulations at the University of Cambridge, UK. 
 
Generation and characterization of doxycycline-inducible Nanog transgene 
TetO-FLBioNanog-UbiP-rtTA3 was amplified from a previously described dox-inducible Nanog 
construct [S26]. TetO denotes the operator/promoter and rtTA3 encodes the dox-controlled 
transactivator of the ‘Tet-On’ system [S27], FLBioNanog codes for FLAG- and BIOTIN-tagged 
murine NANOG, and the ubiquitous promoter UbiP drives constitutive expression of rtTA3. 
Amplification primers were designed to contain Gateway-compatible attB recombination sites: 
FW GGGGACAAGTTTGTACAAAAAAGCAGGCTCCGAGGTTCTAGACGAGTTTACT;  
RV GGGGACCACTTTGTACAAGAAAGCTGGGTCTTACCCGGGGAGCATGT. PCR was performed using 
Phusion Taq polymerase (New England Biolabs, recommended protocol). Successful 
amplification was verified on a 1% agarose gel, from which 
attB1-TetO-FLBioNanog-UbiP-rtTA3-attB2 was purified using a QIAquick gel extraction kit 
(Qiagen). TetO-FLBioNanog-UbiP-rtTA3 was cloned into a PiggyBac (PB) vector, to enable 
efficient and stable integration into the host genome. A Gateway destination PB vector 
containing CAG-attR1-ccdB-attR2-IRES-Bsdr was kindly provided by Yael Costa. To ensure that 
FLBioNanog is expressed only in the presence of dox, the constitutive CAG promoter was 
removed from the destination vector by restriction digestion and re-ligation. 150 ng of the 
attB1-TetO-FLBioNanog-UbiP-rtTA3-attB2 insert was used for Gateway cloning, first into a 
pDonor vector using BP Clonase, then into the PB destination vector by LR Clonase (Invitrogen). 
Restriction digestion and DNA sequencing confirmed the production of 
PB-TetO-FLBioNanog-UbiP-rtTA3-IRES-Bsdr-PB. This resulting iNANOG construct confers 
constitutive blasticidin resistance (Bsdr) driven by UbiP, allowing selection of successfully 
transfected cells irrespective of dox presence. 1 µg/ml dox was found to be the optimal 
concentration for NANOG induction (data not shown). In timed induction experiments, dox was 
added 2 hours before GCSF, to account for the lag between transcription and translation of 
iNANOG (Figure S1D).  
 
Western blotting 
Dissociated cells were lysed in RIPA buffer (as described by Sigma) containing Complete-ULTRA 
protease-inhibitor and PhoStop phosphatase-inhibitor cocktails (Roche), and sonicated with 
Bioruptor200 (Diagenode) at high frequency, alternating 30 s on/off for 3 min. If necessary, 
lysate protein concentration was measured by BCA microplate procedure (Pierce) and adjusted 
prior to loading. SDS-PAGE electrophoresis was performed using NuPAGE 10% Bis-Tris gels 
(Invitrogen), then proteins were transferred onto a nitrocellulose membrane (Amersham) at 
395 mA for 70 minutes. Membranes were stripped between pSTAT3 and total STAT3 blots 
(stripping buffer and protocol as described by Abcam). The following primary antibodies and 
dilutions were used: rabbit monoclonal against p-Y705-STAT3 (9145 1:1000) and rabbit 
polyclonal against total STAT3 (9132 1:1000) from Cell Signalling Technology; mouse 
monoclonal against OCT4 (sc-5279 1:500) from Santa Cruz Biotechnology; mouse monoclonal 
against α-TUBULIN (AB7291 1:5000) from Abcam; rabbit polyclonal against NANOG (A300-397A 
1:5000) from Bethyl Laboratories; goat polyclonal against KLF4 (AF3158 1:1000) from R&D 
Systems. Detection was achieved using HRP-linked secondary antibodies against the 
appropriate species from GE Healthcare (anti-rabbit, anti-rat, anti-mouse) and Santa Cruz 
Biotechnology (anti-goat), and ECL Plus Western Blotting Detection System (GE Healthcare).  
 
RT-qPCR 
Total RNA was extracted using RNeasy kits, according to manufacturer’s spin protocol, including 
on-column DNaseI digest (Qiagen). cDNA was produced from 1 μg RNA using SuperscriptIII 
VILO cDNA synthesis kit, following the recommended protocol including RNaseH treatment 
(Invitrogen). RT-qPCR reactions were performed in triplicate, using StepOnePlus Real Time PCR 
System with recommended thermocycler settings (Applied Biosystems) and TaqMan Fast 
Universal PCR Master Mix (Applied Biosystems). Average gene expression relative to Gapdh 
was determined using FAM-labelled TaqMan assay probe together with VIC-labelled Gapdh 
probe (Applied Biosystems). 
 
Applied Biosystems TaqMan RT-qPCR custom assays: 
Gene Forward primer (5’–3’) 
Reverse primer  
(5’–3’) 
Probe  
(FAM 5’–3' MGB) 
K4eRNA AGGCTTTGGCTGGCTGATAA CTGTCTCCATAGGTACTGACTTCCT CCCAGCTCAGTAATTG 
Endogenous 
Oct4 
TTCCACCAGGCCCCC GGTGAGAAGGCGAAGTCTGAAG CCCACCTTCCCCATGGCT 
Retroviral 
Oct4 
TGGTACGGGAAATCACAAGTTTGTA GGTGAGAAGGCGAAGTCTGAAG CACCTTCCCCATGGCTG 
Retroviral 
Klf4 
TGGTACGGGAAATCACAAGTTTGTA GAGCAGAGCGTCGCTGA CCCCTTCACCATGGCTG 
Retroviral  
c-Myc 
TGGTACGGGAAATCACAAGTTTGTA GGTCATAGTTCCTGTTGGTGAAGTT CCCTTCACCATGCCCC 
 
Applied Biosystems TaqMan RT-qPCR standard assays: 
















NANOG ChIP was performed as follows: cells (10×106 for each sample) were fixed for 10 min in 
1% formaldehyde, washed with ice-cold PBS and incubated for 10 min in lysis buffer 1 
(50 mM HEPES at pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP40 and 0.25% Triton 
X-100) and then for 10 min in lysis buffer 2 (10 mM Tris at pH 8.0, 200 mM NaCl, 
1 mM EDTA and 0.5 mM EGTA). Nuclei were pelleted, resuspended in shearing buffer (1% SDS, 
10 mM EDTA and 50 mM Tris at pH 8.0) and sonicated to obtain an average DNA fragment size 
of 500 base pairs. Lysates were diluted 1:10 in dilution buffer (50 mM Tris-HCl at pH 8.0, 
167 mM NaCl, 1.1% Triton X-100 and 0.11% Na deoxycholate) and pre-cleared for 2 h at 4°C 
with Dynabeads Protein G magnetic beads (Life Technologies) that were pre-incubated with 
isotype IgG antibody. The chromatin was then incubated overnight at 4°C with 2 μg of rabbit 
polyclonal antibody against NANOG (Bethyl Laboratories, A300-397A) or an isotype IgG control 
(Santa Cruz Biotechnology, sc-2027). Lysates were then incubated for 1 h at 4°C with blocked 
Dynabeads magnetic beads, and the beads were washed twice in wash buffer 1 (50 mM Tris-
HCl at pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS, 0.1% Na deoxycholate and 
0.5 mM EGTA), once in wash buffer 2 (50 mM Tris-HCl at pH 8.0, 500 mM NaCl, 1 mM EDTA, 1% 
Triton X-100, 0.1% SDS, 0.1% Na deoxycholate and 0.5 mM EGTA), once in wash buffer 3 
(50 mM Tris at pH 8.0, 250 mM LiCl, 0.5% Na deoxycholate, 0.5% NP40, 1 mM EDTA and 
0.5 mM EGTA) and twice in wash buffer 4 (50 mM Tris at pH 8.0, 10 mM EDTA and 5 mM EGTA). 
Chromatin was eluted for 30 min at 65°C in elution buffer (1% SDS and 0.1 M NaHCO3). 
Samples were incubated overnight at 65°C to reverse the crosslinking and purified using the 
QIAquick PCR Purification kit (Qiagen). Chromatin was analyzed by Fast SYBR Green RT-qPCR 
(Applied Biosystems). Enrichment was calculated relative to the Input sample. 
 
ChIP primers: 
Region Forward primer (5’–3’) Reverse primer (5’–3’) 
Socs3 Proximal GAAAAGGCTTGAGGGTCGGA CGGGCCTGGAATGTCAAACT 
Socs3 Distal TCAGGAGTCCCTGTGCTCTAA GGCAGACGGGTCTACTTTGAA 
Negative control region CTGGGCTTGCAGCTTAGG AGAGACCTGGCTGAGGATGAC 
 
Analysis of ChIP-seq datasets 
The following published ChIP-seq datasets were used to examine transcription factor binding 
and histone modifications at genomic regions of interest in ESCs: NANOG (accession number 
GSE11724); pSTAT3 (GSE11431); MED12 (GSE22562); RNA PolII (GSE23943); H3K27ac 
(GSE24164); H3K36me3 (GSE23943); H3K4me3 (GSE23943) and H3K27me3 (GSE23943). Raw 
ChIP-seq datasets were downloaded from the Gene Expression Omnibus 
(http://www.ncbi.nlm.nih.gov/geo/), realigned to the mouse mm9 genome with Bowtie 
software (http://bowtie-bio.sourceforge.net), and peaks were called with MACS software 
(http://liulab.dfci.harvard.edu/MACS) using default parameters. ‘K4-K36’ domains were 
predicted from H3K4me3 and H3K36me3 patterns by Guttman et al, 2009. 
 
Microarray 
Amplification and labelling of RNA were performed using the TotalPrep-96 RNA Amplification 
Kit for the Illumina platform (Ambion). Subsequent hybridization, staining and scanning were 
performed according to the Whole Genome Gene Expression Direct Hybridization Guide on the 
MouseWG-6 v2.0 Expression BeadChip (Illumina). Data were loaded into the R package lumi 
[S28] and then divided into subsets to be analyzed. The data were transformed using Variance 
Stabilization [S29] and normalized using quantile normalization. Comparisons were performed 
in the R package limma [S30] and the results were corrected using the False Discovery Rate. 
Our analysis employed a 5% confidence interval. 
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